<html lang="en" class="pb-page fonts-loaded fonts-loaded" data-request-id="dc1823b9-7037-44ca-b882-e2c251b35954" style="--article-sticky-top: 82.00019999999999px; --scroll-padding: 163.594px auto auto;"><head data-pb-dropzone="head"><style>.hs-cta-wrapper p, .hs-cta-wrapper div { margin: 0; padding: 0; } a#cta_button_519224_3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f {
    -webkit-font-smoothing: antialiased;
cursor: pointer;
-moz-user-select: none;
-webkit-user-select: none;
-o-user-select: none;
user-select: none;
display: inline-block;
font-weight: normal;
text-align: center;
text-decoration: none;
-moz-transition: all .4s ease;
-webkit-transition: all .4s ease;
-o-transition: all .4s ease;
background: rgb(0,125,188);
border-radius: 6px;
border-width: 0px;
color: rgb(255,255,255);
font-family: sans-serif;
height: auto;
transition: all .4s ease;
padding: 6px 18px;
text-shadow: none;
width: auto;
font-size: 24px;
line-height: 1.5em;

    
border-radius: 5px;
color: #fff;
font-size: 0.875em;
font-weight: bold;
padding: 8px 22px;
display: inline-block;
border:none;
box-shadow: none;
text-shadow:none;
  }

a#cta_button_519224_3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f:hover {
background: rgb(0,137,206);
color: rgb(255,255,255);
}

a#cta_button_519224_3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f:active, #cta_button_519224_3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f:active:hover {
background: rgb(0,100,150);
color: rgb(244,244,244);
}

</style><meta name="pbContext" content=";product:product:elsevier\:product\:cell;website:website:cell-site;ctype:string:Journal Content;journal:journal:cell;pageGroup:string:Article View;article:article:pii\:S0092867420301598;page:string:Show Full Text;requestedJournal:journal:cell;issue:issue:pii\:S0092867419X00070;wgroup:string:Default Website Group;subPage:string:Full Text">




<!-- if there is any customization for Responsive Project widget  -->


























    
    







    
            
        



        
                <meta name="robots" content="noarchive,nocache">
            
    






    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=1, user-scalable=1">











        <meta property="og:title" content="Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity">
    


        <meta property="og:type" content="Article">
    


        <meta property="og:url" content="https://www.cell.com/cell/abstract/S0092-8674(20)30159-8">
    



        <meta property="og:site_name" content="Cell">
    


        <meta property="og:image" content="https://www.cell.com/cms/asset/16486efd-f5ff-4f53-9329-57d6e4ab8c9e/fx1.jpg">
    


        <meta property="og:description" content="An anti-tumoral B cell subset emerges in the tumor microenvironment in response to
chemotherapy-induced immunogenic cell death and complement signaling.">
    











        <meta name="twitter:title" content="Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity">
    




        <meta name="twitter:image" content="https://www.cell.com/cms/asset/16486efd-f5ff-4f53-9329-57d6e4ab8c9e/fx1.jpg">
    


        <meta name="twitter:description" content="An anti-tumoral B cell subset emerges in the tumor microenvironment in response to
chemotherapy-induced immunogenic cell death and complement signaling.">
    

        <meta name="twitter:card" content="summary_large_image">
    











    
    
            
            
        <link rel="canonical" href="https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8">
    


<meta name="tdm-reservation" content="1">
<meta name="tdm-policy" content="https://www.elsevier.com/tdm/tdmrep-policy.json">

<title>Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity: Cell</title><meta name="citation_journal_title" content="Cell"> <meta name="citation_journal_abbrev" content="Cell"> <meta name="citation_publisher" content="Elsevier"> <meta name="citation_title" content="Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity"> <meta name="citation_date" content="2020/03/19"> <meta name="citation_online_date" content="2020/03/05"> <meta name="citation_volume" content="180"> <meta name="citation_issue" content="6"> <meta name="citation_firstpage" content="1081"> <meta name="citation_lastpage" content="1097.e24"> <meta name="citation_pmid" content="32142650"> <meta name="citation_abstract_html_url" content="https://www.cell.com/action/showAbstract?pii=S0092867420301598"> <meta name="citation_fulltext_html_url" content="https://www.cell.com/action/showFullText?pii=S0092867420301598"> <meta name="citation_pdf_url" content="https://www.cell.com/action/showPdf?pii=S0092867420301598"> <meta name="citation_issn" content="0092-8674"> <meta name="citation_issn" content="1097-4172"> <meta name="citation_language" content="English"> <meta name="citation_doi" content="10.1016/j.cell.2020.02.015"> <meta name="citation_pmid" content="32142650"> <meta name="citation_author" content="Yiwen Lu"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Qiyi Zhao"><meta name="citation_author_institution" content="Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China"><meta name="citation_author" content="Jian-You Liao"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Erwei Song"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Qidong Xia"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Jiayao Pan"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Yihong Li"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Jiaqian Li"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Boxuan Zhou"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Yingying Ye"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Can Di"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Shubin Yu"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Yunjie Zeng"><meta name="citation_author_institution" content="Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author" content="Shicheng Su"><meta name="citation_author_email" content="sushch@mail.sysu.edu.cn"><meta name="citation_author_institution" content="Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China"><meta name="citation_author_institution" content="Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China"><meta name="citation_author_institution" content="Department of Immunology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China"><meta name="citation_keywords" content="B cell subsets; ICOSL; complement; immunogenic cell death"><meta name="citation_reference" content="citation_title=B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas; citation_author=N.I. Affara; citation_author=B. Ruffell; citation_author=T.R. Medler; citation_author=A.J. Gunderson; citation_author=M. Johansson; citation_author=S. Bornstein; citation_author=E. Bergsland; citation_author=M. Steinhoff; citation_author=Y. Li; citation_author=Q. Gong; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=809; citation_lastpage=821; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Characterization of human inducible costimulator ligand expression and function; citation_author=A. Aicher; citation_author=M. Hayden-Ledbetter; citation_author=W.A. Brady; citation_author=A. Pezzutto; citation_author=G. Richter; citation_author=D. Magaletti; citation_author=S. Buckwalter; citation_author=J.A. Ledbetter; citation_author=E.A. Clark; citation_journal_title=J.&nbsp;Immunol.; citation_volume=164; citation_firstpage=4689; citation_lastpage=4696; citation_publication_date=2000; "><meta name="citation_reference" content="citation_title=Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma; citation_author=M. Aklilu; citation_author=W.M. Stadler; citation_author=M. Markiewicz; citation_author=N.J. Vogelzang; citation_author=M. Mahowald; citation_author=M. Johnson; citation_author=T.F. Gajewski; citation_journal_title=Ann. Oncol.; citation_volume=15; citation_firstpage=1109; citation_lastpage=1114; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=B-cell-derived lymphotoxin promotes castration-resistant prostate cancer; citation_author=M. Ammirante; citation_author=J.L. Luo; citation_author=S. Grivennikov; citation_author=S. Nedospasov; citation_author=M. Karin; citation_journal_title=Nature; citation_volume=464; citation_firstpage=302; citation_lastpage=305; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=FcRgamma activation regulates inflammation-associated squamous carcinogenesis; citation_author=P. Andreu; citation_author=M. Johansson; citation_author=N.I. Affara; citation_author=F. Pucci; citation_author=T. Tan; citation_author=S. Junankar; citation_author=L. Korets; citation_author=J. Lam; citation_author=D. Tawfik; citation_author=D.G. DeNardo; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=17; citation_firstpage=121; citation_lastpage=134; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype; citation_author=D. Baumjohann; citation_author=S. Preite; citation_author=A. Reboldi; citation_author=F. Ronchi; citation_author=K.M. Ansel; citation_author=A. Lanzavecchia; citation_author=F. Sallusto; citation_journal_title=Immunity; citation_volume=38; citation_firstpage=596; citation_lastpage=605; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Innate immune mediators in cancer: between defense and resistance; citation_author=P. Berraondo; citation_author=L. Minute; citation_author=D. Ajona; citation_author=L. Corrales; citation_author=I. Melero; citation_author=R. Pio; citation_journal_title=Immunol. Rev.; citation_volume=274; citation_firstpage=290; citation_lastpage=306; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B&nbsp;cells expressing low levels of CD20 and CD137L; citation_author=M. Bodogai; citation_author=C. Lee Chang; citation_author=K. Wejksza; citation_author=J. Lai; citation_author=M. Merino; citation_author=R.P. Wersto; citation_author=R.E. Gress; citation_author=A.C. Chan; citation_author=C. Hesdorffer; citation_author=A. Biragyn; citation_journal_title=Cancer Res.; citation_volume=73; citation_firstpage=2127; citation_lastpage=2138; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer; citation_author=E. Bonavita; citation_author=S. Gentile; citation_author=M. Rubino; citation_author=V. Maina; citation_author=R. Papait; citation_author=P. Kunderfranco; citation_author=C. Greco; citation_author=F. Feruglio; citation_author=M. Molgora; citation_author=I. Laface; citation_author=et al.; citation_journal_title=Cell; citation_volume=160; citation_firstpage=700; citation_lastpage=714; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Immunofluorescence and image analysis pipeline for Drosophila motor neurons; citation_author=J.R. Brown; citation_author=C. Phongthachit; citation_author=M.J. Sulkowski; citation_journal_title=Biol. Methods Protoc.; citation_volume=4; citation_firstpage=bpz010; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Regulation of humoral immunity by complement; citation_author=M.C. Carroll; citation_author=D.E. Isenman; citation_journal_title=Immunity; citation_volume=37; citation_firstpage=199; citation_lastpage=207; citation_publication_date=2012; "><meta name="citation_reference" content="citation_title=Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells; citation_author=F. Chen; citation_author=J. Chen; citation_author=L. Yang; citation_author=J. Liu; citation_author=X. Zhang; citation_author=Y. Zhang; citation_author=Q. Tu; citation_author=D. Yin; citation_author=D. Lin; citation_author=P.P. Wong; citation_author=et al.; citation_journal_title=Nat. Cell Biol.; citation_volume=21; citation_firstpage=498; citation_lastpage=510; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in&nbsp;situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer; citation_author=M.V. Dieci; citation_author=N. Radosevic-Robin; citation_author=S. Fineberg; citation_author=G. van den Eynden; citation_author=N. Ternes; citation_author=F. Penault-Llorca; citation_author=G. Pruneri; citation_author=T.M. D’Alfonso; citation_author=S. Demaria; citation_author=C. Castaneda; citation_author=International Immuno-Oncology Biomarker Working Group on Breast Cancer; citation_author=et al.; citation_journal_title=Semin. Cancer Biol.; citation_volume=52; citation_firstpage=16; citation_lastpage=25; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=The versatile functions of complement C3-derived ligands; citation_author=A. Erdei; citation_author=N. Sándor; citation_author=B. Mácsik-Valent; citation_author=S. Lukácsi; citation_author=M. Kremlitzka; citation_author=Z. Bajtay; citation_journal_title=Immunol. Rev.; citation_volume=274; citation_firstpage=127; citation_lastpage=140; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy; citation_author=X. Fan; citation_author=S.A. Quezada; citation_author=M.A. Sepulveda; citation_author=P. Sharma; citation_author=J.P. Allison; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=211; citation_firstpage=715; citation_lastpage=725; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB); citation_author=O.M. Fayanju; citation_author=Y. Ren; citation_author=S.M. Thomas; citation_author=R.A. Greenup; citation_author=J.K. Plichta; citation_author=L.H. Rosenberger; citation_author=N. Tamirisa; citation_author=J. Force; citation_author=J.C. Boughey; citation_author=T. Hyslop; citation_author=E.S. Hwang; citation_journal_title=Ann. Surg.; citation_volume=268; citation_firstpage=591; citation_lastpage=601; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Polyfunctional Melan-A-specific tumor-reactive CD8(+) T&nbsp;cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS; citation_author=O. Franzese; citation_author=B. Palermo; citation_author=C. Di Donna; citation_author=I. Sperduti; citation_author=V. Ferraresi; citation_author=H. Stabile; citation_author=A. Gismondi; citation_author=A. Santoni; citation_author=P. Nisticò; citation_journal_title=OncoImmunology; citation_volume=5; citation_firstpage=e1114203; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes; citation_author=L. Galluzzi; citation_author=S.A. Aaronson; citation_author=J. Abrams; citation_author=E.S. Alnemri; citation_author=D.W. Andrews; citation_author=E.H. Baehrecke; citation_author=N.G. Bazan; citation_author=M.V. Blagosklonny; citation_author=K. Blomgren; citation_author=C. Borner; citation_author=et al.; citation_journal_title=Cell Death Differ.; citation_volume=16; citation_firstpage=1093; citation_lastpage=1107; citation_publication_date=2009; "><meta name="citation_reference" content="citation_title=Immunogenic cell death in cancer and infectious disease; citation_author=L. Galluzzi; citation_author=A. Buqué; citation_author=O. Kepp; citation_author=L. Zitvogel; citation_author=G. Kroemer; citation_journal_title=Nat. Rev. Immunol.; citation_volume=17; citation_firstpage=97; citation_lastpage=111; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=B cells and their mediators as targets for therapy in solid tumors; citation_author=A.J. Gunderson; citation_author=L.M. Coussens; citation_journal_title=Exp. Cell Res.; citation_volume=319; citation_firstpage=1644; citation_lastpage=1649; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Novel mechanisms and functions of complement; citation_author=G. Hajishengallis; citation_author=E.S. Reis; citation_author=D.C. Mastellos; citation_author=D. Ricklin; citation_author=J.D. Lambris; citation_journal_title=Nat. Immunol.; citation_volume=18; citation_firstpage=1288; citation_lastpage=1298; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer; citation_author=A.S. Hamy; citation_author=J.Y. Pierga; citation_author=A. Sabaila; citation_author=E. Laas; citation_author=H. Bonsang-Kitzis; citation_author=C. Laurent; citation_author=A. Vincent-Salomon; citation_author=P. Cottu; citation_author=F. Lerebours; citation_author=R. Rouzier; citation_author=et al.; citation_journal_title=Ann. Oncol.; citation_volume=28; citation_firstpage=2233; citation_lastpage=2240; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Follicular dendritic cells: dynamic antigen libraries; citation_author=B.A. Heesters; citation_author=R.C. Myers; citation_author=M.C. Carroll; citation_journal_title=Nat. Rev. Immunol.; citation_volume=14; citation_firstpage=495; citation_lastpage=504; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients; citation_author=A. Hennequin; citation_author=V. Derangère; citation_author=R. Boidot; citation_author=L. Apetoh; citation_author=J. Vincent; citation_author=D. Orry; citation_author=J. Fraisse; citation_author=S. Causeret; citation_author=F. Martin; citation_author=L. Arnould; citation_author=et al.; citation_journal_title=OncoImmunology; citation_volume=5; citation_firstpage=e1054598; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice; citation_author=M. Horikawa; citation_author=V. Minard-Colin; citation_author=T. Matsushita; citation_author=T.F. Tedder; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=121; citation_firstpage=4268; citation_lastpage=4280; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=NKILA lncRNA promotes tumor immune evasion by sensitizing T&nbsp;cells to activation-induced cell death; citation_author=D. Huang; citation_author=J. Chen; citation_author=L. Yang; citation_author=Q. Ouyang; citation_author=J. Li; citation_author=L. Lao; citation_author=J. Zhao; citation_author=J. Liu; citation_author=Y. Lu; citation_author=Y. Xing; citation_author=et al.; citation_journal_title=Nat. Immunol.; citation_volume=19; citation_firstpage=1112; citation_lastpage=1125; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Inhibitory effects of B cells on antitumor immunity; citation_author=S. Inoue; citation_author=W.W. Leitner; citation_author=B. Golding; citation_author=D. Scott; citation_journal_title=Cancer Res.; citation_volume=66; citation_firstpage=7741; citation_lastpage=7747; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=Rituximab efficiently depletes B cells in lung tumors and normal lung tissue; citation_author=A. Joly-Battaglini; citation_author=C. Hammarström; citation_author=B. Stankovic; citation_author=H. Aamodt; citation_author=J. Stjärne; citation_author=O.T. Brustugun; citation_author=Å. Helland; citation_author=I. Øynebråten; citation_author=A. Corthay; citation_journal_title=F1000Res.; citation_volume=5; citation_firstpage=38; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging; citation_author=Z. Keren; citation_author=S. Naor; citation_author=S. Nussbaum; citation_author=K. Golan; citation_author=T. Itkin; citation_author=Y. Sasaki; citation_author=M. Schmidt-Supprian; citation_author=T. Lapidot; citation_author=D. Melamed; citation_journal_title=Blood; citation_volume=117; citation_firstpage=3104; citation_lastpage=3112; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21); citation_author=S. Khandelwal; citation_author=G.M. Lee; citation_author=C.G. Hester; citation_author=M. Poncz; citation_author=S.E. McKenzie; citation_author=B.S. Sachais; citation_author=L. Rauova; citation_author=G. Kelsoe; citation_author=D.B. Cines; citation_author=M. Frank; citation_author=G.M. Arepally; citation_journal_title=Blood; citation_volume=128; citation_firstpage=1789; citation_lastpage=1799; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Immunogenic cell death in cancer therapy; citation_author=G. Kroemer; citation_author=L. Galluzzi; citation_author=O. Kepp; citation_author=L. Zitvogel; citation_journal_title=Annu. Rev. Immunol.; citation_volume=31; citation_firstpage=51; citation_lastpage=72; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development; citation_author=E.K. Lehrman; citation_author=D.K. Wilton; citation_author=E.Y. Litvina; citation_author=C.A. Welsh; citation_author=S.T. Chang; citation_author=A. Frouin; citation_author=A.J. Walker; citation_author=M.D. Heller; citation_author=H. Umemori; citation_author=C. Chen; citation_author=et al.; citation_journal_title=Neuron; citation_volume=100; citation_firstpage=120; citation_lastpage=134.e6; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=CD47 blockade triggers T&nbsp;cell-mediated destruction of immunogenic tumors; citation_author=X. Liu; citation_author=Y. Pu; citation_author=K. Cron; citation_author=L. Deng; citation_author=J. Kline; citation_author=W.A. Frazier; citation_author=H. Xu; citation_author=H. Peng; citation_author=Y.X. Fu; citation_author=M.M. Xu; citation_journal_title=Nat. Med.; citation_volume=21; citation_firstpage=1209; citation_lastpage=1215; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Cutting edge: Complement (C3d)-linked antigens break B cell anergy; citation_author=T. Lyubchenko; citation_author=J.M. Dal Porto; citation_author=V.M. Holers; citation_author=J.C. Cambier; citation_journal_title=J.&nbsp;Immunol.; citation_volume=179; citation_firstpage=2695; citation_lastpage=2699; citation_publication_date=2007; "><meta name="citation_reference" content="citation_title=Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets; citation_author=E.Z. Macosko; citation_author=A. Basu; citation_author=R. Satija; citation_author=J. Nemesh; citation_author=K. Shekhar; citation_author=M. Goldman; citation_author=I. Tirosh; citation_author=A.R. Bialas; citation_author=N. Kamitaki; citation_author=E.M. Martersteck; citation_author=et al.; citation_journal_title=Cell; citation_volume=161; citation_firstpage=1202; citation_lastpage=1214; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Modulation of the antitumor immune response by complement; citation_author=M.M. Markiewski; citation_author=R.A. DeAngelis; citation_author=F. Benencia; citation_author=S.K. Ricklin-Lichtsteiner; citation_author=A. Koutoulaki; citation_author=C. Gerard; citation_author=G. Coukos; citation_author=J.D. Lambris; citation_journal_title=Nat. Immunol.; citation_volume=9; citation_firstpage=1225; citation_lastpage=1235; citation_publication_date=2008; "><meta name="citation_reference" content="citation_title=Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays; citation_author=D. Mastellos; citation_author=J. Prechl; citation_author=G. László; citation_author=K. Papp; citation_author=E. Oláh; citation_author=E. Argyropoulos; citation_author=S. Franchini; citation_author=R. Tudoran; citation_author=M. Markiewski; citation_author=J.D. Lambris; citation_author=A. Erdei; citation_journal_title=Mol. Immunol.; citation_volume=40; citation_firstpage=1213; citation_lastpage=1221; citation_publication_date=2004; "><meta name="citation_reference" content="citation_title=ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection; citation_author=T.C. Metzger; citation_author=H. Long; citation_author=S. Potluri; citation_author=T. Pertel; citation_author=S.L. Bailey-Bucktrout; citation_author=J.C. Lin; citation_author=T. Fu; citation_author=P. Sharma; citation_author=J.P. Allison; citation_author=R.M. Feldman; citation_journal_title=Cancer Res.; citation_volume=76; citation_firstpage=3684; citation_lastpage=3689; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Complement-dependent clearance of apoptotic cells by human macrophages; citation_author=D. Mevorach; citation_author=J.O. Mascarenhas; citation_author=D. Gershov; citation_author=K.B. Elkon; citation_journal_title=J.&nbsp;Exp. Med.; citation_volume=188; citation_firstpage=2313; citation_lastpage=2320; citation_publication_date=1998; "><meta name="citation_reference" content="citation_title=Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T&nbsp;cells to T-regulatory cells; citation_author=P.B. Olkhanud; citation_author=B. Damdinsuren; citation_author=M. Bodogai; citation_author=R.E. Gress; citation_author=R. Sen; citation_author=K. Wejksza; citation_author=E. Malchinkhuu; citation_author=R.P. Wersto; citation_author=A. Biragyn; citation_journal_title=Cancer Res.; citation_volume=71; citation_firstpage=3505; citation_lastpage=3515; citation_publication_date=2011; "><meta name="citation_reference" content="citation_title=Role of complement in induction of the allergic response; citation_author=M.B. Pepys; citation_journal_title=Nat. New Biol.; citation_volume=237; citation_firstpage=157; citation_lastpage=159; citation_publication_date=1972; "><meta name="citation_reference" content="citation_title=Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer; citation_author=S.V. Puram; citation_author=I. Tirosh; citation_author=A.S. Parikh; citation_author=A.P. Patel; citation_author=K. Yizhak; citation_author=S. Gillespie; citation_author=C. Rodman; citation_author=C.L. Luo; citation_author=E.A. Mroz; citation_author=K.S. Emerick; citation_author=et al.; citation_journal_title=Cell; citation_volume=171; citation_firstpage=1611; citation_lastpage=1624.e24; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Complement in cancer: untangling an intricate relationship; citation_author=E.S. Reis; citation_author=D.C. Mastellos; citation_author=D. Ricklin; citation_author=A. Mantovani; citation_author=J.D. Lambris; citation_journal_title=Nat. Rev. Immunol.; citation_volume=18; citation_firstpage=5; citation_lastpage=18; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Complement: a key system for immune surveillance and homeostasis; citation_author=D. Ricklin; citation_author=G. Hajishengallis; citation_author=K. Yang; citation_author=J.D. Lambris; citation_journal_title=Nat. Immunol.; citation_volume=11; citation_firstpage=785; citation_lastpage=797; citation_publication_date=2010; "><meta name="citation_reference" content="citation_title=Spatial reconstruction of single-cell gene expression data; citation_author=R. Satija; citation_author=J.A. Farrell; citation_author=D. Gennert; citation_author=A.F. Schier; citation_author=A. Regev; citation_journal_title=Nat. Biotechnol.; citation_volume=33; citation_firstpage=495; citation_lastpage=502; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Tertiary lymphoid structures in the era of cancer immunotherapy; citation_author=C. Sautès-Fridman; citation_author=F. Petitprez; citation_author=J. Calderaro; citation_author=W.H. Fridman; citation_journal_title=Nat. Rev. Cancer; citation_volume=19; citation_firstpage=307; citation_lastpage=325; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Objective measurement and clinical significance of TILs in non-small cell lung cancer; citation_author=K.A. Schalper; citation_author=J. Brown; citation_author=D. Carvajal-Hausdorf; citation_author=J. McLaughlin; citation_author=V. Velcheti; citation_author=K.N. Syrigos; citation_author=R.S. Herbst; citation_author=D.L. Rimm; citation_journal_title=J.&nbsp;Natl. Cancer Inst.; citation_volume=107; citation_doi=10.1093/jnci/dju435; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer; citation_author=P. Schmid; citation_author=S. Adams; citation_author=H.S. Rugo; citation_author=A. Schneeweiss; citation_author=C.H. Barrios; citation_author=H. Iwata; citation_author=V. Diéras; citation_author=R. Hegg; citation_author=S.A. Im; citation_author=G. Shaw Wright; citation_author=IMpassion130 Trial Investigators; citation_author=et al.; citation_journal_title=N.&nbsp;Engl. J. Med.; citation_volume=379; citation_firstpage=2108; citation_lastpage=2121; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy; citation_author=S. Shalapour; citation_author=J. Font-Burgada; citation_author=G. Di Caro; citation_author=Z. Zhong; citation_author=E. Sanchez-Lopez; citation_author=D. Dhar; citation_author=G. Willimsky; citation_author=M. Ammirante; citation_author=A. Strasner; citation_author=D.E. Hansel; citation_author=et al.; citation_journal_title=Nature; citation_volume=521; citation_firstpage=94; citation_lastpage=98; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity; citation_author=S. Shalapour; citation_author=X.J. Lin; citation_author=I.N. Bastian; citation_author=J. Brain; citation_author=A.D. Burt; citation_author=A.A. Aksenov; citation_author=A.F. Vrbanac; citation_author=W. Li; citation_author=A. Perkins; citation_author=T. Matsutani; citation_author=et al.; citation_journal_title=Nature; citation_volume=551; citation_firstpage=340; citation_lastpage=345; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=Complement decay accelerating factor (DAF)/CD55 in cancer; citation_author=I. Spendlove; citation_author=J.M. Ramage; citation_author=R. Bradley; citation_author=C. Harris; citation_author=L.G. Durrant; citation_journal_title=Cancer Immunol. Immunother.; citation_volume=55; citation_firstpage=987; citation_lastpage=995; citation_publication_date=2006; "><meta name="citation_reference" content="citation_title=A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis; citation_author=S. Su; citation_author=Q. Liu; citation_author=J. Chen; citation_author=J. Chen; citation_author=F. Chen; citation_author=C. He; citation_author=D. Huang; citation_author=W. Wu; citation_author=L. Lin; citation_author=W. Huang; citation_author=et al.; citation_journal_title=Cancer Cell; citation_volume=25; citation_firstpage=605; citation_lastpage=620; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Blocking the recruitment of naive CD4+ T&nbsp;cells reverses immunosuppression in breast cancer; citation_author=S. Su; citation_author=J. Liao; citation_author=J. Liu; citation_author=D. Huang; citation_author=C. He; citation_author=F. Chen; citation_author=L. Yang; citation_author=W. Wu; citation_author=J. Chen; citation_author=L. Lin; citation_author=et al.; citation_journal_title=Cell Res.; citation_volume=27; citation_firstpage=461; citation_lastpage=482; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness; citation_author=S. Su; citation_author=J. Chen; citation_author=H. Yao; citation_author=J. Liu; citation_author=S. Yu; citation_author=L. Lao; citation_author=M. Wang; citation_author=M. Luo; citation_author=Y. Xing; citation_author=F. Chen; citation_author=et al.; citation_journal_title=Cell; citation_volume=172; citation_firstpage=841; citation_lastpage=856.e16; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages; citation_author=S. Su; citation_author=J. Zhao; citation_author=Y. Xing; citation_author=X. Zhang; citation_author=J. Liu; citation_author=Q. Ouyang; citation_author=J. Chen; citation_author=F. Su; citation_author=Q. Liu; citation_author=E. Song; citation_journal_title=Cell; citation_volume=175; citation_firstpage=442; citation_lastpage=457.e23; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response; citation_author=L. Surace; citation_author=V. Lysenko; citation_author=A.O. Fontana; citation_author=V. Cecconi; citation_author=H. Janssen; citation_author=A. Bicvic; citation_author=M. Okoniewski; citation_author=M. Pruschy; citation_author=R. Dummer; citation_author=J. Neefjes; citation_author=et al.; citation_journal_title=Immunity; citation_volume=42; citation_firstpage=767; citation_lastpage=777; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies; citation_author=R.P. Taylor; citation_author=M.A. Lindorfer; citation_journal_title=Semin. Immunol.; citation_volume=28; citation_firstpage=309; citation_lastpage=316; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44); citation_author=M. Untch; citation_author=G. von Minckwitz; citation_author=B. Gerber; citation_author=C. Schem; citation_author=M. Rezai; citation_author=P.A. Fasching; citation_author=H. Tesch; citation_author=H. Eggemann; citation_author=C. Hanusch; citation_author=J. Huober; citation_author=et al.; citation_journal_title=J. Clin. Oncol.; citation_volume=36; citation_firstpage=1308; citation_lastpage=1316; citation_publication_date=2018; "><meta name="citation_reference" content="citation_title=IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples; citation_author=F. Varghese; citation_author=A.B. Bukhari; citation_author=R. Malhotra; citation_author=A. De; citation_journal_title=PLoS ONE; citation_volume=9; citation_firstpage=e96801; citation_publication_date=2014; "><meta name="citation_reference" content="citation_title=Response-guided neoadjuvant chemotherapy for breast cancer; citation_author=G. von Minckwitz; citation_author=J.U. Blohmer; citation_author=S.D. Costa; citation_author=C. Denkert; citation_author=H. Eidtmann; citation_author=W. Eiermann; citation_author=B. Gerber; citation_author=C. Hanusch; citation_author=J. Hilfrich; citation_author=J. Huober; citation_author=et al.; citation_journal_title=J.&nbsp;Clin. Oncol.; citation_volume=31; citation_firstpage=3623; citation_lastpage=3630; citation_publication_date=2013; "><meta name="citation_reference" content="citation_title=Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients; citation_author=R.H. Wang; citation_author=G. Phillips; citation_author=M.E. Medof; citation_author=C. Mold; citation_journal_title=J.&nbsp;Clin. Invest.; citation_volume=92; citation_firstpage=1326; citation_lastpage=1335; citation_publication_date=1993; "><meta name="citation_reference" content="citation_title=Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop; citation_author=Y. Wang; citation_author=J. Chen; citation_author=L. Yang; citation_author=J. Li; citation_author=W. Wu; citation_author=M. Huang; citation_author=L. Lin; citation_author=S. Su; citation_journal_title=Clin. Cancer Res.; citation_volume=25; citation_firstpage=1957; citation_lastpage=1969; citation_publication_date=2019; "><meta name="citation_reference" content="citation_title=Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade; citation_author=S.C. Wei; citation_author=J.H. Levine; citation_author=A.P. Cogdill; citation_author=Y. Zhao; citation_author=N.A.S. Anang; citation_author=M.C. Andrews; citation_author=P. Sharma; citation_author=J. Wang; citation_author=J.A. Wargo; citation_author=D. Pe’er; citation_author=et al.; citation_journal_title=Cell; citation_volume=170; citation_firstpage=1120; citation_lastpage=1133.e17; citation_publication_date=2017; "><meta name="citation_reference" content="citation_title=PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression; citation_author=X. Xiao; citation_author=X.M. Lao; citation_author=M.M. Chen; citation_author=R.X. Liu; citation_author=Y. Wei; citation_author=F.Z. Ouyang; citation_author=D.P. Chen; citation_author=X.Y. Zhao; citation_author=Q. Zhao; citation_author=X.F. Li; citation_author=et al.; citation_journal_title=Cancer Discov.; citation_volume=6; citation_firstpage=546; citation_lastpage=559; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer; citation_author=C. Zhang; citation_author=H. Xin; citation_author=W. Zhang; citation_author=P.J. Yazaki; citation_author=Z. Zhang; citation_author=K. Le; citation_author=W. Li; citation_author=H. Lee; citation_author=L. Kwak; citation_author=S. Forman; citation_author=et al.; citation_journal_title=Immunity; citation_volume=44; citation_firstpage=913; citation_lastpage=923; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=The clinical impact of ICOS signal in colorectal cancer patients; citation_author=Y. Zhang; citation_author=Y. Luo; citation_author=S.L. Qin; citation_author=Y.F. Mu; citation_author=Y. Qi; citation_author=M.H. Yu; citation_author=M. Zhong; citation_journal_title=OncoImmunology; citation_volume=5; citation_firstpage=e1141857; citation_publication_date=2016; "><meta name="citation_reference" content="citation_title=A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4+ T&nbsp;cell receptor repertoire clonality; citation_author=W. Zhu; citation_author=C. Germain; citation_author=Z. Liu; citation_author=Y. Sebastian; citation_author=P. Devi; citation_author=S. Knockaert; citation_author=P. Brohawn; citation_author=K. Lehmann; citation_author=D. Damotte; citation_author=P. Validire; citation_author=et al.; citation_journal_title=OncoImmunology; citation_volume=4; citation_firstpage=e1051922; citation_publication_date=2015; "><meta name="citation_reference" content="citation_title=Decoding cell death signals in inflammation and immunity; citation_author=L. Zitvogel; citation_author=O. Kepp; citation_author=G. Kroemer; citation_journal_title=Cell; citation_volume=140; citation_firstpage=798; citation_lastpage=804; citation_publication_date=2010; "><meta name="citation_abstract" content="<h2>Summary</h2><p>Understanding molecular mechanisms that dictate B cell diversity is important for targeting B cells as anti-cancer treatment. Through the single-cell dissection of B cell heterogeneity in longitudinal samples of patients with breast cancer before and after neoadjuvant chemotherapy, we revealed that an ICOSL<sup>+</sup> B cell subset emerges after chemotherapy. Using three immunocompetent mouse models, we recapitulated the subset switch of human tumor-infiltrating B cells during chemotherapy. By employing B-cell-specific deletion mice, we showed that ICOSL in B cells boosts anti-tumor immunity by enhancing the effector to regulatory T&nbsp;cell ratio. The signature of ICOSL<sup>+</sup> B cells is imprinted by complement-CR2 signaling, which is triggered by immunogenic cell death. Moreover, we identified that CD55, a complement inhibitory protein, determines the opposite roles of B cells in chemotherapy. Collectively, we demonstrated a critical role of the B cell subset switch in chemotherapy response, which has implications in designing novel anti-cancer therapies.</p><h3>Video Abstract</h3>"><meta charset="UTF-8"><!--

    Pagebuild admin UI
-->



<script type="text/javascript" src="https://bam.nr-data.net/1/16e2192192?a=916957862&amp;sa=1&amp;v=1177.96a4d39&amp;t=Unnamed%20Transaction&amp;rst=8301&amp;ck=1&amp;ref=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8&amp;be=4654&amp;fe=8257&amp;dc=6494&amp;af=err,xhr,stn,ins,spa&amp;perf=%7B%22timing%22:%7B%22of%22:1749585794438,%22n%22:0,%22f%22:3608,%22dn%22:3609,%22dne%22:3609,%22c%22:3609,%22s%22:3609,%22ce%22:3609,%22rq%22:3609,%22rp%22:4632,%22rpe%22:6272,%22dl%22:4637,%22di%22:6476,%22ds%22:6494,%22de%22:6508,%22dc%22:8256,%22l%22:8256,%22le%22:8287%7D,%22navigation%22:%7B%7D%7D&amp;fp=5552&amp;fcp=5552&amp;jsonp=NREUM.setToken"></script><script src="https://js-agent.newrelic.com/nr-spa-1177.min.js"></script><script type="text/javascript">
    ;window.NREUM||(NREUM={});NREUM.init={privacy:{cookies_enabled:true}};
    window.NREUM||(NREUM={}),__nr_require=function(t,e,n){function r(n){if(!e[n]){var o=e[n]={exports:{}};t[n][0].call(o.exports,function(e){var o=t[n][1][e];return r(o||e)},o,o.exports)}return e[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var o=0;o<n.length;o++)r(n[o]);return r}({1:[function(t,e,n){function r(t){try{c.console&&console.log(t)}catch(e){}}var o,i=t("ee"),a=t(26),c={};try{o=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(c.console=!0,o.indexOf("dev")!==-1&&(c.dev=!0),o.indexOf("nr_dev")!==-1&&(c.nrDev=!0))}catch(s){}c.nrDev&&i.on("internal-error",function(t){r(t.stack)}),c.dev&&i.on("fn-err",function(t,e,n){r(n.stack)}),c.dev&&(r("NR AGENT IN DEVELOPMENT MODE"),r("flags: "+a(c,function(t,e){return t}).join(", ")))},{}],2:[function(t,e,n){function r(t,e,n,r,c){try{l?l-=1:o(c||new UncaughtException(t,e,n),!0)}catch(f){try{i("ierr",[f,s.now(),!0])}catch(d){}}return"function"==typeof u&&u.apply(this,a(arguments))}function UncaughtException(t,e,n){this.message=t||"Uncaught error with no additional information",this.sourceURL=e,this.line=n}function o(t,e){var n=e?null:s.now();i("err",[t,n])}var i=t("handle"),a=t(27),c=t("ee"),s=t("loader"),f=t("gos"),u=window.onerror,d=!1,p="nr@seenError",l=0;s.features.err=!0,t(1),window.onerror=r;try{throw new Error}catch(h){"stack"in h&&(t(13),t(12),"addEventListener"in window&&t(6),s.xhrWrappable&&t(14),d=!0)}c.on("fn-start",function(t,e,n){d&&(l+=1)}),c.on("fn-err",function(t,e,n){d&&!n[p]&&(f(n,p,function(){return!0}),this.thrown=!0,o(n))}),c.on("fn-end",function(){d&&!this.thrown&&l>0&&(l-=1)}),c.on("internal-error",function(t){i("ierr",[t,s.now(),!0])})},{}],3:[function(t,e,n){t("loader").features.ins=!0},{}],4:[function(t,e,n){function r(){_++,T=g.hash,this[u]=y.now()}function o(){_--,g.hash!==T&&i(0,!0);var t=y.now();this[h]=~~this[h]+t-this[u],this[d]=t}function i(t,e){E.emit("newURL",[""+g,e])}function a(t,e){t.on(e,function(){this[e]=y.now()})}var c="-start",s="-end",f="-body",u="fn"+c,d="fn"+s,p="cb"+c,l="cb"+s,h="jsTime",m="fetch",v="addEventListener",w=window,g=w.location,y=t("loader");if(w[v]&&y.xhrWrappable){var x=t(10),b=t(11),E=t(8),R=t(6),O=t(13),N=t(7),M=t(14),P=t(9),S=t("ee"),C=S.get("tracer");t(16),y.features.spa=!0;var T,_=0;S.on(u,r),S.on(p,r),S.on(d,o),S.on(l,o),S.buffer([u,d,"xhr-done","xhr-resolved"]),R.buffer([u]),O.buffer(["setTimeout"+s,"clearTimeout"+c,u]),M.buffer([u,"new-xhr","send-xhr"+c]),N.buffer([m+c,m+"-done",m+f+c,m+f+s]),E.buffer(["newURL"]),x.buffer([u]),b.buffer(["propagate",p,l,"executor-err","resolve"+c]),C.buffer([u,"no-"+u]),P.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"]),a(M,"send-xhr"+c),a(S,"xhr-resolved"),a(S,"xhr-done"),a(N,m+c),a(N,m+"-done"),a(P,"new-jsonp"),a(P,"jsonp-end"),a(P,"cb-start"),E.on("pushState-end",i),E.on("replaceState-end",i),w[v]("hashchange",i,!0),w[v]("load",i,!0),w[v]("popstate",function(){i(0,_>1)},!0)}},{}],5:[function(t,e,n){function r(t){}if(window.performance&&window.performance.timing&&window.performance.getEntriesByType){var o=t("ee"),i=t("handle"),a=t(13),c=t(12),s="learResourceTimings",f="addEventListener",u="resourcetimingbufferfull",d="bstResource",p="resource",l="-start",h="-end",m="fn"+l,v="fn"+h,w="bstTimer",g="pushState",y=t("loader");y.features.stn=!0,t(8),"addEventListener"in window&&t(6);var x=NREUM.o.EV;o.on(m,function(t,e){var n=t[0];n instanceof x&&(this.bstStart=y.now())}),o.on(v,function(t,e){var n=t[0];n instanceof x&&i("bst",[n,e,this.bstStart,y.now()])}),a.on(m,function(t,e,n){this.bstStart=y.now(),this.bstType=n}),a.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),this.bstType])}),c.on(m,function(){this.bstStart=y.now()}),c.on(v,function(t,e){i(w,[e,this.bstStart,y.now(),"requestAnimationFrame"])}),o.on(g+l,function(t){this.time=y.now(),this.startPath=location.pathname+location.hash}),o.on(g+h,function(t){i("bstHist",[location.pathname+location.hash,this.startPath,this.time])}),f in window.performance&&(window.performance["c"+s]?window.performance[f](u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["c"+s]()},!1):window.performance[f]("webkit"+u,function(t){i(d,[window.performance.getEntriesByType(p)]),window.performance["webkitC"+s]()},!1)),document[f]("scroll",r,{passive:!0}),document[f]("keypress",r,!1),document[f]("click",r,!1)}},{}],6:[function(t,e,n){function r(t){for(var e=t;e&&!e.hasOwnProperty(u);)e=Object.getPrototypeOf(e);e&&o(e)}function o(t){c.inPlace(t,[u,d],"-",i)}function i(t,e){return t[1]}var a=t("ee").get("events"),c=t("wrap-function")(a,!0),s=t("gos"),f=XMLHttpRequest,u="addEventListener",d="removeEventListener";e.exports=a,"getPrototypeOf"in Object?(r(document),r(window),r(f.prototype)):f.prototype.hasOwnProperty(u)&&(o(window),o(f.prototype)),a.on(u+"-start",function(t,e){var n=t[1],r=s(n,"nr@wrapped",function(){function t(){if("function"==typeof n.handleEvent)return n.handleEvent.apply(n,arguments)}var e={object:t,"function":n}[typeof n];return e?c(e,"fn-",null,e.name||"anonymous"):n});this.wrapped=t[1]=r}),a.on(d+"-start",function(t){t[1]=this.wrapped||t[1]})},{}],7:[function(t,e,n){function r(t,e,n){var r=t[e];"function"==typeof r&&(t[e]=function(){var t=i(arguments),e={};o.emit(n+"before-start",[t],e);var a;e[m]&&e[m].dt&&(a=e[m].dt);var c=r.apply(this,t);return o.emit(n+"start",[t,a],c),c.then(function(t){return o.emit(n+"end",[null,t],c),t},function(t){throw o.emit(n+"end",[t],c),t})})}var o=t("ee").get("fetch"),i=t(27),a=t(26);e.exports=o;var c=window,s="fetch-",f=s+"body-",u=["arrayBuffer","blob","json","text","formData"],d=c.Request,p=c.Response,l=c.fetch,h="prototype",m="nr@context";d&&p&&l&&(a(u,function(t,e){r(d[h],e,f),r(p[h],e,f)}),r(c,"fetch",s),o.on(s+"end",function(t,e){var n=this;if(e){var r=e.headers.get("content-length");null!==r&&(n.rxSize=r),o.emit(s+"done",[null,e],n)}else o.emit(s+"done",[t],n)}))},{}],8:[function(t,e,n){var r=t("ee").get("history"),o=t("wrap-function")(r);e.exports=r;var i=window.history&&window.history.constructor&&window.history.constructor.prototype,a=window.history;i&&i.pushState&&i.replaceState&&(a=i),o.inPlace(a,["pushState","replaceState"],"-")},{}],9:[function(t,e,n){function r(t){function e(){s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}function n(){s.emit("jsonp-error",[],p),s.emit("jsonp-end",[],p),t.removeEventListener("load",e,!1),t.removeEventListener("error",n,!1)}var r=t&&"string"==typeof t.nodeName&&"script"===t.nodeName.toLowerCase();if(r){var o="function"==typeof t.addEventListener;if(o){var a=i(t.src);if(a){var u=c(a),d="function"==typeof u.parent[u.key];if(d){var p={};f.inPlace(u.parent,[u.key],"cb-",p),t.addEventListener("load",e,!1),t.addEventListener("error",n,!1),s.emit("new-jsonp",[t.src],p)}}}}}function o(){return"addEventListener"in window}function i(t){var e=t.match(u);return e?e[1]:null}function a(t,e){var n=t.match(p),r=n[1],o=n[3];return o?a(o,e[r]):e[r]}function c(t){var e=t.match(d);return e&&e.length>=3?{key:e[2],parent:a(e[1],window)}:{key:t,parent:window}}var s=t("ee").get("jsonp"),f=t("wrap-function")(s);if(e.exports=s,o()){var u=/[?&](?:callback|cb)=([^&#]+)/,d=/(.*)\.([^.]+)/,p=/^(\w+)(\.|$)(.*)$/,l=["appendChild","insertBefore","replaceChild"];Node&&Node.prototype&&Node.prototype.appendChild?f.inPlace(Node.prototype,l,"dom-"):(f.inPlace(HTMLElement.prototype,l,"dom-"),f.inPlace(HTMLHeadElement.prototype,l,"dom-"),f.inPlace(HTMLBodyElement.prototype,l,"dom-")),s.on("dom-start",function(t){r(t[0])})}},{}],10:[function(t,e,n){var r=t("ee").get("mutation"),o=t("wrap-function")(r),i=NREUM.o.MO;e.exports=r,i&&(window.MutationObserver=function(t){return this instanceof i?new i(o(t,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype)},{}],11:[function(t,e,n){function r(t){var e=a.context(),n=c(t,"executor-",e),r=new f(n);return a.context(r).getCtx=function(){return e},a.emit("new-promise",[r,e],e),r}function o(t,e){return e}var i=t("wrap-function"),a=t("ee").get("promise"),c=i(a),s=t(26),f=NREUM.o.PR;e.exports=a,f&&(window.Promise=r,["all","race"].forEach(function(t){var e=f[t];f[t]=function(n){function r(t){return function(){a.emit("propagate",[null,!o],i),o=o||!t}}var o=!1;s(n,function(e,n){Promise.resolve(n).then(r("all"===t),r(!1))});var i=e.apply(f,arguments),c=f.resolve(i);return c}}),["resolve","reject"].forEach(function(t){var e=f[t];f[t]=function(t){var n=e.apply(f,arguments);return t!==n&&a.emit("propagate",[t,!0],n),n}}),f.prototype["catch"]=function(t){return this.then(null,t)},f.prototype=Object.create(f.prototype,{constructor:{value:r}}),s(Object.getOwnPropertyNames(f),function(t,e){try{r[e]=f[e]}catch(n){}}),a.on("executor-start",function(t){t[0]=c(t[0],"resolve-",this),t[1]=c(t[1],"resolve-",this)}),a.on("executor-err",function(t,e,n){t[1](n)}),c.inPlace(f.prototype,["then"],"then-",o),a.on("then-start",function(t,e){this.promise=e,t[0]=c(t[0],"cb-",this),t[1]=c(t[1],"cb-",this)}),a.on("then-end",function(t,e,n){this.nextPromise=n;var r=this.promise;a.emit("propagate",[r,!0],n)}),a.on("cb-end",function(t,e,n){a.emit("propagate",[n,!0],this.nextPromise)}),a.on("propagate",function(t,e,n){this.getCtx&&!e||(this.getCtx=function(){if(t instanceof Promise)var e=a.context(t);return e&&e.getCtx?e.getCtx():this})}),r.toString=function(){return""+f})},{}],12:[function(t,e,n){var r=t("ee").get("raf"),o=t("wrap-function")(r),i="equestAnimationFrame";e.exports=r,o.inPlace(window,["r"+i,"mozR"+i,"webkitR"+i,"msR"+i],"raf-"),r.on("raf-start",function(t){t[0]=o(t[0],"fn-")})},{}],13:[function(t,e,n){function r(t,e,n){t[0]=a(t[0],"fn-",null,n)}function o(t,e,n){this.method=n,this.timerDuration=isNaN(t[1])?0:+t[1],t[0]=a(t[0],"fn-",this,n)}var i=t("ee").get("timer"),a=t("wrap-function")(i),c="setTimeout",s="setInterval",f="clearTimeout",u="-start",d="-";e.exports=i,a.inPlace(window,[c,"setImmediate"],c+d),a.inPlace(window,[s],s+d),a.inPlace(window,[f,"clearImmediate"],f+d),i.on(s+u,r),i.on(c+u,o)},{}],14:[function(t,e,n){function r(t,e){d.inPlace(e,["onreadystatechange"],"fn-",c)}function o(){var t=this,e=u.context(t);t.readyState>3&&!e.resolved&&(e.resolved=!0,u.emit("xhr-resolved",[],t)),d.inPlace(t,g,"fn-",c)}function i(t){y.push(t),h&&(b?b.then(a):v?v(a):(E=-E,R.data=E))}function a(){for(var t=0;t<y.length;t++)r([],y[t]);y.length&&(y=[])}function c(t,e){return e}function s(t,e){for(var n in t)e[n]=t[n];return e}t(6);var f=t("ee"),u=f.get("xhr"),d=t("wrap-function")(u),p=NREUM.o,l=p.XHR,h=p.MO,m=p.PR,v=p.SI,w="readystatechange",g=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],y=[];e.exports=u;var x=window.XMLHttpRequest=function(t){var e=new l(t);try{u.emit("new-xhr",[e],e),e.addEventListener(w,o,!1)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}return e};if(s(l,x),x.prototype=l.prototype,d.inPlace(x.prototype,["open","send"],"-xhr-",c),u.on("send-xhr-start",function(t,e){r(t,e),i(e)}),u.on("open-xhr-start",r),h){var b=m&&m.resolve();if(!v&&!m){var E=1,R=document.createTextNode(E);new h(a).observe(R,{characterData:!0})}}else f.on("fn-end",function(t){t[0]&&t[0].type===w||a()})},{}],15:[function(t,e,n){function r(t){if(!c(t))return null;var e=window.NREUM;if(!e.loader_config)return null;var n=(e.loader_config.accountID||"").toString()||null,r=(e.loader_config.agentID||"").toString()||null,f=(e.loader_config.trustKey||"").toString()||null;if(!n||!r)return null;var h=l.generateSpanId(),m=l.generateTraceId(),v=Date.now(),w={spanId:h,traceId:m,timestamp:v};return(t.sameOrigin||s(t)&&p())&&(w.traceContextParentHeader=o(h,m),w.traceContextStateHeader=i(h,v,n,r,f)),(t.sameOrigin&&!u()||!t.sameOrigin&&s(t)&&d())&&(w.newrelicHeader=a(h,m,v,n,r,f)),w}function o(t,e){return"00-"+e+"-"+t+"-01"}function i(t,e,n,r,o){var i=0,a="",c=1,s="",f="";return o+"@nr="+i+"-"+c+"-"+n+"-"+r+"-"+t+"-"+a+"-"+s+"-"+f+"-"+e}function a(t,e,n,r,o,i){var a="btoa"in window&&"function"==typeof window.btoa;if(!a)return null;var c={v:[0,1],d:{ty:"Browser",ac:r,ap:o,id:t,tr:e,ti:n}};return i&&r!==i&&(c.d.tk=i),btoa(JSON.stringify(c))}function c(t){return f()&&s(t)}function s(t){var e=!1,n={};if("init"in NREUM&&"distributed_tracing"in NREUM.init&&(n=NREUM.init.distributed_tracing),t.sameOrigin)e=!0;else if(n.allowed_origins instanceof Array)for(var r=0;r<n.allowed_origins.length;r++){var o=h(n.allowed_origins[r]);if(t.hostname===o.hostname&&t.protocol===o.protocol&&t.port===o.port){e=!0;break}}return e}function f(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.enabled}function u(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.exclude_newrelic_header}function d(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&NREUM.init.distributed_tracing.cors_use_newrelic_header!==!1}function p(){return"init"in NREUM&&"distributed_tracing"in NREUM.init&&!!NREUM.init.distributed_tracing.cors_use_tracecontext_headers}var l=t(23),h=t(17);e.exports={generateTracePayload:r,shouldGenerateTrace:c}},{}],16:[function(t,e,n){function r(t){var e=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var r=0;r<p;r++)t.removeEventListener(d[r],this.listener,!1);e.aborted||(n.duration=a.now()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==e.status&&(e.status=0):i(this,t),n.cbTime=this.cbTime,u.emit("xhr-done",[t],t),c("xhr",[e,n,this.startTime]))}}function o(t,e){var n=s(e),r=t.params;r.host=n.hostname+":"+n.port,r.pathname=n.pathname,t.parsedOrigin=s(e),t.sameOrigin=t.parsedOrigin.sameOrigin}function i(t,e){t.params.status=e.status;var n=v(e,t.lastSize);if(n&&(t.metrics.rxSize=n),t.sameOrigin){var r=e.getResponseHeader("X-NewRelic-App-Data");r&&(t.params.cat=r.split(", ").pop())}t.loadCaptureCalled=!0}var a=t("loader");if(a.xhrWrappable){var c=t("handle"),s=t(17),f=t(15).generateTracePayload,u=t("ee"),d=["load","error","abort","timeout"],p=d.length,l=t("id"),h=t(21),m=t(20),v=t(18),w=window.XMLHttpRequest;a.features.xhr=!0,t(14),t(7),u.on("new-xhr",function(t){var e=this;e.totalCbs=0,e.called=0,e.cbTime=0,e.end=r,e.ended=!1,e.xhrGuids={},e.lastSize=null,e.loadCaptureCalled=!1,t.addEventListener("load",function(n){i(e,t)},!1),h&&(h>34||h<10)||window.opera||t.addEventListener("progress",function(t){e.lastSize=t.loaded},!1)}),u.on("open-xhr-start",function(t){this.params={method:t[0]},o(this,t[1]),this.metrics={}}),u.on("open-xhr-end",function(t,e){"loader_config"in NREUM&&"xpid"in NREUM.loader_config&&this.sameOrigin&&e.setRequestHeader("X-NewRelic-ID",NREUM.loader_config.xpid);var n=f(this.parsedOrigin);if(n){var r=!1;n.newrelicHeader&&(e.setRequestHeader("newrelic",n.newrelicHeader),r=!0),n.traceContextParentHeader&&(e.setRequestHeader("traceparent",n.traceContextParentHeader),n.traceContextStateHeader&&e.setRequestHeader("tracestate",n.traceContextStateHeader),r=!0),r&&(this.dt=n)}}),u.on("send-xhr-start",function(t,e){var n=this.metrics,r=t[0],o=this;if(n&&r){var i=m(r);i&&(n.txSize=i)}this.startTime=a.now(),this.listener=function(t){try{"abort"!==t.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==t.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof e.onload))&&o.end(e)}catch(n){try{u.emit("internal-error",[n])}catch(r){}}};for(var c=0;c<p;c++)e.addEventListener(d[c],this.listener,!1)}),u.on("xhr-cb-time",function(t,e,n){this.cbTime+=t,e?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof n.onload||this.end(n)}),u.on("xhr-load-added",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&!this.xhrGuids[n]&&(this.xhrGuids[n]=!0,this.totalCbs+=1)}),u.on("xhr-load-removed",function(t,e){var n=""+l(t)+!!e;this.xhrGuids&&this.xhrGuids[n]&&(delete this.xhrGuids[n],this.totalCbs-=1)}),u.on("addEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-added",[t[1],t[2]],e)}),u.on("removeEventListener-end",function(t,e){e instanceof w&&"load"===t[0]&&u.emit("xhr-load-removed",[t[1],t[2]],e)}),u.on("fn-start",function(t,e,n){e instanceof w&&("onload"===n&&(this.onload=!0),("load"===(t[0]&&t[0].type)||this.onload)&&(this.xhrCbStart=a.now()))}),u.on("fn-end",function(t,e){this.xhrCbStart&&u.emit("xhr-cb-time",[a.now()-this.xhrCbStart,this.onload,e],e)}),u.on("fetch-before-start",function(t){function e(t,e){var n=!1;return e.newrelicHeader&&(t.set("newrelic",e.newrelicHeader),n=!0),e.traceContextParentHeader&&(t.set("traceparent",e.traceContextParentHeader),e.traceContextStateHeader&&t.set("tracestate",e.traceContextStateHeader),n=!0),n}var n,r=t[1]||{};"string"==typeof t[0]?n=t[0]:t[0]&&t[0].url&&(n=t[0].url),n&&(this.parsedOrigin=s(n),this.sameOrigin=this.parsedOrigin.sameOrigin);var o=f(this.parsedOrigin);if(o&&(o.newrelicHeader||o.traceContextParentHeader))if("string"==typeof t[0]){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),e(i.headers,o)&&(this.dt=o),t.length>1?t[1]=i:t.push(i)}else t[0]&&t[0].headers&&e(t[0].headers,o)&&(this.dt=o)})}},{}],17:[function(t,e,n){var r={};e.exports=function(t){if(t in r)return r[t];var e=document.createElement("a"),n=window.location,o={};e.href=t,o.port=e.port;var i=e.href.split("://");!o.port&&i[1]&&(o.port=i[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===i[0]?"443":"80"),o.hostname=e.hostname||n.hostname,o.pathname=e.pathname,o.protocol=i[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var a=!e.protocol||":"===e.protocol||e.protocol===n.protocol,c=e.hostname===document.domain&&e.port===n.port;return o.sameOrigin=a&&(!e.hostname||c),"/"===o.pathname&&(r[t]=o),o}},{}],18:[function(t,e,n){function r(t,e){var n=t.responseType;return"json"===n&&null!==e?e:"arraybuffer"===n||"blob"===n||"json"===n?o(t.response):"text"===n||""===n||void 0===n?o(t.responseText):void 0}var o=t(20);e.exports=r},{}],19:[function(t,e,n){function r(){}function o(t,e,n){return function(){return i(t,[f.now()].concat(c(arguments)),e?null:this,n),e?void 0:this}}var i=t("handle"),a=t(26),c=t(27),s=t("ee").get("tracer"),f=t("loader"),u=NREUM;"undefined"==typeof window.newrelic&&(newrelic=u);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(t,e){u[e]=o(p+e,!0,"api")}),u.addPageAction=o(p+"addPageAction",!0),u.setCurrentRouteName=o(p+"routeName",!0),e.exports=newrelic,u.interaction=function(){return(new r).get()};var h=r.prototype={createTracer:function(t,e){var n={},r=this,o="function"==typeof e;return i(l+"tracer",[f.now(),t,n],r),function(){if(s.emit((o?"":"no-")+"fn-start",[f.now(),r,o],n),o)try{return e.apply(this,arguments)}catch(t){throw s.emit("fn-err",[arguments,this,t],n),t}finally{s.emit("fn-end",[f.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(t,e){h[e]=o(l+e)}),newrelic.noticeError=function(t,e){"string"==typeof t&&(t=new Error(t)),i("err",[t,f.now(),!1,e])}},{}],20:[function(t,e,n){e.exports=function(t){if("string"==typeof t&&t.length)return t.length;if("object"==typeof t){if("undefined"!=typeof ArrayBuffer&&t instanceof ArrayBuffer&&t.byteLength)return t.byteLength;if("undefined"!=typeof Blob&&t instanceof Blob&&t.size)return t.size;if(!("undefined"!=typeof FormData&&t instanceof FormData))try{return JSON.stringify(t).length}catch(e){return}}}},{}],21:[function(t,e,n){var r=0,o=navigator.userAgent.match(/Firefox[\/\s](\d+\.\d+)/);o&&(r=+o[1]),e.exports=r},{}],22:[function(t,e,n){function r(t,e){var n=t.getEntries();n.forEach(function(t){"first-paint"===t.name?d("timing",["fp",Math.floor(t.startTime)]):"first-contentful-paint"===t.name&&d("timing",["fcp",Math.floor(t.startTime)])})}function o(t,e){var n=t.getEntries();n.length>0&&d("lcp",[n[n.length-1]])}function i(t){t.getEntries().forEach(function(t){t.hadRecentInput||d("cls",[t])})}function a(t){if(t instanceof h&&!v){var e=Math.round(t.timeStamp),n={type:t.type};e<=p.now()?n.fid=p.now()-e:e>p.offset&&e<=Date.now()?(e-=p.offset,n.fid=p.now()-e):e=p.now(),v=!0,d("timing",["fi",e,n])}}function c(t){d("pageHide",[p.now(),t])}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var s,f,u,d=t("handle"),p=t("loader"),l=t(25),h=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){s=new PerformanceObserver(r);try{s.observe({entryTypes:["paint"]})}catch(m){}f=new PerformanceObserver(o);try{f.observe({entryTypes:["largest-contentful-paint"]})}catch(m){}u=new PerformanceObserver(i);try{u.observe({type:"layout-shift",buffered:!0})}catch(m){}}if("addEventListener"in document){var v=!1,w=["click","keydown","mousedown","pointerdown","touchstart"];w.forEach(function(t){document.addEventListener(t,a,!1)})}l(c)}},{}],23:[function(t,e,n){function r(){function t(){return e?15&e[n++]:16*Math.random()|0}var e=null,n=0,r=window.crypto||window.msCrypto;r&&r.getRandomValues&&(e=r.getRandomValues(new Uint8Array(31)));for(var o,i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx",a="",c=0;c<i.length;c++)o=i[c],"x"===o?a+=t().toString(16):"y"===o?(o=3&t()|8,a+=o.toString(16)):a+=o;return a}function o(){return a(16)}function i(){return a(32)}function a(t){function e(){return n?15&n[r++]:16*Math.random()|0}var n=null,r=0,o=window.crypto||window.msCrypto;o&&o.getRandomValues&&Uint8Array&&(n=o.getRandomValues(new Uint8Array(31)));for(var i=[],a=0;a<t;a++)i.push(e().toString(16));return i.join("")}e.exports={generateUuid:r,generateSpanId:o,generateTraceId:i}},{}],24:[function(t,e,n){function r(t,e){if(!o)return!1;if(t!==o)return!1;if(!e)return!0;if(!i)return!1;for(var n=i.split("."),r=e.split("."),a=0;a<r.length;a++)if(r[a]!==n[a])return!1;return!0}var o=null,i=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,s=c.match(a);s&&c.indexOf("Chrome")===-1&&c.indexOf("Chromium")===-1&&(o="Safari",i=s[1])}e.exports={agent:o,version:i,match:r}},{}],25:[function(t,e,n){function r(t){function e(){t(a&&document[a]?document[a]:document[o]?"hidden":"visible")}"addEventListener"in document&&i&&document.addEventListener(i,e,!1)}e.exports=r;var o,i,a;"undefined"!=typeof document.hidden?(o="hidden",i="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(o="msHidden",i="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&&(o="webkitHidden",i="webkitvisibilitychange",a="webkitVisibilityState")},{}],26:[function(t,e,n){function r(t,e){var n=[],r="",i=0;for(r in t)o.call(t,r)&&(n[i]=e(r,t[r]),i+=1);return n}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],27:[function(t,e,n){function r(t,e,n){e||(e=0),"undefined"==typeof n&&(n=t?t.length:0);for(var r=-1,o=n-e||0,i=Array(o<0?0:o);++r<o;)i[r]=t[e+r];return i}e.exports=r},{}],28:[function(t,e,n){e.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(t,e,n){function r(){}function o(t){function e(t){return t&&t instanceof r?t:t?s(t,c,i):i()}function n(n,r,o,i){if(!p.aborted||i){t&&t(n,r,o);for(var a=e(o),c=m(n),s=c.length,f=0;f<s;f++)c[f].apply(a,r);var d=u[y[n]];return d&&d.push([x,n,r,a]),a}}function l(t,e){g[t]=m(t).concat(e)}function h(t,e){var n=g[t];if(n)for(var r=0;r<n.length;r++)n[r]===e&&n.splice(r,1)}function m(t){return g[t]||[]}function v(t){return d[t]=d[t]||o(n)}function w(t,e){f(t,function(t,n){e=e||"feature",y[n]=e,e in u||(u[e]=[])})}var g={},y={},x={on:l,addEventListener:l,removeEventListener:h,emit:n,get:v,listeners:m,context:e,buffer:w,abort:a,aborted:!1};return x}function i(){return new r}function a(){(u.api||u.feature)&&(p.aborted=!0,u=p.backlog={})}var c="nr@context",s=t("gos"),f=t(26),u={},d={},p=e.exports=o();p.backlog=u},{}],gos:[function(t,e,n){function r(t,e,n){if(o.call(t,e))return t[e];var r=n();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(t,e,{value:r,writable:!0,enumerable:!1}),r}catch(i){}return t[e]=r,r}var o=Object.prototype.hasOwnProperty;e.exports=r},{}],handle:[function(t,e,n){function r(t,e,n,r){o.buffer([t],r),o.emit(t,e,n)}var o=t("ee").get("handle");e.exports=r,r.ee=o},{}],id:[function(t,e,n){function r(t){var e=typeof t;return!t||"object"!==e&&"function"!==e?-1:t===window?0:a(t,i,function(){return o++})}var o=1,i="nr@id",a=t("gos");e.exports=r},{}],loader:[function(t,e,n){function r(){if(!E++){var t=b.info=NREUM.info,e=l.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(t&&t.licenseKey&&t.applicationID&&e))return u.abort();f(y,function(e,n){t[e]||(t[e]=n)});var n=a();s("mark",["onload",n+b.offset],null,"api"),s("timing",["load",n]);var r=l.createElement("script");r.src="https://"+t.agent,e.parentNode.insertBefore(r,e)}}function o(){"complete"===l.readyState&&i()}function i(){s("mark",["domContent",a()+b.offset],null,"api")}function a(){return R.exists&&performance.now?Math.round(performance.now()):(c=Math.max((new Date).getTime(),c))-b.offset}var c=(new Date).getTime(),s=t("handle"),f=t(26),u=t("ee"),d=t(24),p=window,l=p.document,h="addEventListener",m="attachEvent",v=p.XMLHttpRequest,w=v&&v.prototype;NREUM.o={ST:setTimeout,SI:p.setImmediate,CT:clearTimeout,XHR:v,REQ:p.Request,EV:p.Event,PR:p.Promise,MO:p.MutationObserver};var g=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-spa-1177.min.js"},x=v&&w&&w[h]&&!/CriOS/.test(navigator.userAgent),b=e.exports={offset:c,now:a,origin:g,features:{},xhrWrappable:x,userAgent:d};t(19),t(22),l[h]?(l[h]("DOMContentLoaded",i,!1),p[h]("load",r,!1)):(l[m]("onreadystatechange",o),p[m]("onload",r)),s("mark",["firstbyte",c],null,"api");var E=0,R=t(28)},{}],"wrap-function":[function(t,e,n){function r(t){return!(t&&t instanceof Function&&t.apply&&!t[a])}var o=t("ee"),i=t(27),a="nr@original",c=Object.prototype.hasOwnProperty,s=!1;e.exports=function(t,e){function n(t,e,n,o){function nrWrapper(){var r,a,c,s;try{a=this,r=i(arguments),c="function"==typeof n?n(r,a):n||{}}catch(f){p([f,"",[r,a,o],c])}u(e+"start",[r,a,o],c);try{return s=t.apply(a,r)}catch(d){throw u(e+"err",[r,a,d],c),d}finally{u(e+"end",[r,a,s],c)}}return r(t)?t:(e||(e=""),nrWrapper[a]=t,d(t,nrWrapper),nrWrapper)}function f(t,e,o,i){o||(o="");var a,c,s,f="-"===o.charAt(0);for(s=0;s<e.length;s++)c=e[s],a=t[c],r(a)||(t[c]=n(a,f?c+o:o,i,c))}function u(n,r,o){if(!s||e){var i=s;s=!0;try{t.emit(n,r,o,e)}catch(a){p([a,n,r,o])}s=i}}function d(t,e){if(Object.defineProperty&&Object.keys)try{var n=Object.keys(t);return n.forEach(function(n){Object.defineProperty(e,n,{get:function(){return t[n]},set:function(e){return t[n]=e,e}})}),e}catch(r){p([r])}for(var o in t)c.call(t,o)&&(e[o]=t[o]);return e}function p(e){try{t.emit("internal-error",e)}catch(n){}}return t||(t=o),n.inPlace=f,n.flag=a,n}},{}]},{},["loader",2,16,5,3,4]);
    ;NREUM.loader_config={accountID:"2095297",trustKey:"2038175",agentID:"916957862",licenseKey:"16e2192192",applicationID:"916957862"}
    ;NREUM.info={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",licenseKey:"16e2192192",applicationID:"916957862",sa:1}
</script>
    <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="dada9834-04e2-4bcd-b5ba-cae44d498dfa"></script>
    <script type="text/javascript">
        function getCookie(name) {
            var value = "; " + document.cookie;
            var parts = value.split("; " + name + "=");
            if (parts.length == 2) {
                return true;
            }
        }
            function OptanonWrapper() {
                var optCookie = getCookie("OptanonAlertBoxClosed");
                var isActiveCategory = "false";
                var isFoundCookieBox = "false";
                if(isActiveCategory == 'false' && isFoundCookieBox == 'false' && optCookie) {
                    OneTrust.InsertScript('/pb-assets/adobe/prod/adobedtm-1616606406233.js', 'head', null, null, '2');
                }
            }
    </script>


<noscript>
    <style>.requiresJS {
        display: none
    }

    .dartAd {
        display: block !important
    }</style>
</noscript>
        <script type="text/javascript" src="/wro/o4ny~selected-legacy.js"></script>
        <link rel="stylesheet" type="text/css" href="/wro/o4ny~selected-legacy.css">
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Open+Sans">
        <script>window.MSInputMethodContext && document.documentMode && document.write('<script src="https://cdn.jsdelivr.net/gh/nuxodin/ie11CustomProperties@4.1.0/ie11CustomProperties.min.js"><\x2fscript>');</script><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/build-b26f3342b722959c7931.css"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/print-b26f3342b722959c7931.css" media="print"><link rel="stylesheet" href="/products/marlin/cell/releasedAssets/css/themes/theme-cell.css">







        
        
        <script class="optanon-category-4" type="text/plain" async="" src="https://www.youtube.com/iframe_api"></script>
        
    





<!---->
<meta http-equiv="X-UA-Compatible" content="IE=edge">












<script src="https://cdn.cookielaw.org/scripttemplates/202411.2.0/otBannerSdk.js" async="" type="text/javascript"></script><style id="onetrust-style">#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk:focus{outline:2px solid #000;outline-offset:-2px}#onetrust-banner-sdk a:focus{outline:2px solid #000}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{outline-offset:1px}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{height:64px;width:64px}#onetrust-banner-sdk .ot-tcf2-vendor-count.ot-text-bold{font-weight:bold}#onetrust-banner-sdk .ot-close-icon,#onetrust-pc-sdk .ot-close-icon,#ot-sync-ntfy .ot-close-icon{background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-banner-sdk .ot-pc-footer-logo a,#onetrust-pc-sdk .powered-by-logo,#onetrust-pc-sdk .ot-pc-footer-logo a,#ot-sync-ntfy .powered-by-logo,#ot-sync-ntfy .ot-pc-footer-logo a{background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block;text-decoration:none;font-size:.75em}#onetrust-banner-sdk .powered-by-logo:hover,#onetrust-banner-sdk .ot-pc-footer-logo a:hover,#onetrust-pc-sdk .powered-by-logo:hover,#onetrust-pc-sdk .ot-pc-footer-logo a:hover,#ot-sync-ntfy .powered-by-logo:hover,#ot-sync-ntfy .ot-pc-footer-logo a:hover{color:#565656}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *,#ot-sync-ntfy h3 *,#ot-sync-ntfy h4 *,#ot-sync-ntfy h6 *,#ot-sync-ntfy button *,#ot-sync-ntfy a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .ot-hide,#onetrust-pc-sdk .ot-hide,#ot-sync-ntfy .ot-hide{display:none !important}#onetrust-banner-sdk button.ot-link-btn:hover,#onetrust-pc-sdk button.ot-link-btn:hover,#ot-sync-ntfy button.ot-link-btn:hover{text-decoration:underline;opacity:1}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type=checkbox]:checked,#onetrust-pc-sdk [type=checkbox]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type=checkbox]:disabled+label::before,#onetrust-pc-sdk [type=checkbox]:disabled+label:after,#onetrust-pc-sdk [type=checkbox]:disabled+label{pointer-events:none;opacity:.8}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type=checkbox]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type=checkbox]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .ot-host-name a,#onetrust-pc-sdk li .accordion-text,#onetrust-pc-sdk li .ot-acc-txt{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px .1ex}#onetrust-pc-sdk .pc-logo,#onetrust-pc-sdk .ot-pc-logo{height:60px;width:180px;background-position:center;background-size:contain;background-repeat:no-repeat;display:inline-flex;justify-content:center;align-items:center}#onetrust-pc-sdk .pc-logo img,#onetrust-pc-sdk .ot-pc-logo img{max-height:100%;max-width:100%}#onetrust-pc-sdk .screen-reader-only,#onetrust-pc-sdk .ot-scrn-rdr,.ot-sdk-cookie-policy .screen-reader-only,.ot-sdk-cookie-policy .ot-scrn-rdr{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk.ot-fade-in,.onetrust-pc-dark-filter.ot-fade-in,#onetrust-banner-sdk.ot-fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.ot-hide{display:none !important}.onetrust-pc-dark-filter.ot-hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#fff;background-color:#468254;height:auto;white-space:normal;word-wrap:break-word;padding:.8em 2em;font-size:.8em;line-height:1.2;cursor:pointer;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#2c6415}#ot-sdk-btn.ot-sdk-show-settings:active,#ot-sdk-btn.optanon-show-settings:active{color:#fff;background-color:#2c6415;border:1px solid rgba(162,192,169,.5)}.onetrust-pc-dark-filter{background:rgba(0,0,0,.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}.ot-cookie-label{text-decoration:underline}@media only screen and (min-width: 426px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk p{font-size:.75em}}#onetrust-banner-sdk .banner-option-input:focus+label{outline:1px solid #000;outline-style:auto}.category-vendors-list-handler+a:focus,.category-vendors-list-handler+a:focus-visible{outline:2px solid #000}#onetrust-pc-sdk .ot-userid-title{margin-top:10px}#onetrust-pc-sdk .ot-userid-title>span,#onetrust-pc-sdk .ot-userid-timestamp>span{font-weight:700}#onetrust-pc-sdk .ot-userid-desc{font-style:italic}#onetrust-pc-sdk .ot-host-desc a{pointer-events:initial}#onetrust-pc-sdk .ot-ven-hdr>p a{position:relative;z-index:2;pointer-events:initial}#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info a{margin-right:auto}#onetrust-pc-sdk .ot-pc-footer-logo img{width:136px;height:16px}#onetrust-pc-sdk .ot-pur-vdr-count{font-weight:400;font-size:.7rem;padding-top:3px;display:block}#onetrust-banner-sdk .ot-optout-signal,#onetrust-pc-sdk .ot-optout-signal{border:1px solid #32ae88;border-radius:3px;padding:5px;margin-bottom:10px;background-color:#f9fffa;font-size:.85rem;line-height:2}#onetrust-banner-sdk .ot-optout-signal .ot-optout-icon,#onetrust-pc-sdk .ot-optout-signal .ot-optout-icon{display:inline;margin-right:5px}#onetrust-banner-sdk .ot-optout-signal svg,#onetrust-pc-sdk .ot-optout-signal svg{height:20px;width:30px;transform:scale(0.5)}#onetrust-banner-sdk .ot-optout-signal svg path,#onetrust-pc-sdk .ot-optout-signal svg path{fill:#32ae88}#onetrust-consent-sdk .ot-general-modal{overflow:hidden;position:fixed;margin:0 auto;top:50%;left:50%;width:40%;padding:1.5rem;max-width:575px;min-width:575px;z-index:2147483647;border-radius:2.5px;transform:translate(-50%, -50%)}#onetrust-consent-sdk .ot-signature-health-group{margin-top:1rem;padding-left:1.25rem;padding-right:1.25rem;margin-bottom:.625rem;width:calc(100% - 2.5rem)}#onetrust-consent-sdk .ot-signature-health-group .ot-signature-health-form{gap:.5rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:70%;gap:.35rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-input{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-consent-sdk .ot-signature-health .ot-signature-subtitle{font-size:1.125rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-group-title{font-size:1.25rem;font-weight:bold}#onetrust-consent-sdk .ot-signature-health,#onetrust-consent-sdk .ot-signature-health-group{display:flex;flex-direction:column;gap:1rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-cont{display:flex;flex-direction:column;gap:.25rem}#onetrust-consent-sdk .ot-signature-health .ot-signature-paragraph,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-paragraph{margin:0;line-height:20px;font-size:max(14px,.875rem)}#onetrust-consent-sdk .ot-signature-health .ot-health-signature-error,#onetrust-consent-sdk .ot-signature-health-group .ot-health-signature-error{color:#4d4d4d;font-size:min(12px,.75rem)}#onetrust-consent-sdk .ot-signature-health .ot-signature-buttons-cont,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-buttons-cont{margin-top:max(.75rem,2%);gap:1rem;display:flex;justify-content:flex-end}#onetrust-consent-sdk .ot-signature-health .ot-signature-button,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button{flex:1;height:auto;color:#fff;cursor:pointer;line-height:1.2;min-width:125px;font-weight:600;font-size:.813em;border-radius:2px;padding:12px 10px;white-space:normal;word-wrap:break-word;word-break:break-word;background-color:#68b631;border:2px solid #68b631}#onetrust-consent-sdk .ot-signature-health .ot-signature-button.reject,#onetrust-consent-sdk .ot-signature-health-group .ot-signature-button.reject{background-color:#fff}#onetrust-consent-sdk .ot-input-field-cont{display:flex;flex-direction:column;gap:.5rem}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:65%}#onetrust-consent-sdk .ot-signature-health-form{display:flex;flex-direction:column}#onetrust-consent-sdk .ot-signature-health-form .ot-signature-label{margin-bottom:0;line-height:20px;font-size:max(14px,.875rem)}@media only screen and (max-width: 600px){#onetrust-consent-sdk .ot-general-modal{min-width:100%}#onetrust-consent-sdk .ot-signature-health .ot-signature-health-form{width:100%}#onetrust-consent-sdk .ot-input-field-cont .ot-signature-input{width:100%}}#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy,#ot-sync-ntfy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before,#ot-sync-ntfy *,#ot-sync-ntfy ::after,#ot-sync-ntfy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .ot-main-content,#onetrust-banner-sdk .ot-toggle,#onetrust-banner-sdk #ot-content,#onetrust-banner-sdk #ot-pc-content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .ot-main-content,#onetrust-pc-sdk .ot-toggle,#onetrust-pc-sdk #ot-content,#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .ot-main-content,#ot-sdk-cookie-policy .ot-toggle,#ot-sdk-cookie-policy #ot-content,#ot-sdk-cookie-policy #ot-pc-content,#ot-sdk-cookie-policy .checkbox,#ot-sync-ntfy div,#ot-sync-ntfy span,#ot-sync-ntfy h1,#ot-sync-ntfy h2,#ot-sync-ntfy h3,#ot-sync-ntfy h4,#ot-sync-ntfy h5,#ot-sync-ntfy h6,#ot-sync-ntfy p,#ot-sync-ntfy img,#ot-sync-ntfy svg,#ot-sync-ntfy button,#ot-sync-ntfy section,#ot-sync-ntfy a,#ot-sync-ntfy label,#ot-sync-ntfy input,#ot-sync-ntfy ul,#ot-sync-ntfy li,#ot-sync-ntfy nav,#ot-sync-ntfy table,#ot-sync-ntfy thead,#ot-sync-ntfy tr,#ot-sync-ntfy td,#ot-sync-ntfy tbody,#ot-sync-ntfy .ot-main-content,#ot-sync-ntfy .ot-toggle,#ot-sync-ntfy #ot-content,#ot-sync-ntfy #ot-pc-content,#ot-sync-ntfy .checkbox{font-family:inherit;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before,#ot-sync-ntfy label:before,#ot-sync-ntfy label:after,#ot-sync-ntfy .checkbox:after,#ot-sync-ntfy .checkbox:before{content:"";content:none}#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media(min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media(min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media(min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:.9em;font-weight:400;line-height:38px;letter-spacing:.01em;text-decoration:none;white-space:nowrap;background-color:rgba(0,0,0,0);border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):hover,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:not(.ot-link-btn):focus{color:#333;border-color:#888;opacity:.9}#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk :not(.ot-leg-btn-container)>button:focus,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk :not(.ot-leg-btn-container)>button:focus,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy :not(.ot-leg-btn-container)>button:focus{outline:2px solid #000}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type=button].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=submit].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=reset].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type=button].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=submit].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=reset].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type=button].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type=text],#onetrust-pc-sdk input[type=text],#ot-sdk-cookie-policy input[type=text]{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk input[type=text]:focus,#onetrust-pc-sdk input[type=text]:focus,#ot-sdk-cookie-policy input[type=text]:focus{border:1px solid #000;outline:0}#onetrust-banner-sdk label,#onetrust-pc-sdk label,#ot-sdk-cookie-policy label{display:block;margin-bottom:.5rem;font-weight:600}#onetrust-banner-sdk input[type=checkbox],#onetrust-pc-sdk input[type=checkbox],#ot-sdk-cookie-policy input[type=checkbox]{display:inline}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-pc-sdk ul ul,#ot-sdk-cookie-policy ul ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block}#onetrust-banner-sdk{box-shadow:0 0 18px rgba(0,0,0,.2)}#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk.otFlat.top{top:0px;bottom:auto}#onetrust-banner-sdk.otRelFont{font-size:1rem}#onetrust-banner-sdk>.ot-sdk-container{overflow:hidden}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1.25em 0 .625em 2em;overflow:hidden}#onetrust-banner-sdk #onetrust-policy .ot-gv-list-handler{float:left;font-size:.82em;padding:0;margin-bottom:0;border:0;line-height:normal;height:auto;width:auto}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3;margin-bottom:10px}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk #onetrust-policy-text a{font-weight:bold;margin-left:5px}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2;font-size:.813em;font-weight:600}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-left:0;padding-right:0}#onetrust-banner-sdk .onetrust-close-btn-ui{width:44px;height:44px;background-size:12px;border:none;position:relative;margin:auto;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk.ot-bnr-w-logo .ot-bnr-logo{position:absolute;top:50%;transform:translateY(-50%);left:0px}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-policy{margin-left:65px}#onetrust-banner-sdk .ot-b-addl-desc{clear:both;float:left;display:block}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk .banner-option-input{cursor:pointer;width:auto;height:auto;border:none;padding:0;padding-right:3px;margin:0 0 10px;font-size:.82em;line-height:1.4}#onetrust-banner-sdk .banner-option-input *{pointer-events:none;font-size:inherit;line-height:inherit}#onetrust-banner-sdk .banner-option-input[aria-expanded=true]~.banner-option-details{display:block;height:auto}#onetrust-banner-sdk .banner-option-input[aria-expanded=true] .ot-arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk .banner-option{margin-bottom:12px;margin-left:0;border:none;float:left;padding:0}#onetrust-banner-sdk .banner-option:first-child{padding-left:2px}#onetrust-banner-sdk .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk .banner-option-header{cursor:pointer;display:inline-block}#onetrust-banner-sdk .banner-option-header :first-child{color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk .banner-option-header .ot-arrow-container{display:inline-block;border-top:6px solid rgba(0,0,0,0);border-bottom:6px solid rgba(0,0,0,0);border-left:6px solid dimgray;margin-left:10px;vertical-align:middle}#onetrust-banner-sdk .banner-option-details{display:none;font-size:.83em;line-height:1.5;padding:10px 0px 5px 10px;margin-right:10px;height:0px}#onetrust-banner-sdk .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}#onetrust-banner-sdk .ot-arrow-container,#onetrust-banner-sdk .banner-option-details{transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk .ot-dpd-container{float:left}#onetrust-banner-sdk .ot-dpd-title{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-title,#onetrust-banner-sdk .ot-dpd-desc{font-size:.88em;line-height:1.4;color:dimgray}#onetrust-banner-sdk .ot-dpd-title *,#onetrust-banner-sdk .ot-dpd-desc *{font-size:inherit;line-height:inherit}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text *{margin-bottom:0}#onetrust-banner-sdk.ot-iab-2 .onetrust-vendors-list-handler{display:block;margin-left:0;margin-top:5px;clear:both;margin-bottom:0;padding:0;border:0;height:auto;width:auto}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk.ot-close-btn-link{padding-top:25px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container{top:15px;transform:none;right:15px}#onetrust-banner-sdk.ot-close-btn-link #onetrust-close-btn-container button{padding:0;white-space:pre-wrap;border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em}#onetrust-banner-sdk #onetrust-policy-text,#onetrust-banner-sdk .ot-dpd-desc,#onetrust-banner-sdk .ot-b-addl-desc{font-size:.813em;line-height:1.5}#onetrust-banner-sdk .ot-dpd-desc{margin-bottom:10px}#onetrust-banner-sdk .ot-dpd-desc>.ot-b-addl-desc{margin-top:10px;margin-bottom:10px;font-size:1em}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:6px;right:2px}#onetrust-banner-sdk #onetrust-policy{margin-left:0;margin-top:3em}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{top:auto;transform:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline;float:none}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-close-btn-container{position:absolute;top:0;right:0}#onetrust-banner-sdk #onetrust-policy{margin-left:1em;margin-right:1em}#onetrust-banner-sdk .onetrust-close-btn-ui{top:10px;right:10px}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:95%}#onetrust-banner-sdk.ot-iab-2 #onetrust-group-container{width:100%}#onetrust-banner-sdk.ot-bnr-w-logo #onetrust-button-group-parent{padding-left:50px}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk #onetrust-button-group button{display:inline-block}#onetrust-banner-sdk #onetrust-button-group{margin-right:0;text-align:center}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler{float:left}#onetrust-banner-sdk .has-reject-all-button #onetrust-reject-all-handler,#onetrust-banner-sdk .has-reject-all-button #onetrust-accept-btn-handler{float:right}#onetrust-banner-sdk .has-reject-all-button #onetrust-button-group{width:calc(100% - 2em);margin-right:0}#onetrust-banner-sdk .has-reject-all-button #onetrust-pc-btn-handler.cookie-setting-link{padding-left:0px;text-align:left}#onetrust-banner-sdk.ot-buttons-fw .ot-sdk-three button{width:100%;text-align:center}#onetrust-banner-sdk.ot-buttons-fw #onetrust-button-group-parent button{float:none}#onetrust-banner-sdk.ot-buttons-fw #onetrust-pc-btn-handler.cookie-setting-link{text-align:center}}@media only screen and (min-width: 550px){#onetrust-banner-sdk .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}@media only screen and (min-width: 425px)and (max-width: 550px){#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group,#onetrust-banner-sdk.ot-iab-2 #onetrust-policy,#onetrust-banner-sdk.ot-iab-2 .banner-option{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-accept-btn-handler,#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group #onetrust-reject-all-handler{float:left}}@media only screen and (min-width: 769px){#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1.25em;width:calc(100% - 7em)}}@media only screen and (min-width: 897px)and (max-width: 1023px){#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:75%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{position:relative;margin:0;right:-22px;top:2px}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-close-btn-container{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;right:0}#onetrust-banner-sdk #onetrust-close-btn-container button{right:-12px}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk .ot-optout-signal{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-title{width:50%}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text,#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:1em;width:50%;border-right:1px solid #d8d8d8;padding-right:1rem}#onetrust-banner-sdk.ot-iab-2 #onetrust-policy-text{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 :not(.ot-dpd-desc)>.ot-b-addl-desc{margin-bottom:0;padding-bottom:1em}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-container{width:45%;padding-left:1rem;display:inline-block;float:none}#onetrust-banner-sdk.ot-iab-2 .ot-dpd-title{line-height:1.7}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group-parent{left:auto;right:4%;margin-left:0}#onetrust-banner-sdk.ot-iab-2 #onetrust-button-group button{display:block}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:auto;width:30%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 890px){#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group-parent{padding-left:3%;padding-right:4%;margin-left:0}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{margin-right:0;margin-top:1.25em;width:100%}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button{width:100%;margin-bottom:5px;margin-top:5px}#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type{margin-bottom:20px}}@media only screen and (min-width: 1280px){#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{width:55%}#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{width:44%;padding-left:2%;padding-right:2%}#onetrust-banner-sdk:not(.ot-iab-2).vertical-align-content #onetrust-button-group-parent{position:absolute;left:55%}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                    #onetrust-consent-sdk #onetrust-policy-text,
                    #onetrust-consent-sdk .ot-b-addl-desc,
                    #onetrust-consent-sdk .ot-dpd-desc,
                    #onetrust-consent-sdk .ot-dpd-title,
                    #onetrust-consent-sdk #onetrust-policy-text *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk .ot-dpd-desc *:not(.onetrust-vendors-list-handler),
                    #onetrust-consent-sdk #onetrust-banner-sdk #banner-options *,
                    #onetrust-banner-sdk .ot-cat-header,
                    #onetrust-banner-sdk .ot-optout-signal
                    {
                        color: #2E2E2E;
                    }
            #onetrust-consent-sdk #onetrust-banner-sdk .banner-option-details {
                    background-color: #E9E9E9;}
             #onetrust-consent-sdk #onetrust-banner-sdk a[href],
                    #onetrust-consent-sdk #onetrust-banner-sdk a[href] font,
                    #onetrust-consent-sdk #onetrust-banner-sdk .ot-link-btn
                        {
                            color: #007398;
                        }#onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler {
                            background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-banner-sdk *:focus,
            #onetrust-consent-sdk #onetrust-banner-sdk:focus {
               outline-color: #000000;
               outline-width: 1px;
            }
            #onetrust-consent-sdk #onetrust-pc-btn-handler,
            #onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                color: #6CC04A; border-color: #6CC04A;
                background-color:
                #FFF;
            }/*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
#onetrust-pc-sdk.otPcCenter{overflow:hidden;position:fixed;margin:0 auto;top:5%;right:0;left:0;width:40%;max-width:575px;min-width:575px;border-radius:2.5px;z-index:2147483647;background-color:#fff;-webkit-box-shadow:0px 2px 10px -3px #999;-moz-box-shadow:0px 2px 10px -3px #999;box-shadow:0px 2px 10px -3px #999}#onetrust-pc-sdk.otPcCenter[dir=rtl]{right:0;left:0}#onetrust-pc-sdk.otRelFont{font-size:1rem}#onetrust-pc-sdk .ot-optout-signal{margin-top:.625rem}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus,#onetrust-pc-sdk .ot-hide-tgl{visibility:hidden}#onetrust-pc-sdk #ot-addtl-venlst .ot-arw-cntr *,#onetrust-pc-sdk #ot-addtl-venlst .ot-plus-minus *,#onetrust-pc-sdk .ot-hide-tgl *{visibility:hidden}#onetrust-pc-sdk #ot-gn-venlst .ot-ven-item .ot-acc-hdr{min-height:40px}#onetrust-pc-sdk .ot-pc-header{height:39px;padding:10px 0 10px 30px;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk #ot-pc-title,#onetrust-pc-sdk #ot-category-title,#onetrust-pc-sdk .ot-cat-header,#onetrust-pc-sdk #ot-lst-title,#onetrust-pc-sdk .ot-ven-hdr .ot-ven-name,#onetrust-pc-sdk .ot-always-active{font-weight:bold;color:dimgray}#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:55%;font-weight:700}#onetrust-pc-sdk .ot-cat-item p{clear:both;float:left;margin-top:10px;margin-bottom:5px;line-height:1.5;font-size:.812em;color:dimgray}#onetrust-pc-sdk .ot-close-icon{height:44px;width:44px;background-size:10px}#onetrust-pc-sdk #ot-pc-title{float:left;font-size:1em;line-height:1.5;margin-bottom:10px;margin-top:10px;width:100%}#onetrust-pc-sdk #accept-recommended-btn-handler{margin-right:10px;margin-bottom:25px;outline-offset:-1px}#onetrust-pc-sdk #ot-pc-desc{clear:both;width:100%;font-size:.812em;line-height:1.5;margin-bottom:25px}#onetrust-pc-sdk #ot-pc-desc *{font-size:inherit;line-height:inherit}#onetrust-pc-sdk #ot-pc-desc ul li{padding:10px 0px}#onetrust-pc-sdk a{color:#656565;cursor:pointer}#onetrust-pc-sdk a:hover{color:#3860be}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk #vdr-lst-dsc{font-size:.812em;line-height:1.5;padding:10px 15px 5px 15px}#onetrust-pc-sdk button{max-width:394px;padding:12px 30px;line-height:1;word-break:break-word;word-wrap:break-word;white-space:normal;font-weight:bold;height:auto}#onetrust-pc-sdk .ot-link-btn{padding:0;margin-bottom:0;border:0;font-weight:normal;line-height:normal;width:auto;height:auto}#onetrust-pc-sdk #ot-pc-content{position:absolute;overflow-y:scroll;padding-left:2px;padding-right:30px;top:60px;bottom:110px;margin:1px 3px 0 30px;width:calc(100% - 63px)}#onetrust-pc-sdk .ot-vs-list .ot-always-active,#onetrust-pc-sdk .ot-cat-grp .ot-always-active{float:right;clear:none;color:#3860be;margin:0;font-size:.813em;line-height:1.3}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-track{margin-right:20px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .ot-pc-scrollbar::-webkit-scrollbar-thumb{border-radius:10px;background:#d8d8d8}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-pc-scrollbar{scrollbar-arrow-color:#d8d8d8;scrollbar-darkshadow-color:#d8d8d8;scrollbar-face-color:#d8d8d8;scrollbar-shadow-color:#d8d8d8}#onetrust-pc-sdk .save-preference-btn-handler{margin-right:20px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-right:10px}#onetrust-pc-sdk #ot-pc-desc .privacy-notice-link{margin-left:0;margin-right:8px}#onetrust-pc-sdk #ot-pc-desc .ot-imprint-handler{margin-left:0;margin-right:8px}#onetrust-pc-sdk .ot-subgrp-cntr{display:inline-block;clear:both;width:100%;padding-top:15px}#onetrust-pc-sdk .ot-switch+.ot-subgrp-cntr{padding-top:10px}#onetrust-pc-sdk ul.ot-subgrps{margin:0;font-size:initial}#onetrust-pc-sdk ul.ot-subgrps li p,#onetrust-pc-sdk ul.ot-subgrps li h5{font-size:.813em;line-height:1.4;color:dimgray}#onetrust-pc-sdk ul.ot-subgrps .ot-switch{min-height:auto}#onetrust-pc-sdk ul.ot-subgrps .ot-switch-nob{top:0}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr{display:inline-block;width:100%}#onetrust-pc-sdk ul.ot-subgrps .ot-acc-txt{margin:0}#onetrust-pc-sdk ul.ot-subgrps li{padding:0;border:none}#onetrust-pc-sdk ul.ot-subgrps li h5{position:relative;top:5px;font-weight:bold;margin-bottom:0;float:left}#onetrust-pc-sdk li.ot-subgrp{margin-left:20px;overflow:auto}#onetrust-pc-sdk li.ot-subgrp>h5{width:calc(100% - 100px)}#onetrust-pc-sdk .ot-cat-item p>ul,#onetrust-pc-sdk li.ot-subgrp p>ul{margin:0px;list-style:disc;margin-left:15px;font-size:inherit}#onetrust-pc-sdk .ot-cat-item p>ul li,#onetrust-pc-sdk li.ot-subgrp p>ul li{font-size:inherit;padding-top:10px;padding-left:0px;padding-right:0px;border:none}#onetrust-pc-sdk .ot-cat-item p>ul li:last-child,#onetrust-pc-sdk li.ot-subgrp p>ul li:last-child{padding-bottom:10px}#onetrust-pc-sdk .ot-pc-logo{height:40px;width:120px}#onetrust-pc-sdk .ot-pc-footer{position:absolute;bottom:0px;width:100%;max-height:160px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-refuse-all-handler{margin-bottom:0px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:160px}#onetrust-pc-sdk.ot-ftr-stacked .ot-pc-footer button{width:100%;max-width:none}#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:0 30px;width:calc(100% - 60px);padding-right:0}#onetrust-pc-sdk .ot-pc-footer-logo{height:30px;width:100%;text-align:right;background:#f4f4f4}#onetrust-pc-sdk .ot-pc-footer-logo a{display:inline-block;margin-top:5px;margin-right:10px}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo{direction:rtl}#onetrust-pc-sdk[dir=rtl] .ot-pc-footer-logo a{margin-right:25px}#onetrust-pc-sdk .ot-tgl{float:right;position:relative;z-index:1}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background-color:#468254;border:1px solid #fff}#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{-webkit-transform:translateX(20px);-ms-transform:translateX(20px);transform:translateX(20px);background-color:#fff;border-color:#fff}#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch{outline:#000 solid 1px}#onetrust-pc-sdk .ot-switch{position:relative;display:inline-block;width:45px;height:25px}#onetrust-pc-sdk .ot-switch-nob{position:absolute;cursor:pointer;top:0;left:0;right:0;bottom:0;background-color:#767676;border:1px solid #ddd;transition:all .2s ease-in 0s;-moz-transition:all .2s ease-in 0s;-o-transition:all .2s ease-in 0s;-webkit-transition:all .2s ease-in 0s;border-radius:20px}#onetrust-pc-sdk .ot-switch-nob:before{position:absolute;content:"";height:18px;width:18px;bottom:3px;left:3px;background-color:#fff;-webkit-transition:.4s;transition:.4s;border-radius:20px}#onetrust-pc-sdk .ot-chkbox input:checked~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]~label::before{background-color:#3860be}#onetrust-pc-sdk .ot-chkbox input[aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox label{position:relative;display:inline-block;padding-left:30px;cursor:pointer;font-weight:500}#onetrust-pc-sdk .ot-chkbox label::before,#onetrust-pc-sdk .ot-chkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-chkbox label::before{height:18px;width:18px;border:1px solid #3860be;left:0px;top:auto}#onetrust-pc-sdk .ot-chkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-label-txt{display:none}#onetrust-pc-sdk .ot-chkbox input,#onetrust-pc-sdk .ot-tgl input{position:absolute;opacity:0;width:0;height:0}#onetrust-pc-sdk .ot-arw-cntr{float:right;position:relative;pointer-events:none}#onetrust-pc-sdk .ot-arw-cntr .ot-arw{width:16px;height:16px;margin-left:5px;color:dimgray;display:inline-block;vertical-align:middle;-webkit-transition:all 150ms ease-in 0s;-moz-transition:all 150ms ease-in 0s;-o-transition:all 150ms ease-in 0s;transition:all 150ms ease-in 0s}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw-cntr svg{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:#000 1px solid}#onetrust-pc-sdk .ot-tgl-cntr,#onetrust-pc-sdk .ot-arw-cntr{display:inline-block}#onetrust-pc-sdk .ot-tgl-cntr{width:45px;float:right;margin-top:2px}#onetrust-pc-sdk #ot-lst-cnt .ot-tgl-cntr{margin-top:10px}#onetrust-pc-sdk .ot-always-active-subgroup{width:auto;padding-left:0px !important;top:3px;position:relative}#onetrust-pc-sdk .ot-label-status{font-size:.75em;display:none;font-size:.75em;position:relative;top:2px;padding-right:5px;float:left}#onetrust-pc-sdk .ot-arw-cntr{margin-top:-1px}#onetrust-pc-sdk .ot-arw-cntr svg{-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s;transition:all 300ms ease-in 0s;height:10px;width:10px}#onetrust-pc-sdk input:checked~.ot-acc-hdr .ot-arw{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk .ot-arw{width:10px;margin-left:15px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0}#onetrust-pc-sdk .ot-hlst-cntr{margin-top:5px;display:inline-block;width:100%}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{clear:both;color:#3860be;margin-left:0;font-size:.813em;text-decoration:none;float:left;overflow:hidden}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-vendors-list-handler+a:hover,#onetrust-pc-sdk .category-host-list-handler:hover{text-decoration-line:underline}#onetrust-pc-sdk .category-vendors-list-handler+a{clear:none}#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{display:inline-block;height:13px;width:13px;background-repeat:no-repeat;margin-left:1px;margin-top:6px;cursor:pointer}#onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{margin-bottom:-1px}#onetrust-pc-sdk .back-btn-handler{font-size:1em;text-decoration:none}#onetrust-pc-sdk .back-btn-handler:hover{opacity:.6}#onetrust-pc-sdk #ot-lst-title h3{display:inline-block;word-break:break-word;word-wrap:break-word;margin-bottom:0;color:#656565;font-size:1em;font-weight:bold;margin-left:15px}#onetrust-pc-sdk #ot-lst-title{margin:10px 0 10px 0px;font-size:1em;text-align:left}#onetrust-pc-sdk #ot-pc-hdr{margin:0 0 0 30px;height:auto;width:auto}#onetrust-pc-sdk #ot-pc-hdr input::placeholder{color:#707070;font-style:italic}#onetrust-pc-sdk #vendor-search-handler{height:31px;width:100%;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left;margin-left:15px}#onetrust-pc-sdk .ot-ven-name{display:block;width:auto;padding-right:5px}#onetrust-pc-sdk #ot-lst-cnt{overflow-y:auto;margin-left:20px;margin-right:7px;width:calc(100% - 27px);max-height:calc(100% - 80px);height:100%;transform:translate3d(0, 0, 0)}#onetrust-pc-sdk #ot-pc-lst{width:100%;bottom:100px;position:absolute;top:60px}#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr .ot-arw-cntr *{visibility:hidden}#onetrust-pc-sdk #ot-pc-lst .ot-tgl-cntr{right:12px;position:absolute}#onetrust-pc-sdk #ot-pc-lst .ot-arw-cntr{float:right;position:relative}#onetrust-pc-sdk #ot-pc-lst .ot-arw{margin-left:10px}#onetrust-pc-sdk #ot-pc-lst .ot-acc-hdr{overflow:hidden;cursor:pointer}#onetrust-pc-sdk .ot-vlst-cntr{overflow:hidden}#onetrust-pc-sdk #ot-sel-blk{overflow:hidden;width:100%;position:sticky;position:-webkit-sticky;top:0;z-index:3}#onetrust-pc-sdk #ot-back-arw{height:12px;width:12px}#onetrust-pc-sdk .ot-lst-subhdr{width:100%;display:inline-block}#onetrust-pc-sdk .ot-search-cntr{float:left;width:78%;position:relative}#onetrust-pc-sdk .ot-search-cntr>svg{width:30px;height:30px;position:absolute;float:left;right:-15px}#onetrust-pc-sdk .ot-fltr-cntr{float:right;right:50px;position:relative}#onetrust-pc-sdk #filter-btn-handler{background-color:#3860be;border-radius:17px;display:inline-block;position:relative;width:32px;height:32px;-moz-transition:.1s ease;-o-transition:.1s ease;-webkit-transition:1s ease;transition:.1s ease;padding:0;margin:0}#onetrust-pc-sdk #filter-btn-handler:hover{background-color:#3860be}#onetrust-pc-sdk #filter-btn-handler svg{width:12px;height:12px;margin:3px 10px 0 10px;display:block;position:static;right:auto;top:auto}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{color:#3860be;text-decoration:none;font-weight:100;display:inline-block;padding-top:10px;transform:translate(0, 1%);-o-transform:translate(0, 1%);-ms-transform:translate(0, 1%);-webkit-transform:translate(0, 1%);position:relative;z-index:2}#onetrust-pc-sdk .ot-ven-link *,#onetrust-pc-sdk .ot-ven-legclaim-link *{font-size:inherit}#onetrust-pc-sdk .ot-ven-link:hover,#onetrust-pc-sdk .ot-ven-legclaim-link:hover{text-decoration:underline}#onetrust-pc-sdk .ot-ven-hdr{width:calc(100% - 160px);height:auto;float:left;word-break:break-word;word-wrap:break-word;vertical-align:middle;padding-bottom:3px}#onetrust-pc-sdk .ot-ven-link,#onetrust-pc-sdk .ot-ven-legclaim-link{letter-spacing:.03em;font-size:.75em;font-weight:400}#onetrust-pc-sdk .ot-ven-dets{border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-ven-dets li:first-child p:first-child{border-top:none}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:not(:first-child){border-top:1px solid #ddd !important}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(odd){width:30%}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc:nth-child(n+3) p:nth-of-type(even){width:50%;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p,#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{padding-top:5px;padding-bottom:5px;display:block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc h5{display:inline-block}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-last-child(-n+1){padding-bottom:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc p:nth-child(-n+2):not(.disc-pur){padding-top:10px}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur-cont{display:inline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur{position:relative;width:50% !important;word-break:break-word;word-wrap:break-word;left:calc(30% + 17px)}#onetrust-pc-sdk .ot-ven-dets .ot-ven-disc .disc-pur:nth-child(-n+1){position:static}#onetrust-pc-sdk .ot-ven-dets p,#onetrust-pc-sdk .ot-ven-dets h5,#onetrust-pc-sdk .ot-ven-dets span{font-size:.69em;text-align:left;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-bottom:10px;padding-left:15px;color:#2e3644}#onetrust-pc-sdk .ot-ven-dets h5{padding-top:5px}#onetrust-pc-sdk .ot-ven-dets span{color:dimgray;padding:0;vertical-align:baseline}#onetrust-pc-sdk .ot-ven-dets .ot-ven-pur h5{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;padding-bottom:5px;margin-bottom:5px;font-weight:bold}#onetrust-pc-sdk #ot-host-lst .ot-sel-all{float:right;position:relative;margin-right:42px;top:10px}#onetrust-pc-sdk #ot-host-lst .ot-sel-all input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #ot-host-lst .ot-sel-all label{height:20px;width:20px;padding-left:0px}#onetrust-pc-sdk #ot-host-lst .ot-acc-txt{overflow:hidden;width:95%}#onetrust-pc-sdk .ot-host-hdr{position:relative;z-index:1;pointer-events:none;width:calc(100% - 125px);float:left}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-desc{display:inline-block;width:90%}#onetrust-pc-sdk .ot-host-name{pointer-events:none}#onetrust-pc-sdk .ot-host-hdr>a{text-decoration:underline;font-size:.82em;position:relative;z-index:2;float:left;margin-bottom:5px;pointer-events:initial}#onetrust-pc-sdk .ot-host-name+a{margin-top:5px}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a,#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{color:dimgray;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-name,#onetrust-pc-sdk .ot-host-name a{font-weight:bold;font-size:.82em;line-height:1.3}#onetrust-pc-sdk .ot-host-name a{font-size:1em}#onetrust-pc-sdk .ot-host-expand{margin-top:3px;margin-bottom:3px;clear:both;display:block;color:#3860be;font-size:.72em;font-weight:normal}#onetrust-pc-sdk .ot-host-expand *{font-size:inherit}#onetrust-pc-sdk .ot-host-desc,#onetrust-pc-sdk .ot-host-info{font-size:.688em;line-height:1.4;font-weight:normal}#onetrust-pc-sdk .ot-host-desc{margin-top:10px}#onetrust-pc-sdk .ot-host-opt{margin:0;font-size:inherit;display:inline-block;width:100%}#onetrust-pc-sdk .ot-host-opt li>div div{font-size:.8em;padding:5px 0}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk .ot-host-opt li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-host-info{border:none;display:inline-block;width:calc(100% - 10px);padding:10px;margin-bottom:10px;background-color:#f8f8f8}#onetrust-pc-sdk .ot-host-info>div{overflow:auto}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk #ot-fltr-modal{width:100%;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow:hidden;opacity:1;right:0}#onetrust-pc-sdk #ot-fltr-modal .ot-label-txt{display:inline-block;font-size:.85em;color:dimgray}#onetrust-pc-sdk #ot-fltr-cnt{z-index:2147483646;background-color:#fff;position:absolute;height:90%;max-height:300px;width:325px;left:210px;margin-top:10px;margin-bottom:20px;padding-right:10px;border-radius:3px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-scrlcnt{overflow-y:auto;overflow-x:hidden;clear:both;max-height:calc(100% - 60px)}#onetrust-pc-sdk #ot-anchor{border:12px solid rgba(0,0,0,0);display:none;position:absolute;z-index:2147483647;right:55px;top:75px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk .ot-fltr-btns{margin-left:15px}#onetrust-pc-sdk #filter-apply-handler{margin-right:15px}#onetrust-pc-sdk .ot-fltr-opt{margin-bottom:5px;margin-left:15px;min-height:20px;width:75%;position:relative}#onetrust-pc-sdk .ot-fltr-opt p{display:inline-block;margin:0;font-size:.9em;color:#2e3644}#onetrust-pc-sdk .ot-chkbox label span{font-size:.85em;color:dimgray}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox][aria-checked=mixed]+label::after{content:""}#onetrust-pc-sdk .ot-chkbox input[type=checkbox]:focus+label::before{outline-style:solid;outline-width:2px;outline-style:auto}#onetrust-pc-sdk #ot-selall-vencntr,#onetrust-pc-sdk #ot-selall-adtlvencntr,#onetrust-pc-sdk #ot-selall-hostcntr,#onetrust-pc-sdk #ot-selall-licntr,#onetrust-pc-sdk #ot-selall-gnvencntr{right:15px;position:relative;width:20px;height:20px;float:right}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label,#onetrust-pc-sdk #ot-selall-gnvencntr label{float:left;padding-left:0}#onetrust-pc-sdk #ot-ven-lst:first-child{border-top:1px solid #e2e2e2}#onetrust-pc-sdk ul{list-style:none;padding:0}#onetrust-pc-sdk ul li{position:relative;margin:0;padding:15px 15px 15px 10px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk ul li h3,#onetrust-pc-sdk ul li h4{font-size:.75em;color:#656565;margin:0;display:inline-block;width:70%;height:auto;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk ul li p{margin:0;font-size:.7em}#onetrust-pc-sdk ul li input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk .ot-cat-item>button:focus,#onetrust-pc-sdk .ot-acc-cntr>button:focus,#onetrust-pc-sdk li>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-cat-item>button,#onetrust-pc-sdk .ot-acc-cntr>button,#onetrust-pc-sdk li>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=false]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-txt,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-cat-item>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk .ot-acc-cntr>button[aria-expanded=true]~.ot-acc-grpcntr,#onetrust-pc-sdk li>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-host-item>button:focus,#onetrust-pc-sdk .ot-ven-item>button:focus{outline:0;border:2px solid #000}#onetrust-pc-sdk .ot-hide-acc>button{pointer-events:none}#onetrust-pc-sdk .ot-hide-acc .ot-plus-minus>*,#onetrust-pc-sdk .ot-hide-acc .ot-arw-cntr>*{visibility:hidden}#onetrust-pc-sdk .ot-hide-acc .ot-acc-hdr{min-height:30px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt){padding-right:10px;width:calc(100% - 37px);margin-top:10px;max-height:calc(100% - 90px)}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk{background-color:#f9f9fc;border:1px solid #e2e2e2;width:calc(100% - 2px);padding-bottom:5px;padding-top:5px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt{border:unset;background-color:unset}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all-hdr{display:none}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all{padding-right:.5rem}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) #ot-sel-blk.ot-vnd-list-cnt .ot-sel-all .ot-chkbox{right:0}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all{padding-right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-sel-all-chkbox{width:auto}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) ul li{border:1px solid #e2e2e2;margin-bottom:10px}#onetrust-pc-sdk.ot-addtl-vendors #ot-lst-cnt:not(.ot-host-cnt) .ot-acc-cntr>.ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk.ot-addtl-vendors .ot-sel-all-chkbox{float:right}#onetrust-pc-sdk.ot-addtl-vendors .ot-plus-minus~.ot-sel-all-chkbox{right:34px}#onetrust-pc-sdk.ot-addtl-vendors #ot-ven-lst:first-child{border-top:none}#onetrust-pc-sdk .ot-acc-cntr{position:relative;border-left:1px solid #e2e2e2;border-right:1px solid #e2e2e2;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr input{z-index:1}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr{background-color:#f9f9fc;padding:5px 0 5px 15px;width:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-plus-minus{vertical-align:middle;top:auto}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr .ot-arw-cntr{right:10px}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-hdr input{z-index:2}#onetrust-pc-sdk .ot-acc-cntr.ot-add-tech .ot-acc-hdr{padding:10px 0 10px 15px}#onetrust-pc-sdk .ot-acc-cntr>input[type=checkbox]:checked~.ot-acc-hdr{border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .ot-acc-cntr>.ot-acc-txt{padding-left:10px;padding-right:10px}#onetrust-pc-sdk .ot-acc-cntr button[aria-expanded=true]~.ot-acc-txt{width:auto}#onetrust-pc-sdk .ot-acc-cntr .ot-addtl-venbox{display:none}#onetrust-pc-sdk .ot-vlst-cntr{margin-bottom:0;width:100%}#onetrust-pc-sdk .ot-vensec-title{font-size:.813em;vertical-align:middle;display:inline-block}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a{margin-left:0;margin-top:10px}#onetrust-pc-sdk #ot-selall-vencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-adtlvencntr.line-through label::after,#onetrust-pc-sdk #ot-selall-licntr.line-through label::after,#onetrust-pc-sdk #ot-selall-hostcntr.line-through label::after,#onetrust-pc-sdk #ot-selall-gnvencntr.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:5px;top:9px}#onetrust-pc-sdk #ot-category-title{float:left;padding-bottom:10px;font-size:1em;width:100%}#onetrust-pc-sdk .ot-cat-grp{margin-top:10px}#onetrust-pc-sdk .ot-cat-item{line-height:1.1;margin-top:10px;display:inline-block;width:100%}#onetrust-pc-sdk .ot-btn-container{text-align:right}#onetrust-pc-sdk .ot-btn-container button{display:inline-block;font-size:.75em;letter-spacing:.08em;margin-top:19px}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon{position:absolute;top:10px;right:0;z-index:1;padding:0;background-color:rgba(0,0,0,0);border:none}#onetrust-pc-sdk #close-pc-btn-handler.ot-close-icon svg{display:block;height:10px;width:10px}#onetrust-pc-sdk #clear-filters-handler{margin-top:20px;margin-bottom:10px;float:right;max-width:200px;text-decoration:none;color:#3860be;font-size:.9em;font-weight:bold;background-color:rgba(0,0,0,0);border-color:rgba(0,0,0,0);padding:1px}#onetrust-pc-sdk #clear-filters-handler:hover{color:#2285f7}#onetrust-pc-sdk #clear-filters-handler:focus{outline:#000 solid 1px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl,#onetrust-pc-sdk .ot-enbl-chr h4~.ot-always-active{right:45px}#onetrust-pc-sdk .ot-enbl-chr h4~.ot-tgl+.ot-tgl{right:120px}#onetrust-pc-sdk .ot-enbl-chr .ot-pli-hdr.ot-leg-border-color span:first-child{width:90px}#onetrust-pc-sdk .ot-enbl-chr li.ot-subgrp>h5+.ot-tgl-cntr{padding-right:25px}#onetrust-pc-sdk .ot-plus-minus{width:20px;height:20px;font-size:1.5em;position:relative;display:inline-block;margin-right:5px;top:3px}#onetrust-pc-sdk .ot-plus-minus span{position:absolute;background:#27455c;border-radius:1px}#onetrust-pc-sdk .ot-plus-minus span:first-of-type{top:25%;bottom:25%;width:10%;left:45%}#onetrust-pc-sdk .ot-plus-minus span:last-of-type{left:25%;right:25%;height:10%;top:45%}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-arw,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:first-of-type,#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{transform:rotate(90deg)}#onetrust-pc-sdk button[aria-expanded=true]~.ot-acc-hdr .ot-plus-minus span:last-of-type{left:50%;right:50%}#onetrust-pc-sdk #ot-selall-vencntr label,#onetrust-pc-sdk #ot-selall-adtlvencntr label,#onetrust-pc-sdk #ot-selall-hostcntr label,#onetrust-pc-sdk #ot-selall-licntr label{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk .ot-host-item .ot-plus-minus,#onetrust-pc-sdk .ot-ven-item .ot-plus-minus{float:left;margin-right:8px;top:10px}#onetrust-pc-sdk .ot-ven-item ul{list-style:none inside;font-size:100%;margin:0}#onetrust-pc-sdk .ot-ven-item ul li{margin:0 !important;padding:0;border:none !important}#onetrust-pc-sdk .ot-pli-hdr{color:#77808e;overflow:hidden;padding-top:7.5px;padding-bottom:7.5px;width:calc(100% - 2px);border-top-left-radius:3px;border-top-right-radius:3px}#onetrust-pc-sdk .ot-pli-hdr span:first-child{top:50%;transform:translateY(50%);max-width:90px}#onetrust-pc-sdk .ot-pli-hdr span:last-child{padding-right:10px;max-width:95px;text-align:center}#onetrust-pc-sdk .ot-li-title{float:right;font-size:.813em}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color{background-color:#f4f4f4;border:1px solid #d8d8d8}#onetrust-pc-sdk .ot-pli-hdr.ot-leg-border-color span:first-child{text-align:left;width:70px}#onetrust-pc-sdk li.ot-subgrp>h5,#onetrust-pc-sdk .ot-cat-header{width:calc(100% - 130px)}#onetrust-pc-sdk li.ot-subgrp>h5+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-acc-grpdesc{margin-bottom:5px}#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-acc-grpcntr .ot-vlst-cntr+.ot-subgrp-cntr{border-top:none}#onetrust-pc-sdk .ot-acc-hdr .ot-arw-cntr+.ot-tgl-cntr,#onetrust-pc-sdk .ot-acc-txt h4+.ot-tgl-cntr{padding-left:13px}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-subgrp>h5,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header{width:calc(100% - 145px)}#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item h5+.ot-tgl-cntr,#onetrust-pc-sdk .ot-pli-hdr~.ot-cat-item .ot-cat-header+.ot-tgl{padding-left:28px}#onetrust-pc-sdk .ot-sel-all-hdr,#onetrust-pc-sdk .ot-sel-all-chkbox{display:inline-block;width:100%;position:relative}#onetrust-pc-sdk .ot-sel-all-chkbox{z-index:1}#onetrust-pc-sdk .ot-sel-all{margin:0;position:relative;padding-right:23px;float:right}#onetrust-pc-sdk .ot-consent-hdr,#onetrust-pc-sdk .ot-li-hdr{float:right;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-li-hdr{max-width:100px;padding-right:10px}#onetrust-pc-sdk .ot-consent-hdr{max-width:55px}#onetrust-pc-sdk #ot-selall-licntr{display:block;width:21px;height:auto;float:right;position:relative;right:80px}#onetrust-pc-sdk #ot-selall-licntr label{position:absolute}#onetrust-pc-sdk .ot-ven-ctgl{margin-left:66px}#onetrust-pc-sdk .ot-ven-litgl+.ot-arw-cntr{margin-left:81px}#onetrust-pc-sdk .ot-enbl-chr .ot-host-cnt .ot-tgl-cntr{width:auto}#onetrust-pc-sdk #ot-lst-cnt:not(.ot-host-cnt) .ot-tgl-cntr{width:auto;top:auto;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox{position:relative;display:inline-block;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-chkbox label{position:absolute;padding:0;width:20px;height:20px}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-acc-grpdesc+.ot-leg-btn-container{padding-left:20px;padding-right:20px;width:calc(100% - 40px);margin-bottom:5px}#onetrust-pc-sdk .ot-subgrp .ot-leg-btn-container{margin-bottom:5px}#onetrust-pc-sdk #ot-ven-lst .ot-leg-btn-container{margin-top:10px}#onetrust-pc-sdk .ot-leg-btn-container{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .ot-leg-btn-container button{height:auto;padding:6.5px 8px;margin-bottom:0;letter-spacing:0;font-size:.75em;line-height:normal}#onetrust-pc-sdk .ot-leg-btn-container svg{display:none;height:14px;width:14px;padding-right:5px;vertical-align:sub}#onetrust-pc-sdk .ot-active-leg-btn{cursor:default;pointer-events:none}#onetrust-pc-sdk .ot-active-leg-btn svg{display:inline-block}#onetrust-pc-sdk .ot-remove-objection-handler{text-decoration:underline;padding:0;font-size:.75em;font-weight:600;line-height:1;padding-left:10px}#onetrust-pc-sdk .ot-obj-leg-btn-handler span{font-weight:bold;text-align:center;font-size:inherit;line-height:1.5}#onetrust-pc-sdk.ot-close-btn-link #close-pc-btn-handler{border:none;height:auto;line-height:1.5;text-decoration:underline;font-size:.69em;background:none;right:15px;top:15px;width:auto;font-weight:normal}#onetrust-pc-sdk .ot-pgph-link{font-size:.813em !important;margin-top:5px;position:relative}#onetrust-pc-sdk .ot-pgph-link.ot-pgph-link-subgroup{margin-bottom:1rem}#onetrust-pc-sdk .ot-pgph-contr{margin:0 2.5rem}#onetrust-pc-sdk .ot-pgph-title{font-size:1.18rem;margin-bottom:2rem}#onetrust-pc-sdk .ot-pgph-desc{font-size:1rem;font-weight:400;margin-bottom:2rem;line-height:1.5rem}#onetrust-pc-sdk .ot-pgph-desc:not(:last-child):after{content:"";width:96%;display:block;margin:0 auto;padding-bottom:2rem;border-bottom:1px solid #e9e9e9}#onetrust-pc-sdk .ot-cat-header{float:left;font-weight:600;font-size:.875em;line-height:1.5;max-width:90%;vertical-align:middle}#onetrust-pc-sdk .ot-vnd-item>button:focus{outline:#000 solid 2px}#onetrust-pc-sdk .ot-vnd-item>button{position:absolute;cursor:pointer;width:100%;height:100%;margin:0;top:0;left:0;z-index:1;max-width:none;border:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=false]~.ot-acc-txt{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-txt{transition:.1s ease-in;margin-top:10px;width:100%;overflow:auto;display:block}#onetrust-pc-sdk .ot-vnd-item>button[aria-expanded=true]~.ot-acc-grpcntr{width:auto;margin-top:0px;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{position:relative;border-radius:2px;margin:0;padding:0;border:1px solid #d8d8d8;border-top:none;width:calc(100% - 2px);float:left}#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{margin-top:10px;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc{padding-left:20px;padding-right:20px;width:calc(100% - 40px);font-size:.812em;margin-bottom:10px;margin-top:15px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul{padding-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpdesc>ul li{padding-top:0;line-height:1.5;padding-bottom:10px}#onetrust-pc-sdk .ot-accordion-layout div+.ot-acc-grpdesc{margin-top:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:first-child{margin-top:10px}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr:last-child,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr:last-child{margin-bottom:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding-top:11.5px;padding-bottom:11.5px;padding-left:20px;padding-right:20px;width:calc(100% - 40px);display:inline-block}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-txt{width:100%;padding:0}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp-cntr{padding-left:20px;padding-right:15px;padding-bottom:0;width:calc(100% - 35px)}#onetrust-pc-sdk .ot-accordion-layout .ot-subgrp{padding-right:5px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-grpcntr{z-index:1;position:relative}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr{position:absolute;top:50%;transform:translateY(-50%);right:20px;margin-top:-2px}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header+.ot-arw-cntr .ot-arw{width:15px;height:20px;margin-left:5px;color:dimgray}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{float:none;color:#2e3644;margin:0;display:inline-block;height:auto;word-wrap:break-word;min-height:inherit}#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr,#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding-left:20px;width:calc(100% - 20px);display:inline-block;margin-top:0;padding-bottom:2px}#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{position:relative;min-height:25px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl,#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{position:absolute;top:50%;transform:translateY(-50%);right:20px}#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl+.ot-tgl{right:95px}#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler,#onetrust-pc-sdk .ot-accordion-layout .category-vendors-list-handler+a{margin-top:5px}#onetrust-pc-sdk #ot-lst-cnt{margin-top:1rem;max-height:calc(100% - 96px)}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 2rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list,#onetrust-pc-sdk .ot-vnd-serv{width:auto;padding:1rem 1.25rem;padding-bottom:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:600;font-size:.95em;line-height:2;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item{border:none;margin:0;padding:0}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button{outline:none;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item button[aria-expanded=true],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item button[aria-expanded=true]{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:first-child{margin-top:.25rem;border-top:unset}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child{margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item:last-child button,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item:last-child button{border-bottom:none}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info-cntr{border:1px solid #d8d8d8;padding:.75rem 1.75rem;padding-bottom:0;width:auto;margin-top:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info{margin-bottom:1rem;padding-left:.75rem;padding-right:.75rem;display:flex;flex-direction:column}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOEmail]{border-top:1px solid #d8d8d8;padding-top:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink],#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info[data-vnd-info-key*=DPOLink]{border-bottom:1px solid #d8d8d8;padding-bottom:1rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-lbl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-lbl{font-weight:bold;font-size:.85em;margin-bottom:.5rem}#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-vnd-info .ot-vnd-cnt,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info .ot-vnd-cnt{margin-left:.5rem;font-weight:500;font-size:.85rem}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt{padding-left:40px}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-size:.8em}#onetrust-pc-sdk .ot-vs-list.ot-vnd-subgrp-cnt .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv.ot-vnd-subgrp-cnt .ot-cat-header{font-size:.8em}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv{margin-bottom:1rem;padding:1rem .95rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr{padding-bottom:.75rem;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .ot-subgrp-cntr .ot-vnd-serv .ot-vnd-serv-hdr-cntr .ot-vnd-serv-hdr{font-weight:700;font-size:.8em;line-height:20px;margin-left:.82rem}#onetrust-pc-sdk .ot-subgrp-cntr .ot-cat-header{font-weight:700;font-size:.8em;line-height:20px}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-vnd-serv .ot-vnd-lst-cont .ot-accordion-layout .ot-acc-hdr div.ot-chkbox{margin-left:.82rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr{padding:.7rem 0;margin:0;display:flex;width:100%;align-items:center;justify-content:space-between}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:first-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:first-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:first-child{margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr div:last-child,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr div:last-child,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr div:last-child{margin-right:.5rem;margin-left:.5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-always-active,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-always-active{position:relative;right:unset;top:unset;transform:unset}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-plus-minus,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-plus-minus{top:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-arw-cntr,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-arw-cntr{float:none;top:unset;right:unset;transform:unset;margin-top:-2px;position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-cat-header,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-cat-header{flex:1;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-tgl,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-tgl{position:relative;transform:none;right:0;top:0;float:none}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox{position:relative;margin:0 .5rem}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label{padding:0}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox label::before,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox label::before{position:relative}#onetrust-pc-sdk .ot-vs-config .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk #ot-pc-lst .ot-vs-list .ot-vnd-item .ot-acc-hdr .ot-chkbox input,#onetrust-pc-sdk .ot-accordion-layout.ot-checkbox-consent .ot-acc-hdr .ot-chkbox input{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0;z-index:1}#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h5.ot-cat-header,#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp .ot-acc-hdr h4.ot-cat-header{margin:0}#onetrust-pc-sdk .ot-vs-config .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp h5{top:0;line-height:20px}#onetrust-pc-sdk .ot-vs-list{display:flex;flex-direction:column;padding:0;margin:.5rem 4px}#onetrust-pc-sdk .ot-vs-selc-all{display:flex;padding:0;float:unset;align-items:center;justify-content:flex-start}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf{justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf.ot-caret-conf .ot-sel-all-chkbox{margin-right:48px}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf .ot-sel-all-chkbox{margin:0;padding:0;margin-right:14px;justify-content:flex-end}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-chkbox,#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr.ot-tgl{display:inline-block;right:unset;width:auto;height:auto;float:none}#onetrust-pc-sdk .ot-vs-selc-all.ot-toggle-conf #ot-selall-vencntr label{width:45px;height:25px}#onetrust-pc-sdk .ot-vs-selc-all .ot-sel-all-chkbox{margin-right:11px;margin-left:.75rem;display:flex;align-items:center}#onetrust-pc-sdk .ot-vs-selc-all .sel-all-hdr{margin:0 1.25rem;font-size:.812em;line-height:normal;text-align:center;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .ot-vnd-list-cnt #ot-selall-vencntr.ot-chkbox{float:unset;right:0}#onetrust-pc-sdk[dir=rtl] #ot-back-arw,#onetrust-pc-sdk[dir=rtl] input~.ot-acc-hdr .ot-arw{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk[dir=rtl] input:checked~.ot-acc-hdr .ot-arw{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk[dir=rtl] .ot-chkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}#onetrust-pc-sdk[dir=rtl] .ot-search-cntr>svg{right:0}@media only screen and (max-width: 600px){#onetrust-pc-sdk.otPcCenter{left:0;min-width:100%;height:100%;top:0;border-radius:0}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk.ot-ftr-stacked .ot-btn-container{margin:1px 3px 0 10px;padding-right:10px;width:calc(100% - 23px)}#onetrust-pc-sdk .ot-btn-container button{max-width:none;letter-spacing:.01em}#onetrust-pc-sdk #close-pc-btn-handler{top:10px;right:17px}#onetrust-pc-sdk p{font-size:.7em}#onetrust-pc-sdk #ot-pc-hdr{margin:10px 10px 0 5px;width:calc(100% - 15px)}#onetrust-pc-sdk .vendor-search-handler{font-size:1em}#onetrust-pc-sdk #ot-back-arw{margin-left:12px}#onetrust-pc-sdk #ot-lst-cnt{margin:0;padding:0 5px 0 10px;min-width:95%}#onetrust-pc-sdk .switch+p{max-width:80%}#onetrust-pc-sdk .ot-ftr-stacked button{width:100%}#onetrust-pc-sdk #ot-fltr-cnt{max-width:320px;width:90%;border-top-right-radius:0;border-bottom-right-radius:0;margin:0;margin-left:15px;left:auto;right:40px;top:85px}#onetrust-pc-sdk .ot-fltr-opt{margin-left:25px;margin-bottom:10px}#onetrust-pc-sdk .ot-pc-refuse-all-handler{margin-bottom:0}#onetrust-pc-sdk #ot-fltr-cnt{right:40px}}@media only screen and (max-width: 476px){#onetrust-pc-sdk .ot-fltr-cntr,#onetrust-pc-sdk #ot-fltr-cnt{right:10px}#onetrust-pc-sdk #ot-anchor{right:25px}#onetrust-pc-sdk button{width:100%}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-sel-all{padding-right:9px}#onetrust-pc-sdk:not(.ot-addtl-vendors) #ot-pc-lst:not(.ot-enbl-chr) .ot-tgl-cntr{right:0}}@media(min-width: 768px){#onetrust-pc-sdk.ot-tgl-with-label .ot-label-status{display:inline}#onetrust-pc-sdk.ot-tgl-with-label #ot-pc-lst .ot-label-status{display:none}}@media only screen and (max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcCenter{left:0;top:0;min-width:100%;height:100%;border-radius:0}#onetrust-pc-sdk .ot-pc-header{height:auto;min-height:20px}#onetrust-pc-sdk .ot-pc-header .ot-pc-logo{max-height:30px}#onetrust-pc-sdk .ot-pc-footer{max-height:60px;overflow-y:auto}#onetrust-pc-sdk #ot-pc-content,#onetrust-pc-sdk #ot-pc-lst{bottom:70px}#onetrust-pc-sdk.ot-ftr-stacked #ot-pc-content{bottom:70px}#onetrust-pc-sdk #ot-anchor{left:initial;right:50px}#onetrust-pc-sdk #ot-lst-title{margin-top:12px}#onetrust-pc-sdk #ot-lst-title *{font-size:inherit}#onetrust-pc-sdk #ot-pc-hdr input{margin-right:0;padding-right:45px}#onetrust-pc-sdk .switch+p{max-width:85%}#onetrust-pc-sdk #ot-sel-blk{position:static}#onetrust-pc-sdk #ot-pc-lst{overflow:auto}#onetrust-pc-sdk #ot-lst-cnt{max-height:none;overflow:initial}#onetrust-pc-sdk #ot-lst-cnt.no-results{height:auto}#onetrust-pc-sdk input{font-size:1em !important}#onetrust-pc-sdk p{font-size:.6em}#onetrust-pc-sdk #ot-fltr-modal{width:100%;top:0}#onetrust-pc-sdk ul li p,#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-vendors-list-handler+a,#onetrust-pc-sdk .category-host-list-handler{font-size:.6em}#onetrust-pc-sdk.ot-shw-fltr #ot-anchor{display:none !important}#onetrust-pc-sdk.ot-shw-fltr #ot-pc-lst{height:100% !important;overflow:hidden;top:0px}#onetrust-pc-sdk.ot-shw-fltr #ot-fltr-cnt{margin:0;height:100%;max-height:none;padding:10px;top:0;width:calc(100% - 20px);position:absolute;right:0;left:0;max-width:none}#onetrust-pc-sdk.ot-shw-fltr .ot-fltr-scrlcnt{max-height:calc(100% - 65px)}}
            #onetrust-consent-sdk #onetrust-pc-sdk,
                #onetrust-consent-sdk #ot-search-cntr,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-switch.ot-toggle,
                #onetrust-consent-sdk #onetrust-pc-sdk ot-grp-hdr1 .checkbox,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title:after
                ,#onetrust-consent-sdk #onetrust-pc-sdk #ot-sel-blk,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-cnt,
                        #onetrust-consent-sdk #onetrust-pc-sdk #ot-anchor {
                    background-color: #FFF;
                }
               
            #onetrust-consent-sdk #onetrust-pc-sdk h3,
                #onetrust-consent-sdk #onetrust-pc-sdk h4,
                #onetrust-consent-sdk #onetrust-pc-sdk h5,
                #onetrust-consent-sdk #onetrust-pc-sdk h6,
                #onetrust-consent-sdk #onetrust-pc-sdk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-ven-lst .ot-ven-opts p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-desc,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-li-title,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-sel-all-hdr span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-fltr-modal #modal-header,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-checkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-sel-blk p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-lst-title h3,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .back-btn-handler p,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst .ot-ven-name,
                #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-lst #ot-ven-lst .consent-category,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-label-status,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-chkbox label span,
                #onetrust-consent-sdk #onetrust-pc-sdk #clear-filters-handler,
                #onetrust-consent-sdk #onetrust-pc-sdk .ot-optout-signal
                {
                    color: #2E2E2E;
                }
             #onetrust-consent-sdk #onetrust-pc-sdk .privacy-notice-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-pgph-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler + a,
                    #onetrust-consent-sdk #onetrust-pc-sdk .category-host-list-handler,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-ven-legclaim-link,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-name a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-acc-hdr .ot-host-expand,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-pc-content #ot-pc-desc .ot-link-btn,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-vnd-serv .ot-vnd-item .ot-vnd-info a,
                    #onetrust-consent-sdk #onetrust-pc-sdk #ot-lst-cnt .ot-vnd-info a
                    {
                        color: #007398;
                    }
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { text-decoration: underline;}
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-subgrp-tgl .ot-switch.ot-toggle
             {
                background-color: #F8F8F8;
            }
             #onetrust-consent-sdk #onetrust-pc-sdk #ot-host-lst .ot-host-info,
                    #onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-txt .ot-ven-dets
                            {
                                background-color: #F8F8F8;
                            }
        #onetrust-consent-sdk #onetrust-pc-sdk
            button:not(#clear-filters-handler):not(.ot-close-icon):not(#filter-btn-handler):not(.ot-remove-objection-handler):not(.ot-obj-leg-btn-handler):not([aria-expanded]):not(.ot-link-btn),
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-active-leg-btn {
                background-color: #007398;border-color: #007398;
                color: #FFF;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-active-menu {
                border-color: #007398;
            }
            
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-remove-objection-handler{
                background-color: transparent;
                border: 1px solid transparent;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-leg-btn-container .ot-inactive-leg-btn {
                background-color: #FFFFFF;
                color: #4D4D4D; border-color: #4D4D4D;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-tgl input:focus + .ot-switch, .ot-switch .ot-switch-nob, .ot-switch .ot-switch-nob:before,
            #onetrust-pc-sdk .ot-checkbox input[type="checkbox"]:focus + label::before,
            #onetrust-pc-sdk .ot-chkbox input[type="checkbox"]:focus + label::before {
                outline-color: #000000;
                outline-width: 1px;
                outline-offset: 1px;
            }
            #onetrust-pc-sdk .ot-host-item > button:focus, #onetrust-pc-sdk .ot-ven-item > button:focus {
                border: 1px solid #000000;
            }
            #onetrust-consent-sdk #onetrust-pc-sdk *:focus,
            #onetrust-consent-sdk #onetrust-pc-sdk .ot-vlst-cntr > a:focus {
               outline: 1px solid #000000;
               outline-offset: 1px;
            }#onetrust-pc-sdk .ot-vlst-cntr .ot-ext-lnk,  #onetrust-pc-sdk .ot-ven-hdr .ot-ext-lnk{
                    background-image: url('https://cdn.cookielaw.org/logos/static/ot_external_link.svg');
                }
            /*! v6.10.0 2021-01-18 */
div#onetrust-consent-sdk #onetrust-banner-sdk{border-top:2px solid #d0d3d4!important;box-shadow:none;padding:24px}div#onetrust-consent-sdk button{border-radius:0!important;box-shadow:none!important;box-sizing:border-box!important;font-size:20px!important;font-weight:400!important;letter-spacing:0!important;max-width:none!important;white-space:nowrap!important}div#onetrust-consent-sdk button:not(.ot-link-btn){background-color:#007dbc!important;border:2px solid #007dbc!important;color:#fff!important;height:48px!important;padding:0 1em!important;width:auto!important}div#onetrust-consent-sdk button:hover{background-color:#fff!important;border-color:#949494!important;color:#2e2e2e!important}div#onetrust-consent-sdk button.ot-link-btn{color:#007dbc!important;font-size:16px!important;text-decoration:underline}div#onetrust-consent-sdk button.ot-link-btn:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-consent-sdk a,div#onetrust-pc-sdk a{color:#007dbc!important;text-decoration:underline!important}div#onetrust-consent-sdk a,div#onetrust-consent-sdk button,div#onetrust-consent-sdk p:hover{opacity:1!important}div#onetrust-consent-sdk a:focus,div#onetrust-consent-sdk button:focus,div#onetrust-consent-sdk input:focus{outline:2px solid #949494!important;outline-offset:1px!important}div#onetrust-banner-sdk .ot-sdk-container{padding:0;width:auto}div#onetrust-banner-sdk .ot-sdk-row{align-items:flex-start;box-sizing:border-box;display:flex;flex-direction:column;justify-content:space-between;margin:auto;max-width:1152px}div#onetrust-banner-sdk .ot-sdk-row:after{display:none}div#onetrust-banner-sdk #onetrust-group-container,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-group-container,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-group-container{flex-grow:1;width:auto}div#onetrust-banner-sdk #onetrust-policy,div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy{margin:0;overflow:visible}div#onetrust-banner-sdk.ot-bnr-flift #onetrust-policy-text,div#onetrust-consent-sdk #onetrust-policy-text{font-size:16px;line-height:24px;max-width:44em;margin:0}div#onetrust-consent-sdk #onetrust-policy-text a[href]{font-weight:400;margin-left:8px}div#onetrust-banner-sdk #onetrust-button-group-parent{flex:0 0 auto;margin:32px 0 0;width:100%}div#onetrust-banner-sdk #onetrust-button-group{display:flex;flex-direction:row;flex-wrap:wrap;justify-content:flex-end;margin:-8px}div#onetrust-banner-sdk .banner-actions-container{display:flex;flex:1 0 auto}div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group button:last-of-type,div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto;margin:8px;width:auto}div#onetrust-consent-sdk #onetrust-pc-btn-handler{background-color:#fff!important;color:inherit!important}div#onetrust-banner-sdk #onetrust-close-btn-container{display:none}@media only screen and (min-width:556px){div#onetrust-consent-sdk #onetrust-banner-sdk{padding:40px}div#onetrust-banner-sdk #onetrust-policy{margin:0 40px 0 0}div#onetrust-banner-sdk .ot-sdk-row{align-items:center;flex-direction:row}div#onetrust-banner-sdk #onetrust-button-group-parent,div#onetrust-banner-sdk.ot-bnr-flift:not(.ot-iab-2) #onetrust-button-group-parent,div#onetrust-banner-sdk:not(.ot-iab-2) #onetrust-button-group-parent{margin:0;padding:0;width:auto}div#onetrust-banner-sdk #onetrust-button-group,div#onetrust-banner-sdk.ot-buttons-fw:not(.ot-iab-2) #onetrust-button-group{align-items:stretch;flex-direction:column-reverse;margin:0}div#onetrust-consent-sdk #onetrust-accept-btn-handler,div#onetrust-consent-sdk #onetrust-pc-btn-handler{flex:1 0 auto}}@media only screen and (min-width:768px){div#onetrust-banner-sdk #onetrust-policy{margin:0 48px 0 0}div#onetrust-consent-sdk #onetrust-banner-sdk{padding:48px}}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-size:16px;line-height:24px}div#onetrust-consent-sdk #onetrust-pc-sdk p,div#onetrust-pc-sdk #ot-pc-desc,div#onetrust-pc-sdk .category-host-list-handler,div#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{font-size:16px;font-weight:400;line-height:24px}div#onetrust-consent-sdk a:hover,div#onetrust-pc-sdk a:hover{color:inherit!important;text-decoration-color:#949494!important}div#onetrust-pc-sdk{border-radius:0;bottom:0;height:auto;left:0;margin:auto;max-width:100%;overflow:hidden;right:0;top:0;width:512px;max-height:800px}div#onetrust-pc-sdk .ot-pc-header{display:none}div#onetrust-pc-sdk #ot-pc-content{overscroll-behavior:contain;padding:0 12px 0 24px;margin:16px 4px 0 0;top:0;right:16px;left:0;width:auto}div#onetrust-pc-sdk #ot-category-title,div#onetrust-pc-sdk #ot-pc-title{font-size:24px;font-weight:400;line-height:32px;margin:0 0 16px}div#onetrust-pc-sdk #ot-pc-desc{padding:0}div#onetrust-pc-sdk #ot-pc-desc a{display:inline}div#onetrust-pc-sdk #accept-recommended-btn-handler{display:none!important}div#onetrust-pc-sdk input[type=checkbox]:focus+.ot-acc-hdr{outline:2px solid #007dbc;outline-offset:-1px;transition:none}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item{border-width:0 0 2px}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item:first-of-type{border-width:2px 0}div#onetrust-pc-sdk .ot-accordion-layout .ot-acc-hdr{padding:8px 0;width:100%}div#onetrust-pc-sdk .ot-plus-minus{transform:translateY(2px)}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item>button{background:0 0!important;border:0!important;height:44px!important;max-width:none!important;width:calc(100% - 48px)!important}div#onetrust-consent-sdk #onetrust-pc-sdk h5{font-weight:700}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr{padding:0}div#onetrust-pc-sdk .ot-accordion-layout.ot-cat-item .ot-acc-grpdesc{padding:0;width:100%}div#onetrust-pc-sdk .ot-acc-grpcntr .ot-subgrp-cntr{border:0;padding:0}div#onetrust-pc-sdk .ot-subgrp-cntr ul.ot-subgrps li.ot-subgrp{margin:0}div#onetrust-pc-sdk .ot-always-active-group .ot-cat-header{width:calc(100% - 160px)}#onetrust-pc-sdk .ot-accordion-layout .ot-cat-header{width:calc(100% - 88px)}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active{color:inherit;font-size:12px;font-weight:400;line-height:1.5;padding-right:48px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:before{border-radius:12px;position:absolute;right:0;top:0;content:'';background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active:after{border-radius:50%;position:absolute;right:5px;top:4px;content:'';background-color:#007dbc;height:12px;width:12px}div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-always-active,div#onetrust-pc-sdk .ot-accordion-layout h4~.ot-tgl{right:2px}div#onetrust-pc-sdk .ot-switch{display:block;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob,div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob{background:#fff;border:2px solid #939393;box-sizing:border-box;height:20px;width:40px}div#onetrust-pc-sdk .ot-tgl input+.ot-switch .ot-switch-nob:before{background-color:#737373;height:8px;left:4px;top:4px;width:8px}div#onetrust-pc-sdk .ot-tgl input:checked+.ot-switch .ot-switch-nob:before{background-color:#007dbc;height:12px;left:0;top:2px;width:12px}div#onetrust-pc-sdk .ot-tgl input:focus+.ot-switch .ot-switch-nob{box-shadow:0 0;outline:2px solid #007dbc!important;outline-offset:1px;transition:none}div#onetrust-consent-sdk #onetrust-pc-sdk .ot-acc-grpcntr.ot-acc-txt{background-color:transparent;padding-left:3px}div#onetrust-pc-sdk .ot-accordion-layout .ot-hlst-cntr,div#onetrust-pc-sdk .ot-accordion-layout .ot-vlst-cntr{overflow:visible;width:100%}div#onetrust-pc-sdk .ot-pc-footer{border-top:0 solid}div#onetrust-pc-sdk .ot-btn-container{padding-top:24px;text-align:center}div#onetrust-pc-sdk .ot-pc-footer button{margin:8px 0;background-color:#fff}div#onetrust-pc-sdk .ot-pc-footer-logo{background-color:#fff}div#onetrust-pc-sdk #ot-lst-title span{font-size:24px;font-weight:400;line-height:32px}div#onetrust-pc-sdk #ot-host-lst .ot-host-desc,div#onetrust-pc-sdk #ot-host-lst .ot-host-expand,div#onetrust-pc-sdk #ot-host-lst .ot-host-name,div#onetrust-pc-sdk #ot-host-lst .ot-host-name a,div#onetrust-pc-sdk .back-btn-handler,div#onetrust-pc-sdk .ot-host-opt li>div div{font-size:16px;font-weight:400;line-height:24px}div#onetrust-pc-sdk #ot-pc-lst{top:0}div#onetrust-pc-sdk .back-btn-handler{text-decoration:none!important}div#onetrust-pc-sdk #filter-btn-handler:hover svg{filter:invert(1)}div#onetrust-pc-sdk .back-btn-handler svg{width:16px;height:16px}div#onetrust-pc-sdk .ot-host-item>button{background:0 0!important;border:0!important;height:66px!important;max-width:none!important;width:calc(100% - 5px)!important;transform:translate(2px,2px)}div#onetrust-pc-sdk .ot-host-item{border-bottom:2px solid #b9b9b9;padding:0}div#onetrust-pc-sdk .ot-host-item .ot-acc-hdr{margin:0 0 -6px;padding:8px 0}div#onetrust-pc-sdk ul li:first-child{border-top:2px solid #b9b9b9}div#onetrust-pc-sdk .ot-host-item .ot-plus-minus{margin:0 8px 0 0}div#onetrust-pc-sdk .ot-search-cntr{width:calc(100% - 48px)}div#onetrust-pc-sdk .ot-host-opt .ot-host-info{background-color:transparent}div#onetrust-pc-sdk .ot-host-opt li>div div{padding:0}div#onetrust-pc-sdk #vendor-search-handler{border-radius:0;border-color:#939393;border-style:solid;border-width:2px 0 2px 2px;font-size:20px;height:48px;margin:0}div#onetrust-pc-sdk .ot-lst-subhdr svg{right:0;top:8px}div#onetrust-pc-sdk .ot-fltr-cntr{box-sizing:border-box;right:0;width:48px}div#onetrust-pc-sdk #filter-btn-handler{width:48px!important;padding:8px!important}div#onetrust-pc-sdk #ot-fltr-modal{max-height:400px}
.ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy.otRelFont{font-size:1rem}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .ot-mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy{font-family:inherit;font-size:1rem}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup{margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group-desc,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-table-header,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td{font-size:.9em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td span,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td a{font-size:inherit}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group{font-size:1em;margin-bottom:.6em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-title{margin-bottom:1.2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy>section{margin-bottom:1em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th{min-width:75px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a:hover{background:#fff}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-mobile-border{display:none}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy section{margin-bottom:2em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li{list-style:disc;margin-left:1.5em}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-subgroup ul li h4{display:inline-block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{border-collapse:inherit;margin:auto;border:1px solid #d7d7d7;border-radius:5px;border-spacing:initial;width:100%;overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border-bottom:1px solid #d7d7d7;border-right:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr th:last-child,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr td:last-child{border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:25%}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}#ot-sdk-cookie-policy h3{font-size:1.5em}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) table,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tbody,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) th,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td,.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{display:block}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr{margin:0 0 1em 0}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd),.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) .ot-mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy:not(#ot-sdk-cookie-policy-v2) li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table{overflow:hidden}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table td{border:none;border-bottom:1px solid #d7d7d7}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{display:block}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-host,#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table .ot-cookies-type{width:auto}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy tr{margin:0 0 1em 0}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{height:100%;width:40%;padding-right:10px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px;z-index:-9999}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td{border-bottom:1px solid #d7d7d7;border-right:0px}#ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table tr:last-child td:last-child{border-bottom:0px}}
                
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h5,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy h6,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy li,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy p,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy a,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy span,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy td,
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-description {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy th {
                        color: #696969;
                    }
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group {
                        color: #696969;
                    }
                    
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy #cookie-policy-title {
                            color: #696969;
                        }
                    
            
                    #ot-sdk-cookie-policy-v2.ot-sdk-cookie-policy table th {
                            background-color: #F8F8F8;
                        }
                    
            .ot-floating-button__front{background-image:url('https://cdn.cookielaw.org/logos/static/ot_persistent_cookie_icon.png')}</style><script src="https://static.addtoany.com/menu/modules/core.pt5ow5lr.js" type="module"></script><style></style><script type="text/javascript" async="" src="//cta-service-cms2.hubspot.com/ctas/v2/public/cs/cta-loaded.js?pid=519224&amp;pg=a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381&amp;lt=1749585800801&amp;dt=1749585800802&amp;at=1749585801226&amp;sl=1"></script><style type="text/css">.a2a_hide{display:none}.a2a_logo_color{background-color:#0166ff}.a2a_menu,.a2a_menu *{-moz-box-sizing:content-box;-webkit-box-sizing:content-box;box-sizing:content-box;float:none;margin:0;padding:0;position:static;height:auto;width:auto}.a2a_menu{border-radius:6px;display:none;direction:ltr;background:#FFF;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;color:#000;line-height:12px;border:1px solid #CCC;vertical-align:baseline;overflow:hidden}.a2a_mini{min-width:200px;position:absolute;width:300px;z-index:9999997}.a2a_overlay{display:none;background:#616c7deb;backdrop-filter:blur(4px);-webkit-backdrop-filter:blur(4px);position:fixed;top:0;right:0;left:0;bottom:0;z-index:9999998;-webkit-tap-highlight-color:transparent;transition:opacity .14s,backdrop-filter .14s}.a2a_full{background:#FFF;border:1px solid #FFF;box-shadow:#2a2a2a1a 0 0 20px 10px;height:auto;height:calc(320px);top:15%;left:50%;margin-left:-320px;position:fixed;text-align:center;width:640px;z-index:9999999;transition:transform .14s,opacity .14s}.a2a_full_footer,.a2a_full_header,.a2a_full_services{border:0;margin:0;padding:12px;box-sizing:border-box}.a2a_full_header{padding-bottom:8px}.a2a_full_services{height:280px;overflow-y:scroll;padding:0 12px;-webkit-overflow-scrolling:touch}.a2a_full_services .a2a_i{display:inline-block;float:none;width:181px;width:calc(33.334% - 18px)}div.a2a_full_footer{font-size:12px;text-align:center;padding:8px 14px}div.a2a_full_footer a,div.a2a_full_footer a:visited{display:inline;font-size:12px;line-height:14px;padding:8px 14px}div.a2a_full_footer a:focus,div.a2a_full_footer a:hover{background:0 0;border:0;color:#0166FF}div.a2a_full_footer a span.a2a_s_a2a,div.a2a_full_footer a span.a2a_w_a2a{background-size:14px;border-radius:3px;display:inline-block;height:14px;line-height:14px;margin:0 3px 0 0;vertical-align:top;width:14px}.a2a_modal{height:0;left:50%;margin-left:-320px;position:fixed;text-align:center;top:15%;width:640px;z-index:9999999;transition:transform .14s,opacity .14s;-webkit-tap-highlight-color:transparent}.a2a_modal_body{background:0 0;border:0;font:24px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;position:relative;height:auto;width:auto}.a2a_thanks{color:#fff;height:auto;margin-top:20px;width:auto}.a2a_thanks>div:first-child{margin:0 0 40px 0}.a2a_thanks div *{height:inherit}#a2a_copy_link{background:#FFF;border:1px solid #FFF;cursor:pointer;margin-top:15%}label.a2a_s_link#a2a_copy_link_icon,label.a2a_w_link#a2a_copy_link_icon{background-size:48px;border-radius:0;display:inline-block;height:48px;left:0;line-height:48px;margin:0 3px 0 0;position:absolute;vertical-align:top;width:48px}#a2a_modal input#a2a_copy_link_text{background-color:transparent;border:0;color:#2A2A2A;cursor:pointer;font:inherit;height:48px;left:62px;max-width:initial;min-height:auto;padding:0;position:relative;width:564px;width:calc(100% - 76px)}#a2a_copy_link_copied{background-color:#0166ff;color:#fff;display:none;font:inherit;font-size:16px;margin-top:1px;padding:3px 8px}@media (forced-colors:active){.a2a_color_buttons a,.a2a_svg{forced-color-adjust:none}}@media (prefers-color-scheme:dark){.a2a_menu a,.a2a_menu a.a2a_i,.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more,i.a2a_i{border-color:#2a2a2a!important;color:#fff!important}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover,.a2a_menu_find_container{border-color:#444!important;background-color:#444!important}.a2a_menu:not(.a2a_thanks){background-color:#2a2a2a;border-color:#2a2a2a}.a2a_menu_find{color:#fff!important}.a2a_menu label.a2a_s_find svg{background-color:transparent!important}.a2a_menu label.a2a_s_find svg path{fill:#fff!important}.a2a_full{box-shadow:#00000066 0 0 20px 10px}.a2a_overlay{background-color:#373737eb}}@media print{.a2a_floating_style,.a2a_menu,.a2a_overlay{visibility:hidden}}@keyframes a2aFadeIn{from{opacity:0}to{opacity:1}}.a2a_starting{opacity:0}.a2a_starting.a2a_full,.a2a_starting.a2a_modal{transform:scale(.8)}@media (max-width:639px){.a2a_full{border-radius:0;top:15%;left:0;margin-left:auto;width:100%}.a2a_modal{left:0;margin-left:10px;width:calc(100% - 20px)}}@media (min-width:318px) and (max-width:437px){.a2a_full .a2a_full_services .a2a_i{width:calc(50% - 18px)}}@media (max-width:317px){.a2a_full .a2a_full_services .a2a_i{width:calc(100% - 18px)}}@media (max-height:436px){.a2a_full{bottom:40px;height:auto;top:40px}}@media (max-height:550px){.a2a_modal{top:30px}}@media (max-height:360px){.a2a_modal{top:20px}.a2a_thanks>div:first-child{margin-bottom:20px}}.a2a_menu a{color:#0166FF;text-decoration:none;font:16px sans-serif-light,HelveticaNeue-Light,"Helvetica Neue Light","Helvetica Neue",Arial,Helvetica,"Liberation Sans",sans-serif;line-height:14px;height:auto;width:auto;outline:0}.a2a_menu a.a2a_i:visited,.a2a_menu a.a2a_more{color:#0166FF}.a2a_menu a.a2a_i:active,.a2a_menu a.a2a_i:focus,.a2a_menu a.a2a_i:hover,.a2a_menu a.a2a_more:active,.a2a_menu a.a2a_more:focus,.a2a_menu a.a2a_more:hover{color:#2A2A2A;border-color:#EEE;border-style:solid;background-color:#EEE;text-decoration:none}.a2a_menu label.a2a_s_find{background-size:24px;height:24px;left:8px;pointer-events:auto;position:absolute;top:7px;width:24px}.a2a_menu label.a2a_s_find svg{background-color:#FFF}.a2a_menu label.a2a_s_find svg path{fill:#CCC}#a2a_menu_container{display:inline-block}.a2a_menu_find_container{border:1px solid #CCC;border-radius:6px;padding:2px 24px 2px 0;position:relative;text-align:left}.a2a_cols_container .a2a_col1{overflow-x:hidden;overflow-y:auto;-webkit-overflow-scrolling:touch}#a2a_modal input,#a2a_modal input[type=text],.a2a_menu input,.a2a_menu input[type=text]{display:block;background-image:none;box-shadow:none;line-height:100%;margin:0;outline:0;overflow:hidden;padding:0;-moz-box-shadow:none;-webkit-box-shadow:none;-webkit-appearance:none}#a2afeed_find_container input,#a2afeed_find_container input[type=text],#a2apage_find_container input,#a2apage_find_container input[type=text]{background-color:transparent;border:0;box-sizing:content-box;color:#2A2A2A;float:none;font:inherit;font-size:16px;height:28px;line-height:20px;left:38px;outline:0;margin:0;max-width:initial;min-height:initial;padding:2px 0;position:relative;width:99%}.a2a_clear{clear:both}.a2a_svg{background-repeat:no-repeat;display:block;overflow:hidden;height:32px;line-height:32px;padding:0;pointer-events:none;width:32px}.a2a_svg svg{background-repeat:no-repeat;background-position:50% 50%;border:none;display:block;left:0;margin:0 auto;overflow:hidden;padding:0;position:relative;top:0;width:auto;height:auto}a.a2a_i,i.a2a_i{display:block;float:left;border:1px solid #FFF;line-height:24px;padding:6px 8px;text-align:left;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;width:132px}a.a2a_i span,a.a2a_more span{display:inline-block;overflow:hidden;vertical-align:top}a.a2a_i .a2a_svg{margin:0 6px 0 0}a.a2a_i .a2a_svg,a.a2a_more .a2a_svg{background-size:24px;height:24px;line-height:24px;width:24px}a.a2a_sss:hover{border-left:1px solid #CCC}a.a2a_more{border-bottom:1px solid #FFF;border-left:0;border-right:0;line-height:24px;margin:6px 0 0;padding:6px;-webkit-touch-callout:none}a.a2a_more span{height:24px;margin:0 6px 0 0}.a2a_kit .a2a_svg{background-repeat:repeat}.a2a_default_style a:empty,.a2a_flex_style a:empty,.a2a_floating_style a:empty,.a2a_overlay_style a:empty{display:none}.a2a_color_buttons a,.a2a_floating_style a{text-decoration:none}.a2a_default_style:not(.a2a_flex_style) a{float:left;line-height:16px;padding:0 2px}.a2a_default_style a:hover .a2a_svg,.a2a_floating_style a:hover .a2a_svg,.a2a_overlay_style a:hover .a2a_svg svg{opacity:.7}.a2a_overlay_style.a2a_default_style a:hover .a2a_svg{opacity:1}.a2a_default_style .a2a_count,.a2a_default_style .a2a_svg,.a2a_floating_style .a2a_svg,.a2a_menu .a2a_svg,.a2a_vertical_style .a2a_count,.a2a_vertical_style .a2a_svg{border-radius:4px}.a2a_default_style .a2a_counter img,.a2a_default_style .a2a_dd,.a2a_default_style .a2a_svg{float:left}.a2a_default_style .a2a_img_text{margin-right:4px}.a2a_default_style .a2a_divider{border-left:1px solid #000;display:inline;float:left;height:16px;line-height:16px;margin:0 5px}.a2a_kit a{cursor:pointer;transition:none}.a2a_floating_style{background-color:#fff;border-radius:6px;position:fixed;z-index:9999995}.a2a_overlay_style{z-index:2147483647}.a2a_floating_style,.a2a_overlay_style{animation:a2aFadeIn .2s ease-in;padding:4px}.a2a_vertical_style:not(.a2a_flex_style) a{clear:left;display:block;overflow:hidden;padding:4px}.a2a_floating_style.a2a_default_style{bottom:0}.a2a_floating_style.a2a_default_style a,.a2a_overlay_style.a2a_default_style a{padding:4px}.a2a_count{background-color:#fff;border:1px solid #ccc;box-sizing:border-box;color:#2a2a2a;display:block;float:left;font:12px Arial,Helvetica,sans-serif;height:16px;margin-left:4px;position:relative;text-align:center;width:50px}.a2a_count:after,.a2a_count:before{border:solid transparent;border-width:4px 4px 4px 0;content:"";height:0;left:0;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:50%;width:0}.a2a_count:before{border-right-color:#ccc}.a2a_count:after{border-right-color:#fff;margin-left:-3px}.a2a_count span{animation:a2aFadeIn .14s ease-in}.a2a_vertical_style .a2a_counter img{display:block}.a2a_vertical_style .a2a_count{float:none;margin-left:0;margin-top:6px}.a2a_vertical_style .a2a_count:after,.a2a_vertical_style .a2a_count:before{border:solid transparent;border-width:0 4px 4px 4px;content:"";height:0;left:50%;line-height:0;margin:-4px 0 0 -4px;position:absolute;top:0;width:0}.a2a_vertical_style .a2a_count:before{border-bottom-color:#ccc}.a2a_vertical_style .a2a_count:after{border-bottom-color:#fff;margin-top:-3px}.a2a_color_buttons .a2a_count,.a2a_color_buttons .a2a_count:after,.a2a_color_buttons .a2a_count:before,.a2a_color_buttons.a2a_vertical_style .a2a_count:after,.a2a_color_buttons.a2a_vertical_style .a2a_count:before{background-color:transparent;border:none;color:#fff;float:none;width:auto}.a2a_color_buttons.a2a_vertical_style .a2a_count{margin-top:0}.a2a_flex_style{display:flex;align-items:flex-start;gap:0}.a2a_default_style.a2a_flex_style{left:0;right:0;width:100%}.a2a_vertical_style.a2a_flex_style{flex-direction:column;top:0;bottom:0}.a2a_flex_style a{display:flex;justify-content:center;flex:1;padding:4px}.a2a_flex_style.a2a_vertical_style a{flex-direction:column}.a2a_floating_style.a2a_color_buttons,.a2a_floating_style.a2a_flex_style{border-radius:0;padding:0}.a2a_floating_style.a2a_default_style.a2a_flex_style{bottom:0}.a2a_kit.a2a_flex_style .a2a_counter img,.a2a_kit.a2a_flex_style .a2a_dd,.a2a_kit.a2a_flex_style .a2a_svg{float:none}.a2a_nowrap{white-space:nowrap}.a2a_note{margin:0 auto;padding:9px;font-size:12px;text-align:center}.a2a_note .a2a_note_note{margin:0;color:#2A2A2A}.a2a_wide a{display:block;margin-top:3px;border-top:1px solid #EEE;text-align:center}.a2a_label{position:absolute!important;clip-path:polygon(0px 0px,0px 0px,0px 0px);-webkit-clip-path:polygon(0px 0px,0px 0px,0px 0px);overflow:hidden;height:1px;width:1px}.a2a_kit,.a2a_menu,.a2a_modal,.a2a_overlay{-ms-touch-action:manipulation;touch-action:manipulation;outline:0}.a2a_dd{-webkit-user-drag:none}.a2a_dd img{border:0}.a2a_button_facebook_like iframe{max-width:none}</style><style>stream {
  position: relative;
  display: block;
}
</style><link href="https://crossmark-cdn.crossref.org/widget/v2.0/style.css" type="text/css" rel="stylesheet"></head>
<body class="pb-ui">
    <div class="skip">
        <a href="#page-body-id" id="skipNavigationLink" title="Skip to Main Content" tabindex="0" class="skipToContent">Skip to Main Content</a>
        <a href="#mega-menu-nav" id="skipToMainMenu" title="Skip to Main Menu" tabindex="0" class="skipToContent">Skip to Main Menu</a>
    </div>



    <div id="pb-page-content" data-ng-non-bindable="">
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="ux3-layout-widget" data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" class="ux3">
        
    

        


    

            

            
                <div class="cell fonts-loaded">
            

            <div data-widget-id="832ad3f3-97ac-45ab-9af1-90c6f7bff54a" data-widget-name="ux3-layout-widget"><div>
    

        


    

            

            

            <div id="a1f1ba25-79af-4194-aaa9-66206104a800" class="widget loginPopup none widget-none widget-compact-all"><div class="wrapped"><div class="widget-body body body-none body-compact-all"><div role="dialog" aria-modal="true" aria-label="Login" class="popup login-popup hidden"><div class="content"><a href="#" aria-label="Close login popup" title="Close login popup" role="button" class="close"><i class="icon-close_thin"></i></a><h2 class="login-title">Login to your account</h2><div class="login-form"><p tabindex="-1" class="message error"></p><form action="/action/doLogin?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" method="post"><input type="hidden" name="redirectUri" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8"><input type="hidden" name="referer" value="/cell/fulltext/S0092-8674(20)30159-8"><input type="hidden" name="ecommRedirect"><input type="hidden" name="code" value="cell-site"><input type="hidden" name="UX3LoginWidget" value="true"><input type="hidden" name="isPopup" value="true"><div class="input-group login-input--wrapper"><div class="label"><label for="login">Email/Username</label></div><input id="login" type="text" name="login" value="" size="15" class="login"><div role="alert" class="error-hint js--hidden"><div class="error-hint__text"><div class="error-text">Your email address is a required field.</div><div class="email-example">E.g., j.smith@mail.com</div></div></div></div><div class="input-group login-input--wrapper"><div class="label"><label for="password">Password</label></div><input id="password" type="password" name="password" value="" autocomplete="off" class="password"><a href="#" class="login__field__action js-show-password">Show</a><div role="alert" class="error-hint js--hidden"><span class="error-hint__text">Your password is a required field.</span></div><div class="actions"><a href="https://www.cell.com/action/requestResetPassword" class="link show-request-reset-password">Forgot password?</a></div></div><div class="remember"><input type="checkbox" name="savePassword" id="a1f1ba25-79af-4194-aaa9-66206104a800-remember" value="1" checked="checked"><label for="a1f1ba25-79af-4194-aaa9-66206104a800-remember">Remember me</label></div><div class="submit"><input type="submit" name="submit" value="Log in" class="button submit primary"></div></form></div><div class="create-account"><div>Don’t have an account?</div><a href="/action/registration?redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" class="show-registration">Create a Free Account</a></div></div></div></div></div></div>

            

        

    

        


    

            

            

            <div role="dialog" aria-modal="true" aria-label="Reset password" class="popup top-drawer request-reset-password-drawer hidden"><div class="content"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" role="button" class="close"><i class="icon-close_thin"></i></a><div class="request-reset"><div class="form"><p class="sub">If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password</p><div tabindex="-1" class="message error"></div><form action="/action/requestResetPassword" method="post" class="request-reset-password-form"><input type="hidden" name="platform"><input type="hidden" name="requestResetPassword" value="true"><input type="hidden" name="codeSite" value="cell-site"><div class="input-group"><div class="label"><label for="reset-password-email">Email*</label></div><input id="reset-password-email" type="text" name="email" value="" size="15" class="email"></div><div class="submit" disabled="disabled"><input type="submit" name="submit" value="Submit" disabled="disabled" class="button primary submit"></div></form></div><div class="success-template hidden"><p>If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password</p></div></div><div class="request-reset-cancel"><a href="#" aria-label="Close reset password popup" title="Close reset password popup" class="cancel">Cancel</a></div></div></div>

            

        

    

        


    

            

            
                <div class="ux3-ads">
            

            <div class="pb-ad">
            <!-- Do Not Modify without contacting ELS-HSOnlineCampaign@elsevier.com -->
<!-- To be kept in sync with Global Commercial Publishing Operations-->
<!-- Start: GPT Async -->
<div id="gpt-Variables" data-adfile="CELLJOURNAL">
	<input type="hidden" id="gptSite" value="cell">
	<input type="hidden" id="gptLoggedIn" value="no">
	<input type="hidden" id="gptAccessType" value="ae:ANON_GUEST|ae:ANON_GUEST">
	<input type="hidden" id="gptDefaultSite" value="cell">
</div>
<div id="gpt-Interscroller" class="gpt-InScrollBox" style="display:none;">
	<div class="gpt-InScrollLabel">ADVERTISEMENT</div>
	<div class="gpt-InScrollContainer">
		<div class="gpt-InScrollWrapper">
			<div class="gpt-InScrollInner">
				<div class="gpt-adinterscroller" data-adsize="interscroller"></div>
			</div>
		</div>
	</div>
	<div class="gpt-InScrollLabel">SCROLL TO CONTINUE WITH CONTENT</div>
</div>
<div id="gpt-DebugDiv" class="gpt-DebugDiv" style="display:none;">
	<div style="width: 100%; display: table;">
		<div style="display: table-row">
			<div style="width: 200px; display: table-cell;">
				<button class="gpt-DebugBtn" onclick="gpt_ShowConsole()">Open GPT Console</button><br>
				<button id="gpt_GrapeShotDebugBtn" class="gpt-DebugBtn" onclick="gpt_GrapeShotDebug();">Open Oracle Keywords</button><br>
				<br>
				<button class="gpt-DebugBtn" onclick="gpt_LoadDebugValues()">Refresh Values</button>
			</div>
			<div style="display: table-cell;">
				<table class="gpt-DebugTable">
					<thead>
						<tr>
							<th>Property</th>
							<th>Value</th>
						</tr>
					</thead>
					<tbody>
						<tr><td class="gpt-DebugTitle">Status</td><td><div class="gptStatus_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Version</td><td><div class="gptVersion_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad File</td><td><div class="gptAdFile_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Disable Ads Flag</td><td><div class="gptDisableAds_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Environment</td><td><div class="gptTestENV_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Init</td><td><div class="gptMoatInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Moat Ready</td><td><div class="gptMoatReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Ready</td><td><div class="gptContextualReady_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual URL</td><td><div class="gptContextualURL_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Initial Segments</td><td><div class="gptContextualInit_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Contextual Used Segments</td><td><div class="gptContextualResult_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">AdUnit</td><td><div class="gptSite_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">SubAdUnit</td><td><div class="gptPage_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Custom Targeting</td><td><div class="gptCustomTargeting_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Ad Events</td><td><div class="gptEvent_Debug"></div></td></tr>
						<tr><td class="gpt-DebugTitle">Invalid Ad Sizes</td><td><div class="gptInvalidAdSize_Debug"></div></td></tr>
					</tbody>
				</table>
			</div>
		</div>
	</div>
</div>
<style type="text/css">
	.gpt-DebugBtn {
		display: inline-block;
		text-align: center;
		text-decoration: none;
		margin: 2px 0;
		border: solid 1px #122b40;
		border-radius: 0.4em;
		padding: 0.5em 1em;
		color: #ffffff;
		background-color: #204d74;
		font-weight: normal;
		font-size: 12px;
	}

	.gpt-DebugDiv {
		margin: 5px;
	}

	.gpt-DebugTitle {
		font-weight: bold;
	}

	.gpt-DebugTable {
		border: 1px solid #dddddd;
		border-collapse: collapse;
		margin: 5px;
		font-size: 0.9em;
		font-family: sans-serif;
		min-width: 400px;
		margin-bottom: 25px;
	}

		.gpt-DebugTable td:first-child {
			padding: 5px;
		}

		.gpt-DebugTable thead tr th {
			background-color: #d9edf7;
			color: #ffffff;
			text-align: left;
			padding: 5px;
			border-bottom: 2px solid #204d74;
		}

		.gpt-DebugTable th,
		.gpt-DebugTable td {
			padding: 5px;
		}

		.gpt-DebugTable tbody tr {
			border-bottom: 1px solid #dddddd;
		}

			.gpt-DebugTable tbody tr:nth-of-type(even) {
				background-color: #f3f3f3;
			}

			.gpt-DebugTable tbody tr:last-of-type {
				border-bottom: 2px solid #204d74;
			}

	.gpt-InScrollLabel {
		background-color: rgb(0, 0, 0);
		color: rgb(255, 255, 255);
		position: relative;
		max-width: 100vw;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		padding: 0;
		text-align: center;
		width: 100vw !important;
		font-size: 10px;
	}

	.gpt-InScrollBox {
		height: 100vh !important;
		width: 100vw;
		cursor: pointer;
		max-width: 100vw;
		position: relative;
		left: 50%;
		right: 50%;
		margin-left: -50vw;
		margin-right: -50vw;
		margin-bottom: 50px;
		padding-top: 5px;
		padding-bottom: 5px;
		z-index: 10001;
		background-color: white;
	}

		.gpt-InScrollBox .gpt-InScrollContainer {
			height: 95vh !important;
			position: relative;
		}

		.gpt-InScrollBox .gpt-InScrollWrapper {
			position: absolute !important;
			top: 0 !important;
			left: 0;
			width: 100%;
			height: 95vh !important;
			border: 0 !important;
			margin: 0 !important;
			padding: 0 !important;
			clip: rect(0, auto, auto, 0) !important;
			-webkit-clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
			clip-path: polygon(0px 0px, 100% 0px, 100% 100%, 0px 100%) !important;
		}

		.gpt-InScrollBox .gpt-InScrollInner {
			position: fixed !important;
			top: 0 !important;
			left: 0 !important;
			bottom: 0;
			margin: auto;
			width: 100vw;
			height: 95vh;
			-webkit-transform: translateZ(0) !important;
			display: -webkit-box;
			display: -ms-flexbox;
			display: flex;
			-webkit-box-orient: vertical;
			-webkit-box-direction: normal;
			-ms-flex-direction: column;
			flex-direction: column;
			-webkit-box-align: center;
			-ms-flex-align: center;
			align-items: center;
			-webkit-box-pack: center;
			-ms-flex-pack: center;
			justify-content: center;
			text-align: center;
		}
</style>
<script class="optanon-category-4" type="text/plain">
	//--------------------------------------------------------------------------
	var gpt_Version = '04072023';
	var gpt_AdFile = $('#gpt-Variables').data('adfile');
	var gpt_MaxMOATInitAttempts = 11;
	var gpt_MaxMOATReadyAttempts = 11;
	var gpt_MaxContextualReadyAttempts = 21;
	var gpt_MOATInitAttempts = 0;
	var gpt_MOATReadyAttempts = 0;
	var gpt_ContextualReadyAttempts = 0;
	var gpt_IsProd = true;
	var gpt_StartTime;
	var gs_channels = 'DEFAULT';
	var gpt_ContextualReady = false;
	var gpt_ContextualURL = 'Not enabled outside of Production';
	var gpt_DisableAdsFlagFound = false;

	var gptEvent_Debug = '';
	var gptCustomTargeting_Debug = '';
	var gptSite_Debug = "";
	var gptPage_Debug = "";
	var gptContextualEnabled = false;
	var gptContextualResult_Debug = '';
	var gptContextualInit_Debug = '';
	var gptContextualURL_Debug = '';
	var gptContextualReady_Debug = '';
	var gptMoatReady_Debug = '';
	var gptMoatInit_Debug = '';
	var gptTestENV_Debug = '';
	var gptDisableAds_Debug = '';
	var gptStatus_Debug = 'GPT Still Loading - Refresh Values';
	var gptInvalidAdSize_Debug = '';
	//--------------------------------------------------------------------------
	$(document).ready(function () {
		//Check to see if we are on a development env
		gpt_CheckEnvironment();

		if (!gpt_DisableAdsFlagFound) {
			gpt_StartTime = new Date();
			if (gpt_AdFile !== "PU") {
				//Once the dom has loaded, begin the process to init the ads.
				gpt_InitScripts();
				gpt_CheckForMOATInit();
			}
		}
	});
</script>
<script type="text/javascript">
	function gpt_CheckEnvironment() {
		if ($('#gptDisableAds').length > 0) {
			gptDisableAds_Debug = 'Flag Detected - Ads Disabled';
			gpt_DisableAdsFlagFound = true;
		}
		else {
			gptDisableAds_Debug = 'Ads Enabled';
			gpt_DisableAdsFlagFound = false;
		}
		switch (gpt_AdFile) {
			case 'PU':
				gptContextualEnabled = true;
				if ($("#Environment").val() !== "Prod") {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			case 'JBS':
			case 'LANCET':
				gptContextualEnabled = true;
				if ($(".gpt-ad").length > 0) {
					//Other ads exist, allow the Prestitial
					$(document.body).append("<div class='gpt-ad' data-adsize='prestitial'></div>");
				}
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
			default:
				//Cell
				gptContextualEnabled = false;
				if (window.location.hostname.toLowerCase().indexOf('.literatumonline.') >= 0) {
					gpt_IsProd = false;
					gptTestENV_Debug = 'Test Environment Detected';
				}
				else {
					gptTestENV_Debug = 'Production Environment Detected';
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
    function gpt_GetNonCMEArticle() {
        var url;
        $('.articleCitation').each(function (i, obj) {
            if ($(obj).find('.toc__item__detials').length > 0) {
                var itemDetails = $(obj).first().find('.toc__item__detials');
                var cmeFound = 0;
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='CME']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='(CME)']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='Education']").length; }
                if (cmeFound == 0) { cmeFound = $(itemDetails).find("img[title~='education']").length; }
                if (cmeFound == 0) {
                    var itemLink = $(itemDetails).first().find('.toc__item__title');
                    var linkCount = $(itemLink).first().find("a:contains('CME')").length;
                    if (linkCount == 0) {
                        url = $(itemLink).first().find('a').attr('href');
                        return false;   //Found a URL, break the loop
                    }
                }
            }
        });
        return url;
    }
	//--------------------------------------------------------------------------
	function gpt_GetElapsedTime() {
		var endTime = new Date();
		var timeDiff = endTime - gpt_StartTime; //in ms
		// strip the ms
		timeDiff /= 1000;

		// get seconds
		return seconds = Math.round(timeDiff) + " seconds";
	}
	//--------------------------------------------------------------------------
	function gpt_CheckSSC() {
		//Check for ScreenShot Client
		var gpt_SSC = gpt_GetQuerystring('gpt_ssc', '');
		if (gpt_SSC == '1') {
			//it's the ScreenShotClient, disable MOAT IVT Detection
			$('#gpt-Variables').append('<input type="hidden" id="gptm_data">');
			$('#gptm_data').val(0);
			gpt_Target("m_data");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_LocalSS(adTypeId) {
		window.scrollTo(0, 0);
		gpt_Sleep(1000);
		gpt_ScrollToAd(adTypeId);
		gpt_PreTearsheet(adTypeId);
	}
	//--------------------------------------------------------------------------
	function gpt_InitScripts() {
		if (gpt_AdFile == "PU") {
			if (gpt_IsProd) {
				gpt_ContextualURL = gpt_CheckForNULL($('#canonicalurl').val());
				if (gpt_ContextualURL === null) {
					gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				}
				else {
					gpt_ContextualURL = window.location.origin + gpt_ContextualURL;
				}
				var useSSL = 'https:' == document.location.protocol;
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}
		}
		else {
			//JBS-Cell-Lancet
			var useSSL = 'https:' == document.location.protocol;

			var gads = document.createElement('script');
			gads.async = true;
			gads.type = 'text/javascript';
			gads.src = (useSSL ? 'https:' : 'http:') + '//securepubads.g.doubleclick.net/tag/js/gpt.js';
			document.head.appendChild(gads);

			if (gpt_IsProd && gptContextualEnabled) {
				gpt_ContextualURL = window.location.href.split('?')[0].split('#')[0];
				var gs = document.createElement('script');
				gs.async = true;
				gs.type = 'text/javascript';
				gs.src = (useSSL ? 'https:' : 'http:') + '//elsevier.gscontxt.net/multizone/channels.cgi?url=' + encodeURIComponent(gpt_ContextualURL);
				gs.onload = function () {
					gpt_ContextualReady = true;
				};
				document.head.appendChild(gs);
			}

			var elsevierMoatHeader = document.createElement('link');
			elsevierMoatHeader.rel = 'preload';
			elsevierMoatHeader.as = 'script';
			elsevierMoatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(elsevierMoatHeader);

			var elsevierMoatAds = document.createElement('link');
			elsevierMoatAds.rel = 'preconnect';
			elsevierMoatAds.src = (useSSL ? 'https:' : 'http:') + '//mb.moatads.com';
			document.head.appendChild(elsevierMoatAds);

			var moatHeader = document.createElement('script');
			moatHeader.async = true; gads.type = 'text/javascript';
			moatHeader.src = (useSSL ? 'https:' : 'http:') + '//z.moatads.com/elsevierheader150204004183/moatheader.js';
			document.head.appendChild(moatHeader);
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForMOATInit() {
		//Check every 1/10 of a second until MOAT is Loaded or 1 second timeout
		if (gpt_MOATInitAttempts < gpt_MaxMOATInitAttempts) {
			gpt_MOATInitAttempts += 1;
			if (typeof window.moatPrebidApi === "object") {
				//MOAT LOADED
				gptMoatInit_Debug = '0.0' + gpt_MOATInitAttempts + ' seconds';
				gpt_CheckForMOATReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATInit(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not LOADED
			gptMoatInit_Debug = 'Timeout Expired';
			var googletag = googletag || {};
			googletag.cmd = googletag.cmd || [];
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForMOATReady() {
		//Check every 1/10 of a second until MOAT is Ready or 1 second timeout
		if (gpt_MOATReadyAttempts < gpt_MaxMOATReadyAttempts) {
			gpt_MOATReadyAttempts += 1;
			if (window.moatPrebidApi.safetyDataAvailable()) {
				//MOAT Ready
				gptMoatReady_Debug = '0.0' + gpt_MOATReadyAttempts + " seconds";
				gpt_CheckForContextualReady();
			}
			else {
				setTimeout(() => { gpt_CheckForMOATReady(); }, 100);
			}
		}
		else {
			//TIMEOUT: MOAT Not Ready
			gptMoatReady_Debug = 'Timeout Expired';
			gpt_CheckForContextualReady();
		}
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForContextualReady() {
		//Check every 1/10 of a second until Contextual is Ready or 2 second timeout
		if (gpt_IsProd && gptContextualEnabled) {
			//Enabled
			if (gpt_ContextualReadyAttempts < gpt_MaxContextualReadyAttempts) {
				gpt_ContextualReadyAttempts += 1;
				if (gpt_ContextualReady) {
					//Contextual Ready
					gptContextualURL_Debug = gpt_ContextualURL;
					gptContextualReady_Debug = '0.0' + gpt_ContextualReadyAttempts + " seconds";
					gptContextualInit_Debug = gs_channels;
					gpt_InitAds();
				}
				else {
					setTimeout(() => { gpt_CheckForContextualReady(); }, 100);
				}
			}
			else {
				//LOG TIMEOUT error
				//REMOVE FOR NOW (SHOULD LOG TO A DIFF LOCATION)
				//TIMEOUT: Contextual Not Ready
				$('#gpt_GrapeShotDebugBtn').remove();
				gptContextualURL_Debug = gpt_ContextualURL;
				gptContextualReady_Debug = 'Timeout Expired';
				gptContextualInit_Debug = "";
				gpt_InitAds();
			}
		}
		else {
			//Not Enabled
			$('#gpt_GrapeShotDebugBtn').remove();
			switch (gpt_AdFile) {
				case 'PU':
				case 'LANCET':
				case 'JBS':
					gptContextualURL_Debug = 'Not enabled outside of Production';
					gptContextualReady_Debug = 'Not enabled outside of Production';
					gptContextualInit_Debug = 'Not enabled outside of Production';
					break;
				case "CELLJOURNAL":
				case "CELLBUCKET":
					gptContextualReady_Debug = 'Not enabled on Cell';
					gptContextualInit_Debug = 'Not enabled on Cell';
					gptContextualURL_Debug = 'Not enabled on Cell';
					break;
			}
			gpt_InitAds();
		}
	}
	//--------------------------------------------------------------------------
	function GPT_GetPageByURL() {
		var host = window.location.host.toLocaleLowerCase()
		var localpath = window.location.pathname.toLocaleLowerCase();

		///Check for Cell.com
		if (host.indexOf('cell.com') >= 0) {
			return null;
		}

		///Check for Cell.com (marlin-stag)
		if (host.indexOf('www-cell-com') >= 0) {
			return null;
		}

		///Check for Lancet
		if (host.indexOf('thelancet') >= 0) {
			return null;
		}

		if (localpath.indexOf('/article/') >= 0) {
			return 'article.fulltext';
		}

		if (localpath.indexOf('/action/dosearch') >= 0) {
			return 'search.searchResults';
		}

		if (localpath.indexOf('/content/') >= 0) {
			return 'periodical.editorial';
		}

		return 'periodical.home';
	}
	//--------------------------------------------------------------------------
	function gpt_CheckForNULL(x, valueifnull) {
		if (typeof valueifnull == "undefined") {
			valueifnull = null;
		}

		if (typeof x == 'undefined') {
			return valueifnull;
		}
		if (x == null) {
			return valueifnull;
		}
		if (x == "null") {
			return valueifnull;
		}
		if ($.trim(x) == '') {
			return valueifnull;
		}

		return x;
	}
	//--------------------------------------------------------------------------
	function gpt_GetAdditionalTargeting() {
		//adds page level targeting of custom variables
		//the id (minus gpt) and the value will be used as a key-value pair
		//eg: <input type="hidden" id="gptissuepii" value="x" class="gpt-Target">
		//eg: target issuepii=x
		$(".gpt-Target").each(function (index) {
			var gptTargetId = $(this).attr('id');
			gptTargetId = gptTargetId.replace('gpt', '').toLowerCase();
			if (gptTargetId !== '') {
				gpt_Target(gptTargetId);
			}
		})
	}
	//--------------------------------------------------------------------------
	function gpt_GetQuerystring(key, default_) {
		//function to read querystring variables
		if (default_ === null) default_ = '';
		key = key.replace(/[\[]/, "\\\[").replace(/[\]]/, "\\\]");
		var regex = new RegExp("[\\?&]" + key + "=([^&#]*)");
		var qs = regex.exec(window.location.href);
		if (qs === null)
			return default_;
		else
			return qs[1];
	}
	//--------------------------------------------------------------------------
	function gpt_GetDFPTestId() {
		//Get any request for a test id from querystring and set custom targeting parameter
		var gptDFPTestId = gpt_GetQuerystring('dfptestid', '');
		if (gptDFPTestId !== '') {
			$('#gpt-Variables').append('<input type="hidden" id="gptDFPTestId">');
			$('#gptDFPTestId').val(gptDFPTestId);
			gpt_Target("DFPTestId");
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Target(targetName) {
		//Set page level target if value is found
		if ($('#gpt' + targetName).length > 0) {
			var targetValue = $('#gpt' + targetName).val();

			if (targetValue !== '') {
				targetValue = targetValue.replace(/[^-a-z0-9]/ig, '');	//Only Allow a-z, 0-9
				googletag.pubads().setTargeting(targetName.toLowerCase(), targetValue.toLowerCase());
				gptCustomTargeting_Debug = gptCustomTargeting_Debug + targetName.toLowerCase() + ' = ' + targetValue.toLowerCase() + '<br>';
			}
		}
	}
	//--------------------------------------------------------------------------
	function gpt_TargetAccessType() {
		var currentAccessType = $('#gptAccessType').val();
		if (typeof currentAccessType == "undefined") {
			currentAccessType = "";
		}
		if (currentAccessType.indexOf('ANON_IP') >= 0) {
			googletag.pubads().setTargeting("loggedin", "yes");
		}
		else {
			gpt_Target("LoggedIn");
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_PreTearsheet(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		//Remove Elsevier Cookie Policy Notice
		if ($("#onetrust-consent-sdk").length > 0) {
			$("#onetrust-consent-sdk").remove();
		}

        //Mobile Nav
        $('#skip').remove();
        $('skipNavigationLink').remove();

		//JBS Modals
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.leadinModal').length > 0) {
			$('.leadinModal').remove();
		}
		if ($('.usabilla__overlay').length > 0) {
			$('.usabilla__overlay').remove();
		}

		//Pendo
		if ($('._pendo-step-container').length > 0) {
			$('._pendo-step-container').remove();
		}
		if ($('._pendo-guide-tt_').length > 0) {
			$('._pendo-guide-tt_').remove();
		}
		if ($('._pendo-image').length > 0) {
			$('._pendo-image').remove();
		}
		if ($('._pendo-badge-image').length > 0) {
			$('._pendo-badge-image').remove();
		}

		switch (gpt_AdFile) {
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Mobile Bug Fix on Cell
				if (parseInt(adTypeId) == 5) {
					$('.widget-horizontalAd').css('position', 'static');
					$('.body-horizontalAd').css('display', 'block');
				}
				break;
			case "JBS":
			case "LANCET":
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 3: //MPU
					case 4: //SkyScraper
						//BUGFIX: Show Sidebar ad for JBS
						//skyscraper & mpu
						if ($('.widget-verticalAd').length > 0) {
							$('.widget-verticalAd').css('display', 'block');
						}
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
					case 6:     //Prestitial
						$('#backgroundLayer').css('display', 'block');
						break;
					default:
						$('#backgroundLayer').css('display', 'none');   //Hide any Prestitial
						break;
				}
				break;
		}
	}
	//--------------------------------------------------------------------------
	function gpt_Sleep(ms) {
		return new Promise(resolve => setTimeout(resolve, ms));
	}
	//--------------------------------------------------------------------------
	async function gpt_ScrollToAd(adTypeId) {
		if (typeof adTypeId === "undefined") {
			adTypeId = 0;
		}
		var adId = "";
		var offset = 0;
		var objLeaderboard = "";
		var gpt_ScrollToAd = true;

		switch (gpt_AdFile) {
			case "PU": //PracticeUpdate
				var hideOtherAds = true;
				$('#modalPrestitial').modal('hide');
				$('.jumbotron-welcome').hide();
				objLeaderboard = ".container-leaderboard";
				offset = 53;
				switch (parseInt(adTypeId)) {
					case 2:
						//LeaderBoard, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 3:
						//MPU
						adId = "adSlot2";
						break;
					case 4:
						//SkyScraper
						adId = "adSlot3";
						$('.most-read').hide();
						break;
					case 5:
						//Mobile, no Scroll Needed
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
					case 6:
						//Interstitial
						gpt_ScrollToAd = false;
						adId = "adSlot15";
						await gpt_Sleep(1000);
						$(objLeaderboard).hide();
						$('#modalPrestitial').unbind();
						$('#modalPrestitial').modal();
						break;
					case 7:
						//Native Ad
						break;
					case 10:
						//Master Companion
						hideOtherAds = false;
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						adId = "adSlot1";
						break;
				}
				if (hideOtherAds) {
					//Hide all other ads
					$('.ad-container').each(function (i, obj) {
						if (this.id !== adId) {
							var tempParent = this.id;
							tempParent = tempParent.replace("adSlot", "adParent");
							$("#" + tempParent).addClass('hide');
						}
					});
				}
				break;
			case "JBS":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$(".widget-verticalAd").hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="sidebar"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					case 13:	    //Phone - Portrait
					case 14:        //Phone - Landscape
						$(objLeaderboard).hide();
						offset = 60;
						adId = 'gpt-Interscroller';
						gpt_ScrollToAd = true;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
			case "CELLJOURNAL":
			case "CELLBUCKET":
				objLeaderboard = ".js__adToHide";
				offset = 260;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="boombox"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				//Hide the second ad if found
				var tCount = 0;
				$(".widget.literatumAd.none.GPT-ad-placeholder.widget-horizontalAd.widget-compact-all").each(function (index) {
					tCount += 1;
					if (tCount !== 1) {
						$(this).hide();
					}
				});
				break;
			case "LANCET":
				objLeaderboard = ".js__adToHide";
				offset = 80;
				switch (parseInt(adTypeId)) {
					case 2:
						//Leaderboard
						gpt_ScrollToAd = false;
						$('.body-verticalAd').hide();
						break;
					case 5:
						//Mobile
						//Scroll to Top
						gpt_ScrollToAd = false;
						break;
					case 3: //MPU
					case 4: //SkyScraper
						$(objLeaderboard).hide();
						adId = $('.gpt-ad-defined[data-adsize="skyscraper"').attr('id');
						break;
					case 10:
						//MasterCompanion
						gpt_ScrollToAd = false;
						break;
					default:
						//Unknown Ad Type
						gpt_ScrollToAd = false;
						break;
				}
				break;
		}

		//Scroll to Top
		var gpt_container = $("html,body");
		gpt_container.animate({ scrollTop: 0, scrollLeft: 0 });

		if (gpt_ScrollToAd) {
			//If Adexists, scroll to it
			var gpt_scrollTo = $('#' + adId);
			if (gpt_scrollTo.length > 0) {
				//Scroll to the Ad
				var gpt_topPosition = gpt_scrollTo.offset().top - gpt_container.offset().top + gpt_container.scrollTop();
				if (gpt_topPosition > 0) {
					gpt_container.animate({ scrollTop: gpt_topPosition, scrollLeft: 0 });
					if (gpt_topPosition - offset > 0 && offset > 0) {
						gpt_container.animate({ scrollTop: gpt_topPosition - offset, scrollLeft: 0 });
					}
				}
			}
		}
	}
	//--------------------------------------------------------------------------
	async function gpt_CheckForCookiePolicy() {
		var returnVal = false;
		if ($('#onetrust-accept-btn-handler').length > 0) {
			$('#onetrust-accept-btn-handler').click();
			returnVal = true;
		}
		return returnVal;
	}
	//--------------------------------------------------------------------------
	function gpt_InitAds() {
		var gpt_ResponsiveHomepage = false;

		switch (gpt_AdFile) {
			case "JBS":
			case "CELLJOURNAL":
			case "CELLBUCKET":
				//Responsive Check
				if ($('#hdrHomeBrand').length > 0) {
					gpt_ResponsiveHomepage = true;
				}
				break;
		}

		//InterScroller Check
		if (gpt_AdFile === "JBS") {
			var gpt_InterScrollerEnabled = false;
			var gpt_InterScrollerInsertObj;

			if ($("#articleHeader").length > 0) {
				//It's an article Page
				if ($('.article__sections > section').length > 0) {
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".article__sections > section");
				}
			}
			else {
				if ($('.toc__section').length > 0) {
					//It's a TOC Page
					gpt_InterScrollerEnabled = true;
					gpt_InterScrollerInsertObj = $(".toc__section").first();
				}
			}

			//Add the Interscroller
			if (gpt_InterScrollerEnabled) {
				gpt_InterScrollerInsertObj.first().append($("#gpt-Interscroller").clone());
				$("#gpt-Interscroller").remove();
				$(".gpt-adinterscroller").addClass("gpt-ad");
			}
		}

		googletag.cmd.push(function () {
			var gptBoomBoxSizeMapping;
			var gptFluidMapping;
			var gptHomePageSidebarMapping;
			var gptCellHomePageSidebarMapping;
			var gptInterscrollerMapping;
			var gptLeaderboardSizeMapping;
			var gptMobileSizeMapping;
			var gptPrestitialMapping;
			var gptRectangleShortSizeMapping;
			var gptRectangleSizeMapping;
			var gptSideBarSizeMapping;
			var gptTallSizeMapping;
			var gptWideSizeMapping;
			var gptWideRectangleSizeMapping;

			//***********************************************
			//Start Define Size mapping based on client Viewport
			//***********************************************
			if (gpt_AdFile === 'PU') {
				gptTallSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 600], [160, 600], [120, 600]]).
					addSize([0, 0], []).
					build();

				gptRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250]]).
					addSize([0, 0], []).
					build();

				gptRectangleShortSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[300, 250], [320, 50], [300, 50]]).
					addSize([0, 0], [[300, 250], [320, 50], [300, 50]]).
					build();

				gptWideSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([760, 0], [[728, 90], [320, 50], [300, 50]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptWideRectangleSizeMapping = googletag.sizeMapping().
					addSize([992, 0], []).
					addSize([760, 0], [[320, 50], [300, 50], [300, 250]]).
					addSize([0, 0], [[320, 50], [300, 50], [300, 250]]).
					build();

				gptMobileSizeMapping = googletag.sizeMapping().
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([760, 0], [[1, 1]]).
					build();
			}
			else {
				//JBS-CELL-LANCET
				gptLeaderboardSizeMapping = googletag.sizeMapping().
					addSize([992, 0], [[728, 90]]).
					addSize([768, 0], [[728, 90]]).
					addSize([0, 0], [[320, 50], [300, 50]]).
					build();

				gptHomePageSidebarMapping = googletag.sizeMapping().
					addSize([2090, 795], [[300, 600], [300, 250], [160, 600], [120, 600]]).
					addSize([1910, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptCellHomePageSidebarMapping = googletag.sizeMapping().
                    addSize([2180, 795], [[300, 600], [160, 600], [120, 600], [300, 250], [336, 280]]).
					addSize([2180, 445], [[336, 280]]).
                    addSize([2090, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
                    addSize([2090, 445], [[300, 250]]).
					addSize([1830, 795], [[160, 600], [120, 600]]).
                    addSize([1740, 795], [[120, 600]]).
					addSize([0, 0], []).
					build();

				gptSideBarSizeMapping = googletag.sizeMapping().
					addSize([1140, 795], [[300, 600], [160, 600], [120, 600], [300, 250]]).
					addSize([1140, 445], [[300, 250]]).
					addSize([0, 0], []). 				
					build();

				gptBoomBoxSizeMapping = googletag.sizeMapping().
					addSize([768, 0], [[300, 250], [336, 280]]).
					addSize([0, 0], []). 						
					build();

				gptFluidMapping = googletag.sizeMapping().
					addSize([0, 0], ['fluid']).
					build();

				gptPrestitialMapping = googletag.sizeMapping().
					addSize([600, 700], [[1, 1]]).
					addSize([0, 0], []).
					build();

				gptInterscrollerMapping = googletag.sizeMapping().
					addSize([1140, 445], []).
					addSize([1024, 768], [[1024, 768]]).
					addSize([768, 1024], [[768, 1024]]).
					addSize([480, 320], [[480, 320]]).
					addSize([320, 480], [[320, 480]]).
					build();
			}
			//***********************************************
			//End Define Size mapping based on client Viewport
			//***********************************************

			//***********************************************
			//Start detection for ad slots on page
			//***********************************************
			var gptMasterPage = gpt_CheckForNULL($('#gptPage').val());
			var gptMasterSite;

			if (gpt_AdFile === 'PU') {
				gptMasterSite = $('#gptSite').val();
			}
			else {
				//JBS-CELL-LANCET
				gptMasterSite = "dev";

				if (gpt_IsProd) {
					gptMasterSite = gpt_CheckForNULL($('#gptSite').val());

					//If there is no master site, check for a defaultsite
					if (gptMasterSite == null) {
						gptMasterSite = gpt_CheckForNULL($('#gptDefaultSite').val());
					}
				}
				else {
					//Dev ENV
					//If the page has no gptSite Value, assume no value which will disable ads
					if (gpt_CheckForNULL($('#gptSite').val()) === null) {
						gptMasterSite = null;
					}
				}

				//If there is no master Page, check for a Page using the URL
				if (gptMasterPage === null) {
					gptMasterPage = GPT_GetPageByURL();
				}
			}

			$(".gpt-ad").each(function (index) {
				var gptPage = '';
				var adSizeMapping = '';
				var gptPOS;
				var gptTC;
				var gptNative;
				var adId;
				var gptSite;
				var tempSlot = null;


                if (gpt_IsProd) {
					if (gpt_AdFile !== "CELLJOURNAL") {
						//Check if the ad slot has it's own site defined
						if (typeof $(this).data('site') === 'undefined') {
							gptSite = gptMasterSite;
						}
						else {
							gptSite = gpt_CheckForNULL($(this).data('site'));
						}
					}
					else {
						gptSite = gptMasterSite;
					}
                }
                else {
					gptSite = gptMasterSite;
                }



				if (gpt_AdFile === 'PU') {
					adId = $(this).attr('id');
				}
				else {
					//JBS-CELL-LANCET
					adId = 'gpt-ad-' + index + 1;
				}

				if (gpt_CheckForNULL(gptSite) !== null) {
					gptSite_Debug = gptSite;

					gptPOS = parseInt($(this).data('pos')) || -1;
					if (gptPOS === -1) {
						gptPOS = index + 1;
					}

					//Check if the ad slot has it's own page defined
					gptPage = $(this).data('page');
					if (gpt_CheckForNULL(gptPage) == null) {
						//Use the Master Page
						gptPage = gptMasterPage;
					}

					//If the page is not null, preceed it with a slash
					if (gptPage !== null) {
						gptPage = '/' + gptPage;
					}
					else {
						gptPage = '';
					}
					gptPage_Debug = gptPage;


					gptTC = $(this).data('tc');
					if (typeof gptTC === "undefined") {
						gptTC = '';
					}

					gptNative = $(this).data('native');
					if (typeof gptNative === "undefined") {
						gptNative = '';
					}

					//Determine sizemapping based on data-adsize
					if (gpt_AdFile === 'PU') {
						switch ($(this).data('adsize')) {
							case 'tall':
								adSizeMapping = gptTallSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600]], adId);
								break;
							case 'rectangle':
								adSizeMapping = gptRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								break;
							case 'rectangleshort':
								adSizeMapping = gptRectangleShortSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [320, 50], [300, 50]], adId);
								break;
							case 'wide':
								adSizeMapping = gptWideSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'widerectangle':
								adSizeMapping = gptWideRectangleSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50], [300, 250]], adId);
								break;
							case 'mobile':
								adSizeMapping = gptMobileSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 50], [300, 50]], adId);
								break;
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[1, 1]], adId);
								break;
						}
					}
					else {
						//JBS-CELL-LANCET
						switch ($(this).data('adsize')) {
							case 'cell-leaderboard':
							case 'leaderboard':
								adSizeMapping = gptLeaderboardSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[728, 90], [320, 50], [300, 50]], adId);
								break;
							case 'bottom':
								if (gpt_ResponsiveHomepage) {
									adSizeMapping = gptHomePageSidebarMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'boombox':
								if (gpt_AdFile === "CELLJOURNAL" || gpt_AdFile == "CELLBUCKET") {
									if (gpt_ResponsiveHomepage) {
										adSizeMapping = gptCellHomePageSidebarMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250], [336, 280]], adId);
									}
									else {
										adSizeMapping = gptBoomBoxSizeMapping;
										tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250], [336, 280]], adId);
									}
								}
								else {
									adSizeMapping = gptBoomBoxSizeMapping;
									tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[300, 250]], adId);
								}
								break;
							case 'interscroller':
								adSizeMapping = gptInterscrollerMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[320, 480], [480, 320], [768, 1024], [1024, 768]], adId);
								break;
							case 'sidebar':
							case 'skyscraper':
								adSizeMapping = gptSideBarSizeMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, [[120, 600], [160, 600], [300, 600], [300, 250]], adId);
								break;
							case 'native':
							case 'fluid':
								adSizeMapping = gptFluidMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
							case 'prestitial':
								adSizeMapping = gptPrestitialMapping;
								tempSlot = googletag.defineSlot('/6053/els.' + gptSite + gptPage, 'fluid', adId);
								break;
						}
					}
				}

				//Ignore any invalid adsizes that could be on the page
				if (adSizeMapping !== '') {
					$(this).addClass('gpt-ad-defined');
					if (gpt_AdFile !== 'PU') {
						$(this).attr('id', adId);
					}
					tempSlot.defineSizeMapping(adSizeMapping).addService(googletag.pubads()).setTargeting("pos", gptPOS);

					if (gptTC !== '') {
						tempSlot.setTargeting("tc", gptTC);
					}
					if (gptNative !== '') {
						tempSlot.setTargeting("native", gptNative);
					}
					gptEvent_Debug = gptEvent_Debug + $(this).data('adsize') + ' Requested<br>';
				}
				else {
					gptInvalidAdSize_Debug = gptInvalidAdSize_Debug + "Invalid Size Found, Id: " + $(this).prop('id') + ', adSize: ' + $(this).data('adsize') + '<br>';
					$(this).remove();
				}
			});
			if (gpt_CheckForNULL(gptInvalidAdSize_Debug) === null) {
				gptInvalidAdSize_Debug = "None Detected";
			}
			//***********************************************
			//End detection for ad slots on page
			//***********************************************

			//***********************************************
			//Start page level targeting
			//***********************************************
			if (gpt_AdFile !== 'PU') {
				//Logged in or IP Access
				gpt_TargetAccessType();

				//Check for Screenshot Client
				gpt_CheckSSC();
			}

			//Check for DFP Test
			gpt_GetDFPTestId();

			//Check for Additional Targeting
			gpt_GetAdditionalTargeting();

			if (gpt_IsProd && gptContextualEnabled) {
				var gpt_ContextualRetry = false;
				//Check for Contextual Targeting
				if (gs_channels !== "DEFAULT") {
					var gpt_ContextualCategories = Array.from(gs_channels);
					for (var i = 0; i < gpt_ContextualCategories.length; i++) {
						if (gpt_ContextualCategories[i] == 'gx_retry') {
							gpt_ContextualRetry = true;
						}
						if (!gpt_ContextualCategories[i].startsWith("custom_")) {
							//Remove any tag that is not custom
							gpt_ContextualCategories.splice(i, 1);
							i--;
						}
						else {
							//Strip the 'custom_' from the tag
							gpt_ContextualCategories[i] = gpt_ContextualCategories[i].replace("custom_", "")
						}
					}
					if (gpt_ContextualCategories.length > 0) {
						googletag.pubads().setTargeting("gs_cat", gpt_ContextualCategories);
					}
					else {
						gpt_ContextualCategories = 'none';
					}
					if (gpt_ContextualRetry) {
						gpt_ContextualCategories = "*Indexing*";
					}
					gptContextualResult_Debug = gpt_ContextualCategories;
				}
				else {
					gptContextualResult_Debug = 'No segments found';
				}
			}
			else {
				//Not Prod || Contextual not enabled
				gptContextualResult_Debug = 'Not enabled';
				
				if (!gpt_IsProd) {
                    var gpt_DevSite = gpt_CheckForNULL($('#gptSite').val(), "dev");
                    $('#gpt-Variables').append('<input type="hidden" id="gptEnvironment" value="' + gpt_DevSite + '">');
                    gpt_Target("Environment");
                }

			}
			//***********************************************
			//End page level targeting
			//***********************************************

			//Enable google dfp services
			if (parseInt($('#gptLazyLoading').val()) === 1) {
				googletag.pubads().enableLazyLoad({
					fetchMarginPercent: 200,
					renderMarginPercent: 0,
					mobileScaling: 2.0
				});
			}
			else {
				googletag.pubads().enableSingleRequest();
			}

			//Add Listener for RenderEnded
			googletag.pubads().addEventListener('slotRenderEnded', function (event) {
				if (!event.isEmpty) {
					if (typeof LocalAdLoaded === "function") {
						LocalAdLoaded(event);
					}
					if (gpt_ResponsiveHomepage) {
						if (typeof positionAd === "function") {
							positionAd();
						}
					}
					if (event.size[0] == "480" || event.size[1] == "480") {
						$('.gpt-InScrollBox').css('display', 'block');
						gptEvent_Debug = gptEvent_Debug + 'Interscroller ' + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}
					else {
						gptEvent_Debug = gptEvent_Debug + event.size + ' rendered: ' + gpt_GetElapsedTime() + '<br>';
					}

				}
			});

			if (gpt_AdFile !== 'PU') {
				googletag.pubads().collapseEmptyDivs();
			}
			googletag.enableServices();

			//Populate Defined Ad Slots
			$(".gpt-ad-defined").each(function (index) {
				var adId = $(this).attr('id');
				googletag.cmd.push(function () { googletag.display(adId); });
			});

			gptStatus_Debug = 'GPT Complete';
		});
	}
	//--------------------------------------------------------------------------
	function gpt_DisplayDebug() {
		//Clone the template and append to Body
		$(document.body).append($('#gpt-DebugDiv').clone());
		$('#gpt-DebugDiv').remove();

		//Populate the Values
		gpt_LoadDebugValues();

		//Display and scroll to debug section
		$('.gpt-DebugDiv').css('display', 'block');
		window.scrollTo(0, document.body.scrollHeight);
	}
	//--------------------------------------------------------------------------
	function gpt_LoadDebugValues() {
		$('.gpt-DebugBtn').blur();
		$('.gptVersion_Debug').text(gpt_Version);
		$('.gptAdFile_Debug').html(gpt_AdFile);
		$('.gptEvent_Debug').html(gptEvent_Debug);
		$('.gptCustomTargeting_Debug').html(gptCustomTargeting_Debug);
		$('.gptSite_Debug').text(gptSite_Debug);
		$('.gptContextualResult_Debug').text(gptContextualResult_Debug);
		$('.gptContextualInit_Debug').text(gptContextualInit_Debug);
		$('.gptContextualURL_Debug').text(gptContextualURL_Debug);
		$('.gptContextualReady_Debug').text(gptContextualReady_Debug);
		$('.gptMoatReady_Debug').text(gptMoatReady_Debug);
		$('.gptMoatInit_Debug').text(gptMoatInit_Debug);
		$('.gptTestENV_Debug').text(gptTestENV_Debug);
		$('.gptDisableAds_Debug').text(gptDisableAds_Debug);
		$('.gptStatus_Debug').text(gptStatus_Debug);
		$('.gptPage_Debug').text(gptPage_Debug);
		$('.gptInvalidAdSize_Debug').html(gptInvalidAdSize_Debug);
	}
	//--------------------------------------------------------------------------
	function gpt_GrapeShotDebug() {
		$('.gpt-DebugBtn').blur();
		window.open("http://admin-elsevier.grapeshot.co.uk/custom/bookmarklet.cgi?blocking=1&vn=2&url=" + encodeURIComponent(document.location), "GRAPESHOT_POPUP", "width=650,height=600,scrollbars=yes,screenX=40,screenY=50,menubar=no,toolbar=no,resizable=yes", "Custom").focus();
	}
	//--------------------------------------------------------------------------
	function gpt_ShowConsole() {
		$('.gpt-DebugBtn').blur();
		googletag.openConsole();
	}
	//--------------------------------------------------------------------------
</script>
        </div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="912135d6-7135-4d45-b457-b503cacc3c8b" data-widget-name="ux3-layout-widget"><header class="header base fixed">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header js__adToHide widget-horizontalAd" id="9d6062d7-fad6-4e64-81cc-7dd25d99b23d">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 1 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="1"></div>
<!-- End AdSlot 1 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" class="header__wrapper clearfix" data-db-parent-of="quickSearch"><div id="brandingRow"><a href="/" data-aa-name="science that inspires" data-aa-region="cp global header" title="Visit Cell.com">Science that inspires</a><p id="brandingRowRight"><a href="/" data-aa-name="cell press endorsement" data-aa-region="cp global header" title="Visit Cell.com">A Cell Press journal</a></p></div>
        
    

        


    

            

            

            <div data-widget-id="3a83e2a6-2e7e-4931-892c-4ef43b6e3312" data-widget-name="ux3-layout-widget"><div class="col-xs-6 header__left-side">
    

        


    

            

            
                <a href="/home" id="cpIconLnk" data-aa-name="cell press logo" data-aa-region="cp global header" title="Cell Press" target="_blank"><svg id="cp_logo" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 100 98.1" style="enable-background:new 0 0 100 98.1;" xml:space="preserve" height="100" width="98.1"><path style="fill:#FFFFFF;" d="M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z"></path></svg></a><div class="journal-logos">
            

            <span data-widget-id="35d8d734-3aa0-4ec8-9e2d-14babe803594" data-widget-name="ux3-general-image"><a href="/cell/home" title="Cell"><img alt="Cell" src="/pb-assets/ux3/logos/cell/Cell_white-1532516611593.svg"></a></span>

            
                </div>
            

        

    

        


    

            

            
                <div class="journal-logos">
            

            <span data-widget-id="3ffcbf1f-79fd-4ba3-85b5-bef10a63475f" data-widget-name="ux3-general-image"><a href="https://www.cell.com/open-access?utm_source=oa-label&amp;__hstc=109691226.e4e812b53ff324eccbdbdb2e4fb9a6ab.1644503737405.1644524234622.1644587109507.4&amp;__hssc=109691226.7.1644587109507&amp;__hsfp=3253153019" title="This journal offers authors two options (open access or subscription) to publish research"><img alt="This journal offers authors two options (open access or subscription) to publish research" src="/pb-assets/ux3/logos/cell/Supports_open_access_border-1645554937897.svg"></a></span>

            
                </div>
            

        
</div><div class="col-xs-6">
    

        


    

            

            

            <div data-widget-id="2555f6db-b333-4edb-8b15-ef9213f1f0a5" data-widget-name="ux3-layout-widget"><div class="header__nav row">
    

        


    

            

            

            <ul data-widget-id="52432d24-0331-4c9d-85f3-2033edc7208b" data-widget-name="UX3ProfileLinksWidget" class="rlist rlist--inline profile-links"><li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login-dropdown"><div class="profile-links__user-list__wrapper"><button data-db-target-for="loginmenu-30291" aria-expanded="false" aria-controls="login-links-30291" title="Log in links dropdown" class="profile-links__username"><span>Log in</span></button><div data-db-target-of="loginmenu-30291" id="login-links--30291" class="profile-links__user-list__holder dropBlock__holder"><ul class="rlist profile-links__list"><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Get Institutional Access</a></li></ul></div></div></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Register</a></li><li class="hidden-lg"> <div class="profile-links__controls"> <button aria-expanded="false" aria-controls="links-dialog-30291" data-opens="#links-dialog-30291" class="profile-links__btn--open"><span class="sr-only">open links dialog</span><i aria-hidden="true" class="icon-gizmo-person"></i></button></div><dialog id="links-dialog-30291" aria-modal="true"><button data-closes="#links-dialog-30291" class="profile-links__btn--close"><span class="sr-only">close links dialog</span><i aria-hidden="true" class="icon-close-solid"></i></button><ul>   <li class="profile-links__submit"><a data-adobe-name="Publish" class="profile-links__submit__btn" title="Submit" href="https://www.editorialmanager.com/cell" target="_self" data-aa-conversiondriver="jbs:global-header:submitpage" data-profile-link="true">Submit</a></li><li class="profile-links__login"><a data-adobe-name="Log In" class="profile-links__login__btn" title="Log in to Cell.com" href="https://www.cell.com/action/idLogin?type=login&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Log in</a></li><li class="profile-links__institution"><a data-adobe-name="Get institutional access" class="profile-links__institution__btn" title="Institutional access" href="https://www.cell.com/action/idLogin?type=institution&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Get Institutional Access</a></li><li class="profile-links__register"><a data-adobe-name="Register" class="profile-links__register__btn" title="Register a username and password for free" href="https://www.cell.com/action/idLogin?type=registration&amp;redirectUri=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8" target="_self" data-profile-link="true">Register</a></li></ul></dialog></li></ul>

            

        
</div></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasInstitutionBanner none  widget-none" id="51b7fa33-2137-4f58-9e98-9746c4400513" style="display: none;">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><div class="ui-state-highlight ui-corner-all csas-institution-banner hidden" data-doi="10.1016/j.cell.2020.02.015">
    <span class="ui-icon ui-icon-close banner-close"></span>
    <p>
        Access provided by <span class="accountName"></span>
    </p>
</div>

<style>
    .csas-institution-banner {
        padding: 10px 0 0 10px;
        margin: 5px;
    }

    .csas-institution-banner.ui-state-highlight .ui-icon {
        background-image: url("/templates/jsp/css/jquery-ui-1.10.2/base/images/ui-icons_454545_256x240.png");
        margin-right: 5px;
        margin-top: -4px;
    }

    .csas-institution-banner .banner-close {
        float: right;
    }
</style>

<script>

    function resetBanner(doi) {
        $.get('/action/getAccount?doi=' + doi, function(data) {
            if (data) {
                $(".csas-institution-banner p .accountName").html(data);
                $(".csasInstitutionBanner").fadeIn();
                $(".csas-institution-banner").fadeIn();
            }
        });
    }

    var flag = 0;
    $(document).ready(function() {
        if(!$(".csas-institution-banner").is(":visible")){
            $(".csasInstitutionBanner").hide();
        }

        $(".banner-close").click(function() {
            $.get("/action/dismissBanner", function(data) {
                $(".csasInstitutionBanner").fadeOut(function () {
                    if(typeof UX !== 'undefined') {
                        UX.pageBody.init();
                    }
                });
            });
        });

        $(".articleContent .tabs li[role='tab'].showFullText").click(function() {
           flag = 1;
        });

        $(document).on("reloadTabsContent", function() {
            var isSelected = $(".articleContent .tabs li[role='tab'].showFullText").hasClass("active");
            if (isSelected) {
                var isHidden =  $(".csas-institution-banner").is(".hidden");
                if (!isHidden) {
                    resetBanner($(".csas-institution-banner").data("doi"));
                    console.log("fadeIn");
                }
            } else {
                $(".csas-institution-banner").fadeOut();
                console.log("fadeOut");
            }
            flag = 0;
        });

        $(document).on("click", ".articleContent .tabs li[role='tab']", function() {

        });
    });
</script></div>
                </div>
                </div>

        
</header></div>

            

        










        <div data-widget-def="graphQueryWidget" data-widget-id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" class="ux3">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget graphQueryWidget none top-padding-handler noMargin axel-mega-menu widget-none widget-compact-all fonts-loaded" id="2a125dae-6dbc-4e76-a75e-3e563f1d3a1d" style="padding-top: 115.594px;">
                
                
                    
                

                <div class="wrapped " id="CP TOP LEVEL NAV MENU">
                    
                    <div class="widget-body body body-none  body-compact-all"><nav id="mega-menu-nav" role="navigation" class="mega-menu-nav">
  <!--.skip//a(href='#searchText' aria-label='Skip menu') Skip menu
  -->
  <div class="mega-menu-nav__wrapper">
    <button class="mega-menu__toggle"><span class="sr-only">Main menu</span><i aria-hidden="true" class="icon-gizmo-hamburger"></i></button>
    <ul role="menubar" class="mega-menu rlist">
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-1" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-1" data-item-link="main-menu-link-1" data-index="0" class="mega-menu__item-link menu-link"><span>This journal</span></a>
        <div id="main-menu-panel-1" aria-labelledby="main-menu-link-1" data-item-wrapper="main-menu-link-1" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <div aria-label="Menu dropzone section" tabindex="-1" class="listDropZone">
    

        


    

            

            

            <div class="cover-image"><div class="cover-image__thumb"><a href="/issue/S0092-8674(24)X0012-4" class="menu-link"><img src="/cms/asset/atypon:cms:attachment:img:d5e6:rev:1748270185670-389:pii:S0092867424X00124/cover.tif.jpg" alt="Cover Image - Cell, Volume 188, Issue 11"></a></div><div class="cover-image__meta"></div></div>

            

        
</div>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-2" class="sub-menu__heading">Read
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/newarticles" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Online now</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/current" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Current issue</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/archive" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Archive</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/action/showPreferences?menuTab=Alerts" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Publication alerts</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sneakpeek" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Sneak Peek - preprints</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-1-3" class="sub-menu__heading">About
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-2">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/advisory-board" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Advisory board</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/aims" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Aims and scope</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/contact" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/editors-and-staff" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Editors and staff</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/editorial-ethics" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Ethics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/permissions" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Permissions</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Reviewer instructions</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-2" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-2" data-item-link="main-menu-link-2" data-index="1" class="mega-menu__item-link menu-link"><span>Journals</span></a>
        <div id="main-menu-panel-2" aria-labelledby="main-menu-link-2" data-item-wrapper="main-menu-link-2" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/5" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-1" class="sub-menu__heading">Life &amp; medical sciences
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-4">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cancer-cell/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cancer Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-chemical-biology" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Chemical Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-genomics/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Genomics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-host-microbe/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Host &amp; Microbe</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-metabolism/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-medicine/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-stem-cell/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Stem Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-systems/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Systems</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/current-biology/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Current Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/developmental-cell/home" data-index="11" role="menuitem" class="sub-menu__item-link menu-link"><span>Developmental Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/immunity/home" data-index="12" role="menuitem" class="sub-menu__item-link menu-link"><span>Immunity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/med/home" data-index="13" role="menuitem" class="sub-menu__item-link menu-link"><span>Med</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-cell/home" data-index="14" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Cell</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/neuron/home" data-index="15" role="menuitem" class="sub-menu__item-link menu-link"><span>Neuron</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/structure/home" data-index="16" role="menuitem" class="sub-menu__item-link menu-link"><span>Structure</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/ajhg/home" data-index="17" role="menuitem" class="sub-menu__item-link menu-link"><span>American Journal of Human Genetics (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysj/home" data-index="18" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Journal (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/biophysreports/home" data-index="19" role="menuitem" class="sub-menu__item-link menu-link"><span>Biophysical Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/hgg-advances/home" data-index="20" role="menuitem" class="sub-menu__item-link menu-link"><span>Human Genetics and Genomics Advances (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-plant/home" data-index="21" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Plant (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/molecular-therapy/home" data-index="22" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/methods/home" data-index="23" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Methods &amp; Clinical Development (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/nucleic-acids/home" data-index="24" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Nucleic Acids (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/molecular-therapy-family/oncology/home" data-index="25" role="menuitem" class="sub-menu__item-link menu-link"><span>Molecular Therapy Oncology (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/plant-communications/home" data-index="26" role="menuitem" class="sub-menu__item-link menu-link"><span>Plant Communications (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/stem-cell-reports/home" data-index="27" role="menuitem" class="sub-menu__item-link menu-link"><span>Stem Cell Reports (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biochemical-sciences/home" data-index="28" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biochemical Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cancer/home" data-index="29" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cancer</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cell-biology/home" data-index="30" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cell Biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/ecology-evolution/home" data-index="31" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Ecology &amp; Evolution</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/endocrinology-metabolism/home" data-index="32" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Endocrinology &amp; Metabolism</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/genetics/home" data-index="33" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Genetics</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/immunology/home" data-index="34" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Immunology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/microbiology/home" data-index="35" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Microbiology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/molecular-medicine/home" data-index="36" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Molecular Medicine</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/neurosciences/home" data-index="37" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Neurosciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/parasitology/home" data-index="38" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Parasitology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/pharmacological-sciences/home" data-index="39" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Pharmacological Sciences</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/plant-science/home" data-index="40" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Plant Science</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 5/6" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-2" class="sub-menu__heading">Physical sciences &amp; engineering
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-biomaterials/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Biomaterials</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-physical-science/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Physical Science</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/chem-catalysis/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Chem Catalysis</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/device/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Device</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/joule/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Joule</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/matter/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>Matter</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/newton/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Newton</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/chemistry/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Chemistry</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 6/7" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-2-3" class="sub-menu__heading">Multidisciplinary
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-methods/home" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Methods</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-reports-sustainability/home" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Reports Sustainability</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/heliyon/home" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Heliyon</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/iscience/home" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>iScience</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/one-earth/home" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>One Earth</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/patterns/home" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Patterns</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/star-protocols/home" data-index="6" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Protocols</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/nexus/home" data-index="7" role="menuitem" class="sub-menu__item-link menu-link"><span>Nexus (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/the-innovation/home" data-index="8" role="menuitem" class="sub-menu__item-link menu-link"><span>The Innovation (<em>partner</em>)</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/biotechnology/home" data-index="9" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Biotechnology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/trends/cognitive-sciences/home" data-index="10" role="menuitem" class="sub-menu__item-link menu-link"><span>Trends in Cognitive Sciences</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-3" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-3" data-item-link="main-menu-link-3" data-index="2" class="mega-menu__item-link menu-link"><span>Publish</span></a>
        <div id="main-menu-panel-3" aria-labelledby="main-menu-link-3" data-item-wrapper="main-menu-link-3" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-1" class="sub-menu__heading">Authors
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://www.editorialmanager.com/cell?__hstc=25856994.7201670a4397fa03148684920d4a8d38.1672762013831.1694716659709.1694718909620.146&amp;__hssc=25856994.15.1694718909620&amp;__hsfp=1366844671" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Submit article
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell/information-for-authors" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for authors</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/multi-journal-submission" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Multi-Journal Submission</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/information-for-authors/star-authors-guide" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>STAR Methods</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-3-2" class="sub-menu__heading">Reviewers
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/reviewers" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Information for reviewers</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-4" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-4" data-item-link="main-menu-link-4" data-index="3" class="mega-menu__item-link menu-link"><span>News &amp; events</span></a>
        <div id="main-menu-panel-4" aria-labelledby="main-menu-link-4" data-item-wrapper="main-menu-link-4" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/newsroom" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Newsroom</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/events" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Events</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/symposia" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Symposia</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/webinars" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Webinars</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/consortia" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Consortia Hub</span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
      <li role="presentation" class="mega-menu__item"><a id="main-menu-link-5" aria-haspopup="true" href="javascript:void(0)" role="menuitem" aria-controls="main-menu-panel-5" data-item-link="main-menu-link-5" data-index="4" class="mega-menu__item-link menu-link"><span>About Cell Press</span></a>
        <div id="main-menu-panel-5" aria-labelledby="main-menu-link-5" data-item-wrapper="main-menu-link-5" aria-expanded="false" class="mega-menu__item-wrapper">
          <ul class="sub-menu rlist mega-menu__sub-menu-heading">
            <li style="grid-column: 1/2" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-1" class="sub-menu__heading">Cell Press
              </h4>
              <ul role="menubar" data-index="0" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/about" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>About Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/contact" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Contact us</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="https://service.elsevier.com/app/overview/cell-press/" data-index="2" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Help &amp; support
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/open-access" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>Open access at Cell Press</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/diversity" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Inclusion and diversity</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-50" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>50th anniversary</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 2/3" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-2" class="sub-menu__heading">Hubs
              </h4>
              <ul role="menubar" data-index="1" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="/biotechnology-bioengineering" data-index="0" role="menuitem" class="sub-menu__item-link menu-link"><span>Biotechnology and bioengineering</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/cell-press-chemistry" data-index="1" role="menuitem" class="sub-menu__item-link menu-link"><span>Chemistry</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/clinical-translational" data-index="2" role="menuitem" class="sub-menu__item-link menu-link"><span>Clinical and translational</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/covid-19" data-index="3" role="menuitem" class="sub-menu__item-link menu-link"><span>COVID-19</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/fundamental-biology" data-index="4" role="menuitem" class="sub-menu__item-link menu-link"><span>Fundamental biology</span></a></li>
                <li role="presentation" class="menu-link__wrapper"><a href="/sustainability" data-index="5" role="menuitem" class="sub-menu__item-link menu-link"><span>Sustainability</span></a></li>
              </ul>
            </li>
            <li style="grid-column: 3/4" class="double-width sub-menu__item">
              <h4 data-item-link="main-menu-link-5-3" class="sub-menu__heading">Careers
              </h4>
              <ul role="menubar" data-index="2" class="rlist heading-list col-count-1">
                <li role="presentation" class="menu-link__wrapper"><a href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" data-index="0" target="_blank" role="menuitem" class="sub-menu__item-link menu-link"><span>Cell Press careers
                      <div class="external-icon"></div><span class="sr-only">External Link</span></span></a></li>
              </ul>
            </li>
          </ul>
        </div>
      </li>
    </ul>
    <div class="mega-menu-nav__quick-search">
    

        


    

            

            

            <div data-widget-id="a1f05748-166f-41e0-b01a-ca8ac1cc95d4" data-widget-name="UX3QuickSearchWidget" class="quick-search"><div class="dropBlock"><form action="https://www.cell.com/action/doSearch?journalCode=cell" name="quickSearchBar" method="get" title="Quick Search"><input id="type" type="hidden" value="quicksearch" name="type"><div class="quick-search__toggle autoCompleteWrapper"><input id="searchText" type="text" name="text1" placeholder="Search for..." enterkeyhint="search" autocomplete="off" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" data-group-titles-conf="3" data-publication-items-conf="3" aria-label="Enter a search term" class="searchText searchText-autocomplete ui-autocomplete-input"><button type="submit" title="Search" aria-label="Submit the search form" class="btn quick-search__button icon-search"><span>Go search</span></button><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a><ul id="ui-id-1" tabindex="0" class="ui-menu ui-widget ui-widget-content ui-autocomplete ui-front" unselectable="on" style="display: none;"></ul></div><div class="quick-search__box"><div class="quick-search__box-inner"><div class="quick-search__box-wrapper"><select name="field1" aria-label="Select a search area"><option value="AllField">All content</option><option value="Title">Article title</option><option value="Contrib">Authors</option><option value="Keyword">Keywords</option><option value="Abstract">Abstract</option><option value="AbstractTitleKeywordFilterField">Article title, abstract, keywords</option></select><input type="hidden" name="journalCode" value="cell"><div class="quick-search__scope-options"><span>Search within:</span><label title="This journal" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeSeries-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" title="This journal" value="cell" checked="checked" aria-label="Search within current journal"><span>This journal</span></label><label title="Full site" class="radio--primary"><input type="radio" name="SeriesKey" id="searchScopeFullSite-a1f05748-166f-41e0-b01a-ca8ac1cc95d4" value="" title="Full site" aria-label="Search within full site"><span>Full site</span></label></div><a href="https://www.cell.com/search/advanced?SeriesKey=cell&amp;ISSN=0092-8674&amp;journalCode=cell" title="Advanced search" class="quick-search__advanced-link">Advanced search</a></div><a href="javascript:void(0)" aria-label="Close search options" title="Close search options" class="quick-search__box-close"><i aria-hidden="true" class="icon-tools_close"></i></a></div></div><div class="quick-search__alert hidden"><p>Please enter a term before submitting your search.</p><a href="#" class="quick-search__alert--close"> Ok</a></div></form></div></div>

            

        
</div>
  </div>
</nav>
<div id="page-body-id" class="page-body-flag"></div></div>
                </div>
                </div>

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="f8c6daf9-9df1-4fd9-ba3a-7f5d7b3d4466" data-widget-name="UX3HTMLWidget"><style>
.journal-logos:nth-of-type(2) img {
max-height: 30px !important;
}
.journal-logos:nth-of-type(3) img {
max-height: 30px !important;
}
.ux3 .journal-logos + .journal-logos {
margin-left: 30px;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 55%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 45%;
}
@media screen and (max-width: 1000px) {
.ux3 .journal-logos + .journal-logos {
display: none;
}
.header__wrapper.clearfix .col-xs-6:first-of-type {
width: 50%;
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
width: 50%;
}
}

.ux3 .journal-logos:first-of-type {
   max-width: 500px;
}

.profile-links {
   white-space: nowrap;
}

@media only screen and (min-width: 740px) and (max-width: 1600px) {
   .journal-logos:nth-of-type(2) img {
      max-width: 250px !important;
   }
}

@media only screen and (min-width: 1024px) and (max-width: 1600px) {
   .header__wrapper.clearfix .col-xs-6:first-of-type {
      width: 60% !important;
   }
   .header__wrapper.clearfix .col-xs-6:nth-of-type(2) {
      width: 40% !important;
   }
}

@media only screen and (max-width: 1240px) {
   .ux3 .journal-logos + .journal-logos {
      display: none !important;
   }
}

</style></div>

            

        
</div></div>

            
                </div>
            

        

        </div>
    

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget axelPublicationContent none  widget-none" id="cadc9b41-a542-448a-9de4-8d0803320174">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none "><link id="build-style-article" rel="stylesheet" type="text/css" href="/products/marlin/cell/releasedAssets/css/build-article-b26f3342b722959c7931.css"><article xmlns="http://www.w3.org/1999/xhtml" data-design="pill" data-has="right-rail" vocab="http://schema.org/" typeof="ScholarlyArticle" data-pii="S0092-8674(20)30159-8" lang="en" dir="ltr"><div data-core-wrapper="header"><header data-extent="frontmatter"><div class="core-container"><div data-article-access="free" data-article-access-type="open" class="meta-panel"><span class="meta-panel__left-content"><span class="meta-panel__type"><span>Article</span></span></span><span class="meta-panel__middle-content"><span class="meta-panel__volumeIssue"><a href="/cell/issue?pii=S0092-8674(19)X0007-0"><span>Volume 180</span>, <span>Issue 6</span></a></span><span class="meta-panel__pages"><span>p1081-1097.e24</span></span><span class="meta-panel__onlineDate">March 19, 2020</span></span><span class="meta-panel__right-content"><span class="meta-panel__access meta-panel__access--archive"><span>Open Archive</span></span></span><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=180&amp;issue=6&amp;pii=S0092-8674%2819%29X0007-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div><h1 property="name">Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity</h1><div class="contributors"><span class="authors"><span role="list"><span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au1" aria-controls="axel_author_au1"><span property="givenName">Yiwen</span> <span property="familyName">Lu</span></a><div id="au1" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yiwen</span> <span property="familyName">Lu</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Lu/Yiwen" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a role="doc-noteref">6</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au2" aria-controls="axel_author_au2"><span property="givenName">Qiyi</span> <span property="familyName">Zhao</span></a><div id="au2" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Qiyi</span> <span property="familyName">Zhao</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China</span></div></div><div class="core-author-link"><a href="/authored-by/Zhao/Qiyi" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a role="doc-noteref">6</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au3" aria-controls="axel_author_au3"><span property="givenName">Jian-You</span> <span property="familyName">Liao</span></a><div id="au3" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jian-You</span> <span property="familyName">Liao</span></div><div class="content"><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Liao/Jian-You" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a role="doc-noteref">6</a></sup></span><span data-displayed-on="all"> ∙ … </span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au4" aria-controls="axel_author_au4"><span property="givenName">Erwei</span> <span property="familyName">Song</span></a><div id="au4" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Erwei</span> <span property="familyName">Song</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Song/Erwei" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au5" aria-controls="axel_author_au5"><span property="givenName">Qidong</span> <span property="familyName">Xia</span></a><div id="au5" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Qidong</span> <span property="familyName">Xia</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Xia/Qidong" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au6" aria-controls="axel_author_au6"><span property="givenName">Jiayao</span> <span property="familyName">Pan</span></a><div id="au6" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jiayao</span> <span property="familyName">Pan</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Pan/Jiayao" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au7" aria-controls="axel_author_au7"><span property="givenName">Yihong</span> <span property="familyName">Li</span></a><div id="au7" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au7"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yihong</span> <span property="familyName">Li</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Li/Yihong" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au8" aria-controls="axel_author_au8"><span property="givenName">Jiaqian</span> <span property="familyName">Li</span></a><div id="au8" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au8"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Jiaqian</span> <span property="familyName">Li</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Li/Jiaqian" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au9" aria-controls="axel_author_au9"><span property="givenName">Boxuan</span> <span property="familyName">Zhou</span></a><div id="au9" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au9"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Boxuan</span> <span property="familyName">Zhou</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Zhou/Boxuan" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au10" aria-controls="axel_author_au10"><span property="givenName">Yingying</span> <span property="familyName">Ye</span></a><div id="au10" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au10"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yingying</span> <span property="familyName">Ye</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Ye/Yingying" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span><span data-hidden-on="all"> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au11" aria-controls="axel_author_au11"><span property="givenName">Can</span> <span property="familyName">Di</span></a><div id="au11" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au11"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Can</span> <span property="familyName">Di</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Di/Can" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au12" aria-controls="axel_author_au12"><span property="givenName">Shubin</span> <span property="familyName">Yu</span></a><div id="au12" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au12"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shubin</span> <span property="familyName">Yu</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Yu/Shubin" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au13" aria-controls="axel_author_au13"><span property="givenName">Yunjie</span> <span property="familyName">Zeng</span></a><div id="au13" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au13"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Yunjie</span> <span property="familyName">Zeng</span></div><div class="content"><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-author-link"><a href="/authored-by/Zeng/Yunjie" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">5</a></sup></span> ∙ <span property="author" typeof="Person" role="listitem" class="corresponding-author"><span class="dropBlock"><a href="#" aria-expanded="false" data-db-target-for="axel_author_au14" aria-controls="axel_author_au14"><span property="givenName">Shicheng</span> <span property="familyName">Su</span></a><div id="au14" property="author" typeof="Person" class="dropBlock__holder" data-db-target-of="axel_author_au14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="heading"><span property="givenName">Shicheng</span> <span property="familyName">Su</span></div><div class="content"><div class="core-author-emails"><div class="label">Correspondence</div><div>Corresponding author</div><div><a id="eadd0010" href="mailto:sushch@mail.sysu.edu.cn" property="email" title="Send email to Shicheng Su">sushch@mail.sysu.edu.cn</a></div></div><div class="core-author-notes"><div class="label">Footnotes</div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div><div class="core-author-affiliations"><div class="label">Affiliations</div><div property="affiliation" typeof="Organization"><span property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China</span></div><div property="affiliation" typeof="Organization"><span property="name">Department of Immunology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China</span></div></div><div class="core-author-link"><a href="/authored-by/Su/Shicheng" rel="nofollow" target="_blank">Search for articles by this author</a></div></div></div><button class="dropBlock__ctrl--close" title="Close contributor details" aria-label="Close contributor details"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span><sup class="xref"><a property="affiliation" typeof="Organization" role="doc-noteref">1</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">2</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">3</a>,<a property="affiliation" typeof="Organization" role="doc-noteref">4</a>,<a role="doc-noteref">7</a></sup> <a id="eadd0010" href="mailto:sushch@mail.sysu.edu.cn" property="email" title="Send email to Shicheng Su">sushch@mail.sysu.edu.cn</a></span><span data-displayed-on="all"> … <span><span data-action="reveal" tabindex="0" role="listitem">Show more</span></span> </span><span data-displayed-on="none" data-on-display="all" aria-hidden="true"> <span data-action="hide" tabindex="0" role="listitem">Show less</span></span></span></span></div><div class="core-self-citation"><div class="expandable-triggers"><button aria-controls="core-affiliations-notes" aria-expanded="false" tabindex="0" role="button"><span>Affiliations &amp; Notes</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button><button aria-controls="core-content-info" aria-expanded="false" tabindex="0" role="button"><span>Article Info</span><i class="icon-arrow_d_n" aria-hidden="true"></i></button></div><div id="core-linked-content">
    

        

</div><div class="expandable-content"><div id="core-affiliations-notes" role="region" data-expandable="item" style="display: none;"><div class="affiliations"><div property="affiliation" typeof="Organization"><span class="label">1</span><span id="aff1" property="name">Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span class="label">2</span><span id="aff2" property="name">Breast Tumor Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div><div property="affiliation" typeof="Organization"><span class="label">3</span><span id="aff3" property="name">Department of Infectious Diseases, Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China</span></div><div property="affiliation" typeof="Organization"><span class="label">4</span><span id="aff4" property="name">Department of Immunology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou 510080, China</span></div><div property="affiliation" typeof="Organization"><span class="label">5</span><span id="aff5" property="name">Department of Pathology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China</span></div></div><div class="core-authors-notes"><div role="doc-footnote" data-has="label"><div class="label">6</div><div id="fn1"><div id="ntpara0010" role="paragraph">These authors contributed equally</div></div></div><div role="doc-footnote" data-has="label"><div class="label">7</div><div id="fn2"><div id="ntpara0015" role="paragraph">Lead Contact</div></div></div></div></div><div id="core-content-info" role="region" data-expandable="item" style="display: none;"><div class="history"><div>Publication History:</div><div><span>Received August 14, 2019</span>; <span>Revised December 16, 2019</span>; <span>Accepted February 5, 2020</span>; <span>Published online March 5, 2020</span></div></div><div class="core-links"><span class="doi">DOI: <a href="https://doi.org/10.1016/j.cell.2020.02.015" property="sameAs" target="_blank">10.1016/j.cell.2020.02.015 <span class="sr-only">External Link</span></a></span><span class="science-direct">Also available on <a href="https://www.sciencedirect.com/science/article/pii/S0092867420301598" target="_blank">ScienceDirect <span class="sr-only">External Link</span></a></span></div><div role="paragraph">Copyright: © 2020 Elsevier Inc.</div><div class="core-links"><span>User License: <a href="http://www.elsevier.com/open-access/userlicense/1.0/" target="_blank">Elsevier user license</a> | <a href="https://www.elsevier.com/open-access" target="_blank">Elsevier's open access license policy</a></span></div><div class="core-crossmark-badge"><a data-target="crossmark" href="#" title="Check for updates on crossmark" data-doi="10.1016/j.cell.2020.02.015" data-id="article-info-crossmark" class="crossmark__link" style="cursor: pointer;"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 290 58" height="22px" role="presentation"><path fill="url(#horizontal_crossmark)" stroke="#948F8F" stroke-miterlimit="10" stroke-width=".75" d="M287 1H3a2 2 0 0 0-2 2v52a2 2 0 0 0 2 2h284a2 2 0 0 0 2-2V3a2 2 0 0 0-2-2Z"></path><path fill="#535353" d="M80.3 23.58a6.395 6.395 0 0 0-.55-1.43 3.92 3.92 0 0 0-2.19-1.86 5.099 5.099 0 0 0-1.71-.29 5 5 0 0 0-2.46.58 4.831 4.831 0 0 0-1.69 1.54 6.921 6.921 0 0 0-1 2.19 10.16 10.16 0 0 0 0 5 6.921 6.921 0 0 0 1 2.19 4.83 4.83 0 0 0 1.69 1.5 5 5 0 0 0 2.46.58 4.44 4.44 0 0 0 1.85-.36 4.12 4.12 0 0 0 1.38-1c.39-.436.695-.942.9-1.49A7.094 7.094 0 0 0 80.4 29h3a8.46 8.46 0 0 1-.69 2.92 7.179 7.179 0 0 1-1.59 2.29 7 7 0 0 1-2.35 1.49 8.14 8.14 0 0 1-3 .52 8.43 8.43 0 0 1-3.59-.74 7.88 7.88 0 0 1-2.69-2 9.001 9.001 0 0 1-1.69-3 11.41 11.41 0 0 1 0-7.23 9.001 9.001 0 0 1 1.69-3 8.001 8.001 0 0 1 2.69-2 8.3 8.3 0 0 1 3.59-.75 9.44 9.44 0 0 1 2.83.41c.866.242 1.68.642 2.4 1.18A6.229 6.229 0 0 1 82.65 21a6.66 6.66 0 0 1 .78 2.58H80.3ZM85.9 17.9h2.85v6.63h.05a4.15 4.15 0 0 1 1.56-1.46 4.61 4.61 0 0 1 2.31-.59 4.83 4.83 0 0 1 3.33 1.1 4.21 4.21 0 0 1 1.22 3.3v8.88H94.4v-8.13a3.51 3.51 0 0 0-.65-2.21 2.36 2.36 0 0 0-1.87-.69 3.1 3.1 0 0 0-1.3.26 2.821 2.821 0 0 0-1 .73A3.41 3.41 0 0 0 89 26.8a3.88 3.88 0 0 0-.23 1.33v7.63H85.9V17.9ZM102.47 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7A5.349 5.349 0 0 1 109.7 35a5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4A5.953 5.953 0 0 1 100 32a8.748 8.748 0 0 1-.41-2.75 7.768 7.768 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.264.905.352 1.852.26 2.79h-9.53Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.594 3.594 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM122.88 27.15a2.666 2.666 0 0 0-1-1.81 3.14 3.14 0 0 0-2-.61c-.4.005-.798.07-1.18.19-.435.136-.83.376-1.15.7a3.92 3.92 0 0 0-.87 1.43 6.783 6.783 0 0 0-.35 2.39c.002.539.065 1.076.19 1.6.113.509.316.993.6 1.43.273.41.635.752 1.06 1a3 3 0 0 0 1.58.39 2.872 2.872 0 0 0 2.06-.77 3.596 3.596 0 0 0 1-2.18h2.85a6.26 6.26 0 0 1-1.91 3.86 5.83 5.83 0 0 1-4 1.34 6.61 6.61 0 0 1-2.69-.51 5.695 5.695 0 0 1-2-1.4 6.001 6.001 0 0 1-1.21-2.11 8.279 8.279 0 0 1-.41-2.65 8.987 8.987 0 0 1 .4-2.72 6.237 6.237 0 0 1 1.2-2.21 5.614 5.614 0 0 1 2-1.47 6.7 6.7 0 0 1 2.79-.54 7.801 7.801 0 0 1 2.14.29 5.634 5.634 0 0 1 1.8.86c.529.386.969.88 1.29 1.45a5 5 0 0 1 .6 2.07h-2.85l.06-.02ZM128.13 17.9H131V28l5.15-5.22h3.5l-5 4.75 5.42 8.17h-3.47l-4-6.27-1.6 1.7v4.63h-2.85V17.9h-.02ZM147.15 22.83h2.13v-1.08a5.505 5.505 0 0 1 .3-2c.161-.456.436-.862.8-1.18.33-.273.721-.462 1.14-.55.44-.094.89-.141 1.34-.14a8.158 8.158 0 0 1 2 .18v2.24a4.113 4.113 0 0 0-.59-.11 6.343 6.343 0 0 0-.74 0 1.74 1.74 0 0 0-1 .27 1.204 1.204 0 0 0-.41 1.08v1.33h2.42V25h-2.42v10.8h-2.85V25h-2.12v-2.17ZM162.23 36.1a6.999 6.999 0 0 1-2.76-.51 5.877 5.877 0 0 1-2-1.41 5.998 5.998 0 0 1-1.33-2.18 8.775 8.775 0 0 1 0-5.48 6.008 6.008 0 0 1 1.27-2.15 5.894 5.894 0 0 1 2-1.41A7.71 7.71 0 0 1 165 23a5.894 5.894 0 0 1 2 1.41 6.003 6.003 0 0 1 1.28 2.15c.585 1.78.585 3.7 0 5.48a5.99 5.99 0 0 1-3.28 3.54 7.002 7.002 0 0 1-2.77.52Zm0-2.25a3.268 3.268 0 0 0 1.65-.4c.447-.262.83-.621 1.12-1.05.304-.444.528-.938.66-1.46a6.581 6.581 0 0 0 0-3.31 4.416 4.416 0 0 0-.66-1.46 3.526 3.526 0 0 0-1.15-1 3.6 3.6 0 0 0-3.3 0 3.526 3.526 0 0 0-1.15 1 4.414 4.414 0 0 0-.66 1.46 6.558 6.558 0 0 0 0 3.31c.132.522.356 1.016.66 1.46a3.47 3.47 0 0 0 1.15 1.05 3.26 3.26 0 0 0 1.68.4ZM171.13 22.83h2.67v2.5c.097-.362.264-.701.49-1 .251-.341.547-.647.88-.91a4.404 4.404 0 0 1 1.14-.66 3.41 3.41 0 0 1 1.28-.25c.23-.013.46-.013.69 0h.39v2.79l-.61-.09a5.173 5.173 0 0 0-.61 0 3.278 3.278 0 0 0-1.36.29 3.131 3.131 0 0 0-1.11.85 4.171 4.171 0 0 0-.75 1.39 6 6 0 0 0-.28 1.9v6.15h-2.85V22.83h.03ZM198.22 35.75h-2.8V34a3.907 3.907 0 0 1-1.56 1.56 4.25 4.25 0 0 1-2.11.59 4.742 4.742 0 0 1-3.75-1.31 5.537 5.537 0 0 1-1.12-3.84v-8.2h2.85v7.92a3.503 3.503 0 0 0 .65 2.4 2.38 2.38 0 0 0 1.83.7 3.599 3.599 0 0 0 1.5-.27 2.66 2.66 0 0 0 1-.74c.259-.326.444-.705.54-1.11a5.79 5.79 0 0 0 .16-1.4v-7.5h2.85v12.95h-.04ZM201.3 22.83h2.7v1.75a3.523 3.523 0 0 1 1.72-1.58 5.568 5.568 0 0 1 2.33-.49 6.17 6.17 0 0 1 2.66.54 5.246 5.246 0 0 1 1.89 1.47c.515.65.899 1.394 1.13 2.19.257.87.385 1.773.38 2.68.001.851-.114 1.7-.34 2.52a6.568 6.568 0 0 1-1 2.16 5.002 5.002 0 0 1-4.21 2.06c-.419 0-.837-.036-1.25-.11a5.39 5.39 0 0 1-1.2-.36A4.737 4.737 0 0 1 205 35a3.567 3.567 0 0 1-.81-.91v6.45h-2.89V22.83Zm10 6.47c0-.574-.078-1.146-.23-1.7a4.606 4.606 0 0 0-.67-1.46 3.475 3.475 0 0 0-1.12-1 3.06 3.06 0 0 0-1.55-.39A3.141 3.141 0 0 0 205 26a5.518 5.518 0 0 0-1 3.3c-.004.611.077 1.22.24 1.81.138.523.38 1.012.71 1.44a3.55 3.55 0 0 0 1.14 1 3.242 3.242 0 0 0 1.54.35 3.18 3.18 0 0 0 1.65-.4c.438-.25.817-.59 1.11-1 .299-.44.513-.931.63-1.45a7.38 7.38 0 0 0 .23-1.75h.05ZM228.67 35.75H226V34a3.38 3.38 0 0 1-1.67 1.61 5.668 5.668 0 0 1-2.33.49 6.17 6.17 0 0 1-2.66-.54 5.307 5.307 0 0 1-1.89-1.46 6.254 6.254 0 0 1-1.12-2.19 9.48 9.48 0 0 1-.37-2.71 8.67 8.67 0 0 1 .47-3 6.058 6.058 0 0 1 1.26-2.1 4.89 4.89 0 0 1 1.8-1.21 5.738 5.738 0 0 1 2.06-.39c.412 0 .824.037 1.23.11.413.073.815.194 1.2.36.38.166.736.381 1.06.64.32.255.594.562.81.91V17.9h2.85v17.85h-.03Zm-10-6.33c-.001.55.069 1.098.21 1.63.13.511.35.996.65 1.43.288.414.668.757 1.11 1a3.241 3.241 0 0 0 1.6.38 3.199 3.199 0 0 0 1.64-.4 3.398 3.398 0 0 0 1.13-1.05c.297-.447.517-.94.65-1.46.14-.542.211-1.1.21-1.66a5.227 5.227 0 0 0-1-3.35 3.175 3.175 0 0 0-2.61-1.2 3.23 3.23 0 0 0-1.69.41 3.478 3.478 0 0 0-1.12 1.07 4.494 4.494 0 0 0-.62 1.5 7.871 7.871 0 0 0-.11 1.7h-.05ZM242.6 32.88c-.018.258.03.516.14.75a.577.577 0 0 0 .54.23h.3c.135-.002.269-.019.4-.05v2l-.39.11-.49.08-.5.08h-.42a2.75 2.75 0 0 1-1.45-.35 1.731 1.731 0 0 1-.75-1.23 4.998 4.998 0 0 1-2.09 1.2 8.224 8.224 0 0 1-2.39.38 5.861 5.861 0 0 1-1.67-.24 4.394 4.394 0 0 1-1.41-.7 3.35 3.35 0 0 1-1-1.18 3.624 3.624 0 0 1-.36-1.66 3.84 3.84 0 0 1 .44-2 3.246 3.246 0 0 1 1.15-1.17 5.195 5.195 0 0 1 1.6-.61c.593-.127 1.19-.223 1.79-.29a14.77 14.77 0 0 1 1.47-.21 6.896 6.896 0 0 0 1.24-.21c.318-.077.611-.236.85-.46a1.286 1.286 0 0 0 .31-.94 1.458 1.458 0 0 0-.26-.9A1.759 1.759 0 0 0 239 25a2.807 2.807 0 0 0-.86-.25 6.941 6.941 0 0 0-.9-.06 3.58 3.58 0 0 0-2 .5 2 2 0 0 0-.87 1.55h-2.85c.021-.73.227-1.442.6-2.07.338-.54.797-.996 1.34-1.33a5.475 5.475 0 0 1 1.84-.7c.692-.134 1.395-.2 2.1-.2.632 0 1.262.067 1.88.2a5.337 5.337 0 0 1 1.66.65 3.6 3.6 0 0 1 1.19 1.16c.314.525.47 1.129.45 1.74v6.65l.02.04Zm-2.85-3.6a3.45 3.45 0 0 1-1.6.51c-.667.06-1.3.147-1.9.26a6.137 6.137 0 0 0-.87.21 2.64 2.64 0 0 0-.75.38c-.22.164-.395.38-.51.63a2.129 2.129 0 0 0-.19.94c-.011.29.085.575.27.8.182.215.407.388.66.51.269.128.555.216.85.26.277.05.558.076.84.08a4.63 4.63 0 0 0 1-.12 3.418 3.418 0 0 0 1-.43 2.73 2.73 0 0 0 .81-.76 1.93 1.93 0 0 0 .32-1.14v-2.14l.07.01ZM244.37 22.83h2.15V19h2.85v3.88h2.58V25h-2.58v6.9a7.064 7.064 0 0 0 0 .77c.016.194.074.381.17.55a.84.84 0 0 0 .41.34 2 2 0 0 0 .75.11h.6c.203-.01.404-.04.6-.09v2.2l-.93.1a8.403 8.403 0 0 1-.92 0 6.33 6.33 0 0 1-1.81-.21 2.421 2.421 0 0 1-1.08-.62 2.15 2.15 0 0 1-.52-1 7.791 7.791 0 0 1-.16-1.42V25h-2.15v-2.17h.04ZM256.22 30c-.002.491.069.98.21 1.45.131.448.348.866.64 1.23a3.08 3.08 0 0 0 1.08.84 3.543 3.543 0 0 0 1.55.31 3.431 3.431 0 0 0 2-.54c.541-.402.94-.966 1.14-1.61h2.7a5.352 5.352 0 0 1-2.1 3.26 5.715 5.715 0 0 1-1.74.85 7 7 0 0 1-2 .29 6.848 6.848 0 0 1-2.7-.5 5.577 5.577 0 0 1-2-1.4 5.947 5.947 0 0 1-1.21-2.18 8.754 8.754 0 0 1-.41-2.75 7.758 7.758 0 0 1 .44-2.61 6.67 6.67 0 0 1 1.25-2.17 5.863 5.863 0 0 1 4.56-2 5.79 5.79 0 0 1 2.74.64c.783.41 1.466.986 2 1.69a6.824 6.824 0 0 1 1.16 2.41c.243.916.308 1.87.19 2.81h-9.5V30Zm6.65-1.87a4.605 4.605 0 0 0-.29-1.3c-.148-.4-.368-.77-.65-1.09a3.22 3.22 0 0 0-1-.75 3 3 0 0 0-1.31-.29 3.431 3.431 0 0 0-1.36.26 3.108 3.108 0 0 0-1 .73 3.575 3.575 0 0 0-.7 1.09 3.798 3.798 0 0 0-.29 1.35h6.65-.05ZM270 31.6a2.154 2.154 0 0 0 .95 1.75c.607.35 1.3.524 2 .5.304-.002.608-.022.91-.06a3.943 3.943 0 0 0 1-.24c.286-.105.54-.28.74-.51a1.23 1.23 0 0 0 .26-.89 1.261 1.261 0 0 0-.4-.9 2.779 2.779 0 0 0-1-.56 9.315 9.315 0 0 0-1.34-.36l-1.5-.33a14.219 14.219 0 0 1-1.54-.42 4.937 4.937 0 0 1-1.33-.68 3.12 3.12 0 0 1-.94-1.09 3.472 3.472 0 0 1-.35-1.64 2.94 2.94 0 0 1 .51-1.76 3.913 3.913 0 0 1 1.3-1.15 5.66 5.66 0 0 1 1.75-.61 10.316 10.316 0 0 1 1.84-.17 8.418 8.418 0 0 1 1.91.21 5.19 5.19 0 0 1 1.65.69c.496.318.916.741 1.23 1.24.341.559.55 1.188.61 1.84h-3a1.783 1.783 0 0 0-.94-1.37 3.892 3.892 0 0 0-1.69-.35 6.093 6.093 0 0 0-.71 0 3.327 3.327 0 0 0-.78.19 1.642 1.642 0 0 0-.61.4 1 1 0 0 0-.25.69 1.093 1.093 0 0 0 .36.85c.294.245.634.428 1 .54.437.153.885.274 1.34.36l1.55.33a20.9 20.9 0 0 1 1.53.42c.479.157.931.386 1.34.68.41.277.751.643 1 1.07.255.494.379 1.045.36 1.6a3.48 3.48 0 0 1-.52 2 4.15 4.15 0 0 1-1.36 1.3 6.19 6.19 0 0 1-1.86.73 9.435 9.435 0 0 1-2 .23 8.823 8.823 0 0 1-2.26-.27 5.265 5.265 0 0 1-1.8-.84 4 4 0 0 1-1.2-1.4 4.445 4.445 0 0 1-.46-2h2.7v-.02Z"></path><path fill="#C72914" d="m21.94 38.74 18.12-12.08v-14.5H21.94v26.58Z"></path><path fill="#EF3340" d="M40.06 38.74 21.94 26.66v-14.5h18.12v26.58Z"></path><path fill="#3EB1C8" d="M31 9a20 20 0 1 0 0 40 20 20 0 0 0 0-40Zm0 35.1a15.1 15.1 0 1 1 0-30.2 15.1 15.1 0 0 1 0 30.2Z"></path><path fill="#FFC72C" d="M42.09 39.23A15.09 15.09 0 0 1 17 23.38l-4.2-2.64a20 20 0 0 0 33.49 21.14l-4.2-2.65Z"></path><defs><linearGradient id="horizontal_crossmark" x1="145" x2="145" y1="7.33" y2="56.82" gradientUnits="userSpaceOnUse"><stop stop-color="#fff"></stop><stop offset="1" stop-color="#c4c4c4"></stop></linearGradient></defs></svg></a></div><div class="core-content-info"></div></div></div></div></div></header><div class="core-header-aside">
    

        


    

            

            

            <div class="cover-image cover-image--axel"><div class="cover-image__thumb"><a href="https://www.cell.com/cell/issue?pii=S0092-8674(19)X0007-0"><img src="/cms/asset/a8f3ab6a-7ade-4536-bafd-5598af7c4c92/cov200h.gif" alt="Cover Image - Cell, Volume 180, Issue 6"></a></div></div>

            

        
</div></div><div data-core-wrapper="content"><div id="dummy-sticky-observer"></div><div data-core-nav="header" data-extent="frontmatter"><div class="core-nav-wrapper core-container" aria-label="Article navigation"><div class="navigation-menu-pdf">
    

        


    

            

            

            <div data-widget-id="ecff07e8-0bc4-4533-b1f1-49365e2ead20" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><a href="/action/showPdf?pii=S0092-8674%2820%2930159-8" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" role="menuitem" class="article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></div>

            

        
</div><div class="core-sections-menu"><button data-id="article-toolbar-showhide" aria-controls="article_sections_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle section navigation menu" style="margin-top: 0px;"><i class="icon-list" aria-hidden="true"></i><span>Outline</span></button><nav id="article_sections_menu" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><div class="heading">Outline<button aria-haspopup="true" aria-controls="article_sections_menu" title="Close outline menu"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div><ul><li><a href="#author-highlights-abstract">Highlights</a></li><li><a href="#author-abstract">Summary</a></li><li><a href="#graphical-abstract">Graphical Abstract</a></li><li><a href="#keywords">Keywords</a></li><li><a href="#sec-1">Introduction</a></li><li><a href="#sec-2">Results</a></li><li><a href="#sec-3">Discussion</a></li><li><a href="#sec-4">STAR★Methods</a></li><li><a href="#acknowledgments">Acknowledgments</a></li><li><a href="#supplementary-material">Supplemental Information (2)</a></li><li><a href="#references">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div><div class="navigation-menu-share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="5f978446-c80a-450c-a185-94d633df2db2" data-widget-name="UX3share" aria-hidden="false" role="group" class="article-tools__dropblock article-tools__share"><button aria-label="Toggle share menu" aria-expanded="false" aria-haspopup="true" role="menuitem" aria-controls="navigation_menu_share_block" aria-labelledby="share-label" class="article-tools__item__share"><i aria-hidden="true" class="icon-article-share"></i><span id="share-label">Share</span></button><div id="navigation_menu_share_block" role="menu" class="share__block axel-share article-tools__dropblock__holder"><h4 class="axel-share__title heading">Share<button title="Close share menu" aria-expanded="false" aria-haspopup="true" aria-controls="navigation_menu_share_block"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930159-8" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="f1a208d3-ac5e-4db2-9c3a-40ef97ddfa10" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.02.015">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</div><div><button data-id="article-nav-menubar-more" aria-controls="article_more_menu" aria-expanded="false" aria-haspopup="true" aria-label="Toggle more menu"><i aria-hidden="true" class="icon-more-mobile"></i><span>More</span></button><div class="info-panel"><div class="info-panel__left-content"><div class="info-panel__article_tools info-panel__item"><div id="article_more_menu" aria-label="More menu" data-core-nav="more"><div class="heading">More<button title="Close more menu" aria-controls="article_more_menu" aria-haspopup="true"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div>
    

        


    

            

            

            <ul data-widget-id="183a17a2-87b5-4e6f-bb85-6b5cda068c89" data-widget-name="UX3ArticleToolsWidget" class="article-tools"><li class="article-tools__item article-tools__pdf"><a href="/action/showPdf?pii=S0092-8674%2820%2930159-8" title="Standard PDF (opens in a new tab)" target="_blank" aria-hidden="false" class="article-tools__ctrl article-tools__item__pdf"><svg focusable="false" viewBox="0 0 32 32" width="20" height="20" title="PDF" class="pdf-icon"><path id="pdfwhite" d="M7 .362h17.875l6.763 6.1V31.64H6.948V16z" stroke="#000" stroke-width=".703" fill="#fff"></path><path id="pdfda0000" d="M.167 2.592H22.39V9.72H.166z" fill="#da0000"></path><path id="pdffff9f9" fill="#fff9f9" d="M5.97 3.638h1.62c1.053 0 1.483.677 1.488 1.564.008.96-.6 1.564-1.492 1.564h-.644v1.66h-.977V3.64m.977.897v1.34h.542c.27 0 .596-.068.596-.673-.002-.6-.32-.667-.596-.667h-.542m3.8.036v2.92h.35c.933 0 1.223-.448 1.228-1.462.008-1.06-.316-1.45-1.23-1.45h-.347m-.977-.94h1.03c1.68 0 2.523.586 2.534 2.39.01 1.688-.607 2.4-2.534 2.4h-1.03V3.64m4.305 0h2.63v.934h-1.657v.894H16.6V6.4h-1.56v2.026h-.97V3.638"></path><path id="pdff91d0a" d="M19.462 13.46c.348 4.274-6.59 16.72-8.508 15.792-1.82-.85 1.53-3.317 2.92-4.366-2.864.894-5.394 3.252-3.837 3.93 2.113.895 7.048-9.25 9.41-15.394zM14.32 24.874c4.767-1.526 14.735-2.974 15.152-1.407.824-3.157-13.72-.37-15.153 1.407zm5.28-5.043c2.31 3.237 9.816 7.498 9.788 3.82-.306 2.046-6.66-1.097-8.925-4.164-4.087-5.534-2.39-8.772-1.682-8.732.917.047 1.074 1.307.67 2.442-.173-1.406-.58-2.44-1.224-2.415-1.835.067-1.905 4.46 1.37 9.065z" fill="#f91d0a"></path></svg><span class="basic">Download PDF</span><span class="alternative">Download PDF</span></a></li><li><a href="https://www.cell.com/action/showCitFormats?doi=10.1016%2Fj.cell.2020.02.015&amp;pii=S0092-8674%2820%2930159-8" title="Cite" target="_blank" aria-label="Open Cite in new tab" class="article-tools__item__displayExportCitation"><i aria-hidden="true" class="icon-export-Citation"></i><span>Cite</span></a></li><li id="article_tools_share">
    

        


    

            

            

            <!-- Go to https://www.addtoany.com/buttons/customize/ to customize your tools --><script type="text/javascript" defer="defer" src="https://static.addtoany.com/menu/page.js"></script><script type="text/javascript">var a2a_config = a2a_config || {};
a2a_config.thanks = {
    postShare: false,
    ad: false,
};</script><script>var a2a_config = a2a_config || {};
let res = window.location.href.replace(/\(/g, "%28").replace(/\)/g, "%29");
a2a_config.templates = a2a_config.templates || {};

a2a_config.templates.email = {
    body: res
};
</script><div data-widget-id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" data-widget-name="UX3share" class="dropBlock article-tools__dropblock article-tools__share"><button data-db-target-for="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" aria-expanded="false" title="open Share menu" class="article-tools__ctrl share__ctrl"><i aria-hidden="true" class="icon-article-share"></i><span>Share</span></button><div data-db-target-of="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da" id="c3faf0bb-84d9-4c61-a6d8-93bfc77be8da_Pop" class="share__block axel-share dropBlock__holder article-tools__dropblock__holder"><h4 class="axel-share__title">Share</h4><div class="axel-share__inner"><span class="sr-only">Share on</span><ul class="a2a__share-list rlist w-slide--list a2a a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-url="https://www.cell.com/cell/fulltext/S0092-8674%2820%2930159-8" style="line-height: 32px;"><li class="a2a_listitem_custom"><a role="link" title="Email" class="a2a_button_email" target="_blank" rel="nofollow noopener" href="/#email"><i aria-hidden="true" class="at-icon-wrapper icon-gizmo-email-plus"></i><span>Email</span></a></li><li class="a2a_listitem_custom"><a role="link" title="formerly known as Twitter" class="a2a_button_twitter" target="_blank" rel="nofollow noopener" href="/#twitter"><i aria-hidden="true" class="at-icon-wrapper icon-x-default"></i><span>X</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Facebook" class="a2a_button_facebook" target="_blank" rel="nofollow noopener" href="/#facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook-square-2"></i><span>Facebook</span></a></li><li class="a2a_listitem_custom"><a role="link" title="LinkedIn" class="a2a_button_linkedin" target="_blank" rel="nofollow noopener" href="/#linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin-square"></i><span>LinkedIn</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Sina Weibo" class="a2a_button_sina_weibo" target="_blank" rel="nofollow noopener" href="/#sina_weibo"><i aria-hidden="true" class="at-icon-wrapper icon-weibo"></i><span>Sina Weibo</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Mendeley" class="a2a_button_mendeley" target="_blank" rel="nofollow noopener" href="/#mendeley"><i aria-hidden="true" class="at-icon-wrapper icon-mendeley-2"></i><span>Mendeley</span></a></li><li class="a2a_listitem_custom"><a role="link" title="Bluesky" class="a2a_button_bluesky" target="_blank" rel="nofollow noopener" href="/#bluesky"><i aria-hidden="true" class="at-icon-wrapper icon-bluesky-logo"></i><span>Bluesky</span></a></li><div style="clear: both;"></div></ul><div class="extra-links-drop-zone">
    

        


    

            

            

            <div data-widget-id="ae9bf5c5-a2ee-4f5c-8e41-9b21638b1a9f" data-widget-name="UX3HTMLWidget"><a class="axel-share__extra" target="_blank" href="/personalize/addFavoritePublication?doi=10.1016/j.cell.2020.02.015">
	<i class="icon-reading-list" aria-hidden="true"></i>
	<span>Add to my reading list</span>
</a></div>

            

        
</div></div></div></div>

            

        
</li><li><a href="https://www.cell.com/action/addCitationAlert?doi=10.1016%2Fj.cell.2020.02.015" title="Set Alert" target="_blank" aria-label="Open Set Alert in new tab" class="article-tools__item__displayCreateCitationAlert"><i aria-hidden="true" class="icon-set-alert"></i><span>Set Alert</span></a></li><li><a href="https://s100.copyright.com/AppDispatchServlet?publisherName=ELS&amp;contentID=S0092867420301598&amp;orderBeanReset=true&amp;orderSource=Phoenix" title="Get Rights" target="_blank" aria-label="Open Get Rights in new tab" class="article-tools__item__request"><i aria-hidden="true" class="icon-get-rights"></i><span>Get Rights</span></a></li><li><a href="https://www.contentednet.com/salesforce-form/?pii=S0092867420301598&amp;issn=00928674&amp;source=jbs" title="Reprints" target="_blank" aria-label="Open Reprints in new tab" class="article-tools__item__reprints"><i aria-hidden="true" class="icon-article-reprints"></i><span>Reprints</span></a></li></ul>

            

        
</div></div><div class="info-panel__download-issue info-panel__item"><div class="article-header__download-full-issue"><button title="Download full issue" type="submit" formaction="/action/downloadMultiplePdf?action=downloadIssuePdf&amp;journal=cell&amp;volume=180&amp;issue=6&amp;pii=S0092-8674%2819%29X0007-0" class="btn--download-issue btn--cancel download-full-issue"><i class="icon-download-new"></i><span>Download Full Issue</span></button><div class="table-of-content__alert table-of-content__alert--download"><p>Download started</p><a href="#" class="table-of-content__alert--close">Ok</a></div></div></div></div><div class="info-panel__right-content"><div class="info-panel__navigation info-panel__item"><div class="content-navigation"><a href="/cell/fulltext/S0092-8674(20)30212-9" aria-label="Previous article" aria-disabled="false" class="content-navigation__prev"><i aria-hidden="true" class="icon-arrow_l"></i><span>Previous article</span></a><a href="/cell/fulltext/S0092-8674(20)30219-1" aria-label="Next article" aria-disabled="false" class="content-navigation__next"><span>Next article</span><i aria-hidden="true" class="icon-arrow_r"></i></a></div></div></div></div></div></div></div><div class="core-sections-menu-outer"><div class="core-sections-menu"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-show-outline" aria-hidden="true"></i><span>Show Outline</span></button><nav id="article_sections_menu-desktop" aria-label="Contents" data-core-nav="article" style="margin-top: 0px;"><button aria-controls="article_sections_menu-desktop" aria-haspopup="true" aria-expanded="false" aria-label="Toggle sections menu" data-id="article-toolbar-showhide"><i class="icon-hide-outline" aria-hidden="true"></i><span>Hide Outline</span></button><ul><li><a href="#author-highlights-abstract" aria-current="true">Highlights</a></li><li><a href="#author-abstract" aria-current="false">Summary</a></li><li><a href="#graphical-abstract" aria-current="false">Graphical Abstract</a></li><li><a href="#keywords" aria-current="false">Keywords</a></li><li><a href="#sec-1" aria-current="false">Introduction</a></li><li><a href="#sec-2" aria-current="false">Results</a></li><li><a href="#sec-3" aria-current="false">Discussion</a></li><li><a href="#sec-4" aria-current="false">STAR★Methods</a></li><li><a href="#acknowledgments" aria-current="false">Acknowledgments</a></li><li><a href="#supplementary-material" aria-current="false">Supplemental Information (2)</a></li><li><a href="#references" aria-current="false">References</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-metrics">Article metrics</a></li><li role="none" class="mobile-only"><a role="menuitem" href="#core-collateral-relatedArticles">Related Articles</a></li></ul></nav></div></div><div><div class="core-content-inner"><div class="core-linked-content"></div><div id="abstracts" data-extent="frontmatter"><div class="core-container"><section id="author-highlights-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Highlights</h2><div id="abspara0020" role="paragraph"><div id="ulist0010" role="list"><div id="u0010" role="listitem"><div class="label">•</div><div class="content"><div id="p0010" role="paragraph">A distinct B cell subset emerges in tumors after chemotherapy</div></div></div><div id="u0015" role="listitem"><div class="label">•</div><div class="content"><div id="p0015" role="paragraph">B cells elicit anti-tumor T&nbsp;cell immunity by ICOSL</div></div></div><div id="u0020" role="listitem"><div class="label">•</div><div class="content"><div id="p0020" role="paragraph">Complement signals initiated by immunogenic cell death shape B cell phenotypes</div></div></div><div id="u0025" role="listitem"><div class="label">•</div><div class="content"><div id="p0025" role="paragraph">Tumor CD55 expression determines the opposite effects of B cells in tumors</div></div></div></div></div></section><section id="author-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Summary</h2><div id="abspara0010" role="paragraph">Understanding molecular mechanisms that dictate B cell diversity is important for targeting B cells as anti-cancer treatment. Through the single-cell dissection of B cell heterogeneity in longitudinal samples of patients with breast cancer before and after neoadjuvant chemotherapy, we revealed that an ICOSL<sup>+</sup> B cell subset emerges after chemotherapy. Using three immunocompetent mouse models, we recapitulated the subset switch of human tumor-infiltrating B cells during chemotherapy. By employing B-cell-specific deletion mice, we showed that ICOSL in B cells boosts anti-tumor immunity by enhancing the effector to regulatory T&nbsp;cell ratio. The signature of ICOSL<sup>+</sup> B cells is imprinted by complement-CR2 signaling, which is triggered by immunogenic cell death. Moreover, we identified that CD55, a complement inhibitory protein, determines the opposite roles of B cells in chemotherapy. Collectively, we demonstrated a critical role of the B cell subset switch in chemotherapy response, which has implications in designing novel anti-cancer therapies.</div><section id="abssec0155"><h3>Video Abstract</h3><div id="abspara0130" role="paragraph"><div class="figure-wrap" data-media-type="video"><figure id="mmc2" data-figureviewer-ignore="true"><div role="paragraph"><div id="mmc2" class="mediaPlayer video ready tracked" data-preload="none" data-thumbnail-image="https://www.cell.com/cms/asset/52e425df-06fa-47d6-ab6a-dba9632766b9/mmc2.sml"><div class="hidden html5__media">/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4</div><div class="mediaPlayer__player"><div class="player-wrapper" style="width: 100%;"><video src="/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4" controls="controls" id="mediaPlayer__player0" shareurl="" preload="none" poster="https://www.cell.com/cms/asset/52e425df-06fa-47d6-ab6a-dba9632766b9/mmc2.sml" class="playerReady html5-media-player" style="width: 100%; height: auto; max-width: 100%;"><source type="video/webm" src="/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4"><source type="video/mpeg" src="/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4"><source type="video/mp4" src="/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4"><source type="video/ogg" src="/cms/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4"></video><div class="player-share-button" tabindex="0" title="Share Video"><div class="share-player-icon"></div></div><div class="player-share-container hidden"><span class="player-close-share" tabindex="0"></span><div class="social-links-container"><ul class="social-links-list"><li class="html5-share-facebook-icon" data-share-url="https://www.facebook.com/sharer/sharer.php?u=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank" tabindex="0"></li><li class="html5-share-twitter-icon" data-share-url="https://twitter.com/share?url=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank" tabindex="0"></li><li class="html5-share-mail-icon" data-share-url="mailto:?body=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank" tabindex="0"></li></ul><input type="text" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" readonly="readonly" class="share-input"></div></div></div></div></div></div><figcaption><div><a href="/cms/10.1016/j.cell.2020.02.015/asset/33e6706e-442e-49fb-856e-70ac4d2dcc5c/main.assets/mmc2.mp4" class="core-download-stream" download="mmc2.mp4">Download video (mp4, 34 MB)</a></div></figcaption></figure></div></div></section></section><section id="graphical-abstract" property="abstract" typeof="Text" role="doc-abstract"><h2 property="name">Graphical Abstract</h2><div id="abspara0015" role="paragraph"><div class="figure-wrap"><figure id="undfig1" class="graphic" data-figureviewer-ignore="true"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/d7410e8d-a238-43fa-968b-6218075599b6/main.assets/fx1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="fx1" alt="Graphical abstract undfig1" src="/cms/10.1016/j.cell.2020.02.015/asset/16486efd-f5ff-4f53-9329-57d6e4ab8c9e/main.assets/fx1.jpg" height="375" width="375" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/d7410e8d-a238-43fa-968b-6218075599b6/main.assets/fx1_lrg.jpg" loading="lazy"></a></figure></div></div></section></div></div><div class="core-linked-content"></div><section id="keywords" property="keywords"><h2>Keywords</h2><ol><li><a href="/action/doSearch?AllField=&quot;B+cell+subsets&quot;" alt="Search on this keyword" rel="nofollow">B cell subsets</a></li><li><a href="/action/doSearch?AllField=&quot;ICOSL&quot;" alt="Search on this keyword" rel="nofollow">ICOSL</a></li><li><a href="/action/doSearch?AllField=&quot;complement&quot;" alt="Search on this keyword" rel="nofollow">complement</a></li><li><a href="/action/doSearch?AllField=&quot;immunogenic+cell+death&quot;" alt="Search on this keyword" rel="nofollow">immunogenic cell death</a></li></ol></section><div class="core-linked-content"></div><div class="core-linked-content"></div><section id="bodymatter" data-extent="bodymatter" property="articleBody" typeof="Text"><div class="core-container"><section id="sec-1"><h2>Introduction</h2><div id="p0030" role="paragraph">An optimal immune response is indispensable for the efficacy of multiple conventional cancer treatments (<span class="dropBlock reference-citations"><a id="body-ref-sref56-1" href="#" role="doc-biblioref" data-xml-rid="bib19 bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-1" aria-controls="sref56-1">Galluzzi et&nbsp;al., 2017; Surace et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref56-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Galluzzi, L. ∙ Buqué, A. ∙ Kepp, O. ...</div><div><strong>Immunogenic cell death in cancer and infectious disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2017; <strong>17</strong>:97-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2016.107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84991619059" target="_blank" aria-label="Open Scopus in new tab">Scopus (2034)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27748397/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2016.107&amp;pmid=27748397" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Surace, L. ∙ Lysenko, V. ∙ Fontana, A.O. ...</div><div><strong>Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response</strong></div><div><em>Immunity.</em> 2015; <strong>42</strong>:767-777</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84928205744" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25888260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2015.03.009&amp;pmid=25888260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Using clinical samples of patients receiving neoadjuvant therapy, we (<span class="dropBlock reference-citations"><a id="body-ref-sref55-1" href="#" role="doc-biblioref" data-xml-rid="bib12 bib54 bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-1" aria-controls="sref55-1">Chen et&nbsp;al., 2019; Su et&nbsp;al., 2018a, 2018b</a><div class="dropBlock__holder" data-db-target-of="sref55-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chen, F. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:498-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-019-0299-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85064202781" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-019-0299-0&amp;pmid=30936474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Su, S. ∙ Zhao, J. ∙ Xing, Y. ...</div><div><strong>Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:442-457.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054030012" target="_blank" aria-label="Open Scopus in new tab">Scopus (205)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30290143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.007&amp;pmid=30290143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and others (<span class="dropBlock reference-citations"><a id="body-ref-sref33" href="#" role="doc-biblioref" data-xml-rid="bib33" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref33" aria-controls="sref33">Liu et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref33"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">33.</div><div>Liu, X. ∙ Pu, Y. ∙ Cron, K. ...</div><div><strong>CD47 blockade triggers T&nbsp;cell-mediated destruction of immunogenic tumors</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:1209-1215</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3931" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84943630992" target="_blank" aria-label="Open Scopus in new tab">Scopus (590)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26322579/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3931&amp;pmid=26322579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) have demonstrated that the immune cell compartment profoundly evolves in the tumor microenvironment (TME), which is exposed to therapeutic intervention. Therefore, combinational strategies of immunotherapy and conventional treatments guided by biomarkers in the TME pave the way for the next generation of precision medicine.</div><div id="p0035" role="paragraph">B lymphocytes constitute a major population of immune cells in the TME and promote tumor progression by the immune complex (<span class="dropBlock reference-citations"><a id="body-ref-sref5" href="#" role="doc-biblioref" data-xml-rid="bib1 bib5" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref5" aria-controls="sref5">Affara et&nbsp;al., 2014; Andreu et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Affara, N.I. ∙ Ruffell, B. ∙ Medler, T.R. ...</div><div><strong>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:809-821</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84902465821" target="_blank" aria-label="Open Scopus in new tab">Scopus (236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24909985/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.026&amp;pmid=24909985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">5.</div><div>Andreu, P. ∙ Johansson, M. ∙ Affara, N.I. ...</div><div><strong>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:121-134</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2009.12.019&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2009.12.019&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-76349088502" target="_blank" aria-label="Open Scopus in new tab">Scopus (474)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20138013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2009.12.019&amp;pmid=20138013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), cytokines (<span class="dropBlock reference-citations"><a id="body-ref-sref4-1" href="#" role="doc-biblioref" data-xml-rid="bib4" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref4-1" aria-controls="sref4-1">Ammirante et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref4-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Ammirante, M. ∙ Luo, J.L. ∙ Grivennikov, S. ...</div><div><strong>B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</strong></div><div><em>Nature.</em> 2010; <strong>464</strong>:302-305</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature08782" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77949379050" target="_blank" aria-label="Open Scopus in new tab">Scopus (503)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20220849/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature08782&amp;pmid=20220849" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), and immune checkpoints (<span class="dropBlock reference-citations"><a id="body-ref-sref63" href="#" role="doc-biblioref" data-xml-rid="bib50 bib63" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref63" aria-controls="sref63">Shalapour et&nbsp;al., 2017; Xiao et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref63"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Shalapour, S. ∙ Lin, X.J. ∙ Bastian, I.N. ...</div><div><strong>Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:340-345</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24302" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85034443159" target="_blank" aria-label="Open Scopus in new tab">Scopus (373)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24302&amp;pmid=29144460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">64.</div><div>Xiao, X. ∙ Lao, X.M. ∙ Chen, M.M. ...</div><div><strong>PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:546-559</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-15-1408" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964771565" target="_blank" aria-label="Open Scopus in new tab">Scopus (239)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26928313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-15-1408&amp;pmid=26928313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, increasing studies have shown that the density of B and Th1 cells is closely correlated and associated with improved patient survival (<span class="dropBlock reference-citations"><a id="body-ref-sref66-1" href="#" role="doc-biblioref" data-xml-rid="bib24 bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-1" aria-controls="sref66-1">Hennequin et&nbsp;al., 2015; Zhu et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref66-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Hennequin, A. ∙ Derangère, V. ∙ Boidot, R. ...</div><div><strong>Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients</strong></div><div><em>OncoImmunology.</em> 2015; <strong>5</strong>:e1054598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1054598" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84959440329" target="_blank" aria-label="Open Scopus in new tab">Scopus (150)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27057426/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1054598&amp;pmid=27057426" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Zhu, W. ∙ Germain, C. ∙ Liu, Z. ...</div><div><strong>A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T&nbsp;cell receptor repertoire clonality</strong></div><div><em>OncoImmunology.</em> 2015; <strong>4</strong>:e1051922</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1051922" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84944548558" target="_blank" aria-label="Open Scopus in new tab">Scopus (79)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26587322/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1051922&amp;pmid=26587322" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). More importantly, animal experiments (<span class="dropBlock reference-citations"><a id="body-ref-sref8-1" href="#" role="doc-biblioref" data-xml-rid="bib8" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref8-1" aria-controls="sref8-1">Bodogai et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref8-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bodogai, M. ∙ Lee Chang, C. ∙ Wejksza, K. ...</div><div><strong>Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B&nbsp;cells expressing low levels of CD20 and CD137L</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2127-2138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-12-4184" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84876008718" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23365136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-12-4184&amp;pmid=23365136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and clinical trials of rituximab (<span class="dropBlock reference-citations"><a id="body-ref-sref28" href="#" role="doc-biblioref" data-xml-rid="bib3 bib28" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref28" aria-controls="sref28">Aklilu et&nbsp;al., 2004; Joly-Battaglini et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref28"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">3.</div><div>Aklilu, M. ∙ Stadler, W.M. ∙ Markiewicz, M. ...</div><div><strong>Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma</strong></div><div><em>Ann. Oncol.</em> 2004; <strong>15</strong>:1109-1114</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdh280&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdh280&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-4143138507" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15205206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdh280&amp;pmid=15205206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">28.</div><div>Joly-Battaglini, A. ∙ Hammarström, C. ∙ Stankovic, B. ...</div><div><strong>Rituximab efficiently depletes B cells in lung tumors and normal lung tissue</strong></div><div><em>F1000Res.</em> 2016; <strong>5</strong>:38</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.12688/f1000research.7599.1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964587596" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27081474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.12688%2Ff1000research.7599.1&amp;pmid=27081474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), an anti-CD20 antibody, show that the depletion of total B cells may have detrimental impacts on antitumor immunity. Together, these conflicting observations strongly suggest that B cells in tumors consist of different subpopulations with opposite functions. However, the detailed understanding of B cells’ diversity in tumors is limited, and the underlying mechanisms of their pro- or anti-tumor phenotype switch remain largely unknown.</div><div id="p0040" role="paragraph">Here, we provide a comprehensive single-cell RNA profile analysis of tumor-infiltrating B cells in paired clinical samples of pre- and post-neoadjuvant chemotherapy. We identify a distinct B cell subset emerging after chemotherapy and reveal how this subset affects anti-tumor immunity.</div></section><section id="sec-2"><h2>Results</h2><section id="sec-2-1"><h3>Single-Cell Profiling of Breast Cancer B Cells Reveals that an ICOSL<sup>+</sup> Subset Emerges after Chemotherapy</h3><div id="p0045" role="paragraph">Neoadjuvant therapy allows direct intra-patient evaluation, which reveals the impact of treatments on the TME. To evaluate the transcriptome of B cells in human tumors experiencing chemotherapy at single-cell resolution, we isolated 998 B cells from pre-treatment biopsy samples and 1,499 B cells from the paired post-treatment resected samples of four patients with breast cancer who received neoadjuvant chemotherapy by fluorescence-activated cell sorting (FACS). Using single-cell RNA sequencing (scRNA-seq) involving a single-tube protocol with unique transcript counting through barcoding with unique molecular identifiers (UMIs), 34.1 million unique transcripts of over 23,074 genes were obtained. Seven unique clusters were identified by using t-distributed stochastic neighbor embedding (t-SNE) (<a id="crosref0185" href="#fig1">Figures 1</a>A and 1B). Consistent with previous reports (<span class="dropBlock reference-citations"><a id="body-ref-sref25" href="#" role="doc-biblioref" data-xml-rid="bib25" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref25" aria-controls="sref25">Horikawa et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref25"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">25.</div><div>Horikawa, M. ∙ Minard-Colin, V. ∙ Matsushita, T. ...</div><div><strong>Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2011; <strong>121</strong>:4268-4280</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI59266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-80555124922" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22019587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI59266&amp;pmid=22019587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), most of the clusters had strong expression of IL-10 before chemotherapy. Interestingly, the percentage of these clusters was markedly reduced in paired samples after chemotherapy (<a id="crosref0195" href="#fig1">Figures 1</a>A–1D).</div><div class="figure-wrap"><figure id="fig1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/29baea55-de29-4c7a-bf61-d9e53e5f609f/main.assets/gr1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.015/asset/268ff6a1-30e0-4656-99da-f0a768dc67a6/main.assets/gr1.jpg" height="861" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/29baea55-de29-4c7a-bf61-d9e53e5f609f/main.assets/gr1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;1</span> <span class="figure__title__text">Single-Cell Profiling of Breast Cancer B Cells Reveals that an ICOSL<sup>+</sup> Subset Emerges after Chemotherapy</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0015" role="paragraph">(A) t-distributed stochastic neighbor embedding (t-SNE) display and graph-based clustering of CD45<sup>+</sup>CD19<sup>+</sup> cells isolated from paired samples before and after neo-adjuvant chemotherapy (NAC) of four patients with breast cancer and subjected to scRNA-seq.</div><div id="fspara0020" role="paragraph">(B) Heatmap displaying key genes for each cluster.</div><div id="fspara0025" role="paragraph">(C) Gene overlays of indicated markers on t-SNE.</div><div id="fspara0030" role="paragraph">(D) The percentage of different tumor-infiltrating B cell subsets before and after chemotherapy.</div><div id="fspara0035" role="paragraph">(E and F) Flow cytometric analysis of B cells from paired breast cancer tissues of patients with different subtypes before and after NAC. Numerical values denote the percentage or mean fluorescent intensity (MFI × 10<sup>2</sup>). Representative plots (E) and quantitation (F) are shown. (HR<sup>+</sup>Her2<sup>−</sup>, n&nbsp;= 21; HR<sup>+</sup>Her2<sup>+</sup>, n&nbsp;= 15; HR<sup>−</sup> Her2<sup>−</sup>, n&nbsp;= 18; HR<sup>−</sup>Her2<sup>+</sup>, n&nbsp;= 25).</div><div id="fspara0040" role="paragraph">(G) Single-cell suspensions were prepared from human breast cancer tissues and analyzed by flow cytometry (n&nbsp;= 8, mean ± SEM).</div><div id="fspara0045" role="paragraph">(H and I) Flow cytometric analysis of ICOSL<sup>+</sup> B cells from paired blood samples of patients before NAC and one month after the last dose of NAC. Representative plots (H) and quantitation (I) are shown.</div><div id="fspara0050" role="paragraph">Mean&nbsp;±&nbsp;SEM, ns, p &gt; 0.05; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests. See also <a id="crosref1060" href="#figs1">Figure&nbsp;S1</a>.</div></div></div></div></figcaption></figure></div><div id="p0050" role="paragraph">By contrast, one cluster, which accounted for less than 1% of B&nbsp;cells in treatment-naive tumors, constituted 45.1% of tumor-infiltrating B cells after chemotherapy (<a id="crosref0200" href="#fig1">Figures 1</a>A–1D). Among the genes coding for transmembrane proteins at a false discovery rate (FDR) of &lt;1% differentially expressed when compared with other clusters, ICOSLG (ICOSL) (<a id="crosref0205" href="#fig1">Figure&nbsp;1</a>C), which has been reported to be mainly expressed in myeloid cells, is required for the clinical efficacy of immunotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref65" href="#" role="doc-biblioref" data-xml-rid="bib2 bib65" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref65" aria-controls="sref65">Aicher et&nbsp;al., 2000; Zhang et&nbsp;al., 2016b</a><div class="dropBlock__holder" data-db-target-of="sref65"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Aicher, A. ∙ Hayden-Ledbetter, M. ∙ Brady, W.A. ...</div><div><strong>Characterization of human inducible costimulator ligand expression and function</strong></div><div><em>J.&nbsp;Immunol.</em> 2000; <strong>164</strong>:4689-4696</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.164.9.4689" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0034193043" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10779774/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.164.9.4689&amp;pmid=10779774" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">66.</div><div>Zhang, Y. ∙ Luo, Y. ∙ Qin, S.L. ...</div><div><strong>The clinical impact of ICOS signal in colorectal cancer patients</strong></div><div><em>OncoImmunology.</em> 2016; <strong>5</strong>:e1141857</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2016.1141857" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84975879195" target="_blank" aria-label="Open Scopus in new tab">Scopus (62)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27467961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2016.1141857&amp;pmid=27467961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). After gating to eliminate dead cells (<a id="crosref0210" href="#figs1">Figure&nbsp;S1</a>A), flow cytometric analysis validated that ICOSL delineated a B&nbsp;cell subset, which dramatically increased in tumors after chemotherapy, especially in the hormone receptor (HR)<sup>−</sup>Her2<sup>−</sup> (triple-negative) subtype (<a id="crosref0215" href="#fig1">Figures 1</a>E and 1F). Additionally, this cluster exhibited high expression of CR2 and low expression of IL-10 (<a id="crosref0220" href="#fig1">Figure&nbsp;1</a>C), which were also validated by flow cytometry (<a id="crosref0225" href="#fig1">Figures 1</a>E, 1F, and <a id="crosref0230" href="#figs1">S1</a>B). More than 80% of ICOSL<sup>+</sup> B cells exhibited a CD20<sup>+</sup>CD38<sup>+</sup>CD27<sup>+</sup>IgA<sup>−</sup>IgD<sup>−</sup> phenotype (<a id="crosref0235" href="#fig1">Figure&nbsp;1</a>G). Moreover, ICOSL<sup>+</sup> B cells increased in the blood of HR<sup>−</sup> patients (<a id="crosref0240" href="#fig1">Figures 1</a>H and 1I), whereas total B cells remained unchanged (<a id="crosref0245" href="#figs1">Figure&nbsp;S1</a>C). Collectively, these data indicate that an ICOSL<sup>+</sup>CR2<sup>high</sup>IL-10<sup>−</sup>CD20<sup>+</sup>CD38<sup>+</sup>CD27<sup>+</sup>IgA<sup>−</sup>IgD<sup>−</sup> B cell subset merges in patients with breast cancer after chemotherapy.</div><div class="figure-wrap"><figure id="figs1" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/edf3a9b3-d003-4b8e-bb83-7ab4d2de8610/main.assets/figs1_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.015/asset/9e764314-a984-476d-aa60-8a936256b69a/main.assets/figs1.jpg" height="263" width="637" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/edf3a9b3-d003-4b8e-bb83-7ab4d2de8610/main.assets/figs1_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs1-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S1</span> <span class="figure__title__text">Single-cell Profiling of Breast Cancer B Cells Reveals that an ICOSL<sup>+</sup> Subset Emerges after Chemotherapy, Related to <a id="crosref1100" href="#fig1">Figure&nbsp;1</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs1-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0410" role="paragraph">(A) Representative gating strategy of flow cytometric analysis in <a id="crosref1105" href="#fig1">Figure&nbsp;1</a>E.</div><div id="fspara0415" role="paragraph">(B) The quantitation of CR2 MFI in <a id="crosref1110" href="#fig1">Figure&nbsp;1</a>E (HR<sup>+</sup>Her2<sup>−</sup>, n&nbsp;= 21; HR<sup>+</sup>Her2<sup>+</sup>, n&nbsp;= 15; HR<sup>−</sup> Her2<sup>−</sup>, n&nbsp;= 18; HR<sup>−</sup>Her2<sup>+</sup>, n&nbsp;= 25; mean&nbsp;±&nbsp;SEM, <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests).</div><div id="fspara0420" role="paragraph">(C) Flow cytometric analysis of B cells from paired blood samples of breast cancer patients before and after neoadjuvant chemotherapy. Representative flow cytometry plots (left) and quantitation (right) are shown. ns, p &gt; 0.05 by paired Student’s t tests (mean&nbsp;±&nbsp;SEM, n&nbsp;= 86 patients).</div></div></div></div></figcaption></figure></div></section><section id="sec-2-2"><h3>ICOSL<sup>+</sup> B Cells Are Associated with Improved Therapeutic Efficacy and Long-Term Prognosis</h3><div id="p0055" role="paragraph">To evaluate the clinical significance of this B subset, we performed immunostaining in 224 paired clinical samples. Automated image analysis (<a id="crosref0250" href="#fig2">Figures 2</a>A and <a id="crosref0255" href="#figs2">S2</a>A) revealed that tumor-infiltrating ICOSL<sup>+</sup> B cells significantly increased after chemotherapy (<a id="crosref0260" href="#fig2">Figures 2</a>B and 2C). By contrast, IL-10<sup>+</sup>CD19<sup>+</sup> cell counts dramatically decreased (<a id="crosref0265" href="#fig2">Figures 2</a>B and <a id="crosref0270" href="#figs2">S2</a>B), corroborating scRNA-seq and flow cytometric analyses. Additionally, the ICOSL<sup>+</sup> B cell density in the residual tissues of patients with partial or complete remission was markedly higher than that of patients with disease progression or stable disease (<a id="crosref0275" href="#fig2">Figure&nbsp;2</a>D). To exclude the possibility that resection sampling yields a different cell count compared to biopsy sampling in the same specimen, we evaluated a group of control treatment-naive samples. We observed a good concordance in counting ICOSL<sup>+</sup> B cells between biopsy samples and matched surgical samples (Pearson’s correlation coefficient r&nbsp;= 0.895, p&nbsp;&lt;&nbsp;0.001) (<a id="crosref0280" href="#figs2">Figures S2</a>C–S2E), indicating that the increase in ICOSL<sup>+</sup> B cells truly reflected the dynamic changes of the TME after chemotherapy.</div><div class="figure-wrap"><figure id="fig2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/d8e2d878-3b70-4c1c-ab46-dd428be94e99/main.assets/gr2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.015/asset/d3cac51b-787f-4e34-8cd8-1b5e79140799/main.assets/gr2.jpg" height="940" width="734" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/d8e2d878-3b70-4c1c-ab46-dd428be94e99/main.assets/gr2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;2</span> <span class="figure__title__text">ICOSL<sup>+</sup> B Cells Are Associated with Improved Therapeutic Efficacy and Long-term Prognosis</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0060" role="paragraph">(A) First row: automated identification of regions of interest was performed by dividing full-face immunofluorescence images into several small grids and analyzing the pixel intensity. Scale bars, 1,000&nbsp;μm. Third row: spots generated from the DAPI channel are defined as the total cell count (yellow). Imaris rendered these nuclei with positive CD19 (green) and ICOSL (red) signals respectively and built CD19<sup>+</sup> ICOSL<sup>+</sup> cells (white). Scale bars, 20&nbsp;μm.</div><div id="fspara0065" role="paragraph">(B) Representative images of hematoxylin and eosin (H&amp;E) and immunofluorescence staining in paired clinical samples before and after NAC. Rectangle in the H&amp;E pictures indicate the area shown in the immunofluorescence pictures. Arrows indicate the area with higher magnification. Scale bars, 20&nbsp;μm.</div><div id="fspara0070" role="paragraph">(C) Quantitation of the percentage of ICOSL<sup>+</sup> B cells in the total CD19<sup>+</sup> B cells shown in (B) (n&nbsp;= 224). Mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests.</div><div id="fspara0075" role="paragraph">(D) The ICOSL<sup>+</sup> B cell percentage in the total B cells in post-treatment samples with different therapeutic responses. pCR, pathological complete response, no invasive carcinoma or ductal carcinoma <i>in situ</i> in breast or axilla, n&nbsp;= 51; B- or A-only pCR, pCR in breast or axilla only, n&nbsp;= 12; PR, partial response, n&nbsp;= 204; SD, stable disease, n&nbsp;= 81; PD, progressive disease, n&nbsp;= 20. Mean&nbsp;±&nbsp;SEM, <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Mann-Whitney U tests.</div><div id="fspara0080" role="paragraph">(E) Representative images of H&amp;E and immunofluorescence for tertiary lymphoid organs (TLOs). Arrows indicate the area with higher magnification. Scale bars, 50&nbsp;μm.</div><div id="fspara0085" role="paragraph">(F) The percentage of patients with tumor-infiltrating TLOs in the treatment-naive and NAC cohort.</div><div id="fspara0090" role="paragraph">(G) Representative immunofluorescence images of ICOSL<sup>+</sup> B cells and T&nbsp;cells in and out of TLOs. Scale bars, 50&nbsp;μm.</div><div id="fspara0095" role="paragraph">(H) Quantitation of ICOSL<sup>+</sup> B cell percentage in post-treatment samples with or without TLOs. Mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Mann-Whitney U tests.</div><div id="fspara0100" role="paragraph">(I) Kaplan-Meier curves for disease-free survival in sub-stratified patients with breast cancer receiving NAC with low (≤53.47%) and high (&gt;53.47%) ICOSL<sup>+</sup> B&nbsp;cells in post-treatment tumors.</div><div id="fspara0105" role="paragraph">See also <a id="crosref1065" href="#figs2">Figure&nbsp;S2</a> and <a id="crosref1070" href="#mmc1">Tables S1–S5</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs2" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/eb6a9460-e89d-405c-aae3-c6e783d79a94/main.assets/figs2_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.015/asset/55c905ea-94c3-4eea-9d6f-049e4c610ec3/main.assets/figs2.jpg" height="939" width="720" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/eb6a9460-e89d-405c-aae3-c6e783d79a94/main.assets/figs2_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs2-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S2</span> <span class="figure__title__text">ICOSL<sup>+</sup> B cells Are Associated with Improved Therapeutic Efficacy and Long-Term Prognosis, Related to <a id="crosref1115" href="#fig2">Figure&nbsp;2</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs2-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0430" role="paragraph">(A) Stained slides were visually examined by two operators after automated scoring. The correlation between two operators for the ICOSL<sup>+</sup> B cell parameter was evaluated (n&nbsp;= 147. Pearson’s correlation coefficient R and p value are shown).</div><div id="fspara0435" role="paragraph">(B) Quantitation of IL-10<sup>+</sup> B cell% in pre-treatment biopsies and post-treatment samples (n&nbsp;= 224, mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests).</div><div id="fspara0440" role="paragraph">(C) The correlation in counting ICOSL<sup>+</sup> B cells between diagnostic biopsies and matched surgical samples in a control group of patients without neoadjuvant chemotherapy (n&nbsp;= 53. Pearson’s correlation coefficient R and p value are shown).</div><div id="fspara0445" role="paragraph">(D) No significant difference in ICOSL<sup>+</sup> B cell abundance was noted between biopsy samples and matched surgical samples in the control group as (C). Mean&nbsp;±&nbsp;SEM, ns, p&nbsp;&gt;&nbsp;0.05 by paired Student’s t tests.</div><div id="fspara0450" role="paragraph">(E) No significant difference in ICOSL<sup>+</sup> B cell abundance in biopsy samples between the control group without neoadjuvant chemotherapy and the study group with neoadjuvant chemotherapy (n&nbsp;= 53 in the control group; n&nbsp;= 224 in the study group; mean&nbsp;±&nbsp;SEM, ns, p &gt; 0.05 by Mann Whitney U tests).</div><div id="fspara0455" role="paragraph">(F) The percentage of patients with tumor-infiltrating TLOs in the NAC cohort with different chemotherapy responses.</div><div id="fspara0460" role="paragraph">(G) The percentage of tumor-infiltrating ICOSL<sup>+</sup> and ICOSL<sup>−</sup> B cells with direct contact with T&nbsp;cells in the NAC cohort (n&nbsp;= 368, mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests).</div><div id="fspara0465" role="paragraph">(H) Kaplan-Meier curves for overall survival in the NAC cohort with higher (&gt; 53.47%) or lower percentage (≤53.47%) of ICOSL<sup>+</sup> B cells.</div><div id="fspara0470" role="paragraph">(I) Kaplan-Meier curves for disease free survival in the treatment-naive cohort with higher (&gt; 17.89%) or lower percentage (≤17.89%) of ICOSL<sup>+</sup> B cells.</div><div id="fspara0475" role="paragraph">(J) To investigate whether the prognostic value of ICOSL<sup>+</sup> B cells in Her2<sup>+</sup> patients is restricted to those receiving Trastuzumab, another cohort of Her2<sup>+</sup> patients (n&nbsp;= 103) who received neoadjuvant chemotherapy without Trastuzumab was included. Kaplan-Meier survival analysis for patients with Her2<sup>+</sup> breast cancers receiving neoadjuvant treatments containing both Trastuzumab and chemotherapy (+ T) or chemotherapy only (- T) according to the tumor-infiltrating ICOSL<sup>+</sup> B&nbsp;cell abundance. The interaction term results from using Cox regression with the treatment (Trastuzumab) -by-biomarker (ICOSL<sup>+</sup> B cell) interaction term.</div><div id="fspara0480" role="paragraph">(K) Relative expression of ICOSLG mRNA in breast cancer tissues of patients without or with neoadjuvant chemotherapy from the Sorlie breast cancer online database. Mean&nbsp;±&nbsp;SEM, <sup>∗</sup>p&nbsp;&lt; 0.05 by Mann Whitney U tests.</div><div id="fspara0485" role="paragraph">(L) Kaplan-Meier curves for overall survival or recurrence-free survival in independent cohorts of the Oncomine online database with higher or lower expression of ICOSLG.</div></div></div></div></figcaption></figure></div><div id="p0060" role="paragraph">Tertiary lymphoid organs (TLOs) promote intratumoral B-cell-T-cell interactions and therapeutic efficacy (<span class="dropBlock reference-citations"><a id="body-ref-sref46" href="#" role="doc-biblioref" data-xml-rid="bib46" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref46" aria-controls="sref46">Sautès-Fridman et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref46"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">46.</div><div>Sautès-Fridman, C. ∙ Petitprez, F. ∙ Calderaro, J. ...</div><div><strong>Tertiary lymphoid structures in the era of cancer immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:307-325</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0144-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85065962322" target="_blank" aria-label="Open Scopus in new tab">Scopus (910)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31092904/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0144-6&amp;pmid=31092904" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). More TLOs were found in breast cancers subjected to chemotherapy compared to treatment-naive specimens (<a id="crosref0290" href="#fig2">Figures 2</a>E and 2F), especially those with therapeutic response (<a id="crosref0295" href="#figs2">Figure&nbsp;S2</a>F). Interestingly, ICOSL<sup>+</sup> B cells accumulated in TLOs and had significantly closer contact with T&nbsp;cells compared to ICOSL<sup>−</sup> B cells (<a id="crosref0300" href="#fig2">Figures 2</a>G, 2H, and <a id="crosref0305" href="#figs2">S2</a>G).</div><div id="p0065" role="paragraph">More importantly, we used X-tile statistical software to determine an optimal cutoff point (53.47%) by a minimal p value approach, and found that the abundance of tumor-infiltrating ICOSL<sup>+</sup> B cells was associated with better disease-free survival (DFS) and overall survival (OS) in all subgroups of patients receiving neoadjuvant-chemotherapy, except for the HR<sup>+</sup>Her2<sup>−</sup> subtype (<a id="crosref0310" href="#mmc1">Table S1</a>; <a id="crosref0315" href="#fig2">Figures 2</a>I and <a id="crosref0320" href="#figs2">S2</a>H). Among them, the lowest hazard ratio was observed in the triple negative subtype (<a id="crosref0325" href="#fig2">Figures 2</a>I and <a id="crosref0330" href="#figs2">S2</a>H). In the treatment-naive cohort (<a id="crosref0335" href="#mmc1">Table S2</a>) with much fewer tumor-infiltrating ICOSL<sup>+</sup> B cells, their abundance was associated with longer DFS in the subgroups of the triple negative subtype, grade 3, and clinical stage III (<a id="crosref0340" href="#figs2">Figure&nbsp;S2</a>I).</div><div id="p0070" role="paragraph">The multivariable Cox regression analysis demonstrated that the tumor size, lymph node status, and ER, the standard clinical factors identified previously (<span class="dropBlock reference-citations"><a id="body-ref-sref70" href="#" role="doc-biblioref" data-xml-rid="bib70" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref70" aria-controls="sref70">Untch et al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref70"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">58.</div><div>Untch, M. ∙ von Minckwitz, G. ∙ Gerber, B. ...</div><div><strong>Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)</strong></div><div><em>J. Clin. Oncol.</em> 2018; <strong>36</strong>:1308-1316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2017.75.9175" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85046041886" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29543566/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2017.75.9175&amp;pmid=29543566" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), showed independent prognostic significance in DFS and OS, suggesting these cohorts matched the expected biology. Importantly, ICOSL<sup>+</sup> B cell abundance was also an independent prognostic factor after adjusting for other conventional variables (<a id="crosref0345" href="#mmc1">Tables S3–S5</a>). Moreover, the p values for interaction analysis between Trastuzumab treatment status and the ICOSL<sup>+</sup> B cell abundance was not statistically significant in Her2<sup>+</sup> patients (<a id="crosref0350" href="#figs2">Figure&nbsp;S2</a>J), suggesting that ICOSL<sup>+</sup> B cell abundance was associated with better prognosis in Her2<sup>+</sup> patients regardless of whether the regimens contained Trastuzumab or not.</div><div id="p0075" role="paragraph">Furthermore, using multiple published datasets, we confirmed the elevated expression of ICOSLG in patients receiving neoadjuvant chemotherapy (<a id="crosref0355" href="#figs2">Figure&nbsp;S2</a>K) and found that this elevation correlated with better prognosis (<a id="crosref0360" href="#figs2">Figure&nbsp;S2</a>L). Collectively, these data indicate that the ICOSL<sup>+</sup> B cell subset is closely associated with improved chemotherapy efficacy and patient prognosis.</div></section><section id="sec-2-3"><h3>ICOSL<sup>+</sup> B Cells Enhance the Immune Response in Chemotherapy</h3><div id="p0080" role="paragraph">To investigate whether animal models can recapitulate the impact of chemotherapy on B cell phenotypes in patients, we administrated doxorubicin to C57/BL6 mice bearing syngeneic E0771 cells and performed scRNA-seq on isolated tumor-infiltrating B cells. Consistent with patients, B cells with strong ICOSL and CR2 expression and low IL-10 expression dramatically increased in mice treated with chemotherapy (<a id="crosref0365" href="#fig3">Figures 3</a>A and 3B). To further validate these findings, we used multiple mouse models, including C57/BL6 mice injected with E0771 cells, BALB/C mice injected with syngeneic 4T1 cells, and MMTV-PyMT mice with spontaneous mammary tumors. Flow cytometry and immunostaining revealed that ICOSL and CR2 levels markedly increased in tumor-infiltrating B cells in mice treated with chemotherapy, whereas IL-10 expression was significantly inhibited (<a id="crosref0370" href="#fig3">Figures 3</a>C–3E and <a id="crosref0375" href="#figs3">S3</a>A–S3C). By contrast, the percentage of total B cells in tumors did not significantly change (<a id="crosref0380" href="#figs3">Figure&nbsp;S3</a>D). Together, these findings indicate that the phenotype of B cells in breast cancer is switched after chemotherapy.</div><div class="figure-wrap"><figure id="fig3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/67bf0d36-e4f4-4cf4-a6bf-e2cc96cb2e70/main.assets/gr3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.015/asset/94d8cc2a-1111-414d-94eb-98e700590623/main.assets/gr3.jpg" height="937" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67bf0d36-e4f4-4cf4-a6bf-e2cc96cb2e70/main.assets/gr3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;3</span> <span class="figure__title__text">ICOSL<sup>+</sup> B Cells Enhance the Immune Response in Chemotherapy</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0115" role="paragraph">(A–E) C57/BL6 mice inoculated with syngeneic E0771 cells were treated with PBS or doxorubicin (Dox). (A) t-SNE display and graph-based clustering of CD45<sup>+</sup>CD19<sup>+</sup> cells isolated from grafts of two mice per group and subjected to scRNA-seq.</div><div id="fspara0120" role="paragraph">(B) Gene overlays of indicated markers on t-SNE. (C) Representative flow cytometry plots of isolated cells. Numerical values denote the percentage or MFI (×10<sup>2</sup>).</div><div id="fspara0125" role="paragraph">(D) Quantitation of (C) (mean&nbsp;±&nbsp;SD, n&nbsp;= 8 per group). (E) Representative confocal pictures of the grafts. Scale bars, 20&nbsp;μm.</div><div id="fspara0130" role="paragraph">(F) Tumor growth in wild-type C57/BL6 and <i>Jh</i><sup><i>−/−</i></sup> mice inoculated with E0771 cells and treated with PBS or 10&nbsp;mg/kg doxorubicin (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group). (G) MMTV-PyMT mice were treated with PBS or 10&nbsp;mg/kg doxorubicin together with cocktail antibodies against CD19, CD20, CD22, and B220 to deplete B cells, or control IgG when tumors were palpable (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group). Tumor weights were measured 32&nbsp;days after treatments. The experimental schematic is shown.</div><div id="fspara0135" role="paragraph">(H) Representative flow cytometry plots for tumor-infiltrating T&nbsp;cells isolated from MMTV-PyMT mice treated with doxorubicin and antibodies to deplete B cells. Numerical values denote mean ± SEM. (I) Immunofluorescence analysis for E0771 grafts of wild-type and <i>Jh</i><sup><i>−/−</i></sup> mice treated with PBS or doxorubicin. Arrows denote the area with higher magnification. Scale bars, 20&nbsp;μm.</div><div id="fspara0140" role="paragraph">(J) ICOSL<sup>+</sup>CD19<sup>+</sup> and ICOSL<sup>−</sup>CD19<sup>+</sup> B cells (1&nbsp;× 10<sup>6</sup>; 98% pure) were isolated from tumors of wild-type C57/BL6 mice treated with doxorubicin and intravenously transferred into E0771 tumor-bearing <i>Jh</i><sup><i>−/−</i></sup> mice (5&nbsp;days after tumor inoculation), which received 10&nbsp;mg/kg doxorubicin 2&nbsp;days later. Tumor growth curves are shown (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0145" role="paragraph">(K) Quantitation of flow cytometric analysis for T-bet- or Foxp3-expressing CD4<sup>+</sup> T&nbsp;cells and granzyme-B-expressing CD8<sup>+</sup> T&nbsp;cells in tumors treated as (I) (n&nbsp;= 8 per group).</div><div id="fspara0150" role="paragraph"><sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests. See also <a id="crosref1075" href="#figs3">Figure&nbsp;S3</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs3" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/67b178fe-4ade-49fe-afba-4cb96d6f5162/main.assets/figs3_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.015/asset/dd6cb35e-8783-4f78-99ab-ced4345e0f2d/main.assets/figs3.jpg" height="820" width="750" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67b178fe-4ade-49fe-afba-4cb96d6f5162/main.assets/figs3_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs3-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S3</span> <span class="figure__title__text">ICOSL<sup>+</sup> B Cells Enhance the Immune Response in Chemotherapy, Related to <a id="crosref1120" href="#fig3">Figure&nbsp;3</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs3-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0495" role="paragraph">(A) The gating strategies of <a id="crosref1125" href="#fig3">Figure&nbsp;3</a>C.</div><div id="fspara0500" role="paragraph">(B) The percentage of ICOSL<sup>+</sup> B cells, fold increase in CR2 MFI and percentage of IL-10<sup>+</sup> B cell in total CD19<sup>+</sup> B cells isolated from tumors of BALB/C mice and MMTV-PyMT ones treated with or without doxorubicin (mean&nbsp;±&nbsp;SD, n&nbsp;= 8 per group).</div><div id="fspara0505" role="paragraph">(C) Quantitation of <a id="crosref1130" href="#fig3">Figure&nbsp;3</a>E (mean&nbsp;±&nbsp;SD, n&nbsp;= 8 per group).</div><div id="fspara0510" role="paragraph">(D) Flow cytometry analysis of percentage of CD19<sup>+</sup> B cells in E0771 tumors of C57/BL6 mice treated with PBS or doxorubicin (left). The quantitation is shown (right). Numerical values denote percentage (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0515" role="paragraph">(E) Tumor growth in C57/BL6 and <i>Jh</i><sup><i>−/−</i></sup> mice inoculated with E0771 cells and treated with docetaxel (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0520" role="paragraph">(F) BALB/C mice were inoculated with 4T1 cells and then treated with PBS or indicated chemotherapy together with cocktail antibodies against CD19, CD20, CD22 and B220 or control IgG when the tumors were palpable. The experimental schematic (left) and growth curves (right) are shown (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0525" role="paragraph">(G) Quantitation of <a id="crosref1135" href="#fig3">Figure&nbsp;3</a>H (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6 per group).</div><div id="fspara0530" role="paragraph">(H) Quantitation of <a id="crosref1140" href="#fig3">Figure&nbsp;3</a>I (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6 per group).</div><div id="fspara0535" role="paragraph">ns, p &gt; 0.05; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div></div></div></div></figcaption></figure></div><div id="p0085" role="paragraph">Consistent with previous reports (<span class="dropBlock reference-citations"><a id="body-ref-sref1-2" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-2" aria-controls="sref1-2">Affara et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref1-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Affara, N.I. ∙ Ruffell, B. ∙ Medler, T.R. ...</div><div><strong>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:809-821</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84902465821" target="_blank" aria-label="Open Scopus in new tab">Scopus (236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24909985/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.026&amp;pmid=24909985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), tumors grown in <i>Jh</i><sup><i>−/−</i></sup> mice, which have no mature B cells, were significantly smaller than those in the wild-type littermates. Unexpectedly, tumors arising in the <i>Jh</i><sup><i>−/−</i></sup> mice were much less sensitive to chemotherapy (<a id="crosref0390" href="#fig3">Figures 3</a>F and <a id="crosref0395" href="#figs3">S3</a>E). Similar results were obtained when B cells were depleted by antibodies against CD19, CD20, CD22, and B220 in MMTV-PyMT or BALB/C mice during chemotherapy (<a id="crosref0400" href="#fig3">Figures 3</a>G and <a id="crosref0405" href="#figs3">S3</a>F), suggesting that the TME exposed to chemotherapy can foster an anti-tumor B cell subset.</div><div id="p0090" role="paragraph">To investigate whether the different chemotherapy response is accompanied by altered T&nbsp;cell immunity, we assessed the tumor-infiltration of Foxp3<sup>+</sup> regulatory T&nbsp;cells (Tregs) and effector T&nbsp;cells associated with anti-tumor immunity, including granzyme-B-expressing CD8<sup>+</sup> T&nbsp;cells, IFN-γ expressing CD4<sup>+</sup> T&nbsp;cells, and T-bet<sup>+</sup> Th1 cells. MMTV-PyMT mice treated with antibodies to deplete B cells exhibited less Tregs and more&nbsp;effector T&nbsp;cells in tumors (<a id="crosref0410" href="#fig3">Figures 3</a>H and <a id="crosref0415" href="#figs3">S3</a>G). By contrast, B cell depletion in mice treated with chemotherapy, in which tumor-infiltrating B cells were predominantly ICOSL<sup>+</sup> (<a id="crosref0420" href="#fig3">Figures 3</a>C–3E), had an opposite effect on the Teff/Treg ratio in tumors (<a id="crosref0425" href="#fig3">Figures 3</a>H and <a id="crosref0430" href="#figs3">S3</a>G). Similar results were observed in the <i>Jh</i><sup><i>−/−</i></sup> mice inoculated with E0771 cells (<a id="crosref0435" href="#fig3">Figures 3</a>I and <a id="crosref0440" href="#figs3">S3</a>H).</div><div id="p0095" role="paragraph">To specifically explore the functions of ICOSL<sup>+</sup> B cells <i>in&nbsp;vivo</i>, we isolated tumor-infiltrating ICOSL<sup>+</sup> B cells from wild-type mice treated with chemotherapy by FACS and intravenously injected into <i>Jh</i><sup><i>−/−</i></sup> mice. The adoptive transfer of ICOSL<sup>+</sup> B cells, rather than ICOSL<sup>−</sup> B cells, significantly improved chemotherapy efficacy (<a id="crosref0445" href="#fig3">Figure&nbsp;3</a>J) and increased the Teff/Treg ratio in tumors (<a id="crosref0450" href="#fig3">Figure&nbsp;3</a>K). Collectively, these data indicate that ICOSL<sup>+</sup> B cells generated in the TME exposed to chemotherapy are required for the optimal anti-tumor immune response.</div></section><section id="sec-2-4"><h3>ICOSL in B Cells Elicits Anti-Tumor T Cell Immunity and Improves Chemotherapy Response</h3><div id="p0100" role="paragraph">Given that ICOSL was significantly elevated in tumor-infiltrating B cells after chemotherapy, we administrated neutralizing antibodies against ICOSL with or without chemotherapy in BALB/C mice bearing 4T1 grafts. ICOSL blockade significantly inhibited chemotherapy efficacy, although anti-ICOSL monotherapy had&nbsp;no appreciable effect on tumor growth (<a id="crosref0455" href="#fig4">Figure&nbsp;4</a>A). The reduced responsiveness to chemotherapy was accompanied by decreased frequencies of granzyme-B- or perforin-expressing CD8<sup>+</sup> T&nbsp;cells and Th1 cells, as well as increased Tregs in tumors (<a id="crosref0460" href="#fig4">Figures 4</a>B and <a id="crosref0465" href="#figs4">S4</a>A). Despite the marked reduction in immune response and chemotherapy efficacy, tumor-infiltrating B cells in mice treated with anti-ICOSL were phenotypically comparable to mice treated by IgG with regard to the expression of CR2 and IL-10 (<a id="crosref0470" href="#figs4">Figures S4</a>B–S4D), suggesting that ICOSL is dispensable for inducing the phenotype of B cells after chemotherapy. Reduced chemosensitivity by ICOSL inhibition was not unique to this experimental setting, as when we implanted E0771 cells into syngeneic <i>Icosl</i><sup><i>−/−</i></sup> mice, the tumors were less responsive to chemotherapy (<a id="crosref0475" href="#fig4">Figure&nbsp;4</a>C). By comparison, the tumors grew similarly in mice treated with PBS, regardless of the host genotype (<a id="crosref0480" href="#fig4">Figure&nbsp;4</a>C).</div><div class="figure-wrap"><figure id="fig4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/1ef8c6df-4630-4be1-8caf-cc47f3a43eb5/main.assets/gr4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.015/asset/2862ed6b-6dea-4d7a-aeb7-2c9b44de777d/main.assets/gr4.jpg" height="948" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/1ef8c6df-4630-4be1-8caf-cc47f3a43eb5/main.assets/gr4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;4</span> <span class="figure__title__text">ICOSL in B Cells Elicits Anti-Tumor T Cell Immunity and Improves Chemotherapy Response</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0160" role="paragraph">(A and B) BALB/C mice inoculated with syngeneic 4T1 breast cancer cells received anti-ICOSL or control IgG with or without doxorubicin treatments. Tumor growth (A) and quantitation of flow cytometric analysis for T&nbsp;cells isolated from grafts (B) are shown (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0165" role="paragraph">(C) Tumor growth in wild-type C57/BL6 and <i>Icosl</i><sup><i>−/−</i></sup> mice inoculated with E0771 cells and treated with PBS or doxorubicin (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0170" role="paragraph">(D) B cells (1&nbsp;× 10<sup>6</sup>; 98% pure) from tumors of wild-type mice treated with doxorubicin were transferred into E0771 tumor-bearing <i>Icosl</i><sup><i>−/−</i></sup> mice (5&nbsp;days after inoculation) that received doxorubicin 2&nbsp;days later. Tumor volumes were determined during week five (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6 per group).</div><div id="fspara0175" role="paragraph">(E) Schematic of the generation of B-cell-specific ICOSL knockout (<i>Cd19-Icosl</i><sup><i>Δ</i></sup>) mice (left). Representative fluorescent images showing ICOSL expression in CD19<sup>+</sup> B cells isolated from the tumors of wild-type mice and <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice treated with doxorubicin (right). Scale bars, 20&nbsp;μm.</div><div id="fspara0180" role="paragraph">(F) Contour plots illustrate the ICOSL levels in B and dendritic cells isolated from the tumors and spleens of wild-type and <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice, respectively (n&nbsp;= 4 per group). ns, p &gt; 0.05; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to wild-type mice by Student’s t tests.</div><div id="fspara0185" role="paragraph">(G and H) Wild-type and <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice were inoculated with E0771 cells and treated with or without doxorubicin. Representative images (G) and quantitation (H) (mean&nbsp;±&nbsp;SEM) of tumor growth monitored by positron emission tomography/computed tomography (PET/CT). The circles indicate tumors (n&nbsp;= 6 per group). %ID/g, the percentage of injected dose per gram of tissue.</div><div id="fspara0190" role="paragraph">(I and J) Immunofluorescence analysis for granzyme-B-expressing CD8<sup>+</sup> T&nbsp;cells and T-bet- or Foxp3-expressing CD4<sup>+</sup> T&nbsp;cells in tumor sections treated as (G). Quantitation (I) (mean&nbsp;±&nbsp;SEM) and representative pictures (J) are shown. Arrows denote the area with higher magnification. Scale bars, 20&nbsp;μm.</div><div id="fspara0195" role="paragraph">Numerical values denote mean ± SEM; ns, p &gt; 0.05; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests. See also <a id="crosref1080" href="#figs4">Figure&nbsp;S4</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs4" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/fab9e195-44eb-4fd1-9140-cc6df2da7737/main.assets/figs4_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.015/asset/1201331f-1aab-48be-80f2-e2eaf857c496/main.assets/figs4.jpg" height="498" width="750" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/fab9e195-44eb-4fd1-9140-cc6df2da7737/main.assets/figs4_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs4-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S4</span> <span class="figure__title__text">ICOSL in B Cells Elicits Anti-Tumor T Cell Immunity and Improves Chemotherapy Response, Related to <a id="crosref1145" href="#fig4">Figure&nbsp;4</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs4-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0545" role="paragraph">(A–E) 4T1 cells were inoculated into the mammary fat-pads of BALB/C mice which were treated with PBS or doxorubicin together with anti-ICOSL or control IgG.</div><div id="fspara0550" role="paragraph">(A) Representative flow cytometry plots for Granzyme B/Perforin-expressing CD8<sup>+</sup> T&nbsp;cells and T-bet/Foxp3-expressing CD4<sup>+</sup> T&nbsp;cells in tumors (mean&nbsp;±&nbsp;SEM, n&nbsp;=&nbsp;8&nbsp;per group).</div><div id="fspara0555" role="paragraph">(B) The gating strategies of (C).</div><div id="fspara0560" role="paragraph">(C) CR2 and IL-10 of CD19<sup>+</sup> B cells in 4T1 grafts were evaluated by flow cytometry. The representative histograms, which were gated on CD19<sup>+</sup> populations, are shown. Values indicate MFI of CR2 ( × 10<sup>2</sup>) and percentage of IL-10-expressing B cells (n&nbsp;= 8 per group).</div><div id="fspara0565" role="paragraph">(D) The quantitation of (C). ns, p &gt; 0.05; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div><div id="fspara0570" role="paragraph">(E) The gating strategies of <a id="crosref1150" href="#fig4">Figure&nbsp;4</a>F.</div></div></div></div></figcaption></figure></div><div id="p0105" role="paragraph">To investigate whether the compromised chemotherapy efficacy in <i>Icosl</i><sup><i>−/−</i></sup> mice is mediated by B cells, B cells from wild-type mice were adoptively transferred into <i>Icosl</i><sup><i>−/−</i></sup> mice. We observed that the reduced tumor response to chemotherapy was rescued by the transfer of wild-type B cells (<a id="crosref0485" href="#fig4">Figure&nbsp;4</a>D). To specifically investigate the function of ICOSL in B cells, we crossed mice with loxP-flanked ICOSL alleles to <i>CD19-Cre</i> mice, developing mice that are homozygous <i>Cd19-Icosl</i><sup><i>−/−</i></sup> (<a id="crosref0490" href="#fig4">Figure&nbsp;4</a>E). The flow cytometric analysis confirmed that ICOSL induction in tumor-infiltrating B cells after chemotherapy was abolished in <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice, whereas ICOSL expression in CD11c<sup>+</sup> cells isolated from the spleen was not affected (<a id="crosref0495" href="#fig4">Figures 4</a>F and <a id="crosref0500" href="#figs4">S4</a>E). Again, the conditional knockout of ICOSL in B cells dramatically undermined the chemotherapy effects (<a id="crosref0505" href="#fig4">Figures 4</a>G and 4H). Furthermore, the absence of ICOSL<sup>+</sup>CD19<sup>+</sup> cells was associated with a decrease in the prevalence of effector T&nbsp;cells and an increase in Treg abundancy in tumors of <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice (<a id="crosref0510" href="#fig4">Figures 4</a>I and 4J). Together, these data indicate that ICOSL induced in tumor-infiltrating B cells after chemotherapy elicit an antitumor T&nbsp;cell immune response and improve chemotherapy efficacy.</div></section><section id="sec-2-5"><h3>The Induction of ICOSL<sup>+</sup> B Cells Depends on Complement-CR2 Signaling in Mice</h3><div id="p0110" role="paragraph">CR2 recognizes complement C3 cleavage products bound to antigens and acts in conjunction with the B cell antigen receptor (BCR) to lower the activation threshold (<span class="dropBlock reference-citations"><a id="body-ref-sref11-1" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-1" aria-controls="sref11-1">Carroll and Isenman, 2012</a><div class="dropBlock__holder" data-db-target-of="sref11-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Carroll, M.C. ∙ Isenman, D.E.</div><div><strong>Regulation of humoral immunity by complement</strong></div><div><em>Immunity.</em> 2012; <strong>37</strong>:199-207</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84865389455" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22921118/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.08.002&amp;pmid=22921118" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and overcome B cell anergy (<span class="dropBlock reference-citations"><a id="body-ref-sref34-1" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-1" aria-controls="sref34-1">Lyubchenko et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref34-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Lyubchenko, T. ∙ Dal Porto, J.M. ∙ Holers, V.M. ...</div><div><strong>Cutting edge: Complement (C3d)-linked antigens break B cell anergy</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>179</strong>:2695-2699</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.179.5.2695" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-37549071968" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17709481/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.179.5.2695&amp;pmid=17709481" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Given that ICOSL<sup>+</sup> B cells exhibited elevated CR2 levels, we asked whether the complement pathway regulates the generation of ICOSL<sup>+</sup> B cells. Similar to radiotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref56-2" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-2" aria-controls="sref56-2">Surace et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref56-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Surace, L. ∙ Lysenko, V. ∙ Fontana, A.O. ...</div><div><strong>Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response</strong></div><div><em>Immunity.</em> 2015; <strong>42</strong>:767-777</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84928205744" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25888260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2015.03.009&amp;pmid=25888260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), complement C3 fragments significantly increased in tumors of mice treated with chemotherapy (<a id="crosref0530" href="#fig5">Figures 5</a>A–5C, <a id="crosref0535" href="#figs5">S5</a>A, and S5B). Complement C3 fragments located predominantly in the proximity of blood vessels 3&nbsp;days after chemotherapy (<a id="crosref0540" href="#fig5">Figures 5</a>A and <a id="crosref0545" href="#figs5">S5</a>A) and also in tumor cells after 24&nbsp;days, especially the Tunel<sup>+</sup> cells (<a id="crosref0550" href="#fig5">Figures 5</a>B and <a id="crosref0555" href="#figs5">S5</a>B).</div><div class="figure-wrap"><figure id="fig5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/ed062f25-baa8-4414-b790-011b6c183838/main.assets/gr5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.015/asset/d6c1c2a0-59f8-4cdd-8fbd-fe3f779b1c50/main.assets/gr5.jpg" height="967" width="767" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/ed062f25-baa8-4414-b790-011b6c183838/main.assets/gr5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;5</span> <span class="figure__title__text">The Induction of ICOSL<sup>+</sup> B Cells Depends on Complement-CR2 Signaling in Mice</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0205" role="paragraph">(A–D) Wild-type and <i>C3</i><sup><i>−/−</i></sup> mice were inoculated with E0771 cells and treated with doxorubicin.</div><div id="fspara0210" role="paragraph">(A and B) Tumors were harvested 3 or 24&nbsp;days after chemotherapy. Sections were immunostained by an antibody recognizing C3b, iC3b, and C3c; CD31 (A) or Tunel (B). Arrows denote the area with higher magnification. BV, blood vessel. Scale bars, 50&nbsp;μm.</div><div id="fspara0215" role="paragraph">(C) C3 cleavage products in tumors were analyzed by immuno-blotting (n&nbsp;= 3).</div><div id="fspara0220" role="paragraph">(D) Tumor growth curves. Mean ± SEM; n&nbsp;= 8 per group.</div><div id="fspara0225" role="paragraph">(E) Immunofluorescence analysis for CD19 and ICOSL. Arrows denote the area with higher magnification. Scale bars, 20&nbsp;μm.</div><div id="fspara0230" role="paragraph">(F–I) Wild-type C57/BL6 mice and B-cell-specific CR2 knockout (<i>Cd19-Cr2</i><sup><i>Δ</i></sup>) mice were inoculated with E0771 cells and treated with doxorubicin.</div><div id="fspara0235" role="paragraph">(F) Histograms for the ICOSL expression of B cells isolated from indicated tumors. The plots were gated on CD19<sup>+</sup> populations. Numerical values indicate MFI (mean ± SEM × 10<sup>2</sup>, n&nbsp;= 6 per group).</div><div id="fspara0240" role="paragraph">(G) Expressions of T-bet or Foxp3 in CD4<sup>+</sup> T&nbsp;cells and granzyme B in CD8<sup>+</sup> T&nbsp;cells isolated from indicated tumors were evaluated by flow cytometry (mean ± SEM, n&nbsp;= 6 per group).</div><div id="fspara0245" role="paragraph">(H) Immunofluorescence analysis for CD8 and granzyme B. Arrows indicate the area with higher magnification. Scale bar, 20&nbsp;μm.</div><div id="fspara0250" role="paragraph">(I) Representative images (right) and quantitation (left) of inoculated tumor growth monitored by PET/CT. The circles indicate tumors (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6 per group).</div><div id="fspara0255" role="paragraph"><sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests. See also <a id="crosref1085" href="#figs5">Figure&nbsp;S5</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs5" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/c491ea93-6a85-496d-9f95-4c53573d6308/main.assets/figs5_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.015/asset/b02a7e72-5814-427a-bca6-817f78c92f7b/main.assets/figs5.jpg" height="444" width="637" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/c491ea93-6a85-496d-9f95-4c53573d6308/main.assets/figs5_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs5-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S5</span> <span class="figure__title__text">The Induction of ICOSL<sup>+</sup> B Cells Depends on Complement-CR2 Signaling in Mice, Related to <a id="crosref1155" href="#fig5">Figure&nbsp;5</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs5-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0580" role="paragraph">(A) The quantitation of <a id="crosref1160" href="#fig5">Figure&nbsp;5</a>A (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0585" role="paragraph">(B) The quantitation of <a id="crosref1165" href="#fig5">Figure&nbsp;5</a>B (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0590" role="paragraph">(C) The quantitation of <a id="crosref1170" href="#fig5">Figure&nbsp;5</a>E (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0595" role="paragraph">(D) PCR genotyping on tail DNA of <i>Cr2-loxp</i>+/+<i>; Cd19-Cre</i>+/+ mice (1,2), <i>Cr2-loxp</i>+/+<i>;Cd19-Cre</i>−/− mice (3,4) and <i>Cr2-loxp</i>−/−<i>;Cd19-Cre</i>−/− (5-7) for Cr2 loxp (wild type at 167&nbsp;bp and Cr2-loxP at 238&nbsp;bp) and Cd19-Cre (wild type at 481&nbsp;bp and Cd19-Cre at 272&nbsp;bp).</div><div id="fspara0600" role="paragraph">(E) The levels of CR2 expression in B cells isolated from spleens of indicated groups were determined by immunoblot (n&nbsp;= 2 per group).</div><div id="fspara0605" role="paragraph">(F) The gating strategies of <a id="crosref1175" href="#fig5">Figure&nbsp;5</a>F.</div><div id="fspara0610" role="paragraph">(G) The quantitation of <a id="crosref1180" href="#fig5">Figure&nbsp;5</a>F (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0615" role="paragraph">(H) The quantitation of <a id="crosref1185" href="#fig5">Figure&nbsp;5</a>G (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0620" role="paragraph">(I) The quantitation of <a id="crosref1190" href="#fig5">Figure&nbsp;5</a>H (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0625" role="paragraph"><sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests in (A–C and G–I) (n&nbsp;= 6 per group).</div></div></div></div></figcaption></figure></div><div id="p0115" role="paragraph">To investigate the effect of complement activation, we administrated chemotherapy to <i>C3</i><sup><i>−/−</i></sup> mice inoculated with tumor cells. Consistent with B cell depletion, C3 knockout reduced tumor growth in treatment-naive states. By contrast, chemotherapy was less effective in <i>C3</i><sup><i>−/−</i></sup> mice (<a id="crosref0560" href="#fig5">Figure&nbsp;5</a>D). More importantly, the abundance of ICOSL<sup>+</sup> B cells in tumors exposed to chemotherapy was abolished by C3 knockout (<a id="crosref0565" href="#fig5">Figures 5</a>E and <a id="crosref0570" href="#figs5">S5</a>C).</div><div id="p0120" role="paragraph">To specifically elucidate the role of complement signals in B cells, we crossed mice having loxP-flanked CR2 alleles with <i>CD19-Cre</i> mice, thereby developing homozygous <i>Cd19-Cr2</i><sup><i>Δ</i></sup> mice (<a id="crosref0575" href="#figs5">Figures S5</a>D and S5E). The upregulation of ICOSL after chemotherapy was absent in CR2-deficient B cells (<a id="crosref0580" href="#fig5">Figure&nbsp;5</a>F, <a id="crosref0585" href="#figs5">S5</a>F, and S5G). As expected, the <i>Cd19-Cr2</i><sup><i>Δ</i></sup> mice had a marked decrease in effector T&nbsp;cells and an increase of Tregs in tumors after chemotherapy (<a id="crosref0590" href="#fig5">Figures 5</a>G, 5H, <a id="crosref0595" href="#figs5">S5</a>H, and S5I). Moreover, the tumor grew more slowly in the <i>Cd19-Cr2</i><sup><i>Δ</i></sup> mice treated with chemotherapy, rather than the ones treated with PBS (<a id="crosref0600" href="#fig5">Figure&nbsp;5</a>I). Collectively, these results indicate that complement activation in the TME exposed to chemotherapy is responsible for inducing ICOSL<sup>+</sup> B cells via CR2 in mice.</div></section><section id="sec-2-6"><h3>Complement-CR2 Is Required for Chemotherapy-Induced ICOSL<sup>+</sup> B Cell Generation in Humans</h3><div id="p0125" role="paragraph">To investigate whether chemotherapy-induced complement activation in mice is similar in humans, we cultured human tumor cells pretreated with chemotherapy in the presence of human serum. Chemotherapy induced bioactive complement fragment production in the supernatant (<a id="crosref0605" href="#figs6">Figure&nbsp;S6</a>A) and on the surface of tumor cells which exhibited features of cell death (<span class="dropBlock reference-citations"><a id="body-ref-sref18" href="#" role="doc-biblioref" data-xml-rid="bib18" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref18" aria-controls="sref18">Galluzzi et&nbsp;al., 2009</a><div class="dropBlock__holder" data-db-target-of="sref18"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">18.</div><div>Galluzzi, L. ∙ Aaronson, S.A. ∙ Abrams, J. ...</div><div><strong>Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes</strong></div><div><em>Cell Death Differ.</em> 2009; <strong>16</strong>:1093-1107</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cdd.2009.44" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-67650751080" target="_blank" aria-label="Open Scopus in new tab">Scopus (572)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19373242/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcdd.2009.44&amp;pmid=19373242" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), including caspase activation, PARP proteolytic processing (<a id="crosref0615" href="#fig6">Figure&nbsp;6</a>A), and PI (propidium iodide) staining (<a id="crosref0620" href="#fig6">Figures 6</a>B and <a id="crosref0625" href="#figs6">S6</a>B). Heat inactivation of the serum (<a id="crosref0630" href="#fig6">Figures 6</a>A, 6B, and <a id="crosref0635" href="#figs6">S6</a>B) or neutralization of phosphatidylserine (PS) (<a id="crosref0640" href="#figs6">Figures S6</a>A and S6D), a phospholipid that is exposed on the outer leaflet of the plasma membrane during apoptosis and activates the complement system via the alternative pathway (<span class="dropBlock reference-citations"><a id="body-ref-sref60" href="#" role="doc-biblioref" data-xml-rid="bib60" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref60" aria-controls="sref60">Wang et&nbsp;al., 1993</a><div class="dropBlock__holder" data-db-target-of="sref60"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">61.</div><div>Wang, R.H. ∙ Phillips, Jr., G. ∙ Medof, M.E. ...</div><div><strong>Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1993; <strong>92</strong>:1326-1335</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI116706" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0027181206" target="_blank" aria-label="Open Scopus in new tab">Scopus (107)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7690777/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI116706&amp;pmid=7690777" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), markedly reduced the complement cleavage despite cell death and remained unchanged (<a id="crosref0650" href="#fig6">Figures 6</a>A, 6B, <a id="crosref0655" href="#figs6">S6</a>B, and S6C). Consistently, the complement cleavage was significantly attenuated by caspase inhibitors (<a id="crosref0660" href="#figs6">Figures S6</a>E and S6F). Collectively, these data indicate that tumor cell death induced by chemotherapy activates the complement system, at least partially, through PS.</div><div class="figure-wrap"><figure id="fig6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/88cc9f4c-136b-4226-9137-a5dd492e97e4/main.assets/gr6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.015/asset/34db35dc-d0fe-448a-adc5-56bed35551a3/main.assets/gr6.jpg" height="964" width="750" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/88cc9f4c-136b-4226-9137-a5dd492e97e4/main.assets/gr6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;6</span> <span class="figure__title__text">Complement-CR2 Is Required for Chemotherapy-Induced ICOSL<sup>+</sup> B Cell Generation in Humans</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0265" role="paragraph">(A and B) MDA-MB-231 cells were treated with or without doxorubicin and then incubated in 15% human serum (HS) or heat-inactivated human serum (IHS). Representative immunofluorescence images (A) and flow cytometry (B) are shown. Scale bar, 20&nbsp;μm.</div><div id="fspara0270" role="paragraph">(C) Flow cytometric quantitation of B cells co-cultured with or without tumors cells (5:1) treated as (A). Numerical values indicate MFI or percentage (mean ± SEM, n&nbsp;= 4).</div><div id="fspara0275" role="paragraph">(D) Human peripheral CD4<sup>+</sup> T&nbsp;cells were co-cultured with autologous DCs pulsed by MDA-MB-231 lysate with or without indicated B cells. Flow cytometric analysis for the percentage of T-bet<sup>+</sup> and Foxp3<sup>+</sup> CD4<sup>+</sup> T&nbsp;cells are shown (mean ± SEM, n&nbsp;= 4).</div><div id="fspara0280" role="paragraph">(E) Human peripheral CD8<sup>+</sup> T&nbsp;cells were co-incubated with autologous DCs pulsed by MDA-MB-231 lysate with or without indicated B cells. Afterward, CD8<sup>+</sup> T&nbsp;cells were retrieved by magnetic beads and co-incubated with MDA-MB-231 cells labeled by CMFDA. Flow cytometric analysis for the percentage of granzyme B<sup>+</sup> CD8<sup>+</sup> T&nbsp;cells and tumor killing are shown. Dead tumor cells were assessed by propidium iodide (PI) uptake (mean ± SEM, n&nbsp;= 4).</div><div id="fspara0285" role="paragraph">(F) Representative flow cytometry plots of B cell subsets in human blood. The plots were gated on CD19<sup>+</sup> populations.</div><div id="fspara0290" role="paragraph">(G) Flow cytometry quantitation of ICOSL<sup>+</sup> B cell percentage in indicated B cell subsets before and after being co-cultured with MDA-MB-231 cells pretreated with doxorubicin in 15% human serum (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8).</div><div id="fspara0295" role="paragraph">(H) Representative flow cytometry plots of naive B cell subsets in human blood. The plots were gated on CD19<sup>+</sup>IgD<sup>+</sup>CD27<sup>−</sup> populations.</div><div id="fspara0300" role="paragraph">(I) Flow cytometry quantitation of ICOSL<sup>+</sup> B cell percentage in indicated subsets treated as (G) (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8).</div><div id="fspara0305" role="paragraph">(J) IgD<sup>+</sup>IgM<sup>+</sup> mature-naive B cells and the B cell pool depleted of mature-naive B cells from wild-type mice were adoptively transfused (ACT) into tumor-bearing <i>Jh</i><sup>−/−</sup> mice, which received doxorubicin 2&nbsp;days later. ICOSL<sup>+</sup> B cell percentage in tumors was determined by flow cytometry (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6 per group).</div><div id="fspara0310" role="paragraph">(K) Representative images of immunohistochemistry (IHC) and immunofluorescence in serial sections of pre- and post-treatment samples from patients receiving neoadjuvant chemotherapy. Arrows indicate the area with higher magnification. Scale bars, 50&nbsp;μm.</div><div id="fspara0315" role="paragraph">(L) Quantitation of (K) (n&nbsp;= 197, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by paired Student’s t tests).</div><div id="fspara0320" role="paragraph">(M) The correlation between the percentage of ICOSL<sup>+</sup> B cells and IHC scores of C3 cleavage in post-NAC samples.</div><div id="fspara0325" role="paragraph">Numerical values denote mean ± SEM. ND, not detectable; ns, p &gt; 0.05; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests unless indicated otherwise. See also <a id="crosref1090" href="#figs6">Figure&nbsp;S6</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs6" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/e2e656ed-fc80-40d7-ad92-a1979b02a0cc/main.assets/figs6_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.015/asset/49b8cc94-9154-4a58-9290-983daadad9a3/main.assets/figs6.jpg" height="940" width="736" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/e2e656ed-fc80-40d7-ad92-a1979b02a0cc/main.assets/figs6_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs6-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S6</span> <span class="figure__title__text">Complement-CR2 Is Required for Chemotherapy-Induced ICOSL<sup>+</sup> B Cell Generation in Humans, Related to <a id="crosref1195" href="#fig6">Figure&nbsp;6</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs6-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0635" role="paragraph">(A) Doxorubicin-treated MDA-MB-231 cells were incubated in the presence or absence of annexin V (anti-PS) in annexin V binding buffer (buffer) for 10&nbsp;min at 4°C before being cultured in media containing 15% human serum. C3 and C3 cleavage products in the supernatant from cells were analyzed by western blotting (n&nbsp;= 3).</div><div id="fspara0640" role="paragraph">(B) Quantification of <a id="crosref1200" href="#fig6">Figure&nbsp;6</a>B. <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to untreated tumor cells; <sup>###</sup>p&nbsp;&lt; 0.001 compared to tumor cells treated with doxorubicin in HS by Student’s t tests (mean&nbsp;±&nbsp;SEM, n&nbsp;= 6).</div><div id="fspara0645" role="paragraph">(C) The levels of cleaved-caspase-3, total-caspase-3, total-PARP and cleaved-PARP in MDA-MB-231 cells treated as (A) were determined by immunoblotting (n&nbsp;= 3).</div><div id="fspara0650" role="paragraph">(D) C3b/iC3b deposition on MDA-MB-231 cells treated as (A) was determined by flow cytometry (n&nbsp;= 5). Mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to untreated tumor cells; <sup>##</sup>p&nbsp;&lt; 0.01 compared to tumor cells treated with doxorubicin by Student’s t tests.</div><div id="fspara0655" role="paragraph">(E) MDA-MB-231 cells were treated with doxorubicin in the presence or absence of DMSO, z-VAD, or z-DEVD for 24 h. The levels of cleaved-caspase-3, total-caspase-3, total-PARP and cleaved-PARP were analyzed by western blotting (n&nbsp;= 3).</div><div id="fspara0660" role="paragraph">(F) C3b/iC3b deposition on MDA-MB-231 cells treated as (E) was determined by flow cytometry (n&nbsp;= 5). Mean&nbsp;±&nbsp;SEM, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to untreated tumor cells; <sup>##</sup>p&nbsp;&lt; 0.01 compared to tumor cells treated with doxorubicin by Student’s t tests.</div><div id="fspara0665" role="paragraph">(G) Representative plots of <a id="crosref1205" href="#fig6">Figure&nbsp;6</a>C. Values indicate MFI of ICOSL ( × 10<sup>2</sup>), MFI of CR2 ( × 10<sup>2</sup>) and percentage of IL-10-expressing B cells (mean&nbsp;±&nbsp;SEM).</div><div id="fspara0670" role="paragraph">(H) Quantitation of <a id="crosref1210" href="#fig6">Figures 6</a>D and 6E. Mean ± SEM; n&nbsp;= 4; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div><div id="fspara0675" role="paragraph">(I) B cells were co-cultured with MDA-MB-231 cells (5:1) pretreated with chemotherapy and 15% human serum and retrieved by magnetic beads. Autologous CD4<sup>+</sup>/CD8<sup>+</sup> T&nbsp;cells were co-cultured with tumor-pulsed DCs (5:1) and retrieved B cells (1:1) in the presence or absence of control IgG or ICOSL-neutralizing antibody. The levels of T-bet and Foxp3 in CD4<sup>+</sup> T&nbsp;cells, and the levels of granzyme B and MDA-MB-231 cell killing of CD8<sup>+</sup> T&nbsp;cells were evaluated by flow cytometry. The quantitation is shown. Mean ± SEM; n&nbsp;= 4; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div><div id="fspara0680" role="paragraph">(J) B cells were incubated with control IgG or CR2-neutralizing antibody and then co-cultured with MDA-MB-231 cells (5:1) pretreated with chemotherapy and 15% human serum. The levels of ICOSL in CD19<sup>+</sup> B cells were analyzed by flow cytometry. Values indicate MFI of ICOSL (mean ± SEM, × 10<sup>2</sup>); n&nbsp;= 4; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to the first group; <sup>###</sup>p&nbsp;&lt; 0.001 compared to the second group by Student’s t tests.</div><div id="fspara0685" role="paragraph">(K) B cells treated as (J) were retrieved by magnetic beads. Autologous CD8<sup>+</sup>/CD4<sup>+</sup> T&nbsp;cells were co-cultured tumor-pulsed DCs (5:1) and retrieved B cells (1:1). The levels of T-bet and Foxp3 in CD4<sup>+</sup> T&nbsp;cells, and the levels of granzyme B and MDA-MB-231 cell killing of CD8<sup>+</sup> T&nbsp;cell were evaluated by flow cytometry. The quantitation is shown. Mean ± SEM; n&nbsp;= 4; <sup>∗∗</sup>p&nbsp;&lt; 0.01, <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div><div id="fspara0690" role="paragraph">(L) Representative plots of <a id="crosref1215" href="#fig6">Figure&nbsp;6</a>G.</div><div id="fspara0695" role="paragraph">(M) Representative plots of <a id="crosref1220" href="#fig6">Figure&nbsp;6</a>I.</div><div id="fspara0700" role="paragraph">(N) Representative plots of <a id="crosref1225" href="#fig6">Figure&nbsp;6</a>J. Values indicate the percentage in CD19<sup>+</sup> cells.</div><div id="fspara0705" role="paragraph">(O) The levels of C3 cleavage products in the lysates of pre-treatment samples and paired post-treatment sample of 8 patients receiving neoadjuvant chemotherapy were determined by immunoblotting.</div></div></div></div></figcaption></figure></div><div id="p0130" role="paragraph">To address whether the complement-mediated B cell phenotype switch in mice is also shared by humans, we co-cultured human B cells with MDA-MB-231 cells with or without previous exposure to chemotherapy and human serum. The IL-10 levels in B cells significantly increased after being co-cultured with treatment-naive tumor cells (<a id="crosref0665" href="#fig6">Figures 6</a>C and <a id="crosref0670" href="#figs6">S6</a>G), which were absent in B cells co-cultured with tumor cells treated with chemotherapy. Moreover, ICOSL and CR2 levels were significantly higher in B cells co-cultured with chemotherapy-exposed tumor cells compared to those cultured alone (<a id="crosref0675" href="#fig6">Figures 6</a>C and <a id="crosref0680" href="#figs6">S6</a>G). To investigate the effect of these B cells on anti-tumor immunity, we generated tumor-specific CD8<sup>+</sup>/CD4<sup>+</sup> T&nbsp;cells by incubating CD8<sup>+</sup>/CD4<sup>+</sup> T&nbsp;cells with autologous dendritic cells pulsed with tumor lysates (<span class="dropBlock reference-citations"><a id="body-ref-sref55-2" href="#" role="doc-biblioref" data-xml-rid="bib53 bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-2" aria-controls="sref55-2">Su et&nbsp;al., 2017, 2018b</a><div class="dropBlock__holder" data-db-target-of="sref55-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Su, S. ∙ Liao, J. ∙ Liu, J. ...</div><div><strong>Blocking the recruitment of naive CD4<sup>+</sup> T&nbsp;cells reverses immunosuppression in breast cancer</strong></div><div><em>Cell Res.</em> 2017; <strong>27</strong>:461-482</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2017.34" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85015196232" target="_blank" aria-label="Open Scopus in new tab">Scopus (159)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28290464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2017.34&amp;pmid=28290464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Su, S. ∙ Zhao, J. ∙ Xing, Y. ...</div><div><strong>Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:442-457.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054030012" target="_blank" aria-label="Open Scopus in new tab">Scopus (205)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30290143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.007&amp;pmid=30290143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). B cells co-cultured with MDA-MB-231 cells increased the percentage of Tregs, reduced the proportion of effector CD4<sup>+</sup> T&nbsp;cells, and inhibited tumoricidal effects of CD8<sup>+</sup> T&nbsp;cells (<a id="crosref0685" href="#fig6">Figures 6</a>D, 6E, and <a id="crosref0690" href="#figs6">S6</a>H). By comparison, B cells co-cultured with chemotherapy-treated tumor cells significantly increased the CD4<sup>+</sup> Teff/Treg ratio and enhanced the CD8<sup>+</sup> T-cell-mediated immune response (<a id="crosref0695" href="#fig6">Figures 6</a>D, 6E, and S6H), which was abrogated by the ICOSL blockade (<a id="crosref0700" href="#figs6">Figure&nbsp;S6</a>I). To investigate whether these effects are complement dependent, we heated the serum to inactivate the complement. The phenotype and function of the B cells co-cultured with chemotherapy-treated tumor cells were reinstated to those co-cultured with treatment-naive tumor cells when the human serum was replaced with the heat-inactivated serum (<a id="crosref0705" href="#fig6">Figures 6</a>C–6E, <a id="crosref0710" href="#figs6">S6</a>G, and S6H). Similar effects were observed by using neutralizing antibodies to CR2 (<a id="crosref0715" href="#figs6">Figures S6</a>J and S6K), collectively supporting an indispensable role of the complement in regulating the characteristics of B cells during chemotherapy.</div><div id="p0135" role="paragraph">To investigate the origin of this B cell subset, we sorted naive, memory, non-switched memory, and double-negative B cells (<a id="crosref0720" href="#fig6">Figure&nbsp;6</a>F) and co-cultured them with chemotherapy-exposed tumor cells. The co-culture significantly increased ICOSL<sup>+</sup> B&nbsp;cells in naive B cells as well as memory B cells, albeit to a much lesser extent (<a id="crosref0725" href="#fig6">Figures 6</a>G and <a id="crosref0730" href="#figs6">S6</a>L). Next, we further isolated transitional and mature-naive B cells from naive B cells (<a id="crosref0735" href="#fig6">Figure&nbsp;6</a>H). Although transitional B cells could give rise to ICOSL<sup>+</sup> B cells, mature-naive B cells showed much stronger potency (<a id="crosref0740" href="#fig6">Figures 6</a>I and <a id="crosref0745" href="#figs6">S6</a>M). More importantly, the transfusion of mature-naive B cells from wild-type mice restored more ICOSL<sup>+</sup> B cells in the tumors of <i>Jh</i><sup><i>−/−</i></sup> mice treated with chemotherapy compared to the B cell pool depleted of mature-naive B cells (<a id="crosref0750" href="#fig6">Figures 6</a>J and <a id="crosref0755" href="#figs6">S6</a>N). Together, these data suggested that mature-naive B cells are important progenitors of ICOSL<sup>+</sup> B cells in chemotherapy-exposed tumors.</div><div id="p0140" role="paragraph">Clinically, we found that C3 cleavage products significantly increased in the human tumors after chemotherapy (<a id="crosref0760" href="#fig6">Figures 6</a>K, 6L, and <a id="crosref0765" href="#figs6">S6</a>O). More importantly, the complement activation in tumors was closely correlated with the number of infiltrating ICOSL<sup>+</sup> B cells (R<sup>2</sup>&nbsp;= 0.322, p&nbsp;&lt; 0.001) (<a id="crosref0770" href="#fig6">Figures 6</a>K and 6M). Together, these data indicated that chemotherapy-induced tumor cell death activates the complement which enhances anti-tumor immunity and chemotherapy efficacy by generating an ICOSL<sup>+</sup> B cell subset.</div></section><section id="sec-2-7"><h3>CD55 in Tumors Induces Chemoresistance by Suppressing the Complement Activation and ICOSL<sup>+</sup> B&nbsp;Cell Generation</h3><div id="p0145" role="paragraph">Interestingly, a fraction of the 11 breast cancer cell lines used failed to induce ICOSL<sup>+</sup> B cells regardless of chemotherapy (<a id="crosref0775" href="#fig7">Figure&nbsp;7</a>A). The aberrant expression of complement regulatory proteins in tumor cells has been reported (<span class="dropBlock reference-citations"><a id="body-ref-sref43-1" href="#" role="doc-biblioref" data-xml-rid="bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43-1" aria-controls="sref43-1">Reis et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref43-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Reis, E.S. ∙ Mastellos, D.C. ∙ Ricklin, D. ...</div><div><strong>Complement in cancer: untangling an intricate relationship</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:5-18</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85039035360" target="_blank" aria-label="Open Scopus in new tab">Scopus (272)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28920587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.97&amp;pmid=28920587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, we analyzed the expression profile of complement regulatory proteins in different breast cancer cell lines from the online transcriptomic data and found that levels of CD55, a complement inhibitory protein bound to the cell membrane or released into the microenvironment, were significantly lower in tumor cells that could induce ICOSL<sup>+</sup> B cells after chemotherapy than in those that could not (<a id="crosref0785" href="#figs7">Figure&nbsp;S7</a>A). The expression pattern was confirmed at the protein level (<a id="crosref0790" href="#fig7">Figure&nbsp;7</a>B).</div><div class="figure-wrap"><figure id="fig7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/868dae05-6094-4bcd-8e7d-4227b1a5e056/main.assets/gr7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.015/asset/4296eb74-5d99-4e1b-a013-c52879a2715c/main.assets/gr7.jpg" height="939" width="732" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/868dae05-6094-4bcd-8e7d-4227b1a5e056/main.assets/gr7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="fig7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;7</span> <span class="figure__title__text">CD55 in Tumors Induces Chemoresistance by Suppressing Complement Activation and ICOSL<sup>+</sup> B Cell Generation</span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="fig7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0335" role="paragraph">(A) Flow cytometric analysis for B cells co-cultured with indicated human breast cancer cell lines pretreated with doxorubicin and 15% human serum. MFI (×10<sup>2</sup>) is shown (n&nbsp;= 4).</div><div id="fspara0340" role="paragraph">(B) The levels of CD55 in indicated cell lines were determined by immunoblotting (n&nbsp;= 3).</div><div id="fspara0345" role="paragraph">(C and D) E0771 cells transduced with lentivirus carrying an empty vector (E0771-vec) or vector expressing CD55 (E0771-CD55) were inoculated into C57/BL6 mice. Mice were treated with doxorubicin when the grafts were palpable.</div><div id="fspara0350" role="paragraph">(C) Tumor growth curves (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0355" role="paragraph">(D) Flow cytometric analysis for B and T&nbsp;cells isolated from harvested grafts. MFI (×10<sup>2</sup>) and percentage are shown (n&nbsp;= 4 mice per group). <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 compared to the second group by Student’s t tests.</div><div id="fspara0360" role="paragraph">(E–G) TRAMP-C2 cells transduced without (-) or with lentivirus vectors carrying GFP shRNA or CD55 shRNA were inoculated into C57/BL6 mice. After 30&nbsp;days, the mice were treated with PBS or docetaxel (Doc) for 4&nbsp;weeks.</div><div id="fspara0365" role="paragraph">(E) MFI (×10<sup>2</sup>) of ICOSL in B cells were evaluated by flow cytometry (n&nbsp;= 5 per group). <sup>∗∗</sup>p&nbsp;&lt; 0.01 compared to the Doc-treated TRAMP-C2 group by Student’s t tests.</div><div id="fspara0370" role="paragraph">(F) Quantitation of the percentage of T-bet- or Foxp3-expressing CD4<sup>+</sup> T&nbsp;cells and granzyme-B-expressing CD8<sup>+</sup> T&nbsp;cells evaluated by flow cytometry (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0375" role="paragraph">(G) Tumor volumes were determined 4&nbsp;weeks after treatments (mean&nbsp;±&nbsp;SEM, n&nbsp;= 8 per group).</div><div id="fspara0380" role="paragraph">(H) Representative images of the immunostaining of CD55 in pre-treatment samples and C3/C3b, CD19, and ICOSL in post-treatment samples of patients receiving NAC. Arrows indicate the area with higher magnification. Scale bar, 50&nbsp;μm.</div><div id="fspara0385" role="paragraph">(I) The correlation between the IHC scores of CD55 in pre-treatment samples and the percentage of ICOSL<sup>+</sup> B cells in post-treatment samples (R, Pearson’s correlation coefficient).</div><div id="fspara0390" role="paragraph">(J) The IHC scores of CD55 in pre-treatment biopsy samples with different responses to NAC. pCR, n&nbsp;= 27; B- or A-only pCR, n&nbsp;= 7; PR, n&nbsp;= 115; SD, n&nbsp;= 62; PD, n&nbsp;=&nbsp;13. Mean&nbsp;±&nbsp;SEM, <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Mann-Whitney U tests.</div><div id="fspara0395" role="paragraph">(K) Kaplan-Meier curves for disease-free survival and overall survival in breast cancer patients with high (&gt;101) and low (≤101) CD55 IHC scores.</div><div id="fspara0400" role="paragraph">Numerical values denote mean ± SEM; ns, not statistically significant; <sup>∗</sup>p&nbsp;&lt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests unless indicated otherwise. See also <a id="crosref1095" href="#figs7">Figure&nbsp;S7</a>.</div></div></div></div></figcaption></figure></div><div class="figure-wrap"><figure id="figs7" class="graphic"><a class="icon-full-screen" href="/cms/10.1016/j.cell.2020.02.015/asset/7a68189f-455b-4574-89dc-048d3682e43e/main.assets/figs7_lrg.jpg" target="_blank" title="View full size image in a new tab"><img id="figs7" src="/cms/10.1016/j.cell.2020.02.015/asset/04fc66a0-c491-4958-8957-b676a4a24c5c/main.assets/figs7.jpg" height="732" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/7a68189f-455b-4574-89dc-048d3682e43e/main.assets/figs7_lrg.jpg" loading="lazy"></a><figcaption class="figure__caption__body"><div id="figs7-title" class="figure__title"><span class="label figure__label">Figure&nbsp;S7</span> <span class="figure__title__text">CD55 in Tumors Inhibits the Response to Chemotherapy by Suppressing Complement Activation and ICOSL<sup>+</sup> B Cell Generation, Related to <a id="crosref1230" href="#fig7">Figure&nbsp;7</a></span></div><div class="accordion"><div><button class="accordion__control" aria-expanded="false" title="Expand"><span>Show full caption</span><i class="icon-section_arrow_d"></i></button><button class="figure__open__ctrl">Figure viewer</button></div><div id="figs7-content" class="accordion__content" style="display: none;"><div class="figure__caption__text__content"><div id="fspara0715" role="paragraph">(A) The relative expression of complement regulatory proteins (CD55, CD46, CRIg, CR1, Factor H, Factor I, FHL1, C4BP, Properdin and C1INH) in BT474, BT549, MDA-MB-231, HCC1937, MDA-MB-361, MDA-MB-436, MDA-MB-468, AU565, SK-BR-3, MCF-7 and MDA-MB-453 cells were evaluated by using mRNA data from the Barretina Cell Line database.</div><div id="fspara0720" role="paragraph">(B) E0771 cells were transduced with lentivirus carrying an empty vector (E0771-vec) or vector expressing CD55 (E0771-CD55). The CD55 levels were determined by western blotting. The representative blots are shown (n&nbsp;= 3).</div><div id="fspara0725" role="paragraph">(C) C57/BL6 mice were inoculated with E0771-vec or E0771-CD55 cells. The mice were treated with doxorubicin weekly after tumors were palpable. C3 cleavage products in the tumors 24&nbsp;h after the last dose of chemotherapy were analyzed by western blotting using a polyclonal anti-C3 antibody. Representative blots are shown (n&nbsp;= 3).</div><div id="fspara0730" role="paragraph">(D) C57/BL6 and <i>C3</i><sup><i>−/−</i></sup> mice were inoculated with E0771-vec or E0771-CD55 cells. The mice were treated with doxorubicin weekly after tumors were palpable. The tumor growth curves are shown. Mean ± SEM; n&nbsp;= 8 per group; ns, p &gt; 0.05; <sup>∗∗</sup>p&nbsp;&lt; 0.01 by Student’s t tests.</div><div id="fspara0735" role="paragraph">(E) Tumor-infiltrating T&nbsp;cells were isolated from mice treated as (D). Percentages of T-bet/Foxp3-expressing CD4<sup>+</sup> T&nbsp;cells and granzyme B/perforin-expressing CD8<sup>+</sup> T&nbsp;cells were evaluated by flow cytometry. The quantitation is shown. Mean ± SEM; n&nbsp;= 8 per group; ns, not statistically significant; <sup>∗∗</sup>p&nbsp;&lt; 0.01; <sup>∗∗∗</sup>p&nbsp;&lt; 0.001 by Student’s t tests.</div><div id="fspara0740" role="paragraph">(F) The expression of CD55 in E0771 and TRAMP-C2 cells were determined by western blotting. The representative blots are shown (n&nbsp;= 3).</div><div id="fspara0745" role="paragraph">(G) The correlation between IHC scores of CD55 in pre-treatment biopsy samples and IHC scores of C3 cleavage in post-treatment samples shown as in <a id="crosref1235" href="#fig7">Figure&nbsp;7</a>H (n&nbsp;= 197, CR samples were excluded as no cancer cells left for analysis of C3 cleavage deposit).</div><div id="fspara0750" role="paragraph">(H) Kaplan-Meier curves for disease free survival in different subgroups of the NAC cohort with higher (&gt; 101) or lower (≤101) CD55 IHC scores in pretreatment samples.</div><div id="fspara0755" role="paragraph">(I) The correlation between the CD55 mRNA relative expression and ICOSLG mRNA relative expression in specimens of breast cancer patients from the Curtis breast cancer online database (n&nbsp;= 1974).</div><div id="fspara0760" role="paragraph">(J) Kaplan-Meier curves for recurrence-free survival or overall survival in breast cancer patients from indicated breast cancer online databases with higher or lower expression of CD55-mRNA expressions.</div></div></div></div></figcaption></figure></div><div id="p0150" role="paragraph">To investigate the role of CD55 in chemosensitivity and tumor immunity <i>in&nbsp;vivo</i>, we injected E0771 cells with or without CD55 overexpression (<a id="crosref0795" href="#figs7">Figure&nbsp;S7</a>B) in mice. CD55 overexpression significantly increased tumor size in mice treated with chemotherapy, but not in those treated with PBS (<a id="crosref0800" href="#fig7">Figure&nbsp;7</a>C). Additionally, chemotherapy increased tumor-infiltrating ICOSL<sup>+</sup> B cells and effector T&nbsp;cells in mice bearing parental E0771 cells, but not in those bearing cells with CD55 overexpression. By contrast, the abundancy of Tregs was more pronounced in CD55-overexpressed tumors treated with chemotherapy (<a id="crosref0805" href="#fig7">Figure&nbsp;7</a>D). As expected, the complement cleavage in tumors induced by chemotherapy was dramatically reduced after CD55 overexpression (<a id="crosref0810" href="#figs7">Figure&nbsp;S7</a>C). Moreover, the effect of CD55 overexpression on chemosensitivity (<a id="crosref0815" href="#figs7">Figure&nbsp;S7</a>D) and T&nbsp;cell complexity (<a id="crosref0820" href="#figs7">Figure&nbsp;S7</a>E) was completely abrogated in <i>C3</i><sup><i>−/−</i></sup> mice, suggesting that it is complement dependent. Together, our results indicate that the aberrant CD55 expression in tumor cells undermines chemotherapy efficacy by inhibiting complement-dependent ICOSL<sup>+</sup> B cell induction.</div><div id="p0155" role="paragraph">B cell depletion enhances chemosensitivity in some mouse tumor models, including transgenic adenocarcinoma of the mouse prostate (TRAMP-C2) model (<span class="dropBlock reference-citations"><a id="body-ref-sref49-1" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-1" aria-controls="sref49-1">Shalapour et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref49-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Shalapour, S. ∙ Font-Burgada, J. ∙ Di Caro, G. ...</div><div><strong>Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy</strong></div><div><em>Nature.</em> 2015; <strong>521</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14395" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929085260" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25924065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14395&amp;pmid=25924065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). TRAMP-C2 tumor cells expressed higher levels of CD55 compared to E0771 cells (<a id="crosref0830" href="#figs7">Figure&nbsp;S7</a>F). Few ICOSL<sup>+</sup> B cells were observed in TRAMP-C2 tumors before or after chemotherapy. However, CD55 knockout significantly increased tumor-infiltrating ICOSL<sup>+</sup> B&nbsp;cells in mice treated with chemotherapy (<a id="crosref0835" href="#fig7">Figure&nbsp;7</a>E). Moreover, the increase of ICOSL<sup>+</sup> B cells in tumors by CD55 silencing was accompanied by enhancement of the Teff/Treg ratio (<a id="crosref0840" href="#fig7">Figure&nbsp;7</a>F) and chemotherapy efficacy (<a id="crosref0845" href="#fig7">Figure&nbsp;7</a>G). Together, these data suggest that CD55 expression in tumor cells determines the role of B cells in anti-tumor immunity and chemotherapy efficacy.</div><div id="p0160" role="paragraph">To investigate the clinical significance of CD55, we analyzed CD55 levels in tumors of patients with breast cancer. CD55 expression was predominantly observed in tumor cells (<a id="crosref0850" href="#fig7">Figure&nbsp;7</a>H). More importantly, CD55 levels in pre-treatment biopsies were negatively correlated with complement cleavage and ICOSL<sup>+</sup> B cell infiltration in paired post-treatment samples (<a id="crosref0855" href="#fig7">Figures 7</a>H, 7I, and <a id="crosref0860" href="#figs7">S7</a>G). Moreover, tumoral CD55 expression was significantly higher in patients resistant to neo-adjuvant chemotherapy than sensitive ones (<a id="crosref0865" href="#fig7">Figure&nbsp;7</a>J) and associated with worse clinical outcomes (<a id="crosref0870" href="#fig7">Figures 7</a>K and <a id="crosref0875" href="#figs7">S7</a>H) validated by multiple independent cohorts (<a id="crosref0880" href="#figs7">Figures S7</a>I and S7J). Collectively, these data indicate that CD55 in tumors induces chemoresistance by impeding the induction of ICOSL<sup>+</sup> B cells.</div></section></section><section id="sec-3"><h2>Discussion</h2><div id="p0165" role="paragraph">Previous use of rituximab to deplete B cells demonstrated no real clinical benefits for patients with solid tumor (<span class="dropBlock reference-citations"><a id="body-ref-sref20" href="#" role="doc-biblioref" data-xml-rid="bib20" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref20" aria-controls="sref20">Gunderson and Coussens, 2013</a><div class="dropBlock__holder" data-db-target-of="sref20"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">20.</div><div>Gunderson, A.J. ∙ Coussens, L.M.</div><div><strong>B cells and their mediators as targets for therapy in solid tumors</strong></div><div><em>Exp. Cell Res.</em> 2013; <strong>319</strong>:1644-1649</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.yexcr.2013.03.005" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84879604267" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499742/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.yexcr.2013.03.005&amp;pmid=23499742" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). This can be explained by the finding that both pro- and anti-tumoral B cells exist in the TME (<span class="dropBlock reference-citations"><a id="body-ref-sref49-2" href="#" role="doc-biblioref" data-xml-rid="bib1 bib4 bib24 bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-2" aria-controls="sref49-2">Affara et&nbsp;al., 2014; Ammirante et&nbsp;al., 2010; Hennequin et&nbsp;al., 2015; Shalapour et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref49-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Affara, N.I. ∙ Ruffell, B. ∙ Medler, T.R. ...</div><div><strong>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:809-821</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84902465821" target="_blank" aria-label="Open Scopus in new tab">Scopus (236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24909985/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.026&amp;pmid=24909985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">4.</div><div>Ammirante, M. ∙ Luo, J.L. ∙ Grivennikov, S. ...</div><div><strong>B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</strong></div><div><em>Nature.</em> 2010; <strong>464</strong>:302-305</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature08782" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77949379050" target="_blank" aria-label="Open Scopus in new tab">Scopus (503)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20220849/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature08782&amp;pmid=20220849" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">24.</div><div>Hennequin, A. ∙ Derangère, V. ∙ Boidot, R. ...</div><div><strong>Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients</strong></div><div><em>OncoImmunology.</em> 2015; <strong>5</strong>:e1054598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1054598" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84959440329" target="_blank" aria-label="Open Scopus in new tab">Scopus (150)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27057426/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1054598&amp;pmid=27057426" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Shalapour, S. ∙ Font-Burgada, J. ∙ Di Caro, G. ...</div><div><strong>Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy</strong></div><div><em>Nature.</em> 2015; <strong>521</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14395" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929085260" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25924065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14395&amp;pmid=25924065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, there is a pressing need to dissect the mechanisms that determine B cell heterogeneity in tumors. Here, we provide insights into some key issues: (1) a B cell subset emerging after chemotherapy elicits anti-tumor T&nbsp;cell immunity and improves therapeutic response by ICOSL, (2) complement-CR2 signals initiated by immunogenic cell death regulate this B cell subset, and (3) the expression of CD55 in tumors determines the opposite effects of B cells on chemotherapy in various malignancies.</div><div id="p0170" role="paragraph">Previous studies have showed that ICOSL is predominantly expressed in myeloid cells (<span class="dropBlock reference-citations"><a id="body-ref-sref64" href="#" role="doc-biblioref" data-xml-rid="bib2 bib64" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref64" aria-controls="sref64">Aicher et&nbsp;al., 2000; Zhang et&nbsp;al., 2016a</a><div class="dropBlock__holder" data-db-target-of="sref64"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">2.</div><div>Aicher, A. ∙ Hayden-Ledbetter, M. ∙ Brady, W.A. ...</div><div><strong>Characterization of human inducible costimulator ligand expression and function</strong></div><div><em>J.&nbsp;Immunol.</em> 2000; <strong>164</strong>:4689-4696</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.164.9.4689" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0034193043" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10779774/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.164.9.4689&amp;pmid=10779774" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">65.</div><div>Zhang, C. ∙ Xin, H. ∙ Zhang, W. ...</div><div><strong>CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:913-923</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2016.04.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2016.04.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964374893" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27096320/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.04.003&amp;pmid=27096320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Surprisingly, we found that a large fraction of B cells was ICOSL<sup>+</sup> after chemotherapy, and this B cell subset was associated with improved prognosis in breast cancer patients, especially those with the triple negative subtype. This finding is clinically important because triple negative breast cancers are the most sensitive and at need for neoadjuvant chemotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref59-1" href="#" role="doc-biblioref" data-xml-rid="bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-1" aria-controls="sref59-1">von Minckwitz et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref59-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>von Minckwitz, G. ∙ Blohmer, J.U. ∙ Costa, S.D. ...</div><div><strong>Response-guided neoadjuvant chemotherapy for breast cancer</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2013; <strong>31</strong>:3623-3630</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2012.45.0940" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84882977388" target="_blank" aria-label="Open Scopus in new tab">Scopus (295)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24002511/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2012.45.0940&amp;pmid=24002511" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and immunotherapy (<span class="dropBlock reference-citations"><a id="body-ref-sref48" href="#" role="doc-biblioref" data-xml-rid="bib48" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref48" aria-controls="sref48">Schmid et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref48"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">48.</div><div>Schmid, P. ∙ Adams, S. ∙ Rugo, H.S. ..., IMpassion130 Trial Investigators</div><div><strong>Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>379</strong>:2108-2121</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1809615" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85056176186" target="_blank" aria-label="Open Scopus in new tab">Scopus (2988)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30345906/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1809615&amp;pmid=30345906" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, this study has limitations of a small retrospective investigation. The hazard ratios in the sub-stratified analysis may be confounded by the group size. Therefore, our findings should be validated in the future hypothesis-testing clinical trial.</div><div id="p0175" role="paragraph">Using B-cell-specific ICOSL knockout mice, we unambiguously demonstrated that ICOSL in B cells boosts chemosensitivity by enhancing tumor-specific CD8<sup>+</sup> T&nbsp;cells and the Th1/Treg ratio. Consistently, ICOS enhances the generation of effector cells in tumors (<span class="dropBlock reference-citations"><a id="body-ref-sref38" href="#" role="doc-biblioref" data-xml-rid="bib15 bib38" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref38" aria-controls="sref38">Fan et&nbsp;al., 2014; Metzger et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref38"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">15.</div><div>Fan, X. ∙ Quezada, S.A. ∙ Sepulveda, M.A. ...</div><div><strong>Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2014; <strong>211</strong>:715-725</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20130590" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84897940775" target="_blank" aria-label="Open Scopus in new tab">Scopus (228)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24687957/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20130590&amp;pmid=24687957" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">38.</div><div>Metzger, T.C. ∙ Long, H. ∙ Potluri, S. ...</div><div><strong>ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection</strong></div><div><em>Cancer Res.</em> 2016; <strong>76</strong>:3684-3689</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-15-3412" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84977540735" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27197182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-15-3412&amp;pmid=27197182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Furthermore, ICOS overexpression in tumor-infiltrating T&nbsp;cells is a distinctive feature of anti-tumor responses observed in patients receiving ipilimumab (<span class="dropBlock reference-citations"><a id="body-ref-sref62" href="#" role="doc-biblioref" data-xml-rid="bib62" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref62" aria-controls="sref62">Wei et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref62"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">63.</div><div>Wei, S.C. ∙ Levine, J.H. ∙ Cogdill, A.P. ...</div><div><strong>Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:1120-1133.e17</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.07.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.07.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85028060533" target="_blank" aria-label="Open Scopus in new tab">Scopus (921)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28803728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.07.024&amp;pmid=28803728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Together, we expand the current model by proposing that ICOSL in multiple types of immune cells plays a crucial role in anti-tumor immunity induced by both conventional therapy and immunotherapy.</div><div id="p0180" role="paragraph">CR2, which colligates with BCR (<span class="dropBlock reference-citations"><a id="body-ref-sref11-2" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-2" aria-controls="sref11-2">Carroll and Isenman, 2012</a><div class="dropBlock__holder" data-db-target-of="sref11-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Carroll, M.C. ∙ Isenman, D.E.</div><div><strong>Regulation of humoral immunity by complement</strong></div><div><em>Immunity.</em> 2012; <strong>37</strong>:199-207</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84865389455" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22921118/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.08.002&amp;pmid=22921118" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), enhances B cell activation by reducing the activation threshold (<span class="dropBlock reference-citations"><a id="body-ref-sref44" href="#" role="doc-biblioref" data-xml-rid="bib44" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref44" aria-controls="sref44">Ricklin et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref44"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">44.</div><div>Ricklin, D. ∙ Hajishengallis, G. ∙ Yang, K. ...</div><div><strong>Complement: a key system for immune surveillance and homeostasis</strong></div><div><em>Nat. Immunol.</em> 2010; <strong>11</strong>:785-797</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.1923" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77955883153" target="_blank" aria-label="Open Scopus in new tab">Scopus (2784)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20720586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.1923&amp;pmid=20720586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Despite the importance of complement in B cell immunity being appreciated for more than 40 years (<span class="dropBlock reference-citations"><a id="body-ref-sref41" href="#" role="doc-biblioref" data-xml-rid="bib41" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref41" aria-controls="sref41">Pepys, 1972</a><div class="dropBlock__holder" data-db-target-of="sref41"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">41.</div><div>Pepys, M.B.</div><div><strong>Role of complement in induction of the allergic response</strong></div><div><em>Nat. New Biol.</em> 1972; <strong>237</strong>:157-159</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/newbio237157a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0015530804" target="_blank" aria-label="Open Scopus in new tab">Scopus (154)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4556375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnewbio237157a0&amp;pmid=4556375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>), its role in tumor-associated B cells remains largely unknown. CR2 is expressed not only on B cells, but also on follicular dendritic cells and a subset of T&nbsp;cells (<span class="dropBlock reference-citations"><a id="body-ref-sref14" href="#" role="doc-biblioref" data-xml-rid="bib14" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref14" aria-controls="sref14">Erdei et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref14"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">14.</div><div>Erdei, A. ∙ Sándor, N. ∙ Mácsik-Valent, B. ...</div><div><strong>The versatile functions of complement C3-derived ligands</strong></div><div><em>Immunol. Rev.</em> 2016; <strong>274</strong>:127-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12498" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84992457824" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27782338/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12498&amp;pmid=27782338" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, CR2 can regulate B cell functions at two levels (<span class="dropBlock reference-citations"><a id="body-ref-sref11-3" href="#" role="doc-biblioref" data-xml-rid="bib11" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref11-3" aria-controls="sref11-3">Carroll and Isenman, 2012</a><div class="dropBlock__holder" data-db-target-of="sref11-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">11.</div><div>Carroll, M.C. ∙ Isenman, D.E.</div><div><strong>Regulation of humoral immunity by complement</strong></div><div><em>Immunity.</em> 2012; <strong>37</strong>:199-207</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84865389455" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22921118/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.08.002&amp;pmid=22921118" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>): (1) CR2 on B cells provides direct signals, and (2) FDCs trap and deliver C3-opsonized antigens to B cells via CR2 during affinity maturation (<span class="dropBlock reference-citations"><a id="body-ref-sref23" href="#" role="doc-biblioref" data-xml-rid="bib23" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref23" aria-controls="sref23">Heesters et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref23"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">23.</div><div>Heesters, B.A. ∙ Myers, R.C. ∙ Carroll, M.C.</div><div><strong>Follicular dendritic cells: dynamic antigen libraries</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:495-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri3689" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84903387500" target="_blank" aria-label="Open Scopus in new tab">Scopus (293)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24948364/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri3689&amp;pmid=24948364" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). By constructing B-cell-specific CR2 knockout mice, we provided clear evidence that co-stimulatory signals provided by complement dictate the fate decision of tumor-associated B cells. The importance of co-stimulation in T-cell-mediated immunity is exploited by cancers as immune evasion. Interestingly, our data suggest that tumors induce immunosuppressive B cells rather than immunoactivative ones because they do not elicit B cell costimulatory signals, which is reminiscent of T&nbsp;cell suppression. Consistently, lack of complement co-stimulation can lead to B cell anergy (<span class="dropBlock reference-citations"><a id="body-ref-sref34-2" href="#" role="doc-biblioref" data-xml-rid="bib34" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref34-2" aria-controls="sref34-2">Lyubchenko et&nbsp;al., 2007</a><div class="dropBlock__holder" data-db-target-of="sref34-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">34.</div><div>Lyubchenko, T. ∙ Dal Porto, J.M. ∙ Holers, V.M. ...</div><div><strong>Cutting edge: Complement (C3d)-linked antigens break B cell anergy</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>179</strong>:2695-2699</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.179.5.2695" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-37549071968" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17709481/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.179.5.2695&amp;pmid=17709481" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Therefore, the previously uncharacterized role of B cell costimulatory signals in tumors described here provides new evidence for the larger concept that the lack of co-stimulatory signals for adaptive immune cell activation facilitates cancer cells to evade immune surveillance.</div><div id="p0185" role="paragraph">Cells can die in many ways; some are immunogenic (<span class="dropBlock reference-citations"><a id="body-ref-sref67" href="#" role="doc-biblioref" data-xml-rid="bib19 bib31 bib67" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref67" aria-controls="sref67">Galluzzi et&nbsp;al., 2017; Kroemer et&nbsp;al., 2013; Zitvogel et&nbsp;al., 2010</a><div class="dropBlock__holder" data-db-target-of="sref67"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">19.</div><div>Galluzzi, L. ∙ Buqué, A. ∙ Kepp, O. ...</div><div><strong>Immunogenic cell death in cancer and infectious disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2017; <strong>17</strong>:97-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2016.107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84991619059" target="_blank" aria-label="Open Scopus in new tab">Scopus (2034)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27748397/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2016.107&amp;pmid=27748397" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">31.</div><div>Kroemer, G. ∙ Galluzzi, L. ∙ Kepp, O. ...</div><div><strong>Immunogenic cell death in cancer therapy</strong></div><div><em>Annu. Rev. Immunol.</em> 2013; <strong>31</strong>:51-72</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-032712-100008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84875552922" target="_blank" aria-label="Open Scopus in new tab">Scopus (2458)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23157435/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-032712-100008&amp;pmid=23157435" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">68.</div><div>Zitvogel, L. ∙ Kepp, O. ∙ Kroemer, G.</div><div><strong>Decoding cell death signals in inflammation and immunity</strong></div><div><em>Cell.</em> 2010; <strong>140</strong>:798-804</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2010.02.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2010.02.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77950366886" target="_blank" aria-label="Open Scopus in new tab">Scopus (470)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20303871/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.02.015&amp;pmid=20303871" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). The complement can be activated by damage-associated molecular patterns (DAMPs) exposed on dead tumor cells (<span class="dropBlock reference-citations"><a id="body-ref-sref43-2" href="#" role="doc-biblioref" data-xml-rid="bib7 bib43" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref43-2" aria-controls="sref43-2">Berraondo et&nbsp;al., 2016; Reis et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref43-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">7.</div><div>Berraondo, P. ∙ Minute, L. ∙ Ajona, D. ...</div><div><strong>Innate immune mediators in cancer: between defense and resistance</strong></div><div><em>Immunol. Rev.</em> 2016; <strong>274</strong>:290-306</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12464" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84992473931" target="_blank" aria-label="Open Scopus in new tab">Scopus (109)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27782320/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12464&amp;pmid=27782320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Reis, E.S. ∙ Mastellos, D.C. ∙ Ricklin, D. ...</div><div><strong>Complement in cancer: untangling an intricate relationship</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:5-18</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85039035360" target="_blank" aria-label="Open Scopus in new tab">Scopus (272)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28920587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.97&amp;pmid=28920587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and promote tumor progression (<span class="dropBlock reference-citations"><a id="body-ref-sref36" href="#" role="doc-biblioref" data-xml-rid="bib9 bib36" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref36" aria-controls="sref36">Bonavita et&nbsp;al., 2015; Markiewski et&nbsp;al., 2008</a><div class="dropBlock__holder" data-db-target-of="sref36"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">9.</div><div>Bonavita, E. ∙ Gentile, S. ∙ Rubino, M. ...</div><div><strong>PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:700-714</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.01.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.01.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84922689090" target="_blank" aria-label="Open Scopus in new tab">Scopus (308)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25679762/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.01.004&amp;pmid=25679762" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">36.</div><div>Markiewski, M.M. ∙ DeAngelis, R.A. ∙ Benencia, F. ...</div><div><strong>Modulation of the antitumor immune response by complement</strong></div><div><em>Nat. Immunol.</em> 2008; <strong>9</strong>:1225-1235</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.1655" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-54549109936" target="_blank" aria-label="Open Scopus in new tab">Scopus (595)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18820683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.1655&amp;pmid=18820683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). However, emerging evidence shows that the complement can also elicit anti-tumor immunity when it acts in concert with certain tumor treatments, such as radiotherapy and monoclonal antibodies (<span class="dropBlock reference-citations"><a id="body-ref-sref57" href="#" role="doc-biblioref" data-xml-rid="bib21 bib56 bib57" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref57" aria-controls="sref57">Hajishengallis et&nbsp;al., 2017; Surace et&nbsp;al., 2015; Taylor and Lindorfer, 2016</a><div class="dropBlock__holder" data-db-target-of="sref57"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">21.</div><div>Hajishengallis, G. ∙ Reis, E.S. ∙ Mastellos, D.C. ...</div><div><strong>Novel mechanisms and functions of complement</strong></div><div><em>Nat. Immunol.</em> 2017; <strong>18</strong>:1288-1298</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.3858" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85034570767" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144501/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.3858&amp;pmid=29144501" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Surace, L. ∙ Lysenko, V. ∙ Fontana, A.O. ...</div><div><strong>Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response</strong></div><div><em>Immunity.</em> 2015; <strong>42</strong>:767-777</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84928205744" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25888260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2015.03.009&amp;pmid=25888260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">57.</div><div>Taylor, R.P. ∙ Lindorfer, M.A.</div><div><strong>Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies</strong></div><div><em>Semin. Immunol.</em> 2016; <strong>28</strong>:309-316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.smim.2016.03.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84961219433" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27009480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.smim.2016.03.003&amp;pmid=27009480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Our results supplement these studies by showing that cell-death-associated PS exposure initiates anti-tumor adaptive immunity, which consists of both B and T&nbsp;cells, via the critical innate immune component complement. Together, we and others demonstrate that the complement can be a potent adjuvant to trigger immune response during immunogenic cell death in multiple cancer therapies.</div><div id="p0190" role="paragraph">B cell depletion enhances chemosensitivity in some mouse tumor models, such as prostate cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref49-3" href="#" role="doc-biblioref" data-xml-rid="bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-3" aria-controls="sref49-3">Shalapour et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref49-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Shalapour, S. ∙ Font-Burgada, J. ∙ Di Caro, G. ...</div><div><strong>Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy</strong></div><div><em>Nature.</em> 2015; <strong>521</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14395" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929085260" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25924065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14395&amp;pmid=25924065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Surprisingly, we found that B cell depletion reduced chemotherapeutic effects in three different breast cancer mouse models. This discrepancy is highly clinically relevant, as B cell density is correlated to both better (Hennequin et&nbsp;al., 2016; <span class="dropBlock reference-citations"><a id="body-ref-sref66-2" href="#" role="doc-biblioref" data-xml-rid="bib66" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref66-2" aria-controls="sref66-2">Zhu et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref66-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">67.</div><div>Zhu, W. ∙ Germain, C. ∙ Liu, Z. ...</div><div><strong>A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T&nbsp;cell receptor repertoire clonality</strong></div><div><em>OncoImmunology.</em> 2015; <strong>4</strong>:e1051922</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1051922" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84944548558" target="_blank" aria-label="Open Scopus in new tab">Scopus (79)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26587322/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1051922&amp;pmid=26587322" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) and worse (<span class="dropBlock reference-citations"><a id="body-ref-sref1-4" href="#" role="doc-biblioref" data-xml-rid="bib1" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref1-4" aria-controls="sref1-4">Affara et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref1-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">1.</div><div>Affara, N.I. ∙ Ruffell, B. ∙ Medler, T.R. ...</div><div><strong>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:809-821</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84902465821" target="_blank" aria-label="Open Scopus in new tab">Scopus (236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24909985/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.026&amp;pmid=24909985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) prognosis in patients with different malignancies. CD55 is a glycosylphosphatidylinositol-anchored protein that accelerates C3 convertases decay and inhibits C3b deposition (<span class="dropBlock reference-citations"><a id="body-ref-sref51" href="#" role="doc-biblioref" data-xml-rid="bib43 bib51" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref51" aria-controls="sref51">Reis et&nbsp;al., 2018; Spendlove et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref51"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">43.</div><div>Reis, E.S. ∙ Mastellos, D.C. ∙ Ricklin, D. ...</div><div><strong>Complement in cancer: untangling an intricate relationship</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:5-18</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85039035360" target="_blank" aria-label="Open Scopus in new tab">Scopus (272)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28920587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.97&amp;pmid=28920587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">51.</div><div>Spendlove, I. ∙ Ramage, J.M. ∙ Bradley, R. ...</div><div><strong>Complement decay accelerating factor (DAF)/CD55 in cancer</strong></div><div><em>Cancer Immunol. Immunother.</em> 2006; <strong>55</strong>:987-995</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00262-006-0136-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-33646367451" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16485129/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00262-006-0136-8&amp;pmid=16485129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Here, we identified that the heterogeneous expression of CD55 in tumor cells determines the conflict effects of B cells on chemotherapy, suggesting that the manipulation of complement signals can be used to shape the B-cell-mediated immune response in tumors.</div><div id="p0195" role="paragraph">In summary, this study reveals that oncological therapy profoundly re-shapes the plasticity of B cells in tumors and uncovers a new role of complement in B-cell-dependent anti-tumor immunity. Equally importantly, we propose CD55 as an attractive therapeutic target to enhance the efficacy of immunogenic chemotherapy.</div></section><section id="sec-4"><h2>STAR★Methods</h2><section id="sec-4-1"><h3>Key Resources Table</h3><div id="p0200" role="paragraph"><div class="figure-wrap"><figure id="undtbl1" class="table" data-figureviewer-ignore="true"><div class="table-wrap"><table data-figureviewer-ignore="true" tabindex="0"><thead><tr class="rowsep"><th>REAGENT or RESOURCE</th><th>SOURCE</th><th>IDENTIFIER</th></tr></thead><tbody><tr class="rowsep"><td colspan="3"><b>Antibodies</b></td></tr><tr><td>Pacific Blue™ anti-human CD45</td><td>Biolegend</td><td>Cat# 304022; RRID: <a id="intref0010" href="https://antibodyregistry.org/AB_493655" target="_blank">AB_493655</a></td></tr><tr><td>Pacific Blue™ Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400151</td></tr><tr><td>FITC anti-human CD45</td><td>Biolegend</td><td>Cat# 304006; RRID: <a id="intref0015" href="https://antibodyregistry.org/AB_314394" target="_blank">AB_314394</a></td></tr><tr><td>FITC mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400107</td></tr><tr><td>PE anti-human CD19</td><td>Biolegend</td><td>Cat# 392506; RRID: AB_ 2750097</td></tr><tr><td>PE Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat#400114</td></tr><tr><td>Pacific Blue™ anti-human CD19</td><td>Biolegend</td><td>Cat# 302224; RRID: <a id="intref0020" href="https://antibodyregistry.org/AB_493653" target="_blank">AB_493653</a></td></tr><tr><td>PE anti-human ICOSL (CD275)</td><td>Biolegend</td><td>Cat# 309404; RRID: AB_ 314770</td></tr><tr><td>PE Mouse IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 401208</td></tr><tr><td>APC anti-human ICOSL (CD275)</td><td>Biolegend</td><td>Cat# 309408; RRID: <a id="intref0025" href="https://antibodyregistry.org/AB_2565557" target="_blank">AB_2565557</a></td></tr><tr><td>APC Mouse IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400319</td></tr><tr><td>APC anti-human CD19</td><td>Biolegend</td><td>Cat# 392504; RRID: AB_ 2728416</td></tr><tr><td>Alexa Fluor 488 anti-human IL-10</td><td>eBioscience</td><td>Cat# 53-7108-42; RRID: AB_ 1834348</td></tr><tr><td>Alexa Fluor 488 Rat IgG1 kappa Isotype Control</td><td>eBioscience</td><td>Cat# 53-4301-80; RRID: <a id="intref0030" href="https://antibodyregistry.org/AB_493962" target="_blank">AB_493962</a></td></tr><tr><td>PE/Cy7 anti-human CR2 (CD21)</td><td>Biolegend</td><td>Cat# 354912; RRID: <a id="intref0035" href="https://antibodyregistry.org/AB_2561577" target="_blank">AB_2561577</a></td></tr><tr><td>PE/Cy7 Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400126</td></tr><tr><td>PE/Cy7 anti-human IgA</td><td>Biolegend</td><td>Cat# 333510; RRID: <a id="intref0040" href="https://antibodyregistry.org/AB_2564595" target="_blank">AB_2564595</a></td></tr><tr><td>PE/Cy7 anti-human CD38</td><td>Biolegend</td><td>Cat# 303516; RRID: <a id="intref0045" href="https://antibodyregistry.org/AB_2072782" target="_blank">AB_2072782</a></td></tr><tr><td>Alexa Fluor® 700 anti-human IgD</td><td>Biolegend</td><td>Cat# 348229; RRID: <a id="intref0050" href="https://antibodyregistry.org/AB_2563334" target="_blank">AB_2563334</a></td></tr><tr><td>Alexa Fluor® 700 Mouse IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400247</td></tr><tr><td>PerCP anti-human CD27</td><td>Biolegend</td><td>Cat# 356432; RRID: <a id="intref0055" href="https://antibodyregistry.org/AB_2650753" target="_blank">AB_2650753</a></td></tr><tr><td>PerCP Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400148</td></tr><tr><td>FITC anti-human CD27</td><td>Biolegend</td><td>Cat# 356404; RRID: <a id="intref0060" href="https://antibodyregistry.org/AB_2561788" target="_blank">AB_2561788</a></td></tr><tr><td>PerCP anti-human CD24</td><td>Biolegend</td><td>Cat# 311114; RRID: AB_</td></tr><tr><td>PerCP Mouse IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400256</td></tr><tr><td>APC anti-human CD20</td><td>Biolegend</td><td>Cat# 302310; RRID: AB_ 314258</td></tr><tr><td>APC Mouse IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400319</td></tr><tr><td>APC anti-human IgG Fc</td><td>Biolegend</td><td>Cat# 409306; RRID: <a id="intref0065" href="https://antibodyregistry.org/AB_11149491" target="_blank">AB_11149491</a></td></tr><tr><td>APC Mouse IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400221</td></tr><tr><td>PE/Cy5 anti-mouse CD45</td><td>Biolegend</td><td>Cat# 103110; RRID: <a id="intref0070" href="https://antibodyregistry.org/AB_312975" target="_blank">AB_312975</a></td></tr><tr><td>PE/Cy5 Rat IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400610</td></tr><tr><td>FITC anti-mouse CD45</td><td>Biolegend</td><td>Cat# 103108; RRID: <a id="intref0075" href="https://antibodyregistry.org/AB_312973" target="_blank">AB_312973</a></td></tr><tr><td>APC anti-mouse CD19</td><td>Biolegend</td><td>Cat# 115512; RRID: <a id="intref0080" href="https://antibodyregistry.org/AB_313647" target="_blank">AB_313647</a></td></tr><tr><td>APC Rat IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400512</td></tr><tr><td>PE anti-mouse ICOSL (CD275)</td><td>Biolegend</td><td>Cat# 107405; RRID: <a id="intref0085" href="https://antibodyregistry.org/AB_2248797" target="_blank">AB_2248797</a></td></tr><tr><td>PE Rat IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400508</td></tr><tr><td>Brilliant Violet 421™ anti-mouse CD21/CD35 (CR2/CR1)</td><td>Biolegend</td><td>Cat# 123422; RRID: <a id="intref0090" href="https://antibodyregistry.org/AB_2650891" target="_blank">AB_2650891</a></td></tr><tr><td>Brilliant Violet 421™ Rat IgG2a, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400535</td></tr><tr><td>FITC anti-mouse IL-10</td><td>Biolegend</td><td>Cat# 505006; RRID: <a id="intref0095" href="https://antibodyregistry.org/AB_315360" target="_blank">AB_315360</a></td></tr><tr><td>FITC Rat IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400634</td></tr><tr><td>APC anti-mouse CD8a</td><td>Biolegend</td><td>Cat# 100711; RRID: <a id="intref0100" href="https://antibodyregistry.org/AB_312750" target="_blank">AB_312750</a></td></tr><tr><td>APC anti-mouse CD4</td><td>Biolegend</td><td>Cat# 100412; RRID: <a id="intref0105" href="https://antibodyregistry.org/AB_312697" target="_blank">AB_312697</a></td></tr><tr><td>APC Rat IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400612</td></tr><tr><td>FITC anti-human/mouse Granzyme B</td><td>Biolegend</td><td>Cat# 515403; RRID: <a id="intref0110" href="https://antibodyregistry.org/AB_2114575" target="_blank">AB_2114575</a></td></tr><tr><td>FITC Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400108</td></tr><tr><td>PE anti-mouse Perforin</td><td>Biolegend</td><td>Cat# 154306; RRID: <a id="intref0115" href="https://antibodyregistry.org/AB_2721639" target="_blank">AB_2721639</a></td></tr><tr><td>FITC anti-mouse IFN-γ</td><td>Biolegend</td><td>Cat# 505806; RRID: <a id="intref0120" href="https://antibodyregistry.org/AB_315400" target="_blank">AB_315400</a></td></tr><tr><td>FITC anti-T-bet</td><td>Biolegend</td><td>Cat# 644812; RRID: <a id="intref0125" href="https://antibodyregistry.org/AB_2200540" target="_blank">AB_2200540</a></td></tr><tr><td>PE anti-T-bet</td><td>Biolegend</td><td>Cat# 644810; RRID: <a id="intref0130" href="https://antibodyregistry.org/AB_2200542" target="_blank">AB_2200542</a></td></tr><tr><td>PE anti-mouse/rat/human FOXP3</td><td>Biolegend</td><td>Cat# 320008; RRID: <a id="intref0135" href="https://antibodyregistry.org/AB_492980" target="_blank">AB_492980</a></td></tr><tr><td>Alexa Fluor® 647 anti-mouse/rat/human FOXP3</td><td>Biolegend</td><td>Cat# 320014; RRID: <a id="intref0140" href="https://antibodyregistry.org/AB_439750" target="_blank">AB_439750</a></td></tr><tr><td>Alexa Fluor® 647 Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400135</td></tr><tr><td>Alexa Fluor® 488 anti-mouse/rat/human FOXP3</td><td>Biolegend</td><td>Cat# 320012; RRID: <a id="intref0145" href="https://antibodyregistry.org/AB_439748" target="_blank">AB_439748</a></td></tr><tr><td>Alexa Fluor® 488 Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400133</td></tr><tr><td>APC anti-human CD8</td><td>Biolegend</td><td>Cat# 344722; RRID: <a id="intref0150" href="https://antibodyregistry.org/AB_2075388" target="_blank">AB_2075388</a></td></tr><tr><td>APC Mouse IgG1, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400120</td></tr><tr><td>APC anti-human CD4</td><td>Biolegend</td><td>Cat# 357408; RRID: <a id="intref0155" href="https://antibodyregistry.org/AB_2565660" target="_blank">AB_2565660</a></td></tr><tr><td>APC Rat IgG2b, κ Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400612</td></tr><tr><td>APC anti-mouse CD11c</td><td>Biolegend</td><td>Cat# 117310; RRID: <a id="intref0160" href="https://antibodyregistry.org/AB_313779" target="_blank">AB_313779</a></td></tr><tr><td>APC Armenian Hamster IgG Isotype Ctrl Antibody</td><td>Biolegend</td><td>Cat# 400912</td></tr><tr><td>FITC anti-mouse IgD</td><td>Biolegend</td><td>Cat# 405704; RRID: <a id="intref0165" href="https://antibodyregistry.org/AB_315026" target="_blank">AB_315026</a></td></tr><tr><td>PE anti-mouse IgM</td><td>Biolegend</td><td>Cat# 406508; RRID: <a id="intref0170" href="https://antibodyregistry.org/AB_315058" target="_blank">AB_315058</a></td></tr><tr><td>FITC anti-complement C3b/iC3b</td><td>Biolegend</td><td>Cat# 846108; RRID: <a id="intref0175" href="https://antibodyregistry.org/AB_2632797" target="_blank">AB_2632797</a></td></tr><tr><td>Mouse anti-human CD19</td><td>Abcam</td><td>Cat# ab31947</td></tr><tr><td>Alexa Fluor 488 anti-human CD19</td><td>eBioscience</td><td>Cat# 53-0194-82; RRID: <a id="intref0180" href="https://antibodyregistry.org/AB_2637167" target="_blank">AB_2637167</a></td></tr><tr><td>Rabbit anti–human ICOSL</td><td>Abcam</td><td>Cat# ab233151</td></tr><tr><td>Rat anti–human IL-10</td><td>eBioscience</td><td>Cat# 14-7108-85</td></tr><tr><td>Goat anti-mouse ICOSL (CD275)</td><td>ThermoFisher Scientific</td><td>Cat# PA5-47161</td></tr><tr><td>Rat anti-mouse IL-10</td><td>Abcam</td><td>Cat# ab189392</td></tr><tr><td>Rat Anti-CD3 antibody</td><td>Abcam</td><td>Cat# ab11089</td></tr><tr><td>Rabbit anti-mouse CD19</td><td>GeneTex</td><td>Cat# GTX101512</td></tr><tr><td>Mouse anti-human C3/C3b</td><td>Abcam</td><td>Cat# ab11871</td></tr><tr><td>Cleaved PARP (Asp214) (D64E10) XP® Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 5625S</td></tr><tr><td>Cleaved Caspase-3 (Asp175) (5A1E) Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 9664S</td></tr><tr><td>PARP (46D11) Rabbit mAb</td><td>Cell Signaling Technology</td><td>Cat# 9532S</td></tr><tr><td>Caspase-3 Antibody</td><td>Cell Signaling Technology</td><td>Cat# 9662S</td></tr><tr><td>Rabbit anti–human CD55/DAF</td><td>Novus Biologicals</td><td>Cat# NBP1-85466</td></tr><tr><td>Rabbit anti-mouse CD55</td><td>Abcam</td><td>Cat# ab231061</td></tr><tr><td>Rat anti-mouse CD8</td><td>ThermoFisher Scientific</td><td>Cat# MA1-70041</td></tr><tr><td>Rabbit anti-mouse Granzyme B</td><td>Abcam</td><td>Cat# ab4059</td></tr><tr><td>Rat anti-mouse CD4</td><td>ThermoFisher Scientific</td><td>Cat# MA1-146</td></tr><tr><td>Mouse anti-mouse T-bet</td><td>Abcam</td><td>Cat# ab91109</td></tr><tr><td>Rabbit anti-mouse Foxp3</td><td>Abcam</td><td>Cat# ab215206</td></tr><tr><td>Rat anti-mouse C3b/iC3b/C3c</td><td>Hycult Biotech</td><td>Cat# HM1065</td></tr><tr><td>Rabbit anti-mouse CD31</td><td>Abcam</td><td>Cat# ab28364</td></tr><tr><td><i>InVivo</i>mAb anti-mouse ICOSL</td><td>BioXCell</td><td>Cat# BE0028; RRID: <a id="intref0185" href="https://antibodyregistry.org/AB_1107566" target="_blank">AB_1107566</a></td></tr><tr><td><i>InVivo</i>mAb rat IgG2a isotype control</td><td>BioXCell</td><td>Cat# BE0089; RRID: <a id="intref0190" href="https://antibodyregistry.org/AB_1107769" target="_blank">AB_1107769</a></td></tr><tr><td><i>InVivo</i>mAb anti-mouse CD19</td><td>BioXCell</td><td>Cat# BE0150; RRID: <a id="intref0195" href="https://antibodyregistry.org/AB_10949187" target="_blank">AB_10949187</a></td></tr><tr><td><i>InVivo</i>mAb anti-mouse B220</td><td>BioXCell</td><td>Cat# BE0067; RRID: <a id="intref0200" href="https://antibodyregistry.org/AB_1107651" target="_blank">AB_1107651</a></td></tr><tr><td><i>InVivoMAb polyclonal rat IgG</i></td><td>BioXCell</td><td>Cat# BE0094; RRID: <a id="intref0205" href="https://antibodyregistry.org/AB_1107795" target="_blank">AB_1107795</a></td></tr><tr><td><i>InVivo</i>mAb anti-mouse CD22</td><td>BioXCell</td><td>Cat# BE0011; RRID: <a id="intref0210" href="https://antibodyregistry.org/AB_1107613" target="_blank">AB_1107613</a></td></tr><tr><td><i>InVivo</i>mAb mouse IgG1 isotype control</td><td>BioXCell</td><td>Cat# BE0083; RRID: <a id="intref0215" href="https://antibodyregistry.org/AB_1107784" target="_blank">AB_1107784</a></td></tr><tr><td><i>InVivo</i>mAb anti-mouse CD20</td><td>BioXCell</td><td>Cat# BE0302; RRID: <a id="intref0220" href="https://antibodyregistry.org/AB_2715460" target="_blank">AB_2715460</a></td></tr><tr><td><i>InVivo</i>mAb anti-rat Kappa Immunoglobulin Light Chain</td><td>BioXCell</td><td>Cat# BE0122; RRID: <a id="intref0225" href="https://antibodyregistry.org/AB_10951292" target="_blank">AB_10951292</a></td></tr><tr><td>Alexa Fluor 488-conjugated donkey anti–mouse IgG</td><td>ThermoFisher Scientific</td><td>Cat# A21202; RRID: <a id="intref0230" href="https://antibodyregistry.org/AB_141607" target="_blank">AB_141607</a></td></tr><tr><td>Alexa Fluor 555-conjugated donkey anti-mouse IgG</td><td>ThermoFisher Scientific</td><td>Cat# A31570; RRID: <a id="intref0235" href="https://antibodyregistry.org/AB_2536180" target="_blank">AB_2536180</a></td></tr><tr><td>Alexa Fluor 488-conjugated donkey anti–rabbit IgG</td><td>ThermoFisher Scientific</td><td>Cat# A21206; RRID: <a id="intref0240" href="https://antibodyregistry.org/AB_2535792" target="_blank">AB_2535792</a></td></tr><tr><td>Alexa Fluor Plus 555-conjugated donkey anti-rabbit IgG</td><td>ThermoFisher Scientific</td><td>Cat# A32794</td></tr><tr><td>Alexa Fluor 647-conjugated donkey anti-rabbit IgG</td><td>ThermoFisher Scientific</td><td>Cat# A31573; RRID: <a id="intref0245" href="https://antibodyregistry.org/AB_2536183" target="_blank">AB_2536183</a></td></tr><tr><td>Alexa Fluor 488-conjugated goat anti–rat IgG</td><td>ThermoFisher Scientific</td><td>Cat# A11006; RRID: <a id="intref0250" href="https://antibodyregistry.org/AB_2534074" target="_blank">AB_2534074</a></td></tr><tr><td>Alexa Fluor 555-conjugated goat anti–rat IgG</td><td>ThermoFisher Scientific</td><td>Cat# A21434; RRID: <a id="intref0255" href="https://antibodyregistry.org/AB_2535855" target="_blank">AB_2535855</a></td></tr><tr><td>Alexa Fluor 488-conjugated donkey anti–goat IgG</td><td>ThermoFisher Scientific</td><td>Cat# A11055; RRID: <a id="intref0260" href="https://antibodyregistry.org/AB_2534102" target="_blank">AB_2534102</a></td></tr><tr><td>Alexa Fluor 647-conjugated donkey anti-goat IgG</td><td>ThermoFisher Scientific</td><td>Cat# A21447; RRID: <a id="intref0265" href="https://antibodyregistry.org/AB_2535864" target="_blank">AB_2535864</a></td></tr><tr><td>Sheep anti-human CD21(CR2)</td><td>R&amp;D Systems</td><td>Cat# AF4909</td></tr><tr><td>Normal Sheep IgG control</td><td>R&amp;D Systems</td><td>Cat# 5-001-A</td></tr><tr><td>Mouse IgG2a isotype control</td><td>eBioscience</td><td>Cat# 16-4724-81: RRID: <a id="intref0270" href="https://antibodyregistry.org/AB_470163" target="_blank">AB_470163</a></td></tr><tr><td>Mouse anti-human ICOSL (CD275)</td><td>eBioscience</td><td>Cat# 16-5889-82; RRID: <a id="intref0275" href="https://antibodyregistry.org/AB_469129" target="_blank">AB_469129</a></td></tr><tr><td>Mouse IgG1 isotype control</td><td>eBioscience</td><td>Cat# 16-4714-82; RRID: <a id="intref0280" href="https://antibodyregistry.org/AB_470161" target="_blank">AB_470161</a></td></tr><tr><td>β-tubulin antibody</td><td>Proteintech</td><td>Cat# 10068-1-AP</td></tr><tr><td>HRP-Conjugated GAPDH Antibody</td><td>Proteintech</td><td>Cat# HRP-60004</td></tr><tr><td>HRP-linked anti-rabbit antibody</td><td>Cell Signaling Technology</td><td>Cat# 7074</td></tr><tr><td>HRP-linked anti-mouse antibody</td><td>Cell Signaling Technology</td><td>Cat# 7076</td></tr><tr><td>HRP-linked Anti-rat antibody</td><td>Cell Signaling Technology</td><td>Cat# 7077</td></tr><tr class="rowsep"><td>Recombinant anti-CR2 (CD21) antibody</td><td>Abcam</td><td>Cat# ab75985</td></tr><tr class="rowsep"><td colspan="3"><b>Bacterial and Virus Strains</b></td></tr><tr><td>LV5 lentiviral vetor</td><td>Genepharma,Shanghai</td><td>N/A</td></tr><tr class="rowsep"><td>LV3 lentiviral vetor</td><td>Genepharma,Shanghai</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Biological Samples</b></td></tr><tr><td>Paraffin breast cancer sections</td><td>Sun Yat-sen Memorial Hospital, Sun Yat-sen University</td><td>N/A</td></tr><tr><td>Fresh breast cancer samples (used for isolation of B cells or flow cytometry analysis)</td><td>Sun Yat-sen Memorial Hospital, Sun Yat-sen University</td><td>N/A</td></tr><tr><td>Peripheral blood samples of patients (used for flow cytometry analysis)</td><td>Sun Yat-sen Memorial Hospital, Sun Yat-sen University</td><td>N/A</td></tr><tr class="rowsep"><td>Peripheral blood samples of healthy donors (used for isolation of immune cells)</td><td>Guangzhou Blood Center</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Chemicals, Peptides, and Recombinant Proteins</b></td></tr><tr><td>LPS</td><td>Sigma-Aldrich</td><td>Cat# L2880</td></tr><tr><td>Recombinant Human IFN-γ</td><td>PeproTech</td><td>Cat# 300-02</td></tr><tr><td>CMFDA Cell Tracker</td><td>ThermoFisher Scientific</td><td>Cat# C7025</td></tr><tr><td>Trypsin-EDTA (0.25%), phenol red</td><td>GIBCO</td><td>Cat# 25200056</td></tr><tr><td>10&nbsp;× TrypLE Select Enzyme</td><td>GIBCO</td><td>Cat# A1217701</td></tr><tr><td>Annexin V</td><td>Sigma-Aldrich</td><td>Cat# A9460</td></tr><tr><td>Propidium Iodide</td><td>eBioscience</td><td>Cat# 00-6990-50</td></tr><tr><td>Ripa Lysis Buffer,10&nbsp;×</td><td>Millipore</td><td>Cat# 20-188</td></tr><tr><td>Protease and Phosphatase Inhibitor Cocktail</td><td>ThermoFisher Scientific</td><td>Cat# 78446</td></tr><tr><td>Polybrene</td><td>Sigma</td><td>Cat# TR-1003</td></tr><tr><td>Recombinant Human GM-CSF</td><td>PeperoTech</td><td>Cat# 300-03</td></tr><tr><td>Recombinant Human IL-4</td><td>PeperoTech</td><td>Cat# 200-04</td></tr><tr><td>FVD-eF780</td><td>eBioscience</td><td>Cat# 65-0865-18</td></tr><tr><td>Calcein AM</td><td>ThermoFisher Scientific</td><td>Cat# C3100MP</td></tr><tr><td>TO-PRO-3 iodide</td><td>ThermoFisher Scientific</td><td>Cat# T3605</td></tr><tr><td>DAPI</td><td>ThermoFisher Scientific</td><td>Ca# D3571</td></tr><tr><td>Dimethyl sulfoxide</td><td>Sigma-Aldrich</td><td>Cat# D2650</td></tr><tr><td>Z-DEVD-FMK</td><td>Selleck</td><td>Cat# S7312</td></tr><tr><td>Z-VAD-FMK</td><td>Selleck</td><td>Cat# S7023</td></tr><tr><td>Collagenase, typeI</td><td>Worthington Biochemical</td><td>Cat# LS004196</td></tr><tr><td>Collagenase, typeIII</td><td>Worthington Biochemical</td><td>Cat# LS004182</td></tr><tr><td>Collagenase, type IV</td><td>Worthington Biochemical</td><td>Cat# LS004188</td></tr><tr><td>hyaluronidase</td><td>Sigma-Aldrich</td><td>H3506</td></tr><tr><td>DNaseI</td><td>Sigma-Aldrich</td><td>DN25</td></tr><tr><td>Cell Stimulation Cocktail (500X)</td><td>eBioscience</td><td>Cat# 00-4970-03</td></tr><tr class="rowsep"><td>Protein Transport Inhibitor Cocktail (500X)</td><td>eBioscience</td><td>Cat# 00-4980-03</td></tr><tr class="rowsep"><td colspan="3"><b>Critical Commercial Assays</b></td></tr><tr><td>B cell Isolation Kit II, human</td><td>Miltenyi Biotec</td><td>Cat# 130-091-151</td></tr><tr><td>CD19 MicroBeads, human</td><td>Miltenyi Biotec</td><td>Cat# 130-050-301</td></tr><tr><td>CD8<sup>+</sup> T&nbsp;cell Isolation Kit, human</td><td>Miltenyi Biotec</td><td>Cat# 130-096-495</td></tr><tr><td>Naive CD4<sup>+</sup> T Cells Isolation Kit II, human</td><td>Miltenyi Biotec</td><td>Cat# 130-094-131</td></tr><tr><td>CD8 Microbeads, human</td><td>Miltenyi Biotec</td><td>Cat# 130-045-201</td></tr><tr><td>CD19 MicroBeads, mouse</td><td>Miltenyi Biotec</td><td>Cat# 130-052-201</td></tr><tr><td>Pan Monocyte Isolation Kit, human</td><td>Miltenyi Biotec</td><td>Cat# 130-096-537</td></tr><tr><td>Ficoll-Paque PLUS, human</td><td>TBDscience(Tianjin,China)</td><td>Cat# LTS1077-1</td></tr><tr><td>Mouse Lymphocyte Separation Medium</td><td>DAKEWE</td><td>Cat# DKW33-R0100</td></tr><tr><td><i>In Situ</i> Cell Death Detection Kit, POD</td><td>Roche</td><td>Cat# 11684817910</td></tr><tr><td>Intracellular Fixation and Permeabilization kit</td><td>eBioscience</td><td>Cat# 88-8824</td></tr><tr><td>True-Nuclear™ Transcription Factor Buffer Set</td><td>Biolegend</td><td>Cat# 424401</td></tr><tr><td>Flow Cytometry Staining Buffer</td><td>eBioscience</td><td>Cat# 00-4222-57</td></tr><tr><td>Cell staining buffer</td><td>Biolegend</td><td>Cat# 420201</td></tr><tr><td>Annexin-V binding buffer</td><td>Biolegend</td><td>Cat# 422201</td></tr><tr><td>Anti-mouse/rabbit IHC Secondary Antibody Kit</td><td>GTVision</td><td>Cat# GK500705</td></tr><tr><td>Pierce BCA Protein Assay Kit</td><td>ThermoFisher Scientific</td><td>Cat# 23225</td></tr><tr><td>FcR Blocking Reagent, mouse</td><td>Miltenyi Biotec</td><td>Cat# 130-092-575</td></tr><tr class="rowsep"><td>FcR Blocking Reagent, human</td><td>Miltenyi Biotec</td><td>Cat# 130-059-901</td></tr><tr class="rowsep"><td colspan="3"><b>Deposited Data</b></td></tr><tr><td>ScRNA sequencing data (Raw and analyzed data)</td><td>This paper</td><td>GEO: <a id="intref0285" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135710" target="_blank">GSE135710</a></td></tr><tr class="rowsep"><td>Mendeley Data</td><td>This paper</td><td><a id="intref0290" href="https://data.mendeley.com/datasets/gkxd6x6yj7/draft?a=4a0fa45d-064e-4e25-8881-1942cea27688" target="_blank">https://data.mendeley.com/datasets/gkxd6x6yj7/draft?a=4a0fa45d-064e-4e25-8881-1942cea27688</a></td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Cell Lines</b></td></tr><tr><td>MDA-MB-231</td><td>ATCC</td><td>HTB-26; RRID:CVCL_0062</td></tr><tr><td>BT474</td><td>ATCC</td><td>HTB-20; RRID:CVCL_0179</td></tr><tr><td>BT549</td><td>ATCC</td><td>HTB-122; RRID: CVCL_1092</td></tr><tr><td>HCC1937</td><td>ATCC</td><td>CRL-2336; RRID: CVCL_0290</td></tr><tr><td>MDA-MB-361</td><td>ATCC</td><td>HTB-27; RRID: CVCL_0620</td></tr><tr><td>MDA-MB-436</td><td>ATCC</td><td>HTB-130; RRID: CVCL_0623</td></tr><tr><td>MDA-MB-468</td><td>ATCC</td><td>HTB-132; RRID: CVCL_0419</td></tr><tr><td>AU565</td><td>ATCC</td><td>CRL-2351; RRID: CVCL_1074</td></tr><tr><td>SK-BR-3</td><td>ATCC</td><td>HTB-30; RRID:CVCL_0033</td></tr><tr><td>MCF-7</td><td>ATCC</td><td>HTB-22; RRID: CVCL_0031</td></tr><tr><td>MDA-MB-453</td><td>ATCC</td><td>HTB-131; RRID: CVCL_0418</td></tr><tr><td>4T1</td><td>ATCC</td><td>CRL-2539; RRID: CVCL_0125</td></tr><tr><td>E0771</td><td>CH3 Biosystems</td><td>Cat# 940001; RRID:CVCL_GR23</td></tr><tr class="rowsep"><td>TRAMP-C2</td><td>ATCC</td><td>CRL-2731; RRID: CVCL_3615</td></tr><tr class="rowsep"><td colspan="3"><b>Experimental Models: Organisms/Strains</b></td></tr><tr><td>B6.129P2-<i>Igh-J</i><sup><i>tm1Cgn</i></sup>/J</td><td>The Jackson Laboratory</td><td>Cat# 002438; RRID: IMSR_JAX:002438</td></tr><tr><td>B6.129S4-<i>C3</i><sup><i>tm1Crr</i></sup>/J</td><td>The Jackson Laboratory</td><td>Cat# JAX:003641; RRID:IMSR_JAX:003641</td></tr><tr><td>B6.129P2-<i>Icosl</i><sup><i>tm1Mak</i></sup>/J</td><td>The Jackson Laboratory</td><td>Cat# JAX:004657, RRID:IMSR_JAX:004657</td></tr><tr><td>B6.129P2(C)-<i>Cd19</i><sup><i>tm1(cre)Cgn</i></sup>/J</td><td>The Jackson Laboratory</td><td>Cat# JAX:006785, RRID:IMSR_JAX:006785</td></tr><tr><td>B6.FVB-Tg(MMTV-PyVT)634Mul/LellJ</td><td>The Jackson Laboratory</td><td>Cat# JAX:022974, RRID:IMSR_JAX:022974</td></tr><tr><td>Cr2<sup>flox/flox</sup> mice</td><td>Shanghai Model Organisms Center</td><td>N/A</td></tr><tr class="rowsep"><td>Icosl<sup>flox/flox</sup> mice</td><td>Shanghai Model Organisms Center, Inc</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Oligonucleotides</b></td></tr><tr><td>Cr2 Loxp Sequence 3′ Primers:<br>F… 5′-CACCTTTCTTTTGTCACCTC-3′<br>R… 5′-CTAAACTACCAACCAAAGCATACA-3′</td><td>This paper</td><td>N/A</td></tr><tr><td>Cre-Cd19 Mutant Sequence Primers:<br>F… 5′-AGCGATGGATTTCCGTCTCTGG-3′<br>R… 5′-AGCTTGCATGATCTCCGGTATTGAA-3′</td><td>This paper</td><td>N/A</td></tr><tr><td>Cre-Cd19 Wild Type Sequence Primers:<br>F… 5′- CCTCTCCCTGTCTCCTTCCT −3′<br>R… 5′- TGGTCTGAGACATTGACAATCA −3′</td><td>This paper</td><td>N/A</td></tr><tr><td>CD55 shRNA1<br>5′-GGUGCAUAGAGAAAUCCAATT-3′</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td>CD55 shRNA2<br>5′-GGCAUUUGUGAUGCAUAUATT-3′</td><td>This paper</td><td>N/A</td></tr><tr class="rowsep"><td colspan="3"><b>Software and Algorithms</b></td></tr><tr><td>FlowJo 10.0</td><td>Treestar</td><td><a id="intref0295" href="https://www.flowjo.com/solutions/flowjo" target="_blank">https://www.flowjo.com/solutions/flowjo</a></td></tr><tr><td>ZEN 2012 light Edition</td><td>Zeiss</td><td>N/A</td></tr><tr><td>Imaris 9.0 Microscopy Image Analysis Software</td><td>N/A</td><td>N/A</td></tr><tr><td>X-tile</td><td>N/A</td><td>N/A</td></tr><tr><td>Prism 7.0</td><td>GraphPad Software</td><td><a id="intref0300" href="https://www.graphpad.com/" target="_blank">https://www.graphpad.com/</a></td></tr><tr><td>R</td><td>N/A</td><td><a id="intref0305" href="https://www.r-project.org/" target="_blank">https://www.r-project.org/</a></td></tr><tr><td>SPSS 23.0</td><td>International Business Machines Corporation</td><td><a id="intref0310" href="https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-23" target="_blank">https://www.ibm.com/support/pages/downloading-ibm-spss-statistics-23</a></td></tr><tr><td>ImageJ</td><td>NIH</td><td><a id="intref0315" href="https://imagej.nih.gov/ij/" target="_blank">https://imagej.nih.gov/ij/</a></td></tr></tbody></table></div><figcaption><div class="core-table-tools"><ul><li><a class="core-table-show-action" href="/action/showFullTableHTML?isHtml=true&amp;tableId=undtbl1&amp;pii=S0092-8674%2820%2930159-8" target="_blank">Open table in a new tab</a></li></ul></div></figcaption></figure></div></div></section><section id="sec-4-2"><h3>Lead Contact and Materials Availability</h3><div id="p0205" role="paragraph">Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Shicheng Su (<a id="intref0320" href="mailto:sushch@mail.sysu.edu.cn">sushch@mail.sysu.edu.cn</a>). All unique/stable reagents generated in this study will be made available on request but we may require a payment and/or a completed Materials Transfer Agreement if there is potential for commercial application.</div></section><section id="sec-4-3"><h3>Experimental Model and Subject Details</h3><section id="sec-4-3-1"><h4>Patients and Human Tumor Samples</h4><div id="p0210" role="paragraph">Paraffin-embedded tumor samples were obtained from 368 female patients with invasive breast carcinoma (stage I-III) who received neoadjuvant chemotherapy at the Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University (Guangzhou, China) from 2010 to 2015. Among them, biopsy samples before neo-adjuvant chemotherapy were available for 224 patients. Fresh tumor samples were obtained from 79 female patients with invasive breast carcinoma (stage I-III) who received neoadjuvant chemotherapy at the Sun Yat-Sen Memorial Hospital from 2017 to 2019. Paired biopsy samples and surgically resected samples were collected from the same patients before and after neoadjuvant chemotherapy. Blood samples were obtained from 86 female patients before neoadjuvant chemotherapy and one month after the last dose of neoadjuvant chemotherapy.</div><div id="p0215" role="paragraph">The neoadjuvant chemotherapy regimens were as follows: doxorubicin 60&nbsp;mg/m<sup>2</sup> plus cyclophosphamide 600&nbsp;mg/m<sup>2</sup> every three weeks for four cycles, followed by paclitaxel (80&nbsp;mg/m<sup>2</sup>) for 12&nbsp;weeks; or docetaxel 75&nbsp;mg/m<sup>2</sup> and cyclophosphamide 600&nbsp;mg/m<sup>2</sup> every three weeks for four to six cycles. Her2-positive patients were treated with concomitant Trastuzumab (initial loading dose of 4&nbsp;mg/kg and subsequent doses of 2&nbsp;mg/kg/wk weekly).</div><div id="p0220" role="paragraph">Therapeutic effects were evaluated according to the standard of Response Evaluation Criteria in Solid Tumors (RECIST). Pathological complete response (pCR) was defined as no any residual invasive carcinoma or ductal carcinoma <i>in situ</i> (DCIS) in any excised breast or lymph node tissue after neoadjuvant chemotherapy detected by microscopy (<span class="dropBlock reference-citations"><a id="body-ref-sref59-2" href="#" role="doc-biblioref" data-xml-rid="bib16 bib59" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref59-2" aria-controls="sref59-2">Fayanju et&nbsp;al., 2018; von Minckwitz et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref59-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">16.</div><div>Fayanju, O.M. ∙ Ren, Y. ∙ Thomas, S.M. ...</div><div><strong>The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)</strong></div><div><em>Ann. Surg.</em> 2018; <strong>268</strong>:591-601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/SLA.0000000000002953" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85059654798" target="_blank" aria-label="Open Scopus in new tab">Scopus (136)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30048319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FSLA.0000000000002953&amp;pmid=30048319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">60.</div><div>von Minckwitz, G. ∙ Blohmer, J.U. ∙ Costa, S.D. ...</div><div><strong>Response-guided neoadjuvant chemotherapy for breast cancer</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2013; <strong>31</strong>:3623-3630</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2012.45.0940" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84882977388" target="_blank" aria-label="Open Scopus in new tab">Scopus (295)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24002511/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2012.45.0940&amp;pmid=24002511" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>); breast-only or node-only pCR was defined as the absence of any residual invasive carcinoma or DCIS limited to the breast or axilla detected by microscopy; partial response (PR) was defined as at least a 30% reduction in the sum of the longest diameter of target lesions detected by clinical examination and imaging studies; progressive disease (PD) was defined as at least a 20% increase in the sum of the longest diameter of target lesions detected by clinical examination and imaging studies; and stable disease (SD) was defined as neither sufficient shrinkage to qualify as PR nor sufficient increase to qualify as PD. Breast- and node-only pCR were only determined for patients who were clinically node-positive at diagnosis. Clinical node stage was defined according to imaging studies, clinical examination demonstrating characteristics highly suspicious for malignancy, and/or pathologic diagnosis obtained via needle biopsy. pCR, breast/node-only pCR and PR were classified as treatment sensitive, while SD and PD were classified as treatment resistant.</div><div id="p0225" role="paragraph">The criteria to determine menopause include any of the following: 1) Prior bilateral oophorectomy; 2) Age ≥ 60 y; 3) Age&nbsp;&lt; 60&nbsp;y and amenorrheic for 12 or more months in the absence of chemotherapy, tamoxifen, toremifene, or ovarian suppression and follicle-stimulating hormone (FSH) and estradiol in the postmenopausal range; 4) If taking tamoxifen or toremifene, and age&nbsp;&lt; 60 y, then FSH and plasma estradiol level in postmenopausal ranges.</div><div id="p0230" role="paragraph">Additionally, another cohort consisting of paraffin-embedded samples from 683 female patients with chemotherapy-naive invasive breast carcinoma from Sun Yat-Sen Memorial Hospital from 2010 to 2015 was obtained for Kaplan-Meier survival analysis. To experimentally excluded the potential spatial sampling biases, a group of paired biopsy samples and surgically resected samples from 53 female patients who received needle core biopsy followed by surgery (without neoadjuvant chemotherapy) from Sun Yat-Sen Memorial Hospital from 2015 to 2019 were selected. The tissue blocks with only or predominantly non-tumor tissues or <i>in situ</i> carcinoma tissues were excluded. To investigate whether the prognostic value of ICOSL<sup>+</sup> B cells in Her2<sup>+</sup> patients is restricted to those receiving Trastuzumab, we used another cohort of Her2<sup>+</sup> female patients (n&nbsp;= 103) who received neoadjuvant chemotherapy without Trastuzumab from Sun Yat-Sen Memorial Hospital from 2006 to 2017. All samples were collected from patients who gave informed consent, and all related procedures were performed with the approval of the internal review and ethics boards of the Sun Yat-Sen Memorial Hospital.</div></section><section id="sec-4-3-2"><h4>Experimental Animals</h4><div id="p0235" role="paragraph">B6.129P2-<i>Igh-J</i><sup><i>tm1Cgn</i></sup>/J, B6.129S4-<i>C3</i><sup><i>tm1Crr</i></sup>/J, B6.129P2-<i>Icosl</i><sup><i>tm1Mak</i></sup>/J, B6.129P2(C)-<i>Cd19</i><sup><i>tm1(cre)Cgn</i></sup>/J and B6.FVB-Tg(MMTV-PyVT)634Mul/LellJ mice were purchased from the Jackson Laboratory. C57/BL6 and BALB/C mice were purchased from Weitonglihua Experimental Animal Technical Company (Beijing, China). All mice were bred in the SPF animal facility of the Laboratory Animal Resource Center of Sun Yat-sen University in individually ventilated cages.</div><div id="p0240" role="paragraph"><i>Cr2</i><sup>flox/flox</sup> and <i>Icosl</i><sup>flox/flox</sup> mice were constructed in Shanghai Model Organisms Center, Inc (Shanghai, China) using CRISPR/Cas9 technology. Progeny were screened by PCR for germline transmission of the targeted alleles. <i>Cr2</i><sup>flox/flox</sup> and <i>Icosl</i><sup>flox/flox</sup> mice were crossed with <i>Cd19</i>-Cre mice respectively to generate mice with <i>Cr2</i> or <i>Icosl</i> conditional knock out in B cells (<i>Cd19-Cr2</i><sup><i>Δ</i></sup> and <i>Cd19-Icosl</i><sup><i>Δ</i></sup>). Genotyping was performed by PCR on tail DNA with specific primers (sequences listed in KEY RESOURCES TABLE). The PCR products were further confirmed by sequencing. Conditional deletion of <i>Cr2</i> and <i>Icosl</i> in <i>Cd19-Cr2</i><sup><i>Δ</i></sup> and <i>Cd19-Icosl</i><sup><i>Δ</i></sup> mice was examined by immunoblotting and immunofluorescence using B cells isolated from the spleens and tumors. Wild-type C57/BL6 and BALB/C mice as well as genetic modified mice with the C57/BL6 background at the age of six weeks, and female MMTV-PyMT mice at the age of 12-14&nbsp;weeks were used. Female mice were used in the experiments using E0771 and 4T1 cells, whereas male mice were used in the experiments using TRAMP-C2 cells. Animal experiments were approved by the Institutional Review Boards and Animal Care and Use Committees of Sun Yat-Sen University.</div></section><section id="sec-4-3-3"><h4>Primary Tumor-Infiltrating Immune Cell Isolation</h4><div id="p0245" role="paragraph">Primary tumor-infiltrating immune cells were isolated from human or mouse tumor samples using flow cytometric cell sorting as we previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref54-2" href="#" role="doc-biblioref" data-xml-rid="bib26 bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-2" aria-controls="sref54-2">Huang et&nbsp;al., 2018; Su et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref54-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Huang, D. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>NKILA lncRNA promotes tumor immune evasion by sensitizing T&nbsp;cells to activation-induced cell death</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1112-1125</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41590-018-0207-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85053483374" target="_blank" aria-label="Open Scopus in new tab">Scopus (317)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30224822/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41590-018-0207-y&amp;pmid=30224822" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, to isolate B cells from human tumors, tissues were exhaustively perfused with PBS to prevent the contamination of peripheral blood cells, minced into small (1-2&nbsp;mm diameter) pieces, and digested with 5% FBS DMEM containing 2&nbsp;mg/mL collagenase I (Worthington Biochemical), 2&nbsp;mg/mL collagenase III (Worthington Biochemical) and 2&nbsp;mg/mL hyaluronidase (Sigma) at 37°C for 2 h. The cells were sequentially filtered through 100 and 70&nbsp;μm cell strainers. Pacific Blue anti-human CD45 (Cat# 304022, Biolegend) and PE anti-human CD19 (Cat# 392506, Biolegend) were used to identify B&nbsp;cells. To exclude dead cells, the cells were stained with 1&nbsp;mM calcein AM (ThermoFisher Scientific) and 0.33&nbsp;mM TO-PRO-3 iodide (ThermoFisher Scientific) immediately prior to sorting. Fluorescence-activated cell sorting (FACS) was performed on a flow cytometer (BD Biosciences) using 488&nbsp;nm (calcein AM, 530/30 filter), 640&nbsp;nm (TO-PRO-3, 670/14 filter), 405&nbsp;nm (Pacific blue, 450/50 filter) and 561&nbsp;nm (PE, 586/15 filter) lasers. Standard forward scatter height versus area criteria were used to discard doublets and capture singlets. Viable cells were identified as calcein<sup>high</sup> and TO-PRO<sup>low</sup>, and CD45<sup>+</sup>CD19<sup>+</sup> gates were used to specifically sort B cells. To isolate tumor-infiltrating B cells from mice, tumor tissues were cut into small (1-2&nbsp;mm) pieces and incubated in DMEM medium supplemented with 5% FBS, 2&nbsp;mg/mL collagenase I (Worthington Biochemical), 2&nbsp;mg/mL collagenase IV (Worthington Biochemical) and 100&nbsp;μg/mL DNase I (Sigma) for 30&nbsp;min at 37°C under constant shaking. During digestion, the tissue pieces in solution was vortexed every 15&nbsp;min. The cell suspensions were filtered through a 40&nbsp;μm cell strainer, washed twice by PBS and were sorted by FACS using a flow cytometer (BD Biosciences). Before cell sorting, isolated cells were resuspended in PBS containing 1% FBS and incubated with antibody against FITC-CD45 (Cat# 103108, Biolegend) and APC-CD19 (Cat# 115512, Biolegend) for 30&nbsp;min at 4°C. To exclude dead cells, the cells were stained for Live/Dead Fixable Viability Dye (FVD-eFluor780, Cat# 65-0865-18, eBioscience) in PBS for 30&nbsp;min at 4°C. The purity of the sorted populations was verified by flow cytometry on a Beckman CytoFLEX flow cytometer (98% pure). The viability and number of purified B cells were assessed using trypan blue (ThermoFisher Scientific) (at least 90% live cells). The harvested cells were either immediately used for further experiments or cryopreserved in the presence of DMSO at –80°C or in liquid nitrogen prior to library preparation.</div></section><section id="sec-4-3-4"><h4>Primary Human Peripheral Blood Immune Cell and Serum Isolation</h4><div id="p0250" role="paragraph">Primary peripheral blood mononuclear cells and human serum were isolated from the peripheral blood or buffy coat of patients and healthy donors from the Guangzhou Blood Center as we previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref55-3" href="#" role="doc-biblioref" data-xml-rid="bib12 bib52 bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-3" aria-controls="sref55-3">Chen et&nbsp;al., 2019; Su et&nbsp;al., 2014; Su et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref55-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chen, F. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:498-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-019-0299-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85064202781" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-019-0299-0&amp;pmid=30936474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Su, S. ∙ Liu, Q. ∙ Chen, J. ...</div><div><strong>A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:605-620</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84900335537" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24823638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.03.021&amp;pmid=24823638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Su, S. ∙ Zhao, J. ∙ Xing, Y. ...</div><div><strong>Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:442-457.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054030012" target="_blank" aria-label="Open Scopus in new tab">Scopus (205)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30290143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.007&amp;pmid=30290143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, primary peripheral blood mononuclear cells were isolated by Ficoll-Paque PLUS (Cat# LTS1077, TBDscience) by density gradient centrifugation (37°C, 450&nbsp;× g, 20&nbsp;min, Beckman). Primary human B cells were purified by a B Cell Isolation Kit II (Cat# 130-091-151, Miltenyi Biotec). In some experiments, B cells were incubated with APC anti-human CD19 (Cat# 392504, Biolegend), Alexa Fluor® 700 anti-human IgD (Cat# 348229, Biolegend), FITC anti-human CD27 (Cat#356404, Biolegend), PE/Cy7 anti-human CD38 (Cat# 303516, Biolegend) and PerCP anti-human CD24 (Cat#311114, Biolegend) for 30&nbsp;min at 4°C and sorted by a flow cytometer (BD Biosciences). CD8<sup>+</sup> T&nbsp;cells and naive CD4<sup>+</sup> T&nbsp;cells were isolated by magnetic-activated cell sorting using direct CD8<sup>+</sup> T Cell Isolation Kit (Cat# 130-096-495, Miltenyi Biotec) and naive CD4<sup>+</sup> T Cells Isolation Kit II (Cat# 130-094-131, Miltenyi Biotec) according to the manufacturer’s instructions respectively. To obtain human serum, the coagulated peripheral blood from healthy donors was centrifuged at 2000&nbsp;× g for 10&nbsp;min at 4°C. Then the serum which located on top of the specimen was carefully transferred into a clean tube and stored at −80°C. The blood samples were negative for antibodies against hepatitis B and C viruses, HIV and syphilis. All related procedures were performed with the approval of the Internal Review and Ethics Boards of the Sun Yat-Sen Memorial Hospital.</div></section><section id="sec-4-3-5"><h4>Tumor Cell Lines</h4><div id="p0255" role="paragraph">Human breast cancer cell lines MDA-MB-231, BT474, BT549, HCC1937, MDA-MB-361, MDA-MB-436, MDA-MB-468, AU565, SK-BR-3, MCF-7, MDA-MB-453, mouse breast cancer cell line 4T1 and mouse prostate cancer cell line TRAMP-C2 were obtained from American Type Culture Collection. Mouse breast cancer cell line E0771 was obtained from CH3 Biosystems. All the cells were grown according to standard protocols.</div></section></section><section id="sec-4-4"><h3>Method Details</h3><section id="sec-4-4-1"><h4>Primary Tumor-Infiltrating B Cells Isolated from Patient Samples</h4><div id="p0260" role="paragraph">Primary tumor-infiltrating B Cells were isolated from human breast cancer tissues as we previously described with slight modifications (<span class="dropBlock reference-citations"><a id="body-ref-sref61-1" href="#" role="doc-biblioref" data-xml-rid="bib54 bib53 bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-1" aria-controls="sref61-1">Su et&nbsp;al., 2018a; Su et&nbsp;al., 2017; Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref61-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Su, S. ∙ Liao, J. ∙ Liu, J. ...</div><div><strong>Blocking the recruitment of naive CD4<sup>+</sup> T&nbsp;cells reverses immunosuppression in breast cancer</strong></div><div><em>Cell Res.</em> 2017; <strong>27</strong>:461-482</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2017.34" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85015196232" target="_blank" aria-label="Open Scopus in new tab">Scopus (159)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28290464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2017.34&amp;pmid=28290464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Wang, Y. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:1957-1969</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-2544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85062945239" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30482778/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-2544&amp;pmid=30482778" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, human tumor tissues were exhaustively perfused with PBS to prevent the contamination of peripheral blood cells, minced into small (1-2&nbsp;mm diameter) pieces with autoclaved surgical instruments, and digested with 5% FBS DMEM containing 2&nbsp;mg/mL collagenase I (Worthington Biochemical), 2&nbsp;mg/mL collagenase III (Worthington Biochemical) and 2&nbsp;mg/mL hyaluronidase (Sigma) at 37°C for 2&nbsp;h under constant shaking. During digestion, the tissue pieces in solution were vortexed every 15&nbsp;min. The cell suspensions were sequentially filtered through 100 and 70&nbsp;μm cell strainers and washed twice with PBS. Pacific Blue anti-human CD45 (Cat# 304022, Biolegend) and PE anti-human CD19 (Cat# 392506, Biolegend) were used to identify B cells. To exclude dead cells, the cells were stained with 1&nbsp;mM calcein AM (ThermoFisher Scientific) and 0.33&nbsp;mM TO-PRO-3 iodide (ThermoFisher Scientific) immediately prior to sorting (<span class="dropBlock reference-citations"><a id="body-ref-sref42" href="#" role="doc-biblioref" data-xml-rid="bib42" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref42" aria-controls="sref42">Puram et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref42"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">42.</div><div>Puram, S.V. ∙ Tirosh, I. ∙ Parikh, A.S. ...</div><div><strong>Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1611-1624.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.10.044&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.10.044&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85035813065" target="_blank" aria-label="Open Scopus in new tab">Scopus (1478)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29198524/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.044&amp;pmid=29198524" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Fluorescence-activated cell sorting (FACS) was performed on a flow cytometer (BD Biosciences) using 488&nbsp;nm (calcein AM, 530/30 filter), 640&nbsp;nm (TO-PRO-3, 670/14 filter), 405&nbsp;nm (Pacific blue, 450/50 filter) and 561&nbsp;nm (PE, 586/15 filter) lasers. Standard forward scatter height versus area criteria were used to discard doublets and capture singlets. Viable cells were identified as calcein<sup>high</sup> and TO-PRO<sup>low</sup>, and CD45<sup>+</sup>CD19<sup>+</sup> gates were used to specifically sort B cells. Viability was confirmed to be &gt; 90% in all samples using trypan blue (ThermoFisher Scientific) exclusion.</div></section><section id="sec-4-4-2"><h4>Single-Cell RNA Sequencing</h4><div id="p0265" role="paragraph">CD45<sup>+</sup>CD19<sup>+</sup> cells from tumors were sorted into Dulbecco’s PBS&nbsp;+ 0.04% BSA as aforementioned and retained on ice. Sorted cells were then counted and assessed for viability with Trypan blue using a Countess II automated counter (ThermoFisher Scientific). The cells were then resuspended at 1&nbsp;× 10<sup>5</sup>–2&nbsp;× 10<sup>5</sup> cells/mL with a final viability of &gt; 90% as determined using the Countess. Single cells were encapsulated into emulsion droplets using Chromium Controller (10&nbsp;× GENOMICS). ScRNA-seq libraries were constructed using Chromium Single Cell 3′ Reagent Kits v3 (10&nbsp;× GENOMICS) according to the manufacturer’s protocol.</div><div id="p0270" role="paragraph">Reverse transcription and library preparation were performed on a Veriti Thermal Cycler with 96-Deep Well Reaction Module (Thermo Fisher Scientific). Amplified cDNA was purified using SPRIselect beads (Beckman Coulter) and sheared to 250-400&nbsp;bp. Qualification was performed using Qubit 3.0 Fluorometer. Libraries were sequenced on an Illumina NovaSeq 6000 system.</div></section><section id="sec-4-4-3"><h4>Single-Cell RNA-Seq Data Preprocessing</h4><div id="p0275" role="paragraph">ScRNA-Seq data was processed using 10&nbsp;× Genomics CellRanger (v3.0.2) pipeline. The resulting fastq files were passed to CellRanger’s count, which aligned all reads against GRCh38 genomes and mm10 genomes using the STAR aligner. The data from libraries were pooled by running through CellRanger aggr to obtain unique molecular identifiers (UMIs) matrices (<span class="dropBlock reference-citations"><a id="body-ref-sref35" href="#" role="doc-biblioref" data-xml-rid="bib35" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref35" aria-controls="sref35">Macosko et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref35"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">35.</div><div>Macosko, E.Z. ∙ Basu, A. ∙ Satija, R. ...</div><div><strong>Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets</strong></div><div><em>Cell.</em> 2015; <strong>161</strong>:1202-1214</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.05.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.05.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929684999" target="_blank" aria-label="Open Scopus in new tab">Scopus (4634)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26000488/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.05.002&amp;pmid=26000488" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Both mkfastq and count were run with default parameters.</div></section><section id="sec-4-4-4"><h4>Cellular Identification and Clustering</h4><div id="p0280" role="paragraph">For each sample, the gene - barcode matrix was passed through the R (v3.5.3) software package Seurat (v2.2.1) (<span class="dropBlock reference-citations"><a id="body-ref-sref45" href="#" role="doc-biblioref" data-xml-rid="bib45" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref45" aria-controls="sref45">Satija et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref45"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">45.</div><div>Satija, R. ∙ Farrell, J.A. ∙ Gennert, D. ...</div><div><strong>Spatial reconstruction of single-cell gene expression data</strong></div><div><em>Nat. Biotechnol.</em> 2015; <strong>33</strong>:495-502</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.3192" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929151009" target="_blank" aria-label="Open Scopus in new tab">Scopus (3233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25867923/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.3192&amp;pmid=25867923" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>) (<a id="intref0325" href="https://satijalab.org/seurat" target="_blank">https://satijalab.org/seurat</a>) for all downstream analyses. To remove doublets and poor-quality cells, cells were excluded from subsequent analysis if they were outliers in terms of number of the genes, UMIs, and the percentage of mitochondrial genes using Seurat. Consequently, 2,497 human single cells (998 from pre-treatment samples and 1,499 from post-treatment samples of four patients) and 7528 mouse single cells (2420 from two PBS-treated mice and 5108 from two doxorubicin-treated mice) were used for the following analysis. The cells were clustered using <i>FindClusters</i> in Seurat. T-distributed stochastic neighbor embedding (t-SNE) and modularity heatmap were created for graph-based cluster identification and subsequent dimensionality reduction. Marker genes for the individual clusters were identified using Seurat’s <i>FindAllMarkers</i> and only significantly upregulated markers (minimum log.FC ≥ 0 and FDR ≤ 1&nbsp;× 10<sup>−75</sup>) were represented.</div></section><section id="sec-4-4-5"><h4>Human B Cells Isolated from the Peripheral Blood</h4><div id="p0285" role="paragraph">Mononuclear cells from the peripheral blood (PBMCs) of patients or healthy donors were isolated as we previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref26-2" href="#" role="doc-biblioref" data-xml-rid="bib12 bib26" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref26-2" aria-controls="sref26-2">Chen et&nbsp;al., 2019; Huang et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref26-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">12.</div><div>Chen, F. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:498-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-019-0299-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85064202781" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-019-0299-0&amp;pmid=30936474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">26.</div><div>Huang, D. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>NKILA lncRNA promotes tumor immune evasion by sensitizing T&nbsp;cells to activation-induced cell death</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1112-1125</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41590-018-0207-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85053483374" target="_blank" aria-label="Open Scopus in new tab">Scopus (317)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30224822/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41590-018-0207-y&amp;pmid=30224822" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To isolate peripheral blood mononuclear cells, the buffy coat or peripheral blood sample was diluted with 2-4&nbsp;× the volume of PBS. Then, 35&nbsp;mL of diluted sample was gently layered over 15&nbsp;mL of Ficoll-Paque PLUS (Cat# LTS1077, TBDscience) and centrifuged with the brake off (37°C, 450&nbsp;× g, 20&nbsp;min, Beckman). The mononuclear cell layer was carefully transferred to a clean 50&nbsp;mL conical tube and washed thoroughly for four times with PBS to reduce platelet contamination. Primary human B cells were purified by a B Cell Isolation Kit II (Cat# 130-091-151, Miltenyi Biotec). In some experiments, B cells were incubated with APC anti-human CD19 (Cat# 392504, Biolegend), Alexa Fluor® 700 anti-human IgD (Cat# 348229, Biolegend), FITC anti-human CD27 (Cat#356404, Biolegend), PE/Cy7 anti-human CD38 (Cat# 303516, Biolegend) and PerCP anti-human CD24 (Cat#311114, Biolegend) for 30&nbsp;min at 4°C and sorted by a flow cytometer (BD Biosciences).</div></section><section id="sec-4-4-6"><h4>Flow Cytometry</h4><div id="p0290" role="paragraph">Suspended cells were stained for Live/Dead Fixable Viability Dye (FVD-eFluor780, Cat# 65-0865-18, eBioscience) in PBS for 30&nbsp;min at 4°C to distinguished live and dead cells. To block non-specific binding, mouse and human cells were incubated with FcR blocking reagent for mice (Cat# 130-092-575, Miltenyi Biotec) and humans (Cat# 130-059-901, Miltenyi Biotec) respectively. For intracellular cytokine staining, cells were re-stimulated with a cell stimulation cocktail (Cat# 00-4970-03, eBioscience; containing PMA and ionomycin) in the presence of a protein transport inhibitor cocktail containing Brefeldin A and Monensin (Cat# 00-4980-03, eBioscience) (<span class="dropBlock reference-citations"><a id="body-ref-sref50-2" href="#" role="doc-biblioref" data-xml-rid="bib50" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref50-2" aria-controls="sref50-2">Shalapour et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref50-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">50.</div><div>Shalapour, S. ∙ Lin, X.J. ∙ Bastian, I.N. ...</div><div><strong>Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:340-345</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24302" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85034443159" target="_blank" aria-label="Open Scopus in new tab">Scopus (373)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24302&amp;pmid=29144460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Cells were stained for fluorochrome-conjugated monoclonal antibodies in PBS with 2% FBS and 2&nbsp;mM EDTA or cell staining buffer (Cat# 00-4222-57, eBioscience or Cat# 420201, Biolegend). The monoclonal antibodies are as follows: human CD45 (Cat# 304022, 304006, Biolegend), human CD19 (Cat# 392504, 392506, 302224, Biolegend), human ICOSL (Cat# 309404, 309408, Biolegend), human IL-10 (Cat# 53-7108-42, eBioscience), human CR2 (Cat# 354912, Biolegend), human CD20 (Cat# 302310, Biolegend), human CD38 (Cat# 303516, Biolegend), human CD27 (Cat# 356432, Biolegend), human IgA (Cat#333510, Biolegend), human IgD (Cat# 348229, Biolegend), human IgG (Cat# 409306, Biolegend), human CD24 (Cat#311114, Biolegend), mouse CD45 (Cat# 103110, 103108, Biolegend), mouse CD19 (Cat# 115512, Biolegend), mouse ICOSL (Cat# 107405, Biolegend), mouse CD21/CD35 (CR2/CR1) (Cat# 123422, Biolegend), mouse IL-10 (Cat# 505006, Biolegend), mouse CD8a (Cat# 100711, Biolegend), mouse CD4 (Cat# 100412, Biolegend), human/mouse Granzyme B (Cat# 515403, Biolegend), mouse Perforin (Cat# 154306, Biolegend), mouse IFN-γ (Cat# 505806, Biolegend), T-bet (Cat# 644812, 644810, Biolegend), mouse/rat/human FOXP3 (Cat# 320008, 320014, 320012, Biolegend), mouse CD11c (Cat# 117310, Biolegend), mouse IgD (Cat# 405704, Biolegend), mouse IgM (Cat# 406508, Biolegend), human CD8 (Cat# 344722, Biolegend), human CD4 (Cat# 357408, Biolegend) and human C3b/iC3b (Cat#846108, Biolegend). Intracellular cytokine staining was performed using an Intracellular Fixation and Permeabilization kit (Cat# 88-8824, eBioscience), according to the manufacturer’s instructions. Intranuclear transcription factor staining was performed using a True-Nuclear Transcription Factor Buffer Set (Cat# 424401, Biolegend). For some experiments, Propidium Iodide (Cat# 00-6990-50, eBioscience) was used to detect the death of tumor cells. The samples were analyzed by the Beckman CytoFLEX Flow cytometer. Data were analyzed by FlowJo software.</div></section><section id="sec-4-4-7"><h4>Immunohistochemistry and Immunofluorescence</h4><div id="p0295" role="paragraph">For immunohistochemistry, paraffin-embedded samples were cut into 4&nbsp;μm consecutive sections and deparaffinized antigens were retrieved via a pressure cooker for 3&nbsp;min in EDTA buffer (pH 8.0). Specimens were incubated with mouse anti-human C3/C3b (Cat# ab11871, Abcam; 1:100) or rabbit anti–human CD55 (Cat# NBP1-85466, Novus Biologicals; 1:50) at 4°C overnight, washed with PBS for three times, and stained with an anti-mouse/rabbit IHC Secondary Antibody Kit (Cat# GK500705, GTVision), following the manufacturer’s instructions. For immunofluorescence analysis, the tissue sections were incubated with mouse anti-human CD19 (Cat# ab31947, Abcam; 1:50), Alexa Fluor 488 rat anti-human CD19 (Cat# 53-0194-82, eBioscience; 1:100), rabbit anti–human ICOSL (Cat# ab233151, Abcam; 1:50), rat anti–human IL-10 (Cat# 14-7108-85, eBioscience; 1:50), rat anti–human CD3 (Cat# ab11089, Abcam; 1:100), goat anti-mouse ICOSL (Cat# PA5-47161, ThermoFisher Scientific; 1:50), rat anti-mouse IL-10 (Cat# ab189392, Abcam; 1:50), rabbit anti-mouse CD19 (Cat# GTX101512, GeneTex; 1:100), mouse anti-human C3/C3b (Cat# ab11871, Abcam; 1:50), rat anti-mouse CD8 (Cat# MA1-70041, ThermoFisher Scientific; 1:100), rabbit anti-mouse Granzyme B (Cat# ab4059, Abcam; 1:200), rat anti-mouse CD4 (Cat# MA1-146, ThermoFisher Scientific; 1:200), mouse anti-mouse T-bet (Cat# ab91109, Abcam; 1:100), rabbit anti-mouse Foxp3 (Cat# ab215206, Abcam; 1:1000), rat anti-mouse C3b/iC3b/C3c (Cat# HM1065, Hycult Biotech; 1:50) and rabbit anti-mouse CD31 (Cat# ab28364, Abcam; 1:100) followed by incubation with Alexa Fluor secondary antibodies (Cat# A21202, Cat# A31570, Cat#A21206, Cat# A32794, Cat# A31573, Cat# A11006, Cat# A21434, Cat# A11055 or Cat# A21447, ThermoFisher Scientific) according to the experiment design. For the TUNEL assay, slides were stained using the <i>In Situ</i> Cell Death Detection Kit, POD (Cat# 11684817910, Roche) at 37°C for 30&nbsp;min after incubation with anti-mouse C3b/iC3b/C3c (Cat# HM1065, Hycult Biotech; 1:50) and Alexa Fluor secondary antibody (Cat# A21434, ThermoFisher Scientific). For CD31 and C3b/iC3b/C3c staining, tumors were collected 3&nbsp;days after chemotherapy. For the TUNEL assay, tumors were harvested 24&nbsp;days after chemotherapy. For the cell mounting slides, B cells were fixed with 4% paraformaldehyde for 15&nbsp;min at room temperature, washed with PBS and blocked in PBS with 2% BSA for 1&nbsp;h at room temperature. After blockade, cells were incubated with rabbit anti-mouse CD19 (Cat# GTX101512, GeneTex; 1:100) and goat anti-mouse ICOSL (Cat# PA5-47161, ThermoFisher Scientific; 1:50) at 4°C overnight, washed with PBS and stained with anti-mouse Alexa Fluor secondary antibody (Cat# A11055 and Cat# A32794, Thermo Fisher Scientific). The cells were counterstained with DAPI (Ca# D3571, ThermoFisher Scientific) and imaged using a confocal laser-scanning microscope (Carl Zeiss) with a core data acquisition system (Applied Precision).</div></section><section id="sec-4-4-8"><h4>Histology Evaluation of Tissue Sections</h4><div id="p0300" role="paragraph">The images of entire clinical tissue sections were captured and deposited by the side scanner Axio Scan.Z1 (Zeiss). The scan of the slices was fully automated. The fluorescence signal was quantitated by the Automated Image Analysis with Background Subtraction (AIABS) method as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref47" href="#" role="doc-biblioref" data-xml-rid="bib10 bib47" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref47" aria-controls="sref47">Brown et&nbsp;al., 2019; Schalper et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref47"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">10.</div><div>Brown, J.R. ∙ Phongthachit, C. ∙ Sulkowski, M.J.</div><div><strong>Immunofluorescence and image analysis pipeline for <i>Drosophila</i> motor neurons</strong></div><div><em>Biol. Methods Protoc.</em> 2019; <strong>4</strong>:bpz010</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/biomethods/bpz010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85082302897" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31403085/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbiomethods%2Fbpz010&amp;pmid=31403085" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">47.</div><div>Schalper, K.A. ∙ Brown, J. ∙ Carvajal-Hausdorf, D. ...</div><div><strong>Objective measurement and clinical significance of TILs in non-small cell lung cancer</strong></div><div><em>J.&nbsp;Natl. Cancer Inst.</em> 2015; <strong>107</strong></div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jnci/dju435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84927173508" target="_blank" aria-label="Open Scopus in new tab">Scopus (320)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fjnci%2Fdju435" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, non-tumoral area was manually excluded according to H&amp;E staining of the serial sections. For post-treatment samples, the assessment was performed within the borders of the residual tumor bed, which was defined by the presence of the residual tumor cells. In the case of pCR, the tissue region as “area of regression” was identified by gross pathology findings and stroma reactions as previously reported by the International Immuno-Oncology Biomarker Working Group on Breast Cancer (<span class="dropBlock reference-citations"><a id="body-ref-sref22" href="#" role="doc-biblioref" data-xml-rid="bib13 bib22" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref22" aria-controls="sref22">Dieci et&nbsp;al., 2018; Hamy et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref22"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">13.</div><div>Dieci, M.V. ∙ Radosevic-Robin, N. ∙ Fineberg, S. ..., International Immuno-Oncology Biomarker Working Group on Breast Cancer</div><div><strong>Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in&nbsp;situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer</strong></div><div><em>Semin. Cancer Biol.</em> 2018; <strong>52</strong>:16-25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.semcancer.2017.10.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85035012871" target="_blank" aria-label="Open Scopus in new tab">Scopus (315)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29024776/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.semcancer.2017.10.003&amp;pmid=29024776" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">22.</div><div>Hamy, A.S. ∙ Pierga, J.Y. ∙ Sabaila, A. ...</div><div><strong>Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer</strong></div><div><em>Ann. Oncol.</em> 2017; <strong>28</strong>:2233-2240</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdx309&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdx309&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85024928134" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28911063/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdx309&amp;pmid=28911063" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, the previous tumor bed was localized by preoperative imaging, including the placement of radiologic clips. The area of regression appeared as a white aspect of the breast parenchyma representing the previous tumor bed modified by neoadjuvant chemotherapy, and was characterized by histiocytes, lymphocytes, macrophages, fibrosis, and elastosis.</div><div id="p0305" role="paragraph">The whole immunofluorescence scanned images were divided into several small grids for analysis. The nuclei area was defined by detecting circular signals in the DAPI channel. Negative control was performed by omitting the primary antibody. Immunofluorescence signal was adjusted by subtracting negative control staining. An algorithm learning tool was performed by the Imaris 9.0. Analysis software package (Bitplane) to evaluate the percentage of ICOSL<sup>+</sup> B cells by dividing colocalizing spots of CD19 and ICOSL by CD19 positive spots in the sample (<span class="dropBlock reference-citations"><a id="body-ref-sref54-4" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-4" aria-controls="sref54-4">Su et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref54-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0310" role="paragraph">We evaluated IHC images by IHC Profiler as an ImageJ plug-in in a blinded manner as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref58" href="#" role="doc-biblioref" data-xml-rid="bib58" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref58" aria-controls="sref58">Varghese et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref58"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">59.</div><div>Varghese, F. ∙ Bukhari, A.B. ∙ Malhotra, R. ...</div><div><strong>IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e96801</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0096801" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84900445093" target="_blank" aria-label="Open Scopus in new tab">Scopus (934)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24802416/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0096801&amp;pmid=24802416" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, we performed color deconvolution of IHC images by the set optical density vectors for DAB and hematoxylin. The cytoplasmic mode was selected to assess the expression of C3 or CD55 in tissue slices. The staining intensity was scored using the following scale: 0, no negative; 1, low positive; 2, positive; 3, high positive. The IHC score, which was determined by multiplying the staining intensity score and percentage of positive cells, was generated from all the girds of the slides. The average score was calculated for each sample. The theoretical limits of the scores ranged from 0 (0% cell staining) to 300 (100% cell staining at 3+ intensity).</div><div id="p0315" role="paragraph">Two operators (J. P. and Y. L.), who had no previous knowledge of the patients’ clinical backgrounds, visually validated the automated scores in a sub-sample group of 147 stained slides. The Pearson correlation coefficient between the two operator performances was evaluated (<a id="crosref0990" href="#figs2">Figure&nbsp;S2</a>A). Scores were also rechecked randomly by a pathologist (Y. Z.). Defective samples or areas with staining artifacts were excluded.</div><div id="p0320" role="paragraph">The presence of TLOs was determined morphologically on H&amp;E stained slides. Follicular aggregates of CD3<sup>+</sup> T and CD19<sup>+</sup> B cells were confirmed by the immunofluorescence staining. The samples with at least one TLO was defined as TLO positive samples. To quantitate the number of CD19<sup>+</sup>ICOSL<sup>+</sup> and CD19<sup>+</sup>ICOSL<sup>-</sup> cells with direct contact with CD3<sup>+</sup> T&nbsp;cells, images were analyzed by Imaris 9.0 Microscopy Image Analysis Software as previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref32" href="#" role="doc-biblioref" data-xml-rid="bib32" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref32" aria-controls="sref32">Lehrman et&nbsp;al., 2018</a><div class="dropBlock__holder" data-db-target-of="sref32"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">32.</div><div>Lehrman, E.K. ∙ Wilton, D.K. ∙ Litvina, E.Y. ...</div><div><strong>CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development</strong></div><div><em>Neuron.</em> 2018; <strong>100</strong>:120-134.e6</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.neuron.2018.09.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.neuron.2018.09.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054542668" target="_blank" aria-label="Open Scopus in new tab">Scopus (285)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30308165/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuron.2018.09.017&amp;pmid=30308165" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, the nucleus was defined in the DAPI channel, and spot channels were generated for the CD3, CD19 and ICOSL respectively. The number of CD19<sup>+</sup>ICOSL<sup>-</sup> and CD19<sup>+</sup>ICOSL<sup>+</sup> spots were determined by the CD19 spots that colocalized with ICOSL or not as aforementioned. CD19<sup>+</sup>ICOSL<sup>-</sup> and CD19<sup>+</sup>ICOSL<sup>+</sup> spots that were within 2.3&nbsp;μm to CD3 spots were determined to be the B cells with direct contact to T&nbsp;cells. To quantitate mouse tissue samples, 10 view-fields at 400&nbsp;× magnification per section were evaluated by Imaris 9.0 Microscopy Image Analysis Software as described above.</div></section><section id="sec-4-4-9"><h4>Oncomine Data Analysis</h4><div id="p0325" role="paragraph"><i>In silico</i> analysis of human ICOSLG (ICOSL), CD55 (CD55), CD46 (CD46), CRIg (CRIg), CR1(CR1), CFH (CFH), CFI (CFI), FHL1 (FHL1), C4BP (C4BP), properdin (properdin) and C1INH (C1INH) mRNA expression was performed using breast cancer microarray gene datasets from the Oncomine database (Compendia Biosciences; <a id="intref0330" href="http://www.oncomine.org" target="_blank">http://www.oncomine.org</a>). Analysis of ICOSLG gene expression in human breast cancer tissues without or with neo-adjuvant chemotherapy was conducted using the Sorlie breast database. Correlation analysis of ICOSLG and CD55 gene expression in human breast cancer tissues was conducted using the Curtis breast database. Analysis of CD55 (CD55), CD46 (CD46), CRIg (CRIg), CR1(CR1), CFH (CFH), CFI (CFI), FHL1 (FHL1), C4BP (C4BP), properdin (properdin) and C1INH (C1INH) gene expression in multiple breast cancer cell lines was conducted using the Barretina Cell Line database. The Kaplan-Meier survival analysis of breast cancer patients with low or high ICOSLG gene expression in human breast cancer tissues was conducted using the Wang breast database, vandeVijver breast and Curtis breast 2 database. The Kaplan-Meier survival analysis of breast cancer patients with low or high CD55 gene expression in human breast cancer tissues was conducted using the Zhang breast, Desmedt breast and Curtis breast database. Patients with benign breast tumors and DCIS were excluded from analysis. Patients without survival status were excluded from Kaplan-Meier survival analysis.</div></section><section id="sec-4-4-10"><h4>Animal Experiments</h4><div id="p0330" role="paragraph">We injected 5&nbsp;× 10<sup>5</sup> E0771 cells (untreated, transduced with empty lentivirus vector or vector expressing CD55) or 1&nbsp;× 10<sup>5</sup> 4T1 cells into the fat pads of six-week-old female mice with C57/BL6 or BALB/C background, respectively. In some experiments, 3&nbsp;× 10<sup>6</sup> TRAMP-C2 cells (transduced without or with lentivirus vector carrying GFP shRNA or CD55 shRNA) were subcutaneously injected into the flank of wild-type six-week-old male C57/BL6 mice. When the syngeneic grafts or spontaneous tumors of MMTV-PyMT mice were palpable, 6-8 mice per group were randomized for different treatments. PBS, doxorubicin (5&nbsp;mg/kg unless stated otherwise in figure legends), carboplatin (50&nbsp;mg/kg) or docetaxel (8&nbsp;mg/kg) were injected intraperitoneally each week. The tumor volumes calculated by the formula: volume&nbsp;= width<sup>2</sup> × length/2 were recorded every 3&nbsp;days. The animals were euthanized when the tumors reached approximately 1.5&nbsp;cm in diameter. Cell suspensions were prepared from tumors or spleen as we previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref53-3" href="#" role="doc-biblioref" data-xml-rid="bib53 bib52" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-3" aria-controls="sref53-3">Su et&nbsp;al., 2017; Su et&nbsp;al., 2014</a><div class="dropBlock__holder" data-db-target-of="sref53-3"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">52.</div><div>Su, S. ∙ Liu, Q. ∙ Chen, J. ...</div><div><strong>A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:605-620</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84900335537" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24823638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.03.021&amp;pmid=24823638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Su, S. ∙ Liao, J. ∙ Liu, J. ...</div><div><strong>Blocking the recruitment of naive CD4<sup>+</sup> T&nbsp;cells reverses immunosuppression in breast cancer</strong></div><div><em>Cell Res.</em> 2017; <strong>27</strong>:461-482</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2017.34" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85015196232" target="_blank" aria-label="Open Scopus in new tab">Scopus (159)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28290464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2017.34&amp;pmid=28290464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Tumor tissues were washed with PBS and cut into small (1-2&nbsp;mm) pieces and incubated in DMEM medium supplemented with 5% FBS, 2&nbsp;mg/mL collagenase I (Worthington Biochemical), 2&nbsp;mg/mL collagenase IV (Worthington Biochemical) and 100&nbsp;μg/mL DNase I (Sigma) for 30&nbsp;min at 37°C under constant shaking. During digestion, the tissue pieces in solution were vortexed every 15&nbsp;min. Spleens were sliced into small pieces and placed onto a strainer attached to a 50&nbsp;mL conical tube. The fragments were pressed through the strainer using the plunger end of a syringe and the strainer was washed with excess PBS to obtain the cell suspension. The cell suspensions were filtered through a 40&nbsp;μm cell strainer, washed twice by PBS and subjected to further experiments.</div><div id="p0335" role="paragraph">To pharmaceutically deplete B cells in mice, the mice were treated with cocktail antibodies together with chemotherapy when the tumors were palpable. Rat anti–mouse CD19 (clone 1D3; BioXcell), rat anti-mouse B220 (clone RA3.3A1/6.1; BioXcell), and mouse anti-mouse CD22 (clone CY34.1; BioXcell) were mixed and injected i.p. weekly, each at 150&nbsp;μg per mouse. After 48 h, the mice were injected with a secondary antibody (mouse anti-rat κ light chain; clone MAR 18.5; BioXcell) at 150&nbsp;μg per mouse. In addition, mice were injected weekly, but not on the same day, with 250&nbsp;μg per mouse rat anti-mouse CD20 (clone AISB12; BioXcell) for 4&nbsp;weeks (<span class="dropBlock reference-citations"><a id="body-ref-sref49-4" href="#" role="doc-biblioref" data-xml-rid="bib29 bib49" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref49-4" aria-controls="sref49-4">Keren et&nbsp;al., 2011; Shalapour et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref49-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">29.</div><div>Keren, Z. ∙ Naor, S. ∙ Nussbaum, S. ...</div><div><strong>B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging</strong></div><div><em>Blood.</em> 2011; <strong>117</strong>:3104-3112</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-09-307983" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-79953097625" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21228330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-09-307983&amp;pmid=21228330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">49.</div><div>Shalapour, S. ∙ Font-Burgada, J. ∙ Di Caro, G. ...</div><div><strong>Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy</strong></div><div><em>Nature.</em> 2015; <strong>521</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14395" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929085260" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25924065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14395&amp;pmid=25924065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Rat IgG2a (Cat# BE0089, BioXCell), IgG (Cat# BE0094, BioXCell) and mouse IgG1 (Cat# BE0083, BioXCell) were used as isotype controls.</div><div id="p0340" role="paragraph">To neutralize ICOSL in mice, 250&nbsp;μg mouse anti-ICOSL antibody (clone HK5.3, BioXCell) or isotype control (Cat# BE0089, BioXcell) were injected i.p. every 2&nbsp;days starting 3&nbsp;days after tumor inoculation (<span class="dropBlock reference-citations"><a id="body-ref-sref6" href="#" role="doc-biblioref" data-xml-rid="bib6" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref6" aria-controls="sref6">Baumjohann et&nbsp;al., 2013</a><div class="dropBlock__holder" data-db-target-of="sref6"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">6.</div><div>Baumjohann, D. ∙ Preite, S. ∙ Reboldi, A. ...</div><div><strong>Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype</strong></div><div><em>Immunity.</em> 2013; <strong>38</strong>:596-605</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.11.020&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.11.020&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84875549975" target="_blank" aria-label="Open Scopus in new tab">Scopus (370)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499493/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.11.020&amp;pmid=23499493" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div><div id="p0345" role="paragraph">To isolate tumor-infiltrating B cells from mice, E0771 syngeneic grafts inoculated in wild-type C57/BL6 mice with or without doxorubicin treatment (5&nbsp;mg/kg) for 4&nbsp;weeks were mechanically dissociated, and single-cell suspensions were prepared as aforementioned. Different subsets of tumor-infiltrating B cells (CD19<sup>+</sup>, CD19<sup>+</sup>ICOSL<sup>+</sup> or CD19<sup>+</sup>ICOSL<sup>-</sup>) were sorted by FACS. The FACS was performed on single cell suspensions using a flow cytometer (BD Biosciences). Before cell sorting, isolated cells were resuspended in PBS containing 1% FBS and incubated with antibody against FITC-CD45 (Cat# 103108, Biolegend), APC-CD19 (Cat# 115512, Biolegend) with or without PE-ICOSL (Cat# 107405, Biolegend) for 30&nbsp;min at 4°C. To exclude dead cells, the cells were stained for Live/Dead Fixable Viability Dye (FVD-eFluor780, Cat# 65-0865-18, eBioscience) in PBS for 30&nbsp;min at 4°C. The purity of the sorted populations was verified by flow cytometry on a Beckman CytoFLEX flow cytometer (98% pure). The viability and number of purified B cells were assessed using trypan blue (ThermoFisher Scientific) (at least 90% live cells).</div><div id="p0350" role="paragraph">To adoptively transfer tumor-infiltrating B cells, purified cells were washed in cold PBS and injected into recipient mice via the tail vein (1&nbsp;× 10<sup>6</sup> cells per mouse in 100&nbsp;μL volume) (CD19<sup>+</sup>, CD19<sup>+</sup>ICOSL<sup>+</sup> or CD19<sup>+</sup>ICOSL<sup>-</sup> B cells). To adoptively transfer mature-naive B cells from mice, cell suspensions from spleens of wild-type C57/BL6 mice were obtained as aforementioned. The cell suspension was filtered through a 40&nbsp;μm cell strainer, washed twice by PBS and resuspended in 5&nbsp;mL of Mouse Lymphocyte Separation Medium (Cat# DKW33-R0100, DAKEWE). Then, the medium containing cells was transferred into a 15&nbsp;mL conical tube and 1&nbsp;mL PBS was gently layered above. The sample was centrifuged with the brake off (37°C, 800&nbsp;× g, 30&nbsp;min, Beckman) and the lymphocyte layer was transferred into a clean tube and washed twice with PBS. Cells were then incubated with antibody against CD19 (Cat# 152410, Biolegend), IgD (Cat# 405704, Biolegend) and IgM (Cat# 406508, Biolegend) for 30&nbsp;min at 4°C. IgD<sup>+</sup>IgM<sup>+</sup> B cells and B cells depleted of IgD<sup>+</sup>IgM<sup>+</sup> B cells were sorted by FACS and injected into <i>Jh</i><sup>−/−</sup> mice via the tail vein (2&nbsp;× 10<sup>6</sup> cells per mouse in 100&nbsp;μL volume).</div><div id="p0355" role="paragraph">In some experiments, the therapeutic effect was assessed by <sup>18</sup>F-flourodeoxyglucose (<sup>18</sup>F-FDG) Positron Emission Tomography/Computed Tomography (PET/CT). Before PET/CT scanning, mice were fasted for 8 h, anesthetized with 400&nbsp;mg/kg chloral hydrate, and injected with 5 uci/g <sup>18</sup>F-FDG in 100&nbsp;μL saline via the tail vein. A 15&nbsp;min static scan was performed 40&nbsp;min after <sup>18</sup>F-FDG injection with an Inveon microPET/CT Scanner (Siemens). The micro PET images were corrected for attenuation, scatter, normalization, and camera dead time and co-registered with micro CT images. Quantification was performed by volume-of-interest (VOI) analysis using Inveon Research Workplace software (Siemens). Activity in triceps muscle was used as nontarget tissue uptake. Activity measurements (Bq/cm3) were divided by the decay-corrected injected dose (Bq) and multiplied by 100 to obtain a tissue uptake index expressed as % ID/g of tissue. Tumor to muscle (T:M) ratio was calculated as the ratio of % ID/g of tumor to that of muscle. All procedures were approved by the Institutional Review Boards and Animal Care and Use Committees of Sun Yat-Sen University.</div></section><section id="sec-4-4-11"><h4>Deposition of C3-Related Fragments</h4><div id="p0360" role="paragraph">Human AB serum, used as a source of complement, was freshly prepared from the peripheral blood of healthy donors as aforementioned. Heat inactivated-normal human serum was obtained by incubating normal human serum at 56°C for 30&nbsp;min (<span class="dropBlock reference-citations"><a id="body-ref-sref39-1" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-1" aria-controls="sref39-1">Mevorach et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref39-1"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Mevorach, D. ∙ Mascarenhas, J.O. ∙ Gershov, D. ...</div><div><strong>Complement-dependent clearance of apoptotic cells by human macrophages</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1998; <strong>188</strong>:2313-2320</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.188.12.2313" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0032416392" target="_blank" aria-label="Open Scopus in new tab">Scopus (601)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9858517/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.188.12.2313&amp;pmid=9858517" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Human serum with or without heat inactivation were stored at −80°C. Human tumor cell lines indicated in the figure legends were cultured in 24-well plates (5&nbsp;× 10<sup>3</sup> cells per well) and treated with PBS with or without 1&nbsp;μM doxorubicin for 24 h. The cells were then washed twice and incubated in 15% human serum (HS), or heat-inactivated normal human serum (IHS) at 37°C for 24 h. Afterward, cells and supernatants were collected for further analysis.</div><div id="p0365" role="paragraph">To block PS, doxorubicin-treated tumor cells were incubated with 1.6&nbsp;mM annexin V (Cat# A9460, Sigma) in 200&nbsp;μL annexin V binding buffer (Cat# 422201, Biolegend) for 10&nbsp;min at 4°C before being cultured in 15% human serum (<span class="dropBlock reference-citations"><a id="body-ref-sref39-2" href="#" role="doc-biblioref" data-xml-rid="bib39" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref39-2" aria-controls="sref39-2">Mevorach et&nbsp;al., 1998</a><div class="dropBlock__holder" data-db-target-of="sref39-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">39.</div><div>Mevorach, D. ∙ Mascarenhas, J.O. ∙ Gershov, D. ...</div><div><strong>Complement-dependent clearance of apoptotic cells by human macrophages</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1998; <strong>188</strong>:2313-2320</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.188.12.2313" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0032416392" target="_blank" aria-label="Open Scopus in new tab">Scopus (601)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9858517/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.188.12.2313&amp;pmid=9858517" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). To inhibit caspase, MDA-MB-231 cells were treated with doxorubicin in the presence of 100&nbsp;μM z-VAD-fmk (Selleck) or z-DEVD-fmk (Selleck) for 24 h.</div><div id="p0370" role="paragraph">For immunofluorescence analysis, the cells were fixed with 4% paraformaldehyde for 15&nbsp;min, permeabilized with 0.1% Triton X-100 for 10&nbsp;min, washed three times with PBS and blocked in PBS with 2% BSA for 1&nbsp;h at room temperature. After blockade, the cells were stained with mouse anti-human C3/C3b (Cat# ab11871, Abcam; 1:50), rabbit anti-human cleaved-PARP (Cat# 5625S, Cell Signaling Technology; 1:50), or rabbit anti-human cleaved-caspase-3 (Cat# 9664S, Cell Signaling Technology; 1:1000) at 4°C overnight. Afterward, the cells were washed with PBS and stained with DAPI and Alexa Fluor secondary antibody (Cat# A21202 and Cat# A32794, Thermo Fisher Scientific).</div><div id="p0375" role="paragraph">For flow cytometric analysis, the cells were digested by 10&nbsp;× TrypLE Selected Enzyme (Cat# A1217701, GIBCO) diluted in PBS containing 1mM EDTA and then incubated at 4°C in PBS containing 2% FBS, 2&nbsp;mM EDTA, APC-conjugated anti-human C3b/iC3b (1:20, Cat# 846106, Biolegend) and PI (1:50, Cat# 421301, Biolegend) or APC mouse IgG1 (1:20, Cat# 400120, Biolegend) for 15&nbsp;min.</div></section><section id="sec-4-4-12"><h4>Western Blot</h4><div id="p0380" role="paragraph">Tumor cells were homogenized by Ripa (Millipore) with proteinase inhibitor cocktail (Cat# 78446, ThermoFisher Scientific). Total protein was quantified using a Pierce BCA Protein Assay Kit (Cat# 23225, ThermoFisher Scientific). Equal amounts of lysates were fractionated by 12% SDS-PAGE and electrotransferred to nitrocellulose membranes (Whatman Protran nitrocellulose membrane; neoLab). After blocking with TBS/0.05% Tween-20/5% skim milk, the membranes were probed with rabbit anti-human CD55 (Cat# NBP1-85466, Novus Biologicals; 1:500), rabbit anti-mouse CD55 (Cat# ab231061, Abcam; 1:200), cleaved-PARP (Cat# 5625S, Cell Signaling Technology; 1:1000), total-PARP (Cat# 9532S, Cell Signaling Technology; 1:1000), cleaved-caspase-3 (Cat# 9664S, Cell Signaling Technology; 1:1000), caspase-3 (Cat# 9662S, Cell Signaling Technology; 1:1000), β-tubulin (Cat# 10068-1-AP, Proteintech; 1:1000) or GAPDH (Cat# HRP-60004, Proteintech; 1:10000).</div><div id="p0385" role="paragraph">To confirm the conditional deletion of Cr2, protein was extracted from B cells isolated from the spleen of <i>Cd19-Cr2</i><sup><i>Δ</i></sup>, <i>Cr2</i><sup>flox/flox</sup>, and wild-type C57/BL6 mice, as aforementioned. Primary antibody against mouse CR2 (CD21) (Cat# ab75985, Abcam; 1:2000) was used. β-tubulin (Cat# 10068-1-AP, Proteintech; 1:1000) was used as the internal standard.</div><div id="p0390" role="paragraph">To evaluate C3-cleavage in tumors, tumor tissues were minced into small pieces (1-2&nbsp;mm in diameter) with autoclaved surgical instruments in PBS containing a cocktail of protease inhibitors (Cat# 78446, ThermoFisher Scientific) prepared according to the manufacturer’s instructions. Tumor pieces were homogenized with the TissueLyser II (QIAGEN GmbH). The protein concentrations in homogenized tumor samples were determined by a NanoDrop ND-1000 Spectrophotometer or the Bradford assay (Promega). Western blots were performed as aforementioned. Activated complements were detected using rat anti-mouse C3b/iC3b/C3c antibody (clone 2/11, Hycult Biotech, 1:200) or mouse anti-human C3/C3b antibody (Cat# ab11871, Abcam, 1:500) (<span class="dropBlock reference-citations"><a id="body-ref-sref37" href="#" role="doc-biblioref" data-xml-rid="bib37" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref37" aria-controls="sref37">Mastellos et&nbsp;al., 2004</a><div class="dropBlock__holder" data-db-target-of="sref37"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">37.</div><div>Mastellos, D. ∙ Prechl, J. ∙ László, G. ...</div><div><strong>Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays</strong></div><div><em>Mol. Immunol.</em> 2004; <strong>40</strong>:1213-1221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.molimm.2003.10.019" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-10744229966" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15104126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.molimm.2003.10.019&amp;pmid=15104126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). β-tubulin (Cat# 10068-1-AP, Proteintech; 1:1000) was used as the internal standard for tissues (<span class="dropBlock reference-citations"><a id="body-ref-sref56-4" href="#" role="doc-biblioref" data-xml-rid="bib56" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref56-4" aria-controls="sref56-4">Surace et&nbsp;al., 2015</a><div class="dropBlock__holder" data-db-target-of="sref56-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">56.</div><div>Surace, L. ∙ Lysenko, V. ∙ Fontana, A.O. ...</div><div><strong>Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response</strong></div><div><em>Immunity.</em> 2015; <strong>42</strong>:767-777</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84928205744" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25888260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2015.03.009&amp;pmid=25888260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Activated complements in the supernatant of doxorubicin-treated tumor cells were detected by using mouse anti-human C3/C3b antibody (Cat# ab11871, Abcam, 1:500). HRP-linked anti-rabbit antibody (Cat# 7074, Cell Signaling Technology; 1:3000), HRP-linked anti-mouse antibody (Cat# 7076, Cell Signaling Technology; 1:3000) and HRP-linked anti-rat antibody (Cat# 7077, Cell Signaling Technology; 1:3000) were used as secondary antibodies.</div></section><section id="sec-4-4-13"><h4>Co-Culture Experiments</h4><div id="p0395" role="paragraph">Primary human B cells were isolated from PBMCs of healthy donors as aforementioned and co-cultured with tumor cells (5:1) pretreated with or without doxorubicin in a 24-well plate for 72&nbsp;h at 37°C in media containing 15% human serum or heat-inactivated human serum (<span class="dropBlock reference-citations"><a id="body-ref-sref27" href="#" role="doc-biblioref" data-xml-rid="bib8 bib27" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref27" aria-controls="sref27">Bodogai et&nbsp;al., 2013; Inoue et&nbsp;al., 2006</a><div class="dropBlock__holder" data-db-target-of="sref27"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">8.</div><div>Bodogai, M. ∙ Lee Chang, C. ∙ Wejksza, K. ...</div><div><strong>Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B&nbsp;cells expressing low levels of CD20 and CD137L</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2127-2138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-12-4184" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84876008718" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23365136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-12-4184&amp;pmid=23365136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">27.</div><div>Inoue, S. ∙ Leitner, W.W. ∙ Golding, B. ...</div><div><strong>Inhibitory effects of B cells on antitumor immunity</strong></div><div><em>Cancer Res.</em> 2006; <strong>66</strong>:7741-7747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-05-3766" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-33747880415" target="_blank" aria-label="Open Scopus in new tab">Scopus (279)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16885377/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-05-3766&amp;pmid=16885377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In some experiments, B cells were incubated with 10&nbsp;μg/mL sheep anti-human CD21(CR2) antibody (Cat# AF4909, R&amp;D Systems) or isotype control (Cat# 5-001-A, R&amp;D Systems) at room temperature for 20&nbsp;min before being co-cultured with tumor cells in media supplemented with 15% human serum (<span class="dropBlock reference-citations"><a id="body-ref-sref30" href="#" role="doc-biblioref" data-xml-rid="bib30" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref30" aria-controls="sref30">Khandelwal et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref30"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">30.</div><div>Khandelwal, S. ∙ Lee, G.M. ∙ Hester, C.G. ...</div><div><strong>The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)</strong></div><div><em>Blood.</em> 2016; <strong>128</strong>:1789-1799</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2016-04-709634" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84990189107" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27412887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2016-04-709634&amp;pmid=27412887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Afterward, B cells were retrieved by a CD19 Isolation Kit (Cat# 130-050-301, Miltenyi Biotec) and subjected to further experiments.</div><div id="p0400" role="paragraph">To obtain monocytes, peripheral blood mononuclear cells (PBMC) were isolated from buffy coat of healthy donors by Ficoll-Paque PLUS (Cat# LTS1077, TBDscience) by density gradient centrifugation (37°C, 450&nbsp;× g, 20&nbsp;min) as aforementioned. Monocytes were isolated from PBMC by magnetic-activated cell sorting using Pan Monocyte Isolation Kit (Cat# 130-096-537, Miltenyi Biotec) and seeded into 24-well plates. Monocyte-derived DCs (mo-DC) were generated by culturing monocytes with 5&nbsp;ng/mL IL-4 (Cat# 200-04, PeproTech) and 25&nbsp;ng/mL GM-CSF (Cat# 300-03, PeproTech) for 6&nbsp;days and the culture medium was changed every two days (<span class="dropBlock reference-citations"><a id="body-ref-sref55-4" href="#" role="doc-biblioref" data-xml-rid="bib55" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref55-4" aria-controls="sref55-4">Su et&nbsp;al., 2018b</a><div class="dropBlock__holder" data-db-target-of="sref55-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">55.</div><div>Su, S. ∙ Zhao, J. ∙ Xing, Y. ...</div><div><strong>Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:442-457.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054030012" target="_blank" aria-label="Open Scopus in new tab">Scopus (205)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30290143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.007&amp;pmid=30290143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). CD8<sup>+</sup> T&nbsp;cells and naive CD4<sup>+</sup> T&nbsp;cells were isolated by magnetic-activated cell sorting using direct CD8<sup>+</sup> T&nbsp;Cell Isolation Kit (Cat# 130-096-495, Miltenyi Biotec) and naive CD4<sup>+</sup> T Cells Isolation Kit II (Cat# 130-094-131, Miltenyi Biotec) according to the manufacturer’s instructions respectively. CD8<sup>+</sup> and CD4<sup>+</sup> T&nbsp;cells were cultured in RPMI 1640 medium (GIBCO) supplemented with 25&nbsp;mmol/L HEPES, 4&nbsp;mmol/L L-glutamine, 25&nbsp;μmol/L 2-mercaptoethanol, and 10% FBS at 37°C. Media were replaced every 2&nbsp;days. The purity of cell populations was more than 90% confirmed by flow cytometry.</div><div id="p0405" role="paragraph">Tumor-specific CD8<sup>+</sup> and CD4<sup>+</sup> T&nbsp;cells were obtained as we previously described (<span class="dropBlock reference-citations"><a id="body-ref-sref53-4" href="#" role="doc-biblioref" data-xml-rid="bib53" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref53-4" aria-controls="sref53-4">Su et&nbsp;al., 2017</a><div class="dropBlock__holder" data-db-target-of="sref53-4"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">53.</div><div>Su, S. ∙ Liao, J. ∙ Liu, J. ...</div><div><strong>Blocking the recruitment of naive CD4<sup>+</sup> T&nbsp;cells reverses immunosuppression in breast cancer</strong></div><div><em>Cell Res.</em> 2017; <strong>27</strong>:461-482</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2017.34" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85015196232" target="_blank" aria-label="Open Scopus in new tab">Scopus (159)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28290464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2017.34&amp;pmid=28290464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, DCs were matured by incubation with 100&nbsp;ng/mL LPS (Cat# L2880, Sigma-Aldrich) and 500&nbsp;U/mL IFN-γ (Cat# 300-02, PeproTech) for 48&nbsp;h and then pulsed with lysates (200&nbsp;μg protein/1&nbsp;× 10<sup>6</sup> cells/mL) of indicated tumor cells. To obtain tumor lysates, tumor cells (1&nbsp;× 10<sup>7</sup> to 2&nbsp;× 10<sup>7</sup>) were washed with PBS and subjected to five freeze (liquid nitrogen) and thaw (37°C water bath) cycles. After removal of large particles by centrifugation (2000&nbsp;× g for 10&nbsp;min at 4°C), the supernatant was collected and stored at −80°C until use. After 24 h, tumor-pulsed DCs were co-cultured with autologous CD8<sup>+</sup>/CD4<sup>+</sup> T (1:5) in the presence or absence of CD19<sup>+</sup> B cells (T cells: B cells, 1:1) treated as aforementioned for five days (<span class="dropBlock reference-citations"><a id="body-ref-sref40" href="#" role="doc-biblioref" data-xml-rid="bib40" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref40" aria-controls="sref40">Olkhanud et&nbsp;al., 2011</a><div class="dropBlock__holder" data-db-target-of="sref40"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">40.</div><div>Olkhanud, P.B. ∙ Damdinsuren, B. ∙ Bodogai, M. ...</div><div><strong>Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4<sup>+</sup> T&nbsp;cells to T-regulatory cells</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:3505-3515</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-4316" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-79956131523" target="_blank" aria-label="Open Scopus in new tab">Scopus (493)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21444674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-4316&amp;pmid=21444674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). In some experiments, 10&nbsp;μg/mL mouse anti-human ICOSL-neutralizing antibody (clone: MIH12, Cat# 16-5889-82, eBioscience) or control IgG1 (Cat# 16-4714-82, eBioscience) were added in the co-culture (<span class="dropBlock reference-citations"><a id="body-ref-sref17" href="#" role="doc-biblioref" data-xml-rid="bib17" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref17" aria-controls="sref17">Franzese et&nbsp;al., 2016</a><div class="dropBlock__holder" data-db-target-of="sref17"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">17.</div><div>Franzese, O. ∙ Palermo, B. ∙ Di Donna, C. ...</div><div><strong>Polyfunctional Melan-A-specific tumor-reactive CD8(+) T&nbsp;cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS</strong></div><div><em>OncoImmunology.</em> 2016; <strong>5</strong>:e1114203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1114203" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964402230" target="_blank" aria-label="Open Scopus in new tab">Scopus (21)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27467927/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1114203&amp;pmid=27467927" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>).</div></section><section id="sec-4-4-14"><h4>Cytotoxicity of Tumor-Specific CD8<sup>+</sup> T Cells</h4><div id="p0410" role="paragraph">Tumor-specific CD8<sup>+</sup> T&nbsp;cells generated as aforementioned were collected using CD8 Microbeads (Cat# 130-045-201, Miltenyi Biotec) and mixed with target tumor cells pre-stained with CMFDA (10:1) for 12 h. Afterward, cells were dyed with propidium iodide (Cat# 00-6990-50, eBioscience; 1:20) and analyzed by flow cytometry. Both CMFDA and propidium iodide positive cells were designated as killed tumor cells. Granzyme B (Cat# 515403, Biolegend) expression of CD8<sup>+</sup> T&nbsp;cells were evaluated by intracellular staining and flow cytometry.</div></section><section id="sec-4-4-15"><h4>Lentiviral Vector-Mediated Silencing or Overexpression of CD55</h4><div id="p0415" role="paragraph">Lentivirus packaging was made by GenePharma Inc (Shanghai, China). A lentiviral vector plasmid pGag/Pol was used to construct the stable clones. In some experiments, E0771 cells were transduced with mouse CD55 gene (NM_010016.3) lentiviral overexpression vectors. Lentiviral shRNAs targeting CD55 were obtained from Genepharma and shRNA silencing sequences are listed in the KEY RESOURCES TABLE. The control shRNA targeted against green fluorescent protein (GFP) (5`- TGACCACCCTGACCTACGGCGTGCAGTGC-3`) was transduced as a negative control. Tumor cells transduction was performed as we described before (<span class="dropBlock reference-citations"><a id="body-ref-sref54-5" href="#" role="doc-biblioref" data-xml-rid="bib54" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref54-5" aria-controls="sref54-5">Su et&nbsp;al., 2018a</a><div class="dropBlock__holder" data-db-target-of="sref54-5"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">54.</div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Briefly, 1&nbsp;× 10<sup>6</sup> cells were transduced with the lentiviral vectors (multiplicity of infection [MOI] of 10 for E0771 cells and MOI of 40 for TRAMP-C2 cells) overnight at 37°C with 5&nbsp;μg/mL polybrene (Sigma).</div></section></section><section id="sec-4-5"><h3>Quantification and Statistical Analysis</h3><div id="p0420" role="paragraph">Information regarding statistical details and methods is indicated in the figure legends, text or methods. Data are presented as either mean or median of continuous values and analyzed for comparison of two groups by Student’s t test or Mann-Whitney <i>U</i> test respectively. X-Tile statistical software was used to group clinical samples. Kaplan-Meier survival curves were plotted and the log-rank (Mantel-Cox) test was used to compare survival curves. We used X-tile statistical software to determine an optimal cutoff point by a minimal p value approach as we and others previously reported (<span class="dropBlock reference-citations"><a id="body-ref-sref61-2" href="#" role="doc-biblioref" data-xml-rid="bib61" href-manipulated="true" class="reference-citations__ctrl" aria-expanded="false" data-db-target-for="sref61-2" aria-controls="sref61-2">Wang et&nbsp;al., 2019</a><div class="dropBlock__holder" data-db-target-of="sref61-2"><div class="dropBlock__body__outer"><div class="dropBlock__body"><div class="citation"><div class="citation-content"><div class="citation-content"><div class="label">62.</div><div>Wang, Y. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:1957-1969</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-2544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85062945239" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30482778/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-2544&amp;pmid=30482778" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><button class="dropBlock__ctrl--close" title="Close info" aria-label="close info"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 70 128" height="24" width="14"><path d="M68.94 36.12L62 29 35 56 8 29l-7 7 27 27L1 90l7 7 27-27 27 27 7-7-27-27 26.94-26.88"></path></svg></button></div></div></span>). Multivariable Cox regression analysis was used to determine the independent prognostic factors. Pearson correlation and regression analysis were used to assess the relationship of ICOSL<sup>+</sup> B cells and C3 cleavage deposited or CD55 levels in tumors. The measurements of all statistical values were performed using GraphPad Prism 7.0 or SPSS 23.0, unless otherwise described in the figure legends or methods. Error bars in the experiments indicate standard error of the mean (SEM) or standard deviation (SD) as mentioned in figure legends for a minimum of three independent experiments.</div></section><section id="sec-4-6"><h3>Data and Code Availability</h3><div id="p0425" role="paragraph">The single-cell RNA sequencing data are available at the GEO database (accession number <a id="intref0335" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135710" target="_blank">GSE135710</a>) (<a id="interref0010" href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135710" target="_blank">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE135710</a>). For further details see the Key Resources Table.</div></section></section><section id="acknowledgments" role="doc-acknowledgments"><h2>Acknowledgments</h2><div id="p0430" role="paragraph">This work was supported by grants from the National Key Research and Development Program of China (2017YFA0106300), the Natural Science Foundation of China (91942309, 81672614, 81971481, 81672621, and 81872155), the Natural Science Foundation of Guangdong Province (2016A030306023, 2017A030313878, and 2018A030313769), Pearl River S&amp;T Nova Program of Guangzhou (201710010083 and 201710010048), and Tip-top Scientific and Technical Innovative Youth Talents of Guangdong special support program (2016TQ03R553).</div><section id="sec-5"><h3>Author Contributions</h3><div id="p0435" role="paragraph">Conceptualization, S.S. and E.S.; Methodology, Y. Lu, Q.Z., J.-Y.L., Q.X., and J.P.; Formal Analysis, S.S., Y. Lu, and Q.Z.; Investigation, Y. Lu, Q.X., J.P., Y. Li, J.L., and B.Z.; Resources, S.Y. and Y.Z.; Data Curation, Y. Lu, Y.Y., and C.D.; Writing, S.S., Y. Lu, and Q.Z.; Visualization, Y. Lu and Q.X.; Supervision, S.S.</div></section><section id="sec-6"><h3>Declaration of Interests</h3><div id="p0440" role="paragraph">The authors declare no competing interests.</div></section></section><section id="supplementary-material" data-type="supplementary-materials"><h2>Supplemental Information (2)</h2><div id="p0450" role="paragraph"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div id="mmc1" class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="/cms/10.1016/j.cell.2020.02.015/attachment/a473a9c0-c9b1-4629-a7aa-f989a031fdc6/mmc1.pdf" download="mmc1.pdf" aria-labelledby="mmc1-heading mmc1-link"><span id="mmc1-link">PDF (286.64 KB)</span></a></div><div class="core-description"><div id="mmc1-heading" class="heading">Document S1. Tables S1–S5, Related to Figure&nbsp;2</div></div></div><div class="core-supplementary-material" data-category="video"><div class="core-link"><div class="cloudflare-stream-container" id="mmc2" data-type="mp4"><span id="video_stream_mmc2_src" class="video-stream-source" style="display:none">eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJmYjc0NjEwNTJiYTMxZGU2MmE2YjEwN2VkYmExZjQxOSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA3NDAwfQ.ef0PrbuzLkecRej7-KwSml1Nz5zhAS5JGbU9u1yC2NUNHpK7NVkGeRWrr826xKHFl4CR1Jg6-RhVdbj2kWYMhSAdoZekuHQ5M-2NP4DlG6MZV0Nym659C4eBICHpXMFocXxRzCZ0xgEskxGD9Bss-anH-r5YiYUQPCxX3ZdcfyKtf04s-b2c8krpnTTG2dOtONQpnoX4gXhq4jljsB5PFLKMDtLRd4F6-lRa4_scCJeOpI1rmrre1jghL1fjNtKnT7ABW9m3EWpB2RbNUN5WQFzxqtWrF1R9UkbkBe9J8kPGiHyxlaTR_RMLmVdUlkv1QLMhUaxdZ_X3LBLU4sgrVw</span><stream src="eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJmYjc0NjEwNTJiYTMxZGU2MmE2YjEwN2VkYmExZjQxOSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA3NDAwfQ.ef0PrbuzLkecRej7-KwSml1Nz5zhAS5JGbU9u1yC2NUNHpK7NVkGeRWrr826xKHFl4CR1Jg6-RhVdbj2kWYMhSAdoZekuHQ5M-2NP4DlG6MZV0Nym659C4eBICHpXMFocXxRzCZ0xgEskxGD9Bss-anH-r5YiYUQPCxX3ZdcfyKtf04s-b2c8krpnTTG2dOtONQpnoX4gXhq4jljsB5PFLKMDtLRd4F6-lRa4_scCJeOpI1rmrre1jghL1fjNtKnT7ABW9m3EWpB2RbNUN5WQFzxqtWrF1R9UkbkBe9J8kPGiHyxlaTR_RMLmVdUlkv1QLMhUaxdZ_X3LBLU4sgrVw" class="cloudflare-stream-player ready tracked" id="video_stream_mmc2" controls="true"><div class="player-share-button" title="Share Video"><div class="share-player-icon"></div></div><div class="player-share-container hidden"><span class="player-close-share"></span><div class="social-links-container"><ul class="social-links-list"><li class="html5-share-facebook-icon" data-share-url="https://www.facebook.com/sharer/sharer.php?u=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank"></li><li class="html5-share-twitter-icon" data-share-url="https://twitter.com/share?url=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank"></li><li class="html5-share-mail-icon" data-share-url="mailto:?body=https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" target="_blank"></li></ul><input type="text" value="https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8" readonly="readonly" class="share-input"></div></div><div style="position: relative; height: 0px; width: 100%; padding-top: 56.25%;"><iframe src="https://embed.cloudflarestream.com/embed/iframe.fla9.823df22.html?videoId=eyJraWQiOiI4ZjUxYWNhY2IzYjhiNjNlNzFlYmIzYWFmYTU5NmZmYyIsImFsZyI6IlJTMjU2In0.eyJzdWIiOiJmYjc0NjEwNTJiYTMxZGU2MmE2YjEwN2VkYmExZjQxOSIsImtpZCI6IjhmNTFhY2FjYjNiOGI2M2U3MWViYjNhYWZhNTk2ZmZjIiwiZXhwIjoxNzQ5NjA3NDAwfQ.ef0PrbuzLkecRej7-KwSml1Nz5zhAS5JGbU9u1yC2NUNHpK7NVkGeRWrr826xKHFl4CR1Jg6-RhVdbj2kWYMhSAdoZekuHQ5M-2NP4DlG6MZV0Nym659C4eBICHpXMFocXxRzCZ0xgEskxGD9Bss-anH-r5YiYUQPCxX3ZdcfyKtf04s-b2c8krpnTTG2dOtONQpnoX4gXhq4jljsB5PFLKMDtLRd4F6-lRa4_scCJeOpI1rmrre1jghL1fjNtKnT7ABW9m3EWpB2RbNUN5WQFzxqtWrF1R9UkbkBe9J8kPGiHyxlaTR_RMLmVdUlkv1QLMhUaxdZ_X3LBLU4sgrVw" allowfullscreen="true" allow="autoplay; picture-in-picture" style="height: 100%; width: 100%; position: absolute; top: 0px; left: 0px; border: none;"></iframe></div></stream></div><a href="/cms/10.1016/j.cell.2020.02.015/attachment/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4" download="mmc2.mp4" aria-labelledby="mmc2-heading mmc2-link"><span id="mmc2-link">Video (34.45 MB)</span></a></div><div class="core-description"><div id="mmc2-heading" class="heading">Video Abstract</div></div></div></div></section></div></section><div class="core-linked-content">
    

        

</div><section id="backmatter" data-extent="backmatter"><div class="core-container"><section id="references"><h2>References</h2><div id="bibliography" role="doc-bibliography"><div role="list"><div role="listitem" data-has="label"><div id="bib1" class="citations"><div id="sref1" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">1.</a></div><div>Affara, N.I. ∙ Ruffell, B. ∙ Medler, T.R. ...</div><div><strong>B cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:809-821</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.04.026&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_1_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84902465821" target="_blank" aria-label="Open Scopus in new tab">Scopus (236)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24909985/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.04.026&amp;pmid=24909985" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib2" class="citations"><div id="sref2" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">2.</a></div><div>Aicher, A. ∙ Hayden-Ledbetter, M. ∙ Brady, W.A. ...</div><div><strong>Characterization of human inducible costimulator ligand expression and function</strong></div><div><em>J.&nbsp;Immunol.</em> 2000; <strong>164</strong>:4689-4696</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.164.9.4689" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_2_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0034193043" target="_blank" aria-label="Open Scopus in new tab">Scopus (215)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/10779774/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.164.9.4689&amp;pmid=10779774" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib3" class="citations"><div id="sref3" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">3.</a></div><div>Aklilu, M. ∙ Stadler, W.M. ∙ Markiewicz, M. ...</div><div><strong>Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma</strong></div><div><em>Ann. Oncol.</em> 2004; <strong>15</strong>:1109-1114</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdh280&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdh280&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_3_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-4143138507" target="_blank" aria-label="Open Scopus in new tab">Scopus (54)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15205206/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdh280&amp;pmid=15205206" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib4" class="citations"><div id="sref4" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref4-1" title="View in article">4.</a></div><div>Ammirante, M. ∙ Luo, J.L. ∙ Grivennikov, S. ...</div><div><strong>B-cell-derived lymphotoxin promotes castration-resistant prostate cancer</strong></div><div><em>Nature.</em> 2010; <strong>464</strong>:302-305</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature08782" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_4_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77949379050" target="_blank" aria-label="Open Scopus in new tab">Scopus (503)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20220849/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature08782&amp;pmid=20220849" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib5" class="citations"><div id="sref5" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref5" title="View in article">5.</a></div><div>Andreu, P. ∙ Johansson, M. ∙ Affara, N.I. ...</div><div><strong>FcRgamma activation regulates inflammation-associated squamous carcinogenesis</strong></div><div><em>Cancer Cell.</em> 2010; <strong>17</strong>:121-134</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2009.12.019&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2009.12.019&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_5_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-76349088502" target="_blank" aria-label="Open Scopus in new tab">Scopus (474)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20138013/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2009.12.019&amp;pmid=20138013" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib6" class="citations"><div id="sref6" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref6" title="View in article">6.</a></div><div>Baumjohann, D. ∙ Preite, S. ∙ Reboldi, A. ...</div><div><strong>Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype</strong></div><div><em>Immunity.</em> 2013; <strong>38</strong>:596-605</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.11.020&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.11.020&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_6_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84875549975" target="_blank" aria-label="Open Scopus in new tab">Scopus (370)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499493/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.11.020&amp;pmid=23499493" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib7" class="citations"><div id="sref7" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43-2" title="View in article">7.</a></div><div>Berraondo, P. ∙ Minute, L. ∙ Ajona, D. ...</div><div><strong>Innate immune mediators in cancer: between defense and resistance</strong></div><div><em>Immunol. Rev.</em> 2016; <strong>274</strong>:290-306</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12464" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_7_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84992473931" target="_blank" aria-label="Open Scopus in new tab">Scopus (109)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27782320/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12464&amp;pmid=27782320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib8" class="citations"><div id="sref8" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref8-1" title="View in article">8.</a></div><div>Bodogai, M. ∙ Lee Chang, C. ∙ Wejksza, K. ...</div><div><strong>Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B&nbsp;cells expressing low levels of CD20 and CD137L</strong></div><div><em>Cancer Res.</em> 2013; <strong>73</strong>:2127-2138</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-12-4184" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_8_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84876008718" target="_blank" aria-label="Open Scopus in new tab">Scopus (100)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23365136/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-12-4184&amp;pmid=23365136" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib9" class="citations"><div id="sref9" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">9.</a></div><div>Bonavita, E. ∙ Gentile, S. ∙ Rubino, M. ...</div><div><strong>PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer</strong></div><div><em>Cell.</em> 2015; <strong>160</strong>:700-714</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.01.004&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.01.004&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_9_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84922689090" target="_blank" aria-label="Open Scopus in new tab">Scopus (308)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25679762/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.01.004&amp;pmid=25679762" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib10" class="citations"><div id="sref10" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">10.</a></div><div>Brown, J.R. ∙ Phongthachit, C. ∙ Sulkowski, M.J.</div><div><strong>Immunofluorescence and image analysis pipeline for <i>Drosophila</i> motor neurons</strong></div><div><em>Biol. Methods Protoc.</em> 2019; <strong>4</strong>:bpz010</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/biomethods/bpz010" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_10_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85082302897" target="_blank" aria-label="Open Scopus in new tab">Scopus (4)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31403085/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fbiomethods%2Fbpz010&amp;pmid=31403085" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib11" class="citations"><div id="sref11" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref11-1" title="View in article">11.</a></div><div>Carroll, M.C. ∙ Isenman, D.E.</div><div><strong>Regulation of humoral immunity by complement</strong></div><div><em>Immunity.</em> 2012; <strong>37</strong>:199-207</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2012.08.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_11_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84865389455" target="_blank" aria-label="Open Scopus in new tab">Scopus (291)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22921118/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2012.08.002&amp;pmid=22921118" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib12" class="citations"><div id="sref12" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">12.</a></div><div>Chen, F. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells</strong></div><div><em>Nat. Cell Biol.</em> 2019; <strong>21</strong>:498-510</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41556-019-0299-0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_12_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85064202781" target="_blank" aria-label="Open Scopus in new tab">Scopus (490)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30936474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41556-019-0299-0&amp;pmid=30936474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib13" class="citations"><div id="sref13" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">13.</a></div><div>Dieci, M.V. ∙ Radosevic-Robin, N. ∙ Fineberg, S. ..., International Immuno-Oncology Biomarker Working Group on Breast Cancer</div><div><strong>Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in&nbsp;situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer</strong></div><div><em>Semin. Cancer Biol.</em> 2018; <strong>52</strong>:16-25</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.semcancer.2017.10.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_13_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85035012871" target="_blank" aria-label="Open Scopus in new tab">Scopus (315)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29024776/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.semcancer.2017.10.003&amp;pmid=29024776" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib14" class="citations"><div id="sref14" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref14" title="View in article">14.</a></div><div>Erdei, A. ∙ Sándor, N. ∙ Mácsik-Valent, B. ...</div><div><strong>The versatile functions of complement C3-derived ligands</strong></div><div><em>Immunol. Rev.</em> 2016; <strong>274</strong>:127-140</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1111/imr.12498" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_14_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84992457824" target="_blank" aria-label="Open Scopus in new tab">Scopus (30)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27782338/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1111%2Fimr.12498&amp;pmid=27782338" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib15" class="citations"><div id="sref15" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">15.</a></div><div>Fan, X. ∙ Quezada, S.A. ∙ Sepulveda, M.A. ...</div><div><strong>Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy</strong></div><div><em>J.&nbsp;Exp. Med.</em> 2014; <strong>211</strong>:715-725</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.20130590" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_15_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84897940775" target="_blank" aria-label="Open Scopus in new tab">Scopus (228)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24687957/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.20130590&amp;pmid=24687957" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib16" class="citations"><div id="sref16" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-2" title="View in article">16.</a></div><div>Fayanju, O.M. ∙ Ren, Y. ∙ Thomas, S.M. ...</div><div><strong>The Clinical Significance of Breast-only and Node-only Pathologic Complete Response (pCR) After Neoadjuvant Chemotherapy (NACT): A Review of 20,000 Breast Cancer Patients in the National Cancer Data Base (NCDB)</strong></div><div><em>Ann. Surg.</em> 2018; <strong>268</strong>:591-601</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1097/SLA.0000000000002953" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_16_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85059654798" target="_blank" aria-label="Open Scopus in new tab">Scopus (136)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30048319/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1097%2FSLA.0000000000002953&amp;pmid=30048319" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib17" class="citations"><div id="sref17" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref17" title="View in article">17.</a></div><div>Franzese, O. ∙ Palermo, B. ∙ Di Donna, C. ...</div><div><strong>Polyfunctional Melan-A-specific tumor-reactive CD8(+) T&nbsp;cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS</strong></div><div><em>OncoImmunology.</em> 2016; <strong>5</strong>:e1114203</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1114203" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_17_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964402230" target="_blank" aria-label="Open Scopus in new tab">Scopus (21)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27467927/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1114203&amp;pmid=27467927" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib18" class="citations"><div id="sref18" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref18" title="View in article">18.</a></div><div>Galluzzi, L. ∙ Aaronson, S.A. ∙ Abrams, J. ...</div><div><strong>Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes</strong></div><div><em>Cell Death Differ.</em> 2009; <strong>16</strong>:1093-1107</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cdd.2009.44" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_18_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-67650751080" target="_blank" aria-label="Open Scopus in new tab">Scopus (572)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/19373242/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcdd.2009.44&amp;pmid=19373242" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib19" class="citations"><div id="sref19" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">19.</a></div><div>Galluzzi, L. ∙ Buqué, A. ∙ Kepp, O. ...</div><div><strong>Immunogenic cell death in cancer and infectious disease</strong></div><div><em>Nat. Rev. Immunol.</em> 2017; <strong>17</strong>:97-111</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2016.107" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_19_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84991619059" target="_blank" aria-label="Open Scopus in new tab">Scopus (2034)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27748397/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2016.107&amp;pmid=27748397" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib20" class="citations"><div id="sref20" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref20" title="View in article">20.</a></div><div>Gunderson, A.J. ∙ Coussens, L.M.</div><div><strong>B cells and their mediators as targets for therapy in solid tumors</strong></div><div><em>Exp. Cell Res.</em> 2013; <strong>319</strong>:1644-1649</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.yexcr.2013.03.005" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_20_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84879604267" target="_blank" aria-label="Open Scopus in new tab">Scopus (64)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23499742/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.yexcr.2013.03.005&amp;pmid=23499742" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib21" class="citations"><div id="sref21" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">21.</a></div><div>Hajishengallis, G. ∙ Reis, E.S. ∙ Mastellos, D.C. ...</div><div><strong>Novel mechanisms and functions of complement</strong></div><div><em>Nat. Immunol.</em> 2017; <strong>18</strong>:1288-1298</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.3858" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_21_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85034570767" target="_blank" aria-label="Open Scopus in new tab">Scopus (358)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144501/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.3858&amp;pmid=29144501" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib22" class="citations"><div id="sref22" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref22" title="View in article">22.</a></div><div>Hamy, A.S. ∙ Pierga, J.Y. ∙ Sabaila, A. ...</div><div><strong>Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer</strong></div><div><em>Ann. Oncol.</em> 2017; <strong>28</strong>:2233-2240</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdx309&amp;cf=fulltext&amp;site=annonc-site" target="_blank" aria-label="Open Full Text in new tab">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1093%2Fannonc%2Fmdx309&amp;cf=pdf&amp;site=annonc-site" target="_blank" aria-label="Open Full Text (PDF) in new tab">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_22_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85024928134" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28911063/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fannonc%2Fmdx309&amp;pmid=28911063" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib23" class="citations"><div id="sref23" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref23" title="View in article">23.</a></div><div>Heesters, B.A. ∙ Myers, R.C. ∙ Carroll, M.C.</div><div><strong>Follicular dendritic cells: dynamic antigen libraries</strong></div><div><em>Nat. Rev. Immunol.</em> 2014; <strong>14</strong>:495-504</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri3689" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_23_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84903387500" target="_blank" aria-label="Open Scopus in new tab">Scopus (293)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24948364/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri3689&amp;pmid=24948364" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib24" class="citations"><div id="sref24" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">24.</a></div><div>Hennequin, A. ∙ Derangère, V. ∙ Boidot, R. ...</div><div><strong>Tumor infiltration by Tbet+ effector T&nbsp;cells and CD20+ B cells is associated with survival in gastric cancer patients</strong></div><div><em>OncoImmunology.</em> 2015; <strong>5</strong>:e1054598</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1054598" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_24_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84959440329" target="_blank" aria-label="Open Scopus in new tab">Scopus (150)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27057426/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1054598&amp;pmid=27057426" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib25" class="citations"><div id="sref25" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref25" title="View in article">25.</a></div><div>Horikawa, M. ∙ Minard-Colin, V. ∙ Matsushita, T. ...</div><div><strong>Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 2011; <strong>121</strong>:4268-4280</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI59266" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_25_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-80555124922" target="_blank" aria-label="Open Scopus in new tab">Scopus (155)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/22019587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI59266&amp;pmid=22019587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib26" class="citations"><div id="sref26" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref54-2" title="View in article">26.</a></div><div>Huang, D. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>NKILA lncRNA promotes tumor immune evasion by sensitizing T&nbsp;cells to activation-induced cell death</strong></div><div><em>Nat. Immunol.</em> 2018; <strong>19</strong>:1112-1125</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41590-018-0207-y" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_26_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85053483374" target="_blank" aria-label="Open Scopus in new tab">Scopus (317)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30224822/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41590-018-0207-y&amp;pmid=30224822" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib27" class="citations"><div id="sref27" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref27" title="View in article">27.</a></div><div>Inoue, S. ∙ Leitner, W.W. ∙ Golding, B. ...</div><div><strong>Inhibitory effects of B cells on antitumor immunity</strong></div><div><em>Cancer Res.</em> 2006; <strong>66</strong>:7741-7747</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-05-3766" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_27_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-33747880415" target="_blank" aria-label="Open Scopus in new tab">Scopus (279)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16885377/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-05-3766&amp;pmid=16885377" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib28" class="citations"><div id="sref28" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref28" title="View in article">28.</a></div><div>Joly-Battaglini, A. ∙ Hammarström, C. ∙ Stankovic, B. ...</div><div><strong>Rituximab efficiently depletes B cells in lung tumors and normal lung tissue</strong></div><div><em>F1000Res.</em> 2016; <strong>5</strong>:38</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.12688/f1000research.7599.1" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_28_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964587596" target="_blank" aria-label="Open Scopus in new tab">Scopus (10)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27081474/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.12688%2Ff1000research.7599.1&amp;pmid=27081474" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib29" class="citations"><div id="sref29" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-4" title="View in article">29.</a></div><div>Keren, Z. ∙ Naor, S. ∙ Nussbaum, S. ...</div><div><strong>B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging</strong></div><div><em>Blood.</em> 2011; <strong>117</strong>:3104-3112</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2010-09-307983" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_29_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-79953097625" target="_blank" aria-label="Open Scopus in new tab">Scopus (71)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21228330/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2010-09-307983&amp;pmid=21228330" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib30" class="citations"><div id="sref30" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref30" title="View in article">30.</a></div><div>Khandelwal, S. ∙ Lee, G.M. ∙ Hester, C.G. ...</div><div><strong>The antigenic complex in HIT binds to B cells via complement and complement receptor 2 (CD21)</strong></div><div><em>Blood.</em> 2016; <strong>128</strong>:1789-1799</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1182/blood-2016-04-709634" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_30_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84990189107" target="_blank" aria-label="Open Scopus in new tab">Scopus (41)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27412887/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1182%2Fblood-2016-04-709634&amp;pmid=27412887" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib31" class="citations"><div id="sref31" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">31.</a></div><div>Kroemer, G. ∙ Galluzzi, L. ∙ Kepp, O. ...</div><div><strong>Immunogenic cell death in cancer therapy</strong></div><div><em>Annu. Rev. Immunol.</em> 2013; <strong>31</strong>:51-72</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1146/annurev-immunol-032712-100008" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_31_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84875552922" target="_blank" aria-label="Open Scopus in new tab">Scopus (2458)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/23157435/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1146%2Fannurev-immunol-032712-100008&amp;pmid=23157435" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib32" class="citations"><div id="sref32" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref32" title="View in article">32.</a></div><div>Lehrman, E.K. ∙ Wilton, D.K. ∙ Litvina, E.Y. ...</div><div><strong>CD47 Protects Synapses from Excess Microglia-Mediated Pruning during Development</strong></div><div><em>Neuron.</em> 2018; <strong>100</strong>:120-134.e6</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.neuron.2018.09.017&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.neuron.2018.09.017&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_32_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054542668" target="_blank" aria-label="Open Scopus in new tab">Scopus (285)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30308165/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.neuron.2018.09.017&amp;pmid=30308165" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib33" class="citations"><div id="sref33" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref33" title="View in article">33.</a></div><div>Liu, X. ∙ Pu, Y. ∙ Cron, K. ...</div><div><strong>CD47 blockade triggers T&nbsp;cell-mediated destruction of immunogenic tumors</strong></div><div><em>Nat. Med.</em> 2015; <strong>21</strong>:1209-1215</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nm.3931" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_33_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84943630992" target="_blank" aria-label="Open Scopus in new tab">Scopus (590)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26322579/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnm.3931&amp;pmid=26322579" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib34" class="citations"><div id="sref34" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref34-1" title="View in article">34.</a></div><div>Lyubchenko, T. ∙ Dal Porto, J.M. ∙ Holers, V.M. ...</div><div><strong>Cutting edge: Complement (C3d)-linked antigens break B cell anergy</strong></div><div><em>J.&nbsp;Immunol.</em> 2007; <strong>179</strong>:2695-2699</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.4049/jimmunol.179.5.2695" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_34_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-37549071968" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/17709481/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.4049%2Fjimmunol.179.5.2695&amp;pmid=17709481" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib35" class="citations"><div id="sref35" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref35" title="View in article">35.</a></div><div>Macosko, E.Z. ∙ Basu, A. ∙ Satija, R. ...</div><div><strong>Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets</strong></div><div><em>Cell.</em> 2015; <strong>161</strong>:1202-1214</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.05.002&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2015.05.002&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_35_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929684999" target="_blank" aria-label="Open Scopus in new tab">Scopus (4634)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26000488/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2015.05.002&amp;pmid=26000488" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib36" class="citations"><div id="sref36" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref36" title="View in article">36.</a></div><div>Markiewski, M.M. ∙ DeAngelis, R.A. ∙ Benencia, F. ...</div><div><strong>Modulation of the antitumor immune response by complement</strong></div><div><em>Nat. Immunol.</em> 2008; <strong>9</strong>:1225-1235</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.1655" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_36_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-54549109936" target="_blank" aria-label="Open Scopus in new tab">Scopus (595)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/18820683/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.1655&amp;pmid=18820683" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib37" class="citations"><div id="sref37" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref37" title="View in article">37.</a></div><div>Mastellos, D. ∙ Prechl, J. ∙ László, G. ...</div><div><strong>Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays</strong></div><div><em>Mol. Immunol.</em> 2004; <strong>40</strong>:1213-1221</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.molimm.2003.10.019" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_37_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-10744229966" target="_blank" aria-label="Open Scopus in new tab">Scopus (55)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/15104126/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.molimm.2003.10.019&amp;pmid=15104126" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib38" class="citations"><div id="sref38" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref38" title="View in article">38.</a></div><div>Metzger, T.C. ∙ Long, H. ∙ Potluri, S. ...</div><div><strong>ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor Rejection</strong></div><div><em>Cancer Res.</em> 2016; <strong>76</strong>:3684-3689</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-15-3412" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_38_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84977540735" target="_blank" aria-label="Open Scopus in new tab">Scopus (49)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27197182/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-15-3412&amp;pmid=27197182" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib39" class="citations"><div id="sref39" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref39-1" title="View in article">39.</a></div><div>Mevorach, D. ∙ Mascarenhas, J.O. ∙ Gershov, D. ...</div><div><strong>Complement-dependent clearance of apoptotic cells by human macrophages</strong></div><div><em>J.&nbsp;Exp. Med.</em> 1998; <strong>188</strong>:2313-2320</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1084/jem.188.12.2313" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_39_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0032416392" target="_blank" aria-label="Open Scopus in new tab">Scopus (601)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/9858517/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1084%2Fjem.188.12.2313&amp;pmid=9858517" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib40" class="citations"><div id="sref40" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref40" title="View in article">40.</a></div><div>Olkhanud, P.B. ∙ Damdinsuren, B. ∙ Bodogai, M. ...</div><div><strong>Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4<sup>+</sup> T&nbsp;cells to T-regulatory cells</strong></div><div><em>Cancer Res.</em> 2011; <strong>71</strong>:3505-3515</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/0008-5472.CAN-10-4316" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_40_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-79956131523" target="_blank" aria-label="Open Scopus in new tab">Scopus (493)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/21444674/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F0008-5472.CAN-10-4316&amp;pmid=21444674" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib41" class="citations"><div id="sref41" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref41" title="View in article">41.</a></div><div>Pepys, M.B.</div><div><strong>Role of complement in induction of the allergic response</strong></div><div><em>Nat. New Biol.</em> 1972; <strong>237</strong>:157-159</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/newbio237157a0" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_41_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0015530804" target="_blank" aria-label="Open Scopus in new tab">Scopus (154)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/4556375/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnewbio237157a0&amp;pmid=4556375" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib42" class="citations"><div id="sref42" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref42" title="View in article">42.</a></div><div>Puram, S.V. ∙ Tirosh, I. ∙ Parikh, A.S. ...</div><div><strong>Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer</strong></div><div><em>Cell.</em> 2017; <strong>171</strong>:1611-1624.e24</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.10.044&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.10.044&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_42_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85035813065" target="_blank" aria-label="Open Scopus in new tab">Scopus (1478)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29198524/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.10.044&amp;pmid=29198524" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib43" class="citations"><div id="sref43" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref43-1" title="View in article">43.</a></div><div>Reis, E.S. ∙ Mastellos, D.C. ∙ Ricklin, D. ...</div><div><strong>Complement in cancer: untangling an intricate relationship</strong></div><div><em>Nat. Rev. Immunol.</em> 2018; <strong>18</strong>:5-18</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nri.2017.97" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_43_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85039035360" target="_blank" aria-label="Open Scopus in new tab">Scopus (272)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28920587/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnri.2017.97&amp;pmid=28920587" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib44" class="citations"><div id="sref44" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref44" title="View in article">44.</a></div><div>Ricklin, D. ∙ Hajishengallis, G. ∙ Yang, K. ...</div><div><strong>Complement: a key system for immune surveillance and homeostasis</strong></div><div><em>Nat. Immunol.</em> 2010; <strong>11</strong>:785-797</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/ni.1923" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_44_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77955883153" target="_blank" aria-label="Open Scopus in new tab">Scopus (2784)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20720586/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fni.1923&amp;pmid=20720586" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib45" class="citations"><div id="sref45" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref45" title="View in article">45.</a></div><div>Satija, R. ∙ Farrell, J.A. ∙ Gennert, D. ...</div><div><strong>Spatial reconstruction of single-cell gene expression data</strong></div><div><em>Nat. Biotechnol.</em> 2015; <strong>33</strong>:495-502</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nbt.3192" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_45_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929151009" target="_blank" aria-label="Open Scopus in new tab">Scopus (3233)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25867923/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnbt.3192&amp;pmid=25867923" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib46" class="citations"><div id="sref46" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref46" title="View in article">46.</a></div><div>Sautès-Fridman, C. ∙ Petitprez, F. ∙ Calderaro, J. ...</div><div><strong>Tertiary lymphoid structures in the era of cancer immunotherapy</strong></div><div><em>Nat. Rev. Cancer.</em> 2019; <strong>19</strong>:307-325</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/s41568-019-0144-6" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_46_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85065962322" target="_blank" aria-label="Open Scopus in new tab">Scopus (910)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/31092904/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fs41568-019-0144-6&amp;pmid=31092904" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib47" class="citations"><div id="sref47" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref47" title="View in article">47.</a></div><div>Schalper, K.A. ∙ Brown, J. ∙ Carvajal-Hausdorf, D. ...</div><div><strong>Objective measurement and clinical significance of TILs in non-small cell lung cancer</strong></div><div><em>J.&nbsp;Natl. Cancer Inst.</em> 2015; <strong>107</strong></div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1093/jnci/dju435" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_47_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84927173508" target="_blank" aria-label="Open Scopus in new tab">Scopus (320)</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1093%2Fjnci%2Fdju435" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib48" class="citations"><div id="sref48" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref48" title="View in article">48.</a></div><div>Schmid, P. ∙ Adams, S. ∙ Rugo, H.S. ..., IMpassion130 Trial Investigators</div><div><strong>Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer</strong></div><div><em>N.&nbsp;Engl. J. Med.</em> 2018; <strong>379</strong>:2108-2121</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1056/NEJMoa1809615" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_48_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85056176186" target="_blank" aria-label="Open Scopus in new tab">Scopus (2988)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30345906/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1056%2FNEJMoa1809615&amp;pmid=30345906" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib49" class="citations"><div id="sref49" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref49-1" title="View in article">49.</a></div><div>Shalapour, S. ∙ Font-Burgada, J. ∙ Di Caro, G. ...</div><div><strong>Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy</strong></div><div><em>Nature.</em> 2015; <strong>521</strong>:94-98</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature14395" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_49_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84929085260" target="_blank" aria-label="Open Scopus in new tab">Scopus (431)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25924065/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature14395&amp;pmid=25924065" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib50" class="citations"><div id="sref50" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">50.</a></div><div>Shalapour, S. ∙ Lin, X.J. ∙ Bastian, I.N. ...</div><div><strong>Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity</strong></div><div><em>Nature.</em> 2017; <strong>551</strong>:340-345</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/nature24302" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_50_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85034443159" target="_blank" aria-label="Open Scopus in new tab">Scopus (373)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29144460/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fnature24302&amp;pmid=29144460" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib51" class="citations"><div id="sref51" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref51" title="View in article">51.</a></div><div>Spendlove, I. ∙ Ramage, J.M. ∙ Bradley, R. ...</div><div><strong>Complement decay accelerating factor (DAF)/CD55 in cancer</strong></div><div><em>Cancer Immunol. Immunother.</em> 2006; <strong>55</strong>:987-995</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1007/s00262-006-0136-8" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_51_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-33646367451" target="_blank" aria-label="Open Scopus in new tab">Scopus (47)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/16485129/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1007%2Fs00262-006-0136-8&amp;pmid=16485129" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib52" class="citations"><div id="sref52" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-3" title="View in article">52.</a></div><div>Su, S. ∙ Liu, Q. ∙ Chen, J. ...</div><div><strong>A positive feedback loop between mesenchymal-like cancer cells and macrophages is essential to breast cancer metastasis</strong></div><div><em>Cancer Cell.</em> 2014; <strong>25</strong>:605-620</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.ccr.2014.03.021&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_52_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84900335537" target="_blank" aria-label="Open Scopus in new tab">Scopus (588)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24823638/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.ccr.2014.03.021&amp;pmid=24823638" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib53" class="citations"><div id="sref53" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-2" title="View in article">53.</a></div><div>Su, S. ∙ Liao, J. ∙ Liu, J. ...</div><div><strong>Blocking the recruitment of naive CD4<sup>+</sup> T&nbsp;cells reverses immunosuppression in breast cancer</strong></div><div><em>Cell Res.</em> 2017; <strong>27</strong>:461-482</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1038/cr.2017.34" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_53_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85015196232" target="_blank" aria-label="Open Scopus in new tab">Scopus (159)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28290464/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1038%2Fcr.2017.34&amp;pmid=28290464" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib54" class="citations"><div id="sref54" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">54.</a></div><div>Su, S. ∙ Chen, J. ∙ Yao, H. ...</div><div><strong>CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness</strong></div><div><em>Cell.</em> 2018; <strong>172</strong>:841-856.e16</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.01.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_54_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85041504714" target="_blank" aria-label="Open Scopus in new tab">Scopus (842)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29395328/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.01.009&amp;pmid=29395328" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib55" class="citations"><div id="sref55" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref55-1" title="View in article">55.</a></div><div>Su, S. ∙ Zhao, J. ∙ Xing, Y. ...</div><div><strong>Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages</strong></div><div><em>Cell.</em> 2018; <strong>175</strong>:442-457.e23</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2018.09.007&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_55_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85054030012" target="_blank" aria-label="Open Scopus in new tab">Scopus (205)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30290143/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2018.09.007&amp;pmid=30290143" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib56" class="citations"><div id="sref56" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref56-1" title="View in article">56.</a></div><div>Surace, L. ∙ Lysenko, V. ∙ Fontana, A.O. ...</div><div><strong>Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response</strong></div><div><em>Immunity.</em> 2015; <strong>42</strong>:767-777</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2015.03.009&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_56_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84928205744" target="_blank" aria-label="Open Scopus in new tab">Scopus (133)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/25888260/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2015.03.009&amp;pmid=25888260" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib57" class="citations"><div id="sref57" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref57" title="View in article">57.</a></div><div>Taylor, R.P. ∙ Lindorfer, M.A.</div><div><strong>Cytotoxic mechanisms of immunotherapy: Harnessing complement in the action of anti-tumor monoclonal antibodies</strong></div><div><em>Semin. Immunol.</em> 2016; <strong>28</strong>:309-316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1016/j.smim.2016.03.003" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_57_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84961219433" target="_blank" aria-label="Open Scopus in new tab">Scopus (61)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27009480/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.smim.2016.03.003&amp;pmid=27009480" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib70" class="citations"><div id="sref70" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref70" title="View in article">58.</a></div><div>Untch, M. ∙ von Minckwitz, G. ∙ Gerber, B. ...</div><div><strong>Survival Analysis After Neoadjuvant Chemotherapy With Trastuzumab or Lapatinib in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer in the GeparQuinto (G5) Study (GBG 44)</strong></div><div><em>J. Clin. Oncol.</em> 2018; <strong>36</strong>:1308-1316</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2017.75.9175" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_58_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85046041886" target="_blank" aria-label="Open Scopus in new tab">Scopus (37)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/29543566/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2017.75.9175&amp;pmid=29543566" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib58" class="citations"><div id="sref58" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref58" title="View in article">59.</a></div><div>Varghese, F. ∙ Bukhari, A.B. ∙ Malhotra, R. ...</div><div><strong>IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples</strong></div><div><em>PLoS ONE.</em> 2014; <strong>9</strong>:e96801</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1371/journal.pone.0096801" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_59_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84900445093" target="_blank" aria-label="Open Scopus in new tab">Scopus (934)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24802416/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1371%2Fjournal.pone.0096801&amp;pmid=24802416" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib59" class="citations"><div id="sref59" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref59-1" title="View in article">60.</a></div><div>von Minckwitz, G. ∙ Blohmer, J.U. ∙ Costa, S.D. ...</div><div><strong>Response-guided neoadjuvant chemotherapy for breast cancer</strong></div><div><em>J.&nbsp;Clin. Oncol.</em> 2013; <strong>31</strong>:3623-3630</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1200/JCO.2012.45.0940" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_60_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84882977388" target="_blank" aria-label="Open Scopus in new tab">Scopus (295)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/24002511/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1200%2FJCO.2012.45.0940&amp;pmid=24002511" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib60" class="citations"><div id="sref60" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref60" title="View in article">61.</a></div><div>Wang, R.H. ∙ Phillips, Jr., G. ∙ Medof, M.E. ...</div><div><strong>Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients</strong></div><div><em>J.&nbsp;Clin. Invest.</em> 1993; <strong>92</strong>:1326-1335</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1172/JCI116706" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_61_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-0027181206" target="_blank" aria-label="Open Scopus in new tab">Scopus (107)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/7690777/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1172%2FJCI116706&amp;pmid=7690777" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib61" class="citations"><div id="sref61" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref61-1" title="View in article">62.</a></div><div>Wang, Y. ∙ Chen, J. ∙ Yang, L. ...</div><div><strong>Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine-Paracrine Loop</strong></div><div><em>Clin. Cancer Res.</em> 2019; <strong>25</strong>:1957-1969</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/1078-0432.CCR-18-2544" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_62_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85062945239" target="_blank" aria-label="Open Scopus in new tab">Scopus (60)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/30482778/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F1078-0432.CCR-18-2544&amp;pmid=30482778" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib62" class="citations"><div id="sref62" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref62" title="View in article">63.</a></div><div>Wei, S.C. ∙ Levine, J.H. ∙ Cogdill, A.P. ...</div><div><strong>Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade</strong></div><div><em>Cell.</em> 2017; <strong>170</strong>:1120-1133.e17</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.07.024&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2017.07.024&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_63_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-85028060533" target="_blank" aria-label="Open Scopus in new tab">Scopus (921)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/28803728/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2017.07.024&amp;pmid=28803728" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib63" class="citations"><div id="sref63" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref63" title="View in article">64.</a></div><div>Xiao, X. ∙ Lao, X.M. ∙ Chen, M.M. ...</div><div><strong>PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression</strong></div><div><em>Cancer Discov.</em> 2016; <strong>6</strong>:546-559</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1158/2159-8290.CD-15-1408" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_64_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964771565" target="_blank" aria-label="Open Scopus in new tab">Scopus (239)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26928313/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1158%2F2159-8290.CD-15-1408&amp;pmid=26928313" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib64" class="citations"><div id="sref64" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref64" title="View in article">65.</a></div><div>Zhang, C. ∙ Xin, H. ∙ Zhang, W. ...</div><div><strong>CD5 Binds to Interleukin-6 and Induces a Feed-Forward Loop with the Transcription Factor STAT3 in B Cells to Promote Cancer</strong></div><div><em>Immunity.</em> 2016; <strong>44</strong>:913-923</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2016.04.003&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.immuni.2016.04.003&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_65_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84964374893" target="_blank" aria-label="Open Scopus in new tab">Scopus (114)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27096320/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.immuni.2016.04.003&amp;pmid=27096320" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib65" class="citations"><div id="sref65" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref65" title="View in article">66.</a></div><div>Zhang, Y. ∙ Luo, Y. ∙ Qin, S.L. ...</div><div><strong>The clinical impact of ICOS signal in colorectal cancer patients</strong></div><div><em>OncoImmunology.</em> 2016; <strong>5</strong>:e1141857</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2016.1141857" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_66_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84975879195" target="_blank" aria-label="Open Scopus in new tab">Scopus (62)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/27467961/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2016.1141857&amp;pmid=27467961" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib66" class="citations"><div id="sref66" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref66-1" title="View in article">67.</a></div><div>Zhu, W. ∙ Germain, C. ∙ Liu, Z. ...</div><div><strong>A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4<sup>+</sup> T&nbsp;cell receptor repertoire clonality</strong></div><div><em>OncoImmunology.</em> 2015; <strong>4</strong>:e1051922</div></div><div class="external-links"><div class="core-xlink-crossref"><a href="https://doi.org/10.1080/2162402X.2015.1051922" target="_blank" aria-label="Open Crossref in new tab">Crossref</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_67_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-84944548558" target="_blank" aria-label="Open Scopus in new tab">Scopus (79)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/26587322/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1080%2F2162402X.2015.1051922&amp;pmid=26587322" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div><div role="listitem" data-has="label"><div id="bib67" class="citations"><div id="sref67" class="citation"><div class="citation-content"><div class="label"><a href="#body-ref-sref67" title="View in article">68.</a></div><div>Zitvogel, L. ∙ Kepp, O. ∙ Kroemer, G.</div><div><strong>Decoding cell death signals in inflammation and immunity</strong></div><div><em>Cell.</em> 2010; <strong>140</strong>:798-804</div></div><div class="external-links"><div class="core-xlink-fulltext"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2010.02.015&amp;cf=fulltext&amp;site=cell-site">Full Text</a></div><div class="core-xlink-pdf"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=4&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=10.1016%2Fj.cell.2010.02.015&amp;cf=pdf&amp;site=cell-site">Full Text (PDF)</a></div><div class="core-xlink-scopus"><a href="/servlet/linkout?suffix=e_1_5_1_2_68_2&amp;dbid=137438953472&amp;doi=10.1016%2Fj.cell.2020.02.015&amp;key=2-s2.0-77950366886" target="_blank" aria-label="Open Scopus in new tab">Scopus (470)</a></div><div class="core-xlink-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/20303871/" target="_blank" aria-label="Open PubMed in new tab">PubMed</a></div><div class="core-xlink-google-scholar"><a href="https://scholar.google.com/scholar_lookup?doi=10.1016%2Fj.cell.2010.02.015&amp;pmid=20303871" target="_blank" aria-label="Open Google Scholar in new tab">Google Scholar</a></div></div></div></div></div></div></div></section></div></section><div class="core-linked-content">
    

        


    

            

            

            <div data-widget-id="8633d695-b258-4908-b86f-e2c268ec3c6b" data-widget-name="UX3HTMLWidget"><script type="text/javascript">
if($('.content-navigation__body__title').length){
$('.content-navigation__body__title').each(function(){
var html=this.innerHTML;
var div = document.createElement("div");
div.innerHTML = html;
var text = div.textContent || div.innerText || "";
this.innerHTML=text;
});
}
</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="393effff-5b44-4681-a9b4-4f029b3540b7" data-widget-name="UX3HTMLWidget"><style>
.linkback-ad .pb-ad {
    display: block;
   height: auto;
    margin-left: 0px;
    margin-right: auto;
}
</style></div>

            

        

    

        

</div></div></div><div class="core-collateral-aside"><section id="core-collateral-figures"><h2>Figures (14)<button class="js--openFigureViewer"><span>Figure Viewer</span></button></h2><div class="core-collateral-aside-wrapper"><div class="grid"><a class="figure__open__ctrl" href="#fig1" aria-label="Go to Figure&amp;nbsp;1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/268ff6a1-30e0-4656-99da-f0a768dc67a6/main.assets/gr1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs1" aria-label="Go to Figure&amp;nbsp;S1"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/9e764314-a984-476d-aa60-8a936256b69a/main.assets/figs1.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig2" aria-label="Go to Figure&amp;nbsp;2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/d3cac51b-787f-4e34-8cd8-1b5e79140799/main.assets/gr2.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs2" aria-label="Go to Figure&amp;nbsp;S2"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/55c905ea-94c3-4eea-9d6f-049e4c610ec3/main.assets/figs2.jpg" aria-hidden="true"></a></div><div id="collapsible-figures" data-expandable="item"><div class="content grid" style="display:none;" role="region" id="collapsible-figures_content"><a class="figure__open__ctrl" href="#fig3" aria-label="Go to Figure&amp;nbsp;3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/94d8cc2a-1111-414d-94eb-98e700590623/main.assets/gr3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs3" aria-label="Go to Figure&amp;nbsp;S3"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/dd6cb35e-8783-4f78-99ab-ced4345e0f2d/main.assets/figs3.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig4" aria-label="Go to Figure&amp;nbsp;4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/2862ed6b-6dea-4d7a-aeb7-2c9b44de777d/main.assets/gr4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs4" aria-label="Go to Figure&amp;nbsp;S4"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/1201331f-1aab-48be-80f2-e2eaf857c496/main.assets/figs4.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig5" aria-label="Go to Figure&amp;nbsp;5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/d6c1c2a0-59f8-4cdd-8fbd-fe3f779b1c50/main.assets/gr5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs5" aria-label="Go to Figure&amp;nbsp;S5"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/b02a7e72-5814-427a-bca6-817f78c92f7b/main.assets/figs5.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig6" aria-label="Go to Figure&amp;nbsp;6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/34db35dc-d0fe-448a-adc5-56bed35551a3/main.assets/gr6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs6" aria-label="Go to Figure&amp;nbsp;S6"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/49b8cc94-9154-4a58-9290-983daadad9a3/main.assets/figs6.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#fig7" aria-label="Go to Figure&amp;nbsp;7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/4296eb74-5d99-4e1b-a013-c52879a2715c/main.assets/gr7.jpg" aria-hidden="true"></a><a class="figure__open__ctrl" href="#figs7" aria-label="Go to Figure&amp;nbsp;S7"><img src="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/asset/04fc66a0-c491-4958-8957-b676a4a24c5c/main.assets/figs7.jpg" aria-hidden="true"></a></div><button class="trigger" aria-controls="collapsible-figures_content" aria-expanded="false" tabindex="0" role="button"><span class="expand">Show all figures</span><span class="collapse">Hide figures</span><i class="icon-section_arrow_d" aria-hidden="true"></i></button></div></div></section>
    

        


    

            

            

            <section id="core-collateral-metrics" class="publication-list__axel-section"><h2>Article metrics</h2><div><ul class="publication-list rlist publication-list--list plum-x--lazy-load publication-list--axel js--loaded" data-plum-x-url="/pb/widgets/ux3/publicationList/plumx?widgetId=66dd7e11-7768-4006-93d8-a72b60e2a264&amp;pbContext=%3Bproduct%3Aproduct%3Aelsevier%5C%3Aproduct%5C%3Acell%3Bwebsite%3Awebsite%3Acell-site%3Bctype%3Astring%3AJournal+Content%3Bjournal%3Ajournal%3Acell%3BpageGroup%3Astring%3AArticle+View%3Barticle%3Aarticle%3Apii%5C%3AS0092867420301598%3Bpage%3Astring%3AShow+Full+Text%3BrequestedJournal%3Ajournal%3Acell%3Bissue%3Aissue%3Apii%5C%3AS0092867419X00070%3Bwgroup%3Astring%3ADefault+Website+Group%3BsubPage%3Astring%3AFull+Text" data-pb-mode-enabled="false">
                <li class="publication-list__box publication-list__box-axel">
                    <ul class="rlist axel-list__box">
                        
                        
            <li class="plum-x-wrapper">
                <div class="plum-x plum-x--axel">
                    <div class="plum-x__items">
                        
                    <div class="plum-x__item plum-x-citation">
                        <div class="plum-x__item-num">200</div>
                        <div class="plum-x__item-title">Citations</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-capture">
                        <div class="plum-x__item-num">269</div>
                        <div class="plum-x__item-title">Captures</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-mention">
                        <div class="plum-x__item-num">1</div>
                        <div class="plum-x__item-title">Mentions</div>
                    </div>    
                
                    <div class="plum-x__item plum-x-socialMedia">
                        <div class="plum-x__item-num">87</div>
                        <div class="plum-x__item-title">Social Media</div>
                    </div>    
                
                    </div>
                    <div class="plum-x__details">
                        <div class="plum-x__logo">
                            <img src="/products/marlin/releasedAssets/images/plumx-logo.png" alt="Plum X logo">
                        </div>
                        <a class="plum-x__view-details" href="https://plu.mx/plum/a/?doi=10.1016/j.cell.2020.02.015&amp;theme=plum-jbs-theme&amp;hideUsage=true" target="_blank">
                            <span>View details</span>
                            <span class="sr-only">opens in a new tab</span>
                            <i class="icon-external-arrow" aria-hidden="true"></i>
                        </a>
                    </div>
                </div>  
            </li>
        
                    </ul>
                </li></ul></div></section>

            

        
<section id="core-collateral-supplementary"><h2>Supplemental information (2)</h2><div class="core-collateral-aside-wrapper"><div class="core-supplementary-material"><div class="core-link"><button class="downloadAllSupplementary"><span>Download all</span></button></div></div><div class="core-supplementary-material" data-category="pdf"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/attachment/a473a9c0-c9b1-4629-a7aa-f989a031fdc6/mmc1.pdf" download="mmc1.pdf"><span id="mmc1-link">PDF (286.64 KB)</span></a><div class="core-description">Document S1. Tables S1–S5, Related to Figure&nbsp;2</div></div></div><div class="core-supplementary-material" data-category="video"><div class="core-link"><a href="https://www.cell.com/cms/10.1016/j.cell.2020.02.015/attachment/33e6706e-442e-49fb-856e-70ac4d2dcc5c/mmc2.mp4" download="mmc2.mp4"><span id="mmc2-link">Video (34.45 MB)</span></a><div class="core-description">Video Abstract</div></div></div></div></section>
    

        


    

            

            

            <section id="core-collateral-relatedArticles" class="axel-related-articles"><h2 id="relatedArticles" class="top axel-related-articles__title" data-title="Related articles">Related Articles</h2><div data-pb-widget-type="ux3-relatedArticles" data-widget-id="8d3844d1-450e-497c-ab75-a63fc41750ac" data-widget-name="AtyponTempUX3RelatedArticlesWidget" data-article-pii="S0092867420301598" class="ux3DeferredOnScrollWidget axel-related-articles__body" data-show-more="true"></div></section>

            

        
</div></div><aside data-core-aside="right-rail"><div class="inner-wrapper">

    

        


    

            

            

            <div data-widget-id="dca7470d-9085-4d21-a6f4-a66397718146" data-widget-name="UX3HTMLWidget"><input type="hidden" id="gptPage" value="cell-videos"></div>

            

        

    

        


    

            

            

            <div data-widget-id="68b29b4e-03a8-4bbc-b533-825f0a9fb6b9" data-widget-name="UX3HTMLWidget"><!--HubSpot Call-to-Action Code --><span class="hs-cta-wrapper" id="hs-cta-wrapper-a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381"><span class="hs-cta-node hs-cta-a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381" id="hs-cta-a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381" data-hs-drop="true" style="visibility: visible;"><a id="cta_button_519224_3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f" class="cta_button " href="https://info.cell.com/cs/c/?cta_guid=3c6be4e2-d8ba-4906-9c3a-cd4a609cce6f&amp;signature=AAH58kFHB_tdtuzCguDM_EjQPQY0JIPb9A&amp;portal_id=519224&amp;placement_guid=a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381&amp;click=560dbe9b-495d-47f4-b4ae-08b64718296d&amp;redirect_url=APefjpE3NwfwNSG26N9QDUlgywFouGDTZnFxNiefARxebN02s--1h4v03W26pux1zSd_am6lW38Ek50ofBDNroD6SZbv_V0sRHZ1o9XwvOJU0nLrdb1VTt9ndXj-jV-QkhUQ_PmT8eBH&amp;hsutk=&amp;canon=https%3A%2F%2Fwww.cell.com%2Fcell%2Ffulltext%2FS0092-8674%2820%2930159-8&amp;ts=1749585801091" target="_blank" rel="noopener" style="" cta_dest_link="https://star-protocols.cell.com/protocols/90" title="Read the related protocol  in&nbsp;STAR Protocols"><p style="line-height: 1.5;"><span style="font-family: helvetica;"><span style="font-size: 18px;">Read the related protocol</span></span></p>
<p style="line-height: 1.5;"><span style="font-size: 18px; font-family: helvetica;">in&nbsp;<em>STAR Protocols</em></span></p></a></span><script charset="utf-8" src="https://js.hscta.net/cta/current.js"></script><script type="text/javascript"> hbspt.cta.load(519224, 'a1928dcb-40ca-4c9f-8c7b-45ea9c4c0381', {}); </script><br><br></span><!-- end HubSpot Call-to-Action Code --></div>

            

        











        <div data-widget-def="literatumAd" data-widget-id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc" class="adplaceholders" style="right: 0px; position: static;">
        
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd alignCenter  widget-verticalAd" id="481d10c2-bbe0-470e-a5ba-207a81ecc8dc">
                
                
                    
                

                <div class="wrapped " id="Marketplace-Recs">
                    
                    <div class="widget-body body body-verticalAd "><div class="verticalAdContainer">
    <div class="verticalAdLabelContainer">
        <div class="verticalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adVert.gif" alt="Advertisement">
        </div>
    </div>
    <div class="verticalAd">
        





        <div class="pb-ad">
            <script src="//cdn.pbgrd.com/core-cell.js" async=""></script>
<div id="pbgrd-skyr-c"><div id="pbgrd-skyr" style="width: inherit; position: relative; background: transparent;"></div></div>
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

        </div>
    

</div></aside><div class="core-authors-details" style="display:none"><section class="core-authors"></section></div></article><div data-extent="article-wrapper"><div class="core-container"></div></div><script id="axel-publication-metadata" type="application/json">{"doi":"10.1016/j.cell.2020.02.015","data-is-retraction":false,"data-is-retired":false}
</script><script type="text/javascript" data-ot-ignore="data-ot-ignore" defer="defer" src="https://static.addtoany.com/menu/page.js" class="optanon-category-C0004 ot-vscat-C0004"></script><template id="figure_nav_template"><a href="#" class="open-in-viewer btn btn-dark figure-pop-btn"><i aria-hidden="true" class="icon-export_citation"></i><span>Open in viewer</span></a></template><div id="figure-viewer" role="dialog" aria-modal="true" aria-label="Figure Viewer" class="showCaption showThumbstrip figure-viewer"><nav class="nav-bar figure-viewer__top"><a href="#" title="Close Figure Viewer" role="button" class="figure-viewer__close"><i aria-hidden="true" class="icon-tools_close"></i></a><div class="figure-viewer__title">Complement Signals Determine Opposite Effects of B Cells in Chemotherapy-Induced Immunity</div></nav><div class="frames"><ul class="frames__list"><li><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.015/asset/268ff6a1-30e0-4656-99da-f0a768dc67a6/main.assets/gr1.jpg" height="861" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/29baea55-de29-4c7a-bf61-d9e53e5f609f/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.015/asset/9e764314-a984-476d-aa60-8a936256b69a/main.assets/figs1.jpg" height="263" width="637" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/edf3a9b3-d003-4b8e-bb83-7ab4d2de8610/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.015/asset/d3cac51b-787f-4e34-8cd8-1b5e79140799/main.assets/gr2.jpg" height="940" width="734" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/d8e2d878-3b70-4c1c-ab46-dd428be94e99/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.015/asset/55c905ea-94c3-4eea-9d6f-049e4c610ec3/main.assets/figs2.jpg" height="939" width="720" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/eb6a9460-e89d-405c-aae3-c6e783d79a94/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.015/asset/94d8cc2a-1111-414d-94eb-98e700590623/main.assets/gr3.jpg" height="937" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67bf0d36-e4f4-4cf4-a6bf-e2cc96cb2e70/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.015/asset/dd6cb35e-8783-4f78-99ab-ced4345e0f2d/main.assets/figs3.jpg" height="820" width="750" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67b178fe-4ade-49fe-afba-4cb96d6f5162/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.015/asset/2862ed6b-6dea-4d7a-aeb7-2c9b44de777d/main.assets/gr4.jpg" height="948" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/1ef8c6df-4630-4be1-8caf-cc47f3a43eb5/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.015/asset/1201331f-1aab-48be-80f2-e2eaf857c496/main.assets/figs4.jpg" height="498" width="750" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/fab9e195-44eb-4fd1-9140-cc6df2da7737/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.015/asset/d6c1c2a0-59f8-4cdd-8fbd-fe3f779b1c50/main.assets/gr5.jpg" height="967" width="767" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/ed062f25-baa8-4414-b790-011b6c183838/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.015/asset/b02a7e72-5814-427a-bca6-817f78c92f7b/main.assets/figs5.jpg" height="444" width="637" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/c491ea93-6a85-496d-9f95-4c53573d6308/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.015/asset/34db35dc-d0fe-448a-adc5-56bed35551a3/main.assets/gr6.jpg" height="964" width="750" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/88cc9f4c-136b-4226-9137-a5dd492e97e4/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.015/asset/49b8cc94-9154-4a58-9290-983daadad9a3/main.assets/figs6.jpg" height="940" width="736" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/e2e656ed-fc80-40d7-ad92-a1979b02a0cc/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.015/asset/4296eb74-5d99-4e1b-a013-c52879a2715c/main.assets/gr7.jpg" height="939" width="732" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/868dae05-6094-4bcd-8e7d-4227b1a5e056/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li><li><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.02.015/asset/04fc66a0-c491-4958-8957-b676a4a24c5c/main.assets/figs7.jpg" height="732" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/7a68189f-455b-4574-89dc-048d3682e43e/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0" class="ui-draggable ui-draggable-handle" style="position: relative;"></div></li></ul><a href="#" title="Previous Frame" class="frameButton previousFrameButton frames__prev"><!--span Previous Frame--><i class="icon-arrow_l"></i></a><a href="#" title="Next Frame" class="frameButton nextFrameButton frames__next"><!--span Next Frame--><i class="icon-arrow_r"></i></a></div><div class="caption"><div class="figure-viewer__caption-body"></div></div><div class="toolbar figure-viewer__toolbar"><span class="figure-viewer__counter"></span><a href="#" class="button toggle-caption-button figure-viewer__caption__ctrl"><i aria-hidden="true" class="icon icon-info"></i><span class="label">Hide Caption</span></a><a href="#" class="button download-options-button"><i aria-hidden="true" class="icon icon-gizmo-folder-in download-size-icon"></i><span class="label">Download</span></a><a href="#figures" class="button see-figures figure-viewer__see-figure__ctrl"><i aria-hidden="true" class="icon icon-gizmo-image_figure viewer-size-icon"></i><span class="label">See figure in Article</span></a></div><div class="thumbstrip"><a href="#" class="toggleButton thumbstrip__ctrl"><span>Toggle Thumbstrip</span></a><a href="#" title="Previous Thumbnails" class="thumbstripButton previousThumbstripButton thumbstrip__prev"><i aria-hidden="true" class="icon-arrow_l"></i></a><a href="#" title="Next Thumbnails" class="thumbstripButton nextThumbstripButton thumbstrip__next"><i aria-hidden="true" class="icon-arrow_r"></i></a><div class="thumbstrip__wrapper"><ul class="rlist figure-viewer__thumbslist"><li><div class="thumbnail__label">Figure&nbsp;1</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr1" src="/cms/10.1016/j.cell.2020.02.015/asset/268ff6a1-30e0-4656-99da-f0a768dc67a6/main.assets/gr1.jpg" height="861" width="750" aria-labelledby="fig1-title fig1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/29baea55-de29-4c7a-bf61-d9e53e5f609f/main.assets/gr1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S1</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs1" src="/cms/10.1016/j.cell.2020.02.015/asset/9e764314-a984-476d-aa60-8a936256b69a/main.assets/figs1.jpg" height="263" width="637" aria-labelledby="figs1-title figs1-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/edf3a9b3-d003-4b8e-bb83-7ab4d2de8610/main.assets/figs1_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;2</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr2" src="/cms/10.1016/j.cell.2020.02.015/asset/d3cac51b-787f-4e34-8cd8-1b5e79140799/main.assets/gr2.jpg" height="940" width="734" aria-labelledby="fig2-title fig2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/d8e2d878-3b70-4c1c-ab46-dd428be94e99/main.assets/gr2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S2</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs2" src="/cms/10.1016/j.cell.2020.02.015/asset/55c905ea-94c3-4eea-9d6f-049e4c610ec3/main.assets/figs2.jpg" height="939" width="720" aria-labelledby="figs2-title figs2-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/eb6a9460-e89d-405c-aae3-c6e783d79a94/main.assets/figs2_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;3</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr3" src="/cms/10.1016/j.cell.2020.02.015/asset/94d8cc2a-1111-414d-94eb-98e700590623/main.assets/gr3.jpg" height="937" width="752" aria-labelledby="fig3-title fig3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67bf0d36-e4f4-4cf4-a6bf-e2cc96cb2e70/main.assets/gr3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S3</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs3" src="/cms/10.1016/j.cell.2020.02.015/asset/dd6cb35e-8783-4f78-99ab-ced4345e0f2d/main.assets/figs3.jpg" height="820" width="750" aria-labelledby="figs3-title figs3-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/67b178fe-4ade-49fe-afba-4cb96d6f5162/main.assets/figs3_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;4</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr4" src="/cms/10.1016/j.cell.2020.02.015/asset/2862ed6b-6dea-4d7a-aeb7-2c9b44de777d/main.assets/gr4.jpg" height="948" width="750" aria-labelledby="fig4-title fig4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/1ef8c6df-4630-4be1-8caf-cc47f3a43eb5/main.assets/gr4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S4</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs4" src="/cms/10.1016/j.cell.2020.02.015/asset/1201331f-1aab-48be-80f2-e2eaf857c496/main.assets/figs4.jpg" height="498" width="750" aria-labelledby="figs4-title figs4-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/fab9e195-44eb-4fd1-9140-cc6df2da7737/main.assets/figs4_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;5</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr5" src="/cms/10.1016/j.cell.2020.02.015/asset/d6c1c2a0-59f8-4cdd-8fbd-fe3f779b1c50/main.assets/gr5.jpg" height="967" width="767" aria-labelledby="fig5-title fig5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/ed062f25-baa8-4414-b790-011b6c183838/main.assets/gr5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S5</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs5" src="/cms/10.1016/j.cell.2020.02.015/asset/b02a7e72-5814-427a-bca6-817f78c92f7b/main.assets/figs5.jpg" height="444" width="637" aria-labelledby="figs5-title figs5-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/c491ea93-6a85-496d-9f95-4c53573d6308/main.assets/figs5_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;6</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr6" src="/cms/10.1016/j.cell.2020.02.015/asset/34db35dc-d0fe-448a-adc5-56bed35551a3/main.assets/gr6.jpg" height="964" width="750" aria-labelledby="fig6-title fig6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/88cc9f4c-136b-4226-9137-a5dd492e97e4/main.assets/gr6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S6</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs6" src="/cms/10.1016/j.cell.2020.02.015/asset/49b8cc94-9154-4a58-9290-983daadad9a3/main.assets/figs6.jpg" height="940" width="736" aria-labelledby="figs6-title figs6-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/e2e656ed-fc80-40d7-ad92-a1979b02a0cc/main.assets/figs6_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;7</div><div class="thumbnail"><div class="thumbnail__image"><img id="gr7" src="/cms/10.1016/j.cell.2020.02.015/asset/4296eb74-5d99-4e1b-a013-c52879a2715c/main.assets/gr7.jpg" height="939" width="732" aria-labelledby="fig7-title fig7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/868dae05-6094-4bcd-8e7d-4227b1a5e056/main.assets/gr7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li><li><div class="thumbnail__label">Figure&nbsp;S7</div><div class="thumbnail"><div class="thumbnail__image"><img id="figs7" src="/cms/10.1016/j.cell.2020.02.015/asset/04fc66a0-c491-4958-8957-b676a4a24c5c/main.assets/figs7.jpg" height="732" width="750" aria-labelledby="figs7-title figs7-content" data-viewer-src="/cms/10.1016/j.cell.2020.02.015/asset/7a68189f-455b-4574-89dc-048d3682e43e/main.assets/figs7_lrg.jpg" loading="lazy" tabindex="0"></div></div></li></ul></div></div><div class="download figure-viewer__download"><div class="pointer"></div><ul class="rlist downlad__wrapper"><li class="hidden-xs hidden-sm"><a href="/action/downloadFigures?pii=e00489&amp;id=" class="downloadAllButton"><i class="icon icon-gizmo-ppt figure-viewer__download__viewer-size-icon figure-viewer__download__viewer-size-icon--ppt"></i><span class="figure-viewer__download__text"> Download .PPT</span></a></li></ul></div></div><template id="toCitationLink" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></a></div></template><template id="toCitationButton" data-citation="Citation" data-footnote="Footnote"><div class="to-citation__wrapper"><button class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span>Go to</span></button></div></template><template id="toCitationAccordion" data-collapse-citation="Hide Citations" data-expand-citation="Show Citations" data-collapse-footnote="Hide Footnotes" data-expand-footnote="Show Footnotes"><div class="to-citation__wrapper"><button aria-controls="aria-controls" aria-expanded="false" aria-label="Toggle citations menu" class="to-citation__toggle"><i aria-hidden="true" class="icon-plus"></i><span data-expand-title="data-expand-title" data-collapsed-title="data-collapsed-title" class="accordion__toggle__title"></span></button><div role="menu" aria-label="links" class="to-citation__accordion no-separator"><ul></ul></div></div></template><template id="toCitationAccordionItem"><li><a class="to-citation"><i aria-hidden="true" class="icon-subdirectory_arrow_left"></i><span></span></a></li></template><template id="citations_truncate_template"><div class="citations-truncation"><button data-label-expand="Show all references" data-label-collapse="Show fewer" data-label-remaining="references remaining" class="btn btn--inverse"><span>Show all references</span></button></div></template><template id="collateral_texts_template" data-do="Digital Object" data-figures="Figures" data-metrics="Article Metrics" data-related="Related articles" data-supplementary="Supplemental information"></template><template id="collapsible_authors_template"><button aria-expanded="false" data-expandable="all" data-label-expand="Expand All" data-label-collapse="Collapse All" class="collateral-contributors-control"><span>Expand All</span></button></template>
<template id="collapsible_tables_collapse_template"><div class="collapsible-figure-btn__wrapper expanded"><button aria-expanded="true" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-up"></i><span class="text-uppercase">Collapse</span></button></div></template>
<template id="collapsible_tables_expand_template"><div class="collapsible-figure-btn__wrapper collapsed"><button aria-expanded="false" class="btn collapsible-figure-btn btn--inverse"><i aria-hidden="true" class="icon-arrow-down"></i><span class="text-uppercase">Expand Table</span></button></div></template><template id="authorsAffiliationsLink"><a href="#tab-contributors" class="to-authors-affiliations">Authors Info &amp; Affiliations</a></template></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-  widget-compact-all" id="756cf18d-e910-4468-936c-0225ae7c669f">
                
                
                    
                

                <div class="wrapped " id="ad for nucleus-single-molecule-technologies">
                    
                    <div class="widget-body body body-  body-compact-all"><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8';

if(URL_var.indexOf("S0165-6147(17)30205-5") > -1
|| URL_var.indexOf("S0167-7799(18)30204-X") > -1 
|| URL_var.indexOf("S0092-8674(18)31649-0") > -1 
|| URL_var.indexOf("S0092-8674(19)30404-0") > -1 
|| URL_var.indexOf("S1097-2765(18)30756-1") > -1 
|| URL_var.indexOf("S0092-8674(18)31452-1") > -1 
|| URL_var.indexOf("S1097-2765(19)30175-3") > -1 
|| URL_var.indexOf("S0092-8674(18)30852-3") > -1 
|| URL_var.indexOf("S0006-3495(18)30295-9") > -1 
|| URL_var.indexOf("S1097-2765(19)30063-2") > -1 
|| URL_var.indexOf("S0006-3495(17)33208-3") > -1 
|| URL_var.indexOf("S2211-1247(18)31639-5") > -1 
|| URL_var.indexOf("S1097-2765(18)30978-X") > -1 
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-single-molecule-technologies" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none  widget-" id="754b1780-1117-4371-9285-9cd7020963d5">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body- "><div class="pb-ad">
            <script type="text/javascript">
URL_var = 'https://www.cell.com/cell/fulltext/S0092-8674(20)30159-8';

if(URL_var.indexOf("S1535-6108(19)30104-7") > -1
|| URL_var.indexOf("S0092-8674(18)31394-1") > -1
|| URL_var.indexOf("S1074-7613(19)30033-0") > -1
|| URL_var.indexOf("S1535-6108(18)30473-2") > -1
|| URL_var.indexOf("S0092-8674(19)30154-0") > -1
|| URL_var.indexOf("S1550-4131(18)30178-5") > -1
|| URL_var.indexOf("S1535-6108(19)30242-9") > -1
|| URL_var.indexOf("S1074-7613(18)30431-X") > -1
|| URL_var.indexOf("S0092-8674(19)30618-X") > -1
|| URL_var.indexOf("S1535-6108(18)30472-0") > -1
|| URL_var.indexOf("S1535-6108(18)30120-X") > -1
|| URL_var.indexOf("S0092-8674(18)31247-9") > -1
|| URL_var.indexOf("S1074-7613(18)30085-2") > -1
|| URL_var.indexOf("S1074-7613(18)30080-3") > -1
|| URL_var.indexOf("S1471-4906(18)30210-2") > -1
|| URL_var.indexOf("S1550-4131(19)30304-3") > -1
|| URL_var.indexOf("S1934-5909(18)30599-X") > -1
|| URL_var.indexOf("S2405-8033(19)30024-X") > -1
|| URL_var.indexOf("S1535-6108(18)30109-0") > -1
|| URL_var.indexOf("S0962-8924(18)30127-2") > -1
)
    {
document.write('<input type="hidden" id="gpttc" value="nucleus-tumor-immune-microenvironment" class="gpt-Target">')
}
</script>
        </div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="9c9ff7a1-a035-49f6-a336-600c9419c518" data-widget-name="UX3HTMLWidget"><!-- Start of HubSpot Embed Code --> 

<script type="text/plain" class="optanon-category-4" id="hs-script-loader" async="" defer="" src="//js.hs-scripts.com/519224.js"></script> 

<!-- End of HubSpot Embed Code --></div>

            

        

    

        


    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget sessionValidationWidget none  widget-none  widget-compact-all" id="0257aef7-6074-4898-a989-1c3f693225a2">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><script>
    $.ajax({
        url: "https://www.cell.com/ssoSessionCheck",
        type: "GET",
        dataType: "jsonp",
        success: function (data) {
            if(data.RefreshSession) {
                location.reload();
            }
        },
        error : function (){
            console.warn("can't validate CSAS session.");
        }
    });
</script></div>
                </div>
                </div>

        

    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                            
                        
                        
                            
                            
                            
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget csasSsoUrls none  widget-none  widget-compact-all" id="948bc5c4-8b0d-47be-b5ad-6570559802d1">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-none  body-compact-all"><!-- clear SSO URLs after all iFrames are rendered or after passing a time out-->
<script>
    setTimeout(clearSsoUrlsFun,10000);
    var iFramesList = document.getElementById("sso-urls-div").getElementsByTagName("iframe");
    var renderedIFramesCount = 0;
    var numberOfIFrames = iFramesList.length;
    var skipRefresh = false;
    for (var i = 0; i < iFramesList.length; i++) {
        var iFrame = iFramesList[i];
        iFrame.addEventListener("load", function() {
            renderedIFramesCount = renderedIFramesCount + 1;
            if (renderedIFramesCount >= numberOfIFrames)
            {
                clearSsoUrlsFun();
            }
        });
    }

    function clearSsoUrlsFun() {
        if (skipRefresh == false && numberOfIFrames > 0)
        {
            skipRefresh = true;
            $.ajax({
                url: "https://www.cell.com/action/clearSsoUrls",
                type: "GET",
                dataType: "jsonp",
                error : errorCallingAjx
            });
        }
    }

    function errorCallingAjx(){
        console.log("can't delete sso urls .")
    }
</script></div>
                </div>
                </div>

        










        <div data-widget-def="ux3-layout-widget" data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" class="ux3 ">
        
    

        


    

            

            

            <div data-widget-id="d95b4a46-dc4d-4ca8-83f9-8b6724c649ec" data-widget-name="ux3-layout-widget" class="fonts-loaded"><div class="footer clearfix">
    

        


    

                
                
                
                
                
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                    
                
                    
                
                    
                        
                        
                        
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                    
                
                
                
                <div class="widget literatumAd none adplaceholder adplaceholder--header widget-horizontalAd" id="a07ee92b-3942-49f8-9186-a2a08fc3fc56">
                
                

                <div class="wrapped ">
                    
                    <div class="widget-body body body-horizontalAd "><div class="horizontalAdContainer">
    <div class="horizontalAdLabelContainer">
        <div class="horizontalAdLabel">
                <img src="/templates/jsp/_style2/_marlin/images/bg_adHoriz.gif" alt="Advertisement">
        </div>
    </div>
    <div class="horizontalAd">
        





        <div class="pb-ad">
            <!-- Beginning Async AdSlot 4 for Ad unit els.cellpress/cell  ### size: [[728,90]] -->
<div class="gpt-ad" data-adsize="cell-leaderboard" data-page="" data-site="cell" data-pos="4"></div>
<!-- End AdSlot 4 -->
        </div>
    

    </div>
</div></div>
                </div>
                </div>

        

    

        


    

            

            

            <div data-widget-id="23703bbc-af46-4f3f-a5bb-dd52891ff0ff" data-widget-name="UX3HTMLWidget"><div class="footer__top">
    <div class="footer__logo centered"><a href="/home" title="Cell Press"><!-- Generator: Adobe Illustrator 25.2.1, SVG Export Plug-In . SVG Version: 6.00 Build 0)  -->
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 300 72" style="enable-background:new 0 0 300 72;" xml:space="preserve">
<style type="text/css">
	.st0{fill:#007DBC;}
</style>
<g>
	<path class="st0" d="M39.4,7.5c-2.3-0.3-4.4,1.1-4.9,3.3l-1.8,7.4c-0.4,1.8-1.9,3.1-3.8,3.3l-10.5,1.2C7.1,24-1,34.3,0.7,45.6
		c1.3,9,8.6,15.7,17.2,17c2.3,0.3,4.4-1.1,4.9-3.3l1.8-7.4c0.4-1.8,1.9-3.1,3.8-3.3l10.5-1.2c11.3-1.2,19.4-11.6,17.8-22.9
		C55.3,15.4,48.1,8.8,39.4,7.5z M37.1,34l-6.6,0.8c-1.1,0.1-2,0.9-2.3,2l-1.9,8.1c-0.6,2.4-2.5,4.2-5,4.5c-3.8,0.4-7.1-2.4-7.4-6.2
		c-0.3-3.7,2.6-6.8,6.3-7.2l6.6-0.8c1.1-0.1,2-0.9,2.3-2l1.9-8.1c0.6-2.4,2.5-4.2,5-4.5c3.8-0.4,7.1,2.4,7.4,6.2
		C43.7,30.5,40.8,33.6,37.1,34z"></path>
	<rect x="153.1" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M90.2,20.4c7.3,0,8.6,4.8,9.4,7.3h8.8c-0.5-6.2-5.6-14.9-18.2-14.9c-10.9,0-19.4,7.5-19.4,22.3
		c0,14.6,8.1,22.2,19.3,22.2c10.6,0,16.6-6.4,18.4-15.6h-8.8c-1.1,5.2-4.5,7.9-9.4,7.9c-7.5,0-10.5-6.8-10.5-14.4
		C79.7,23.3,85.9,20.4,90.2,20.4z"></path>
	<path class="st0" d="M125.2,24c-13.7,0-15,12.1-15,15.8c0,12.9,6.8,17.1,15.6,17.1c5.4,0,11.6-2.5,13.8-10H131
		c-0.7,2.2-3,3.4-5.3,3.4c-6.6,0-7.1-5.3-7.3-7.7h21.5v-1.5C139.9,27,131.3,24,125.2,24z M118.6,37.4c0.5-4.1,2.5-6.6,6.4-6.6
		c2.6,0,5.9,1.5,6.4,6.6H118.6z"></path>
	<rect x="142" y="13.9" class="st0" width="8.2" height="42.3"></rect>
	<path class="st0" d="M174,13.8h-9.8V21h7.2c4.3,0,8.2,0.9,8.2,6.4c0,5.4-3.9,6.4-8.2,6.4h-7.2V41h9.8c10.6,0,14.7-6.7,14.7-13.6
		C188.7,20.5,184.6,13.8,174,13.8z"></path>
	<path class="st0" d="M210.5,24.9c-0.5-0.2-1.2-0.3-1.8-0.3c-4.1,0-8.3,2.7-9.8,6.5h-0.1v-5.7h-8v30.7h8.4V42.3
		c0-5.4,2.1-9.9,8.3-9.9c1,0,2.3,0.1,3,0.3V24.9z"></path>
	<path class="st0" d="M225.6,24.6c-9.3,0-15.7,7-15.7,16.2c0,9.5,6,16.1,15.7,16.1c6.9,0,12-3.1,14.4-10.3h-7.4
		c-0.5,1.9-3.3,4-6.6,4c-4.7,0-7.3-2.4-7.5-7.8h22.1C241.1,33.4,236,24.6,225.6,24.6z M218.4,37.5c0.1-2.4,1.7-6.5,7-6.5
		c4.1,0,5.9,2.3,6.7,6.5H218.4z"></path>
	<path class="st0" d="M260.3,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		C242,54.3,248.9,57,256,57c7,0,14-2.6,14-10.7C270.1,40.6,265.2,38.8,260.3,37.7z"></path>
	<path class="st0" d="M289.8,37.7c-4.8-1.1-9.6-1.5-9.6-4.6c0-2.5,2.8-2.9,4.7-2.9c3,0,5.5,0.9,5.8,4.2h8c-0.7-7.5-6.8-9.8-13.5-9.8
		c-6.6,0-13.4,2-13.4,9.9c0,5.4,4.9,7.1,9.7,8.2c6.1,1.3,9.6,2.2,9.6,4.8c0,3-3.1,3.9-5.5,3.9c-3.3,0-6.4-1.5-6.5-5.2h-8
		c0.4,8.1,7.3,10.8,14.4,10.8c7,0,14-2.6,14-10.7C299.6,40.6,294.7,38.8,289.8,37.7z"></path>
	<path class="st0" d="M34.1,57.6c0.3-0.2,0.4-0.6,0.4-1c0-0.5-0.2-0.9-0.5-1.1c-0.3-0.2-0.8-0.3-1.4-0.3h-1.9v5.1h0.8V58h0.8
		l1.3,2.2h0.9l-1.4-2.2C33.6,57.9,33.9,57.8,34.1,57.6z M32.5,57.3h-0.9v-1.5h1c0.1,0,0.3,0,0.4,0c0.1,0,0.3,0,0.4,0.1
		c0.1,0,0.2,0.1,0.3,0.2c0.1,0.1,0.1,0.2,0.1,0.4c0,0.2,0,0.3-0.1,0.4c-0.1,0.1-0.2,0.2-0.3,0.2c-0.1,0.1-0.2,0.1-0.4,0.1
		C32.8,57.3,32.6,57.3,32.5,57.3z"></path>
	<path class="st0" d="M35.6,54.2c-0.4-0.4-0.9-0.7-1.4-0.9c-0.5-0.2-1.1-0.3-1.7-0.3c-0.6,0-1.2,0.1-1.7,0.3c-0.6,0.2-1,0.5-1.4,0.9
		c-0.4,0.4-0.7,0.9-1,1.5c-0.2,0.6-0.4,1.2-0.4,1.9c0,0.7,0.1,1.3,0.3,1.8c0.2,0.6,0.5,1,0.9,1.5c0.4,0.4,0.9,0.7,1.4,1
		c0.6,0.2,1.2,0.4,1.8,0.4c0.6,0,1.2-0.1,1.7-0.3c0.5-0.2,1-0.5,1.4-0.9c0.4-0.4,0.7-0.9,1-1.5c0.2-0.6,0.4-1.2,0.4-1.9
		c0-0.7-0.1-1.3-0.4-1.9C36.4,55.1,36,54.6,35.6,54.2z M35.7,59.1c-0.2,0.5-0.4,0.9-0.8,1.2c-0.3,0.3-0.7,0.6-1.1,0.8
		c-0.4,0.2-0.9,0.3-1.4,0.3c-0.6,0-1-0.1-1.5-0.3c-0.4-0.2-0.8-0.5-1.1-0.8c-0.3-0.3-0.5-0.7-0.7-1.2c-0.2-0.5-0.2-1-0.2-1.5
		c0-0.6,0.1-1.1,0.3-1.5c0.2-0.5,0.4-0.9,0.8-1.2c0.3-0.3,0.7-0.6,1.1-0.8c0.4-0.2,0.9-0.3,1.4-0.3c0.5,0,1,0.1,1.4,0.3
		c0.4,0.2,0.8,0.4,1.1,0.8c0.3,0.3,0.6,0.7,0.8,1.2c0.2,0.5,0.3,1,0.3,1.5C36,58.1,35.9,58.6,35.7,59.1z"></path>
</g>
</svg></a></div>
    <div class="footer__social-links">
        <ul class="rlist rlist--inline centered">
            <li><a href="http://on.fb.me/1tgHakh" title="Facebook" target="_blank"><i aria-hidden="true" class="icon-Icon_Facebook"></i></a></li>

            <li><a href="https://www.instagram.com/cellpress/" title="Instagram" target="_blank"><svg width="18px" height="18px" viewBox="0 0 18 18" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-147.000000, -16.000000)" fill-rule="nonzero" fill="#969696"> <g id="Instagram-Logo" transform="translate(147.000000, 16.000000)"> <path d="M9,1.62580645 C11.4096774,1.62580645 11.7,1.62580645 12.6290323,1.68387097 C13.5,1.71290323 13.9935484,1.85806452 14.3129032,2.00322581 C14.7193548,2.17741935 15.0387097,2.3516129 15.3580645,2.67096774 C15.6774194,2.99032258 15.8806452,3.28064516 16.0258065,3.71612903 C16.1419355,4.03548387 16.2870968,4.5 16.3451613,5.4 C16.3741935,6.35806452 16.4032258,6.61935484 16.4032258,9.02903226 C16.4032258,11.4387097 16.4032258,11.7290323 16.3451613,12.6580645 C16.316129,13.5290323 16.1709677,14.0225806 16.0258065,14.3419355 C15.8516129,14.7483871 15.6774194,15.0677419 15.3580645,15.3870968 C15.0387097,15.7064516 14.7483871,15.9096774 14.3129032,16.0548387 C13.9935484,16.1709677 13.5290323,16.316129 12.6290323,16.3741935 C11.6709677,16.4032258 11.4096774,16.4322581 9,16.4322581 C6.59032258,16.4322581 6.3,16.4322581 5.37096774,16.3741935 C4.5,16.3451613 4.00645161,16.2 3.68709677,16.0548387 C3.28064516,15.8806452 2.96129032,15.7064516 2.64193548,15.3870968 C2.32258065,15.0677419 2.11935484,14.7774194 1.97419355,14.3419355 C1.85806452,14.0225806 1.71290323,13.5580645 1.65483871,12.6580645 C1.62580645,11.7 1.62580645,11.4096774 1.62580645,9 C1.62580645,6.59032258 1.62580645,6.3 1.68387097,5.37096774 C1.71290323,4.5 1.85806452,4.00645161 2.00322581,3.68709677 C2.17741935,3.28064516 2.3516129,2.96129032 2.67096774,2.64193548 C2.99032258,2.32258065 3.28064516,2.11935484 3.71612903,1.97419355 C4.03548387,1.85806452 4.5,1.71290323 5.4,1.65483871 C6.3,1.62580645 6.59032258,1.62580645 9,1.62580645 L9,1.62580645 Z M9,0 C6.56129032,0 6.24193548,0 5.28387097,0.0580645161 C4.32580645,0.116129032 3.65806452,0.261290323 3.10645161,0.464516129 C2.52580645,0.696774194 2.00322581,1.01612903 1.50967742,1.50967742 C1.01612903,2.00322581 0.696774194,2.52580645 0.464516129,3.10645161 C0.232258065,3.68709677 0.0870967742,4.32580645 0.0580645161,5.28387097 C0,6.24193548 0,6.56129032 0,9 C0,11.4387097 0,11.7580645 0.0580645161,12.716129 C0.116129032,13.6741935 0.261290323,14.3419355 0.464516129,14.8935484 C0.696774194,15.4741935 1.01612903,15.9967742 1.50967742,16.4903226 C2.00322581,16.983871 2.52580645,17.3032258 3.10645161,17.5354839 C3.68709677,17.7677419 4.32580645,17.9129032 5.28387097,17.9419355 C6.24193548,18 6.56129032,18 9,18 C11.4387097,18 11.7580645,18 12.716129,17.9419355 C13.6741935,17.883871 14.3419355,17.7387097 14.8935484,17.5354839 C15.4741935,17.3032258 15.9967742,16.983871 16.4903226,16.4903226 C16.983871,15.9967742 17.3032258,15.4741935 17.5354839,14.8935484 C17.7677419,14.3129032 17.9129032,13.6741935 17.9419355,12.716129 C18,11.7580645 18,11.4387097 18,9 C18,6.56129032 18,6.24193548 17.9419355,5.28387097 C17.883871,4.32580645 17.7387097,3.65806452 17.5354839,3.10645161 C17.3032258,2.52580645 16.983871,2.00322581 16.4903226,1.50967742 C15.9967742,1.01612903 15.4741935,0.696774194 14.8935484,0.464516129 C14.3129032,0.232258065 13.6741935,0.0870967742 12.716129,0.0580645161 C11.7580645,0 11.4387097,0 9,0 L9,0 Z"></path> <path d="M9,4.38387097 C6.44516129,4.38387097 4.38387097,6.44516129 4.38387097,9 C4.38387097,11.5548387 6.44516129,13.616129 9,13.616129 C11.5548387,13.616129 13.616129,11.5548387 13.616129,9 C13.616129,6.44516129 11.5548387,4.38387097 9,4.38387097 Z M9,11.9903226 C7.34516129,11.9903226 6.00967742,10.6548387 6.00967742,9 C6.00967742,7.34516129 7.34516129,6.00967742 9,6.00967742 C10.6548387,6.00967742 11.9903226,7.34516129 11.9903226,9 C11.9903226,10.6548387 10.6548387,11.9903226 9,11.9903226 Z"></path> <circle id="Oval" cx="13.7903226" cy="4.20967742" r="1.07419355"></circle> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.linkedin.com/company/cell-press/" title="LinkedIn" target="_blank"><i aria-hidden="true" class="icon-linkedin"></i></a></li>
            
                        <li><a href="http://bit.ly/1zq7Q5T" title="Twitter" target="_blank">
                <!--<i aria-hidden="true" class="icon-Icon_Twitter"></i></a>-->
                
                <svg id="xicon" viewBox="0 0 1200 1227" xmlns="http://www.w3.org/2000/svg" aria-hidden="true" role="none"><path fill="#969696" d="M714.163 519.284L1160.89 0H1055.03L667.137 450.887L357.328 0H0L468.492 681.821L0 1226.37H105.866L515.491 750.218L842.672 1226.37H1200L714.137 519.284H714.163ZM569.165 687.828L521.697 619.934L144.011 79.6944H306.615L611.412 515.685L658.88 583.579L1055.08 1150.3H892.476L569.165 687.854V687.828Z"></path></svg> 

                    <style>
                    .footer svg#xicon {
                      height: 16px;
                    }
                    </style>
            </a></li>

            
            <li><a href="/pb-assets/marketing/WeChat/WeChat-1557753222727.jpg" title="WeChat" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-122.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="wechat" transform="translate(122.000000, 17.000000)"> <path d="M12.375,4.5 L12.375,4.5 L12.4875,4.5 L12.4875,4.5 C12.6898579,4.48604473 12.8520408,4.32704187 12.87,4.125 C12.8705905,4.04725572 12.8470025,3.9712499 12.8025,3.9075 C11.94,1.5675 9.4425,0 6.5625,0 C2.9475,0 0,2.52 0,5.625 C0.0313772094,7.34410122 0.895513317,8.94093526 2.3175,9.9075 L1.5675,11.46 C1.49009368,11.6087816 1.52088865,11.7908702 1.64291494,11.9059236 C1.76494122,12.0209769 1.94852501,12.0410168 2.0925,11.955 L4.08,10.8225 C4.61861992,11.0129999 5.17724298,11.1413322 5.745,11.205 C5.86564124,11.2178337 5.98503738,11.1715098 6.06545426,11.0806685 C6.14587113,10.9898272 6.17737153,10.865694 6.15,10.7475 C6.06148727,10.4219419 6.01114891,10.0871918 6,9.75 C6,6.855 8.8575,4.5 12.375,4.5 Z M8.25,3 C8.66421356,3 9,3.33578644 9,3.75 C9,4.16421356 8.66421356,4.5 8.25,4.5 C7.83578644,4.5 7.5,4.16421356 7.5,3.75 C7.5,3.33578644 7.83578644,3 8.25,3 Z M4.5,4.5 C4.08578644,4.5 3.75,4.16421356 3.75,3.75 C3.75,3.33578644 4.08578644,3 4.5,3 C4.91421356,3 5.25,3.33578644 5.25,3.75 C5.25,4.16421356 4.91421356,4.5 4.5,4.5 Z"></path> <path d="M18,9.75 C18,7.2675 15.48,5.25 12.375,5.25 C9.27,5.25 6.75,7.2675 6.75,9.75 C6.75,12.2325 9.27,14.25 12.375,14.25 C12.9568557,14.2502837 13.5364258,14.1772075 14.1,14.0325 L15.96,14.9625 C16.0114248,14.9874074 16.0678613,15.0002339 16.125,15 C16.2497193,14.9993787 16.3659682,14.9367912 16.4351508,14.8330172 C16.5043335,14.7292432 16.5173955,14.5978644 16.47,14.4825 L15.96,13.2075 C17.1784092,12.4716325 17.9450305,11.1723221 18,9.75 L18,9.75 Z M10.5,9 C10.0857864,9 9.75,8.66421356 9.75,8.25 C9.75,7.83578644 10.0857864,7.5 10.5,7.5 C10.9142136,7.5 11.25,7.83578644 11.25,8.25 C11.25,8.66421356 10.9142136,9 10.5,9 Z M14.25,9 C13.8357864,9 13.5,8.66421356 13.5,8.25 C13.5,7.83578644 13.8357864,7.5 14.25,7.5 C14.6642136,7.5 15,7.83578644 15,8.25 C15,8.66421356 14.6642136,9 14.25,9 Z" opacity="0.959999979"></path> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.weibo.com/CellPress" title="Weibo" target="_blank"><svg width="18px" height="15px" viewBox="0 0 18 15" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-99.000000, -17.000000)" fill-rule="nonzero" fill="#969696"> <g id="weibo" transform="translate(99.000000, 14.000000)"> <g transform="translate(0.000000, 3.000000)"> <path d="M13.2402211,7.47054172 C12.9918392,7.39866484 12.821608,7.34902326 12.9514975,7.03290287 C13.232804,6.34602189 13.2622915,5.75359781 12.9571055,5.33095486 C12.3847236,4.5380684 10.8191759,4.58064295 9.02514573,5.30975376 C9.02514573,5.30889193 8.46144724,5.54882627 8.60544724,5.11515185 C8.88150754,4.25435294 8.83953769,3.53386047 8.41043216,3.11759508 C7.43716583,2.17285363 4.84824121,3.15344733 2.62745729,5.3059617 C0.964944724,6.9186238 0,8.62798358 0,10.105855 C0,12.9324952 3.73748744,14.8235294 7.39429146,14.8235294 C12.1877186,14.8235294 15.3768844,11.9501778 15.3768844,9.80576471 C15.3768844,8.50974008 14.2514774,7.77442408 13.2402211,7.47054172 Z M7.40424121,13.5561176 C4.48625126,13.8315595 1.9678794,12.5686293 1.77811055,10.7327524 C1.58870352,8.89773735 3.80098492,7.18579207 6.71861307,6.90948837 C9.63678392,6.63266758 12.1556985,7.89663201 12.3447437,9.73164706 C12.533608,11.5675239 10.3227739,13.2796416 7.40424121,13.5561176 Z M18,5.16875787 C17.9985528,2.31402189 15.5695477,0 12.5728643,0 C12.222995,0 11.9396985,0.270098495 11.9396985,0.603283174 C11.9396985,0.936640219 12.222995,1.20656635 12.5728643,1.20656635 C14.8708945,1.20656635 16.7336683,2.98159781 16.7336683,5.17099863 C16.7336683,5.50435568 17.0173266,5.77428181 17.3668342,5.77428181 C17.7167035,5.77428181 18,5.50435568 18,5.17099863 C18,5.17099863 18,5.1696197 18,5.16875787 Z M15.4841608,5.08016142 C15.1948945,3.73415048 14.0812462,2.67323393 12.6683819,2.39744733 C12.3262915,2.33039672 11.9914372,2.54051163 11.9212462,2.86680164 C11.8506935,3.19309166 12.0712161,3.51179754 12.4133065,3.57919289 C13.3319397,3.75845417 14.0559196,4.44774829 14.2438794,5.32302599 C14.3146131,5.64931601 14.6491055,5.85925855 14.9915578,5.7923803 C15.3338291,5.72498495 15.5541709,5.40627907 15.4841608,5.08016142 Z M5.90761809,8.7069275 C4.7321005,8.9320383 3.93901508,9.87126402 4.1358392,10.8044569 C4.33248241,11.7378222 5.44504523,12.311803 6.62056281,12.0865198 C7.79571859,11.861409 8.58916583,10.922528 8.3921608,9.98899042 C8.19569849,9.0559699 7.08277387,8.48181669 5.90761809,8.7069275 Z"></path> </g> </g> </g> </g></svg></a></li>
            
            <li><a href="https://www.youtube.com/user/cellvideoabstracts" title="YouTube" target="_blank"><svg width="18px" height="13px" viewBox="0 0 18 13" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"> <g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"> <g transform="translate(-76.000000, -19.000000)" fill-rule="nonzero" fill="#969696"> <g id="youtube" transform="translate(76.000000, 14.000000)"> <path d="M17.2984219,6.41974219 C16.6486641,5.64735937 15.4490625,5.33232422 13.1580703,5.33232422 L4.84175391,5.33232422 C2.49834375,5.33232422 1.27838672,5.66771484 0.631089844,6.49001953 C0,7.29172266 0,8.47304297 0,10.1080547 L0,13.2243047 C0,16.3917773 0.748792969,18 4.84175391,18 L13.1581055,18 C15.1448555,18 16.2457383,17.7219844 16.9579688,17.040375 C17.688375,16.3413984 18,15.2001211 18,13.2243047 L18,10.1080547 C18,8.38381641 17.951168,7.19553516 17.2984219,6.41974219 Z M11.5560703,12.0963867 L7.77965625,14.0700586 C7.69524609,14.1141797 7.60289062,14.136082 7.51071094,14.136082 C7.40629687,14.136082 7.30212891,14.1079922 7.20987891,14.0521289 C7.03613672,13.9468711 6.93007031,13.7585391 6.93007031,13.5554414 L6.93007031,9.62075391 C6.93007031,9.41800781 7.03585547,9.22985156 7.20924609,9.12452344 C7.38267187,9.01919531 7.59839062,9.01198828 7.77832031,9.10546875 L11.5547344,11.0664141 C11.7468633,11.1661523 11.8675195,11.3645039 11.8678008,11.5809258 C11.8680469,11.7975586 11.747918,11.9961914 11.5560703,12.0963867 Z"></path> </g> </g> </g></svg></a></li>
            
        </ul>
    </div>
</div>

<style>

.ux3 .footer__logo svg {
    max-width: 160px !important;
}

.ux3 .footer__social-links a svg {
    max-width: 26px;
    height: 1.15rem;
    width: auto;
}

.ux3 .footer__social-links a:hover svg path {
    fill: #353535;
}

</style></div>

            

        

    

        


    

            

            
                <div class="footer__bottom text-onDark">
            

            <div data-widget-id="06227714-c621-4651-9879-b0ce5176cccc" data-widget-name="ux3-layout-widget"><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="07e1d276-b4dd-4870-b858-ed74e70d64ef" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Life &amp; medical sciences journals</h2>
		<ul class="rlist clearfix sided">
		<li>
			<a alt="Cell" href="/cell/home">Cell</a>
		</li>
		<li>
			<a alt="Cancer Cell" href="/cancer-cell/home">Cancer Cell</a>
		</li>
		<li>
			<a alt="Cell Chemical Biology" href="/cell-chemical-biology">Cell Chemical Biology</a>
		</li>
		<li>
			<a alt="Cell Genomics" href="/cell-genomics/home">Cell Genomics</a>
		</li>
		<li>
			<a alt="Cell Host and Microbe" href="/cell-host-microbe/home">Cell Host &amp; Microbe</a>
		</li>
		<li>
			<a alt="Cell Metabolism" href="/cell-metabolism/home">Cell Metabolism</a>
		</li>
		<li>
			<a alt="Cell Reports" href="/cell-reports/home">Cell Reports</a>
		</li>
		<li>
			<a alt="Cell Reports Medicine" href="/cell-reports-medicine/home">Cell Reports Medicine</a>
		</li>
		<li>
			<a alt="Cell Stem Cell" href="/cell-stem-cell/home">Cell Stem Cell</a>
		</li>
		<li>
			<a alt="Cell Systems" href="/cell-systems/home">Cell Systems</a>
		</li>
		<li>
			<a alt="Current Biology" href="/current-biology/home">Current Biology</a>
		</li>
		<li>
			<a alt="Developmental Cell" href="/developmental-cell/home">Developmental Cell</a>
		</li>
		<li>
			<a alt="Immunity" href="/immunity/home">Immunity</a>
		</li>
		<li>
			<a alt="Med" href="/med/home">Med</a>
		</li>
		<li>
			<a alt="Molecular Cell" href="/molecular-cell/home">Molecular Cell</a>
		</li>
		<li>
			<a alt="Neuron" href="/neuron/home">Neuron</a>
		</li>
		<li>
			<a alt="Structure" href="/structure/home">Structure</a>
		</li>
		<li>
			<a alt="American Journal of Human Genetics" href="/ajhg/home">American Journal of Human Genetics (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Journal" href="/biophysj/home">Biophysical Journal (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Biophysical Reports" href="/biophysreports/home">Biophysical Reports (<i>partner</i>)</a>
		</li>	
		<li>
			<a alt="HGG Advances" href="/hgg-advances/home">Human Genetics and Genomics Advances (<i>partner</i>)</a></li>
		<li>
			<a alt="Molecular Plant" href="/molecular-plant/home">Molecular Plant (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy" href="/molecular-therapy-family/molecular-therapy/home">Molecular Therapy (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Methods and Clinical Development" href="/molecular-therapy-family/methods/home">Molecular Therapy Methods &amp; Clinical Development (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Nucleic Acids" href="/molecular-therapy-family/nucleic-acids/home">Molecular Therapy Nucleic Acids (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Molecular Therapy Oncology" href="/molecular-therapy-family/oncology/home">Molecular Therapy Oncology (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Plant Communications" href="/plant-communications/home">Plant Communications (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Stem Cell Reports" href="/stem-cell-reports/home">Stem Cell Reports (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biochemical Sciences" href="/trends/biochemical-sciences/home">Trends in Biochemical Sciences</a>
		</li>
		<li>
		</li><li>
			<a alt="Trends in Cancer" href="/trends/cancer/home">Trends in Cancer</a>
		</li>
		<li>
			<a alt="Trends in Cell Biology" href="/trends/cell-biology/home">Trends in Cell Biology</a>
		</li>
		<li>
			<a alt="Trends in Ecology and Evolution" href="/trends/ecology-evolution/home">Trends in Ecology &amp; Evolution</a>
		</li>
		<li>
			<a alt="Trends in Endocrinology and Metabolism" href="/trends/endocrinology-metabolism/home">Trends in Endocrinology &amp; Metabolism</a>
		</li>
		<li>
			<a alt="Trends in Genetics" href="/trends/genetics/home">Trends in Genetics</a>
		</li>
		<li>
			<a alt="Trends in Immunology" href="/trends/immunology/home">Trends in Immunology</a>
		</li>
		<li>
			<a alt="Trends in Microbiology" href="/trends/microbiology/home">Trends in Microbiology</a>
		</li>
		<li>
			<a alt="Trends in Molecular Medicine" href="/trends/molecular-medicine/home">Trends in Molecular Medicine</a>
		</li>
		<li>
			<a alt="Trends in Neurosciences" href="/trends/neurosciences/home">Trends in Neurosciences</a>
		</li>
		<li>
			<a alt="Trends in Parasitology" href="/trends/parasitology/home">Trends in Parasitology</a>
		</li>
		<li>
			<a alt="Trends in Pharmacological Sciences" href="/trends/pharmacological-sciences/home">Trends in Pharmacological Sciences</a>
		</li>
		<li>
			<a alt="Trends in Plant Science" href="/trends/plant-science/home">Trends in Plant Science</a>
		</li>
		</ul>
	</div>

	<div class="group">
		<h2 class="group__title">Physical sciences &amp; engineering journals</h2>
		<ul class="rlist clearfix sided">
		  <li><a alt="Cell Biomaterials" href="/cell-biomaterials/home">Cell Biomaterials</a></li>
		  <li>
			<a alt="Cell Reports Physical Science" href="/cell-reports-physical-science/home">Cell Reports Physical Science</a>
		</li>
		<li>
			<a alt="Chem" href="/chem/home">Chem</a>
		</li>
		<li>
			<a alt="Chem Catalysis" href="/chem-catalysis/home">Chem Catalysis</a>
		</li>
		<li>
			<a alt="Device" href="/device/home">Device</a>
		</li>
		<li>
			<a alt="Joule" href="/joule/home">Joule</a>
		</li>
		<li>
			<a alt="Matter" href="/matter/home">Matter</a>
		</li>	
		<li><a alt="Matter" href="/newton/home">Newton</a></li>
		<li>
			<a alt="Trends in Chemistry" href="/trends/chemistry/home">Trends in Chemistry</a>
		</li>			
		</ul>
	</div>

<div class="group">
	<h2 class="group__title">Multidisciplinary journals</h2>
	<ul class="rlist clearfix sided">
	  		<li>
			<a alt="Cell Reports Methods" href="/cell-reports-methods/home">Cell Reports Methods</a>
		</li>
		<li>
			<a alt="Cell Reports Sustainability" href="/cell-reports-sustainability/home">Cell Reports Sustainability</a>
		</li>
		<li>
			<a alt="Heliyon" href="/heliyon/home">Heliyon</a>
		</li>	
		<li>
			<a alt="iScience" href="/iscience/home">iScience</a>
		</li>
		<li>
			<a alt="One Earth" href="/one-earth/home">One Earth</a>
		</li>
		<li>
			<a alt="Patterns" href="/patterns/home">Patterns</a>
		</li>
		<li>
			<a alt="STAR Protocols" href="/star-protocols/home">STAR Protocols</a>
		</li>
		<li>
			<a alt="Nexus" href="/nexus/home">Nexus (<i>partner</i>)</a>
		</li>			
        <li>
			<a alt="The Innovation" href="/the-innovation/home">The Innovation (<i>partner</i>)</a>
		</li>
		<li>
			<a alt="Trends in Biotechnology" href="/trends/biotechnology/home">Trends in Biotechnology</a>
		</li>
		<li>
			<a alt="Trends in Cognitive Sciences" href="/trends/cognitive-sciences/home">Trends in Cognitive Sciences</a>
		</li>
	</ul>
</div>

</div>
</div>

            

        
</div><div class="col-sm-4 col-md-5 clearfix">
    

        


    

            

            

            <div data-widget-id="850476de-00cb-4c0d-943c-bf1881da24f9" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="clearfix">
		<div class="group sided">
			<h2 class="group__title">Authors</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Submit article" href="/submit-to-cell-press">Submit article</a>
				</li>
				<li>
					<a alt="Multi-Journal Submission" href="/multi-journal-submission">Multi-Journal Submission</a>
				</li>
				<li>
					<a alt="STAR Methods" href="/star-authors-guide">STAR Methods</a>
				</li>
				<li>
					<a alt="Sneak Peek – Preprints" href="/sneakpeek">Sneak Peek – Preprints</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Reviewers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Reviewers" href="/reviewers">Information for reviewers</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">News &amp; events</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Newsroom" href="/newsroom">Newsroom</a>
				</li>
				<li>
					<a alt="Events" href="/events">Events</a>
				</li>
				<li>
					<a alt="Cell Symposia" href="/symposia">Cell Symposia</a>
				</li>
				<li>
					<a alt="Consortia Hub" href="/consortia">Consortia Hub</a>
				</li>
				<li>
					<a alt="Webinars" href="/webinars">Webinars</a>
				</li>
								<li>
					&nbsp;
				</li>
			</ul>
		<h2 class="group__title">Multimedia</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Podcast" href="/podcast">Cell Press Podcast</a>
				</li>
				<li>
					<a alt="Cell Press Videos" href="/video">Cell Press Videos</a>
				</li>
				<li>
					<a alt="Color and Comics" href="/comics">Coloring and Comics</a>
				</li>
				<li>
					<a alt="Figure360" href="/video-guidelines">Figure360</a>
				</li>
				<li>
					<a alt="Cell Picture Show" href="/pictureshow">Cell Picture Show</a>
				</li>
				<li>
					<a alt="Research Arc" href="/research-arc">Research Arc</a>
				</li>
			</ul>
		</div>

		<div class="group sided">
			<h2 class="group__title">About</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="About Cell Press" href="/about">About Cell Press</a>
				</li>

				<li>
					<a alt="Open access" href="/open-access">Open access</a>
				</li>
				<li>
					<a alt="COVID Hub" href="/covid-19">COVID Hub</a>
				</li>
				<li>
					<a alt="Sustainability" href="/sustainability">Sustainability hub</a>
				</li>
				<li>
					<a alt="Inclusion and diversity" href="/diversity">Inclusion and diversity</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Contact</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Contact us" href="/contact">Contact us</a>
				</li>
				<li>
					<a alt="Help and Support" href="https://service.elsevier.com/app/overview/cell-press/" target="_blank">Help &amp; Support</a>
				</li>
				<li>
					&nbsp;
				</li>
			</ul>
			<h2 class="group__title">Careers</h2>
			<ul class="rlist clearfix">
				<li>
					<a alt="Cell Press Careers" href="https://relx.wd3.myworkdayjobs.com/en-US/ElsevierJobs" target="_blank">Cell Press Careers</a>
				</li>
			</ul>
		</div>
	</div>
</div></div>

            

        
</div><div class="col-sm-4 col-md-2 clearfix">
    

        


    

            

            

            <div data-widget-id="beafac41-1cfc-440b-9b55-74aba4a5612c" data-widget-name="UX3HTMLWidget"><div class="groups">
	<div class="group">
		<h2 class="group__title">Access</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Subscribe" href="/subscribe">Subscribe</a>
			</li>
			<li>
				<a alt="Claim" href="/activate">Claim</a>
			</li>
			<li>
				<a alt="Read It Now" href="/read-it-now">Read-It-Now</a>
			</li>
			<li>
				<a alt="Recommend to Librarian" href="http://info.cell.com/request-access-to-cell-press-content" target="_blank">Recommend to Librarian</a>
			</li>
			<li>
				<a alt="Publication Alerts" href="/action/showPreferences?menuTab=Alerts">Publication Alerts</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Collections</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="Best of Cell Press" href="/bestof">Best of Cell Press</a>
			</li>
			<li>
				<a alt="Cell Press Reviews" href="/reviews">Cell Press Reviews</a>
			</li>
			<li>
				<a alt="Cell Selections" href="/selections">Cell Press Selections</a>
			</li>
			<li>
				<a alt="Nucleus Collections" href="/nucleus">Nucleus Collections</a>
			</li>
			<li>
				<a alt="SnapShots" href="/snapshots">SnapShot Archive</a>
			</li>
		</ul>
	</div>
	<div class="group">
		<h2 class="group__title">Information</h2>
		<ul class="rlist clearfix">
			<li>
				<a alt="For Advertisters" href="/media-kit">For Advertisers</a>
			</li>
			<li>
				<a alt="For Recruiters" target="_blank" href="/pb-assets/Cell/common/CP-RecruitmentKit-US-2018-LowRes-1712070648.pdf">For Recruiters</a>
			</li>
			<li>
				<a alt="For Librarians" target="_blank" href="https://www.elsevier.com/products/sciencedirect/journals/direct-subscription-journals">For Librarians</a>
			</li>
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms and Conditions</a>
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>
			</li>
		</ul>
	</div>
</div></div>

            

        
</div></div>

            
                </div>
            

        

    

        


    

            

            

            <div data-widget-id="779ad11f-7bcd-4a2a-a2cd-8c67b649cbb2" data-widget-name="UX3HTMLWidget"><style>
 
button#cookieBtn {
   text-decoration: none;
   background-color: transparent;
   color: #005789;
   font-weight: bold;
   padding: 0;
   margin: 0;
   font-size: 14px;
}
 
button#cookieBtn:hover {
   text-decoration: underline;
}

</style>
<script>
// HIDE ONETRUST BACKGROUND AFTER USER PRESSES ESCAPE KEY
setTimeout(function(){ 
   $("#onetrust-pc-sdk").on("keydown", function(e) { 
      if (e.keyCode == 27) {  // ESC key
         setTimeout(function(){ 
            $(".onetrust-pc-dark-filter").css("display","none");
         }, 100); 
      }
   });
}, 5000);
</script>

<span class="align-center copy-right">
<hr>
<p align="center"><b>The content on this site is intended for healthcare professionals and researchers across all fields of science.</b></p>
<hr>
<div>
<p>We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the 
      <b><button id="cookieBtn" class="ot-sdk-show-settings" type="button" aria-label="Manage cookie consent preferences">Cookie Settings</button></b> for this site.<br>

All content on this site: Copyright © 2025 Elsevier Inc., its licensors, and contributors. <br>All rights are reserved, including those for text and data mining, AI training, and similar technologies. <br>For all open access content, the relevant licensing terms apply.
</p>
<ul class="rlist--inline">
			<li>
				<a alt="Privacy Policy" target="_blank" href="https://www.elsevier.com/legal/privacy-policy">Privacy Policy</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Terms and Conditions" target="_blank" href="https://www.elsevier.com/legal/elsevier-website-terms-and-conditions">Terms &amp; Conditions</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Accessibility" href="/accessibility">Accessibility</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Help and Support" target="_blank" href="https://service.elsevier.com/app/overview/cell-press/">Help &amp; Support</a>&nbsp;&nbsp;
			</li>
			<li>
				<a alt="Contact" href="/contact">Contact</a>
			</li>
			</ul>
<p>
<a href="https://www.relx.com"><img src="/pb/assets/raw/Health%20Advance/images/relx-1554393210983.png" alt="RELX" rel="nofollow" target="_new"></a></p>
</div>

</span></div>

            

        

    

        


    

            

            

            <div data-widget-id="c5e179c1-156e-41e3-af7f-5e307efa8acf" data-widget-name="UX3HTMLWidget"><style>#brandingRow{
    background-color:#fff;
    padding:7px 26px 7px 30px;
    color:#007DBC;
    font-size:14px;
    clear:both;
    width:100%
}
#brandingRow a{
    text-decoration:none;
    color:#007DBC
}
#brandingRow a:hover{
    text-decoration:underline
}
#brandingRowRight{
    display:inline;
    float:right;
    width:auto;
    padding:0;
    margin:0
}
svg#cp_logo {
  float: none;
  height: 36px;
  width: 36px;
  margin-left: 0px;
  margin-top: 0px;
}

footer hr {
  display: block;
}

@media screen and (max-width: 600px){
    #brandingRow{
        font-size:12px
    }
}
@media screen and (max-width: 750px){
    #brandingRow{
        padding:7px 18px 7px 16px
    }
    svg#cp_logo{
        margin-right:10px
    }
}
@media screen and (max-width: 800px) {
   a#cpIconLnk {
      display: none;
   }
}

.header__wrapper.clearfix .col-xs-6:first-of-type{
    width:55%
}
.header__wrapper.clearfix .col-xs-6:nth-of-type(2){
    width:45%
}
@media screen and (min-width: 800px) and (max-width: 1000px){
    .header__wrapper.clearfix .col-xs-6:first-of-type{
        width:75%
    }
    .header__wrapper.clearfix .col-xs-6:nth-of-type(2){
        width:25%
    }
}

</style>

<script>
var partnerx = false;
var overrideEndorsement = "";
var tmpj = $("input[name='journalCode']").attr("value");
	
if (window.location.pathname == "/molecular-therapy-family/home") {
	tmpj = "ymthe";
}
	
var ribbonx = "";
if (tmpj == "ajhg" || tmpj == "bpj" || tmpj == "molp" || tmpj == "xplc" || tmpj == "stemcr" || tmpj == "ymthe" || tmpj == "xhgg" || tmpj == "omtn" || tmpj == "omto" || tmpj == "omtm" || tmpj == "biophysreports" ||  tmpj == "bpr" || tmpj == "xinn" || tmpj == "omton") {
	partnerx = true;
	ribbonx = "<a href='https://www.cell.com' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press partner journal</a>";
} else if (tmpj != "" && tmpj != "undefined" && tmpj != undefined) {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press journal</a>";
} else {
	ribbonx = "<a href='/' data-aa-name='cell press endorsement' data-aa-region='cp global header' title='Visit Cell.com'>A Cell Press resource</a>";
}
	
if (window.location.pathname == "/") {
	ribbonx = "";
}
if (overrideEndorsement != "") {
	ribbonx = overrideEndorsement;
}

$(".header__wrapper.clearfix").prepend("<div id='brandingRow'><a href='/' data-aa-name='science that inspires' data-aa-region='cp global header' title='Visit Cell.com'>Science that inspires</a><p id='brandingRowRight'>" + ribbonx + "</p></div>");
	
// handle scrolling effect on article pages
if ($("article").length > 0) {
	var scrollx;
	$(window).scroll(function() {
		scrollx = $(window).scrollTop();
		if (scrollx > 0) { 
			$("#brandingRow").css("display","none"); 
		} else {
			$("#brandingRow").css("display","block");
		}
	});
}

if (window.location.pathname == "/" || partnerx == false) {
               $("<a href='/home' id='cpIconLnk' data-aa-name='cell press logo' data-aa-region='cp global header' title='Cell Press' target='_blank'><svg id='cp_logo' version='1.1' xmlns='http://www.w3.org/2000/svg' xmlns:xlink='http://www.w3.org/1999/xlink' x='0px' y='0px' viewBox='0 0 100 98.1' style='enable-background:new 0 0 100 98.1;' xml:space='preserve' height='100' width='98.1'><path style='fill:#FFFFFF;' d='M69.09,0.09c-4.01-0.6-7.83,1.94-8.78,5.89l-3.14,13.11c-0.76,3.19-3.44,5.56-6.7,5.93l-18.6,2.13          C11.83,29.31-2.53,47.66,0.37,67.78c2.3,15.96,15.18,27.77,30.54,30.08c4.01,0.6,7.83-1.94,8.78-5.89l3.14-13.11 c0.76-3.19,3.44-5.56,6.69-5.93l18.6-2.13c20.04-2.17,34.41-20.52,31.5-40.65C97.32,14.21,84.45,2.39,69.09,0.09z M65.06,47.2  l-11.75,1.4c-1.98,0.21-3.62,1.65-4.08,3.59l-3.43,14.3c-1.01,4.22-4.5,7.39-8.8,8c-6.66,0.72-12.63-4.2-13.15-10.92                c-0.51-6.5,4.6-12.11,11.08-12.81l11.75-1.39c1.98-0.22,3.62-1.65,4.08-3.59l3.43-14.3c1.01-4.22,4.5-7.39,8.8-8          c6.66-0.72,12.63,4.19,13.15,10.92C76.66,40.89,71.55,46.5,65.06,47.2z'/></svg></a>").insertBefore(".header__wrapper.clearfix .journal-logos:eq(0)");
}


</script></div>

            

        

    

        


    

            

            

            <div data-widget-id="1af759b7-9bb6-4413-ada9-51a8333e8fb8" data-widget-name="UX3HTMLWidget"><style>
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-444969 - c#4]*/
    [data-tab-id="changelogTab"] {
        display: none !important;
    }
    
    /*This was added temporarily until the PB changelog tab issue got fixed. [LIT-518839]*/
    @media (min-width: 769px) {
        .ux3 .quick-search .dropBlock [data-db-target-of],
        .quick-search .dropBlock [data-db-target-of] {
            width: 100vw !important;
        }
    }
</style></div>

            

        
</div></div>

            

        

        </div>
    

    

        


    

            

            

            <div data-widget-id="d7e0813b-a300-497a-ab37-9c3ddaf03e71" data-widget-name="UX3HTMLWidget"><!--
<div class="session-reminder hidden">
    <div class="session-reminder__overlay">
        <div class="session-reminder__dialog">
            <div class="session-reminder__dialog-inner">
                <div class="dialog-header" role="dialog" aria-labelledby="dialog-title" aria-describedby="dialog-desc">
                    <h2 class="dialog-header-title" id="dialog-title">
                        <span>Session Timeout</span>
                        <div class="dialog-timer">(2:00)</div>
                    </h2>
                    <button class="dialog-close" type="button" aria-label="close dialog">
                        <i class="icon-tools_close" aria-hidden="true"></i>
                    </button>
                </div>
                <div class="dialog-body">
                    <p class="dialog-desc" id="dialog-desc">Your session will expire shortly. If you are still working, click the ‘Keep Me Logged In’ button below. If you do not respond within the next minute, you will be automatically logged out.</p>
                    <p class="dialog-expired sr-only" aria-live="polite"></p>
                </div>
                <div class="dialog-footer">
                    <button class="session-reset" type="button">Keep Me Logged In</button>
                </div>
            </div>
        </div>
    </div>
</div>
<a class="sr-only" href="javascript:void(0)" aria-hidden="true"></a>
--></div>

            

        
        </div>
    </div>


































    



















        
        
            
                <script src="/products/marlin/cell/releasedAssets/js/main.bundle-90475670808d5d3eee41.js"></script>
            
        
        
        

    




<script type="text/javascript">
    var pageData =  {"journal":{"specialty":"Cell Press","issn":"0092-8674","name":"Cell"},"page":{"loadTimestamp":"1749585800522","server":"cell","environment":"prod","businessUnit":"ELS:RAP:JBS","noTracking":"","name":"fulltext:html","section":"Cell","language":"en","type":"CP-CA","productName":"JB"},"visitor":{"departmentName":"|ae:ScienceDirect Guests","accessType":"ae:ANON_GUEST|ae:ANON_GUEST","accountId":"ae:838949|ae:228598","accountName":"ae:Cell Guest Account|ae:ScienceDirect Guests","departmentId":"ae:977212|ae:291352","ipAddress":"189.120.74.179","loginStatus":"anonymous","userId":"ae:246228266|ae:12975512"},"content":[{"accessType":"article:free:openarchive","volumeNumber":"180","issueNumber":"6","viewState":"fulltext","format":"MIME-HTML","id":"pii:S0092867420301598","coverDate":"202003","type":"XOCS-JOURNAL:SCOPE-FULL","title":"Complement Signals Determine Opposite Effects of B Cells in ChemotherapyInduced Immunity","status":"S300"}]};
</script>

<script type="text/javascript">
    if(typeof pageDataTracker !== "undefined") {
        pageDataTracker.trackPageLoad();
    }
</script>
<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'94db78a5f9954298',t:'MTc0OTU4NTc5OC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height="1" width="1" style="position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;"></iframe><script defer="" src="https://static.cloudflareinsights.com/beacon.min.js/vcd15cbe7772f49c399c6a5babf22c1241717689176015" integrity="sha512-ZpsOmlRQV6y907TI0dKBHq9Md29nnaEIPlkf84rnaERnq6zvWvPUqr2ft8M1aS28oN72PdrCzSjY4U6VaAw1EQ==" data-cf-beacon="{&quot;rayId&quot;:&quot;94db78a5f9954298&quot;,&quot;serverTiming&quot;:{&quot;name&quot;:{&quot;cfExtPri&quot;:true,&quot;cfEdge&quot;:true,&quot;cfOrigin&quot;:true,&quot;cfL4&quot;:true,&quot;cfSpeedBrain&quot;:true,&quot;cfCacheStatus&quot;:true}},&quot;version&quot;:&quot;2025.5.0&quot;,&quot;token&quot;:&quot;57a02315956f4b2e82817b3dfa99b1a2&quot;}" crossorigin="anonymous"></script>


<div id="addtoany" style="position: static;"><div class="a2a_overlay" id="a2a_overlay"></div><div id="a2a_modal" class="a2a_modal a2a_hide" role="dialog" tabindex="-1" aria-label=""><div class="a2a_modal_body a2a_menu a2a_hide" id="a2a_copy_link"><label for="a2a_copy_link_text" id="a2a_copy_link_icon" class="a2a_svg a2a_s_link a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><title>Copy link</title><path fill="#FFF" d="M7.591 21.177c0-.36.126-.665.377-.917l2.804-2.804a1.235 1.235 0 0 1 .913-.378c.377 0 .7.144.97.43-.026.028-.11.11-.255.25-.144.14-.24.236-.29.29a2.82 2.82 0 0 0-.2.256 1.056 1.056 0 0 0-.177.344 1.43 1.43 0 0 0-.046.37c0 .36.126.666.377.918a1.25 1.25 0 0 0 .918.377c.126.001.251-.015.373-.047.125-.037.242-.096.345-.175.09-.06.176-.127.256-.2.1-.094.196-.19.29-.29.14-.142.223-.23.25-.254.297.28.445.607.445.984 0 .36-.126.664-.377.916l-2.778 2.79a1.242 1.242 0 0 1-.917.364c-.36 0-.665-.118-.917-.35l-1.982-1.97a1.223 1.223 0 0 1-.378-.9l-.001-.004Zm9.477-9.504c0-.36.126-.665.377-.917l2.777-2.79a1.235 1.235 0 0 1 .913-.378c.35 0 .656.12.917.364l1.984 1.968c.254.252.38.553.38.903 0 .36-.126.665-.38.917l-2.802 2.804a1.238 1.238 0 0 1-.916.364c-.377 0-.7-.14-.97-.418.026-.027.11-.11.255-.25a7.5 7.5 0 0 0 .29-.29c.072-.08.139-.166.2-.255.08-.103.14-.22.176-.344.032-.12.048-.245.047-.37 0-.36-.126-.662-.377-.914a1.247 1.247 0 0 0-.917-.377c-.136 0-.26.015-.37.046-.114.03-.23.09-.346.175a3.868 3.868 0 0 0-.256.2c-.054.05-.15.148-.29.29-.14.146-.222.23-.25.258-.294-.278-.442-.606-.442-.983v-.003ZM5.003 21.177c0 1.078.382 1.99 1.146 2.736l1.982 1.968c.745.75 1.658 1.12 2.736 1.12 1.087 0 2.004-.38 2.75-1.143l2.777-2.79c.75-.747 1.12-1.66 1.12-2.737 0-1.106-.392-2.046-1.183-2.818l1.186-1.185c.774.79 1.708 1.186 2.805 1.186 1.078 0 1.995-.376 2.75-1.13l2.803-2.81c.751-.754 1.128-1.671 1.128-2.748 0-1.08-.382-1.993-1.146-2.738L23.875 6.12C23.13 5.372 22.218 5 21.139 5c-1.087 0-2.004.382-2.75 1.146l-2.777 2.79c-.75.747-1.12 1.66-1.12 2.737 0 1.105.392 2.045 1.183 2.817l-1.186 1.186c-.774-.79-1.708-1.186-2.805-1.186-1.078 0-1.995.377-2.75 1.132L6.13 18.426c-.754.755-1.13 1.672-1.13 2.75l.003.001Z"></path></svg></label><input id="a2a_copy_link_text" type="text" title="Copy link" readonly=""><div id="a2a_copy_link_copied">✓</div></div><div class="a2a_modal_body a2a_menu a2a_thanks a2a_hide" id="a2a_thanks"><div class="a2a_localize" data-a2a-localize="inner,ThanksForSharing">Thanks for sharing!</div></div></div><div class="a2a_menu a2a_full a2a_localize" id="a2apage_full" role="dialog" tabindex="-1" aria-label="Share" data-a2a-localize="title,Share"><div class="a2a_full_header"><div id="a2apage_find_container" class="a2a_menu_find_container"><label for="a2apage_find" id="a2apage_find_icon" class="a2a_svg a2a_s_find"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" aria-hidden="true"><title>Find any service</title><path fill="#CCC" d="M19.7 18.2l-4.5-4.5c.7-1.1 1.2-2.3 1.2-3.6 0-3.5-2.8-6.3-6.3-6.3s-6.3 2.8-6.3 6.3 2.8 6.3 6.3 6.3c1.4 0 2.6-.4 3.6-1.2l4.5 4.5c.6.6 1.3.7 1.7.2.5-.4.4-1.1-.2-1.7zm-9.6-3.6c-2.5 0-4.5-2.1-4.5-4.5 0-2.5 2.1-4.5 4.5-4.5 2.5 0 4.5 2.1 4.5 4.5s-2 4.5-4.5 4.5z"></path></svg></label><input id="a2apage_find" class="a2a_menu_find a2a_localize" type="text" autocomplete="off" title="Find any service" data-a2a-localize="title,FindAnyServiceToAddTo"></div></div><div class="a2a_full_services" id="a2apage_full_services" role="presentation"></div><div class="a2a_full_footer"><a href="https://www.addtoany.com" title="Share Buttons" rel="noopener" target="_blank"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span>AddToAny</a></div></div><div id="a2apage_dropdown" class="a2a_menu a2a_mini a2a_localize a2a_hide" tabindex="-1" aria-label="Share" data-a2a-localize="label,Share"><div class="a2a_mini_services" id="a2apage_mini_services"></div><div id="a2apage_cols_container" class="a2a_cols_container"><div class="a2a_col1" id="a2apage_col1"></div><div id="a2apage_2_col1" class="a2a_hide"></div><div class="a2a_clear"></div></div><div class="a2apage_wide a2a_wide"><a href="#addtoany" id="a2apage_show_more_less" class="a2a_more a2a_localize" title="Show all" data-a2a-localize="title,ShowAll"><span class="a2a_svg a2a_s__default a2a_s_a2a a2a_logo_color"><svg focusable="false" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 32 32"><g fill="#FFF"><path d="M14 7h4v18h-4z"></path><path d="M7 14h18v4H7z"></path></g></svg></span><span class="a2a_localize" data-a2a-localize="inner,More">More…</span></a></div></div><div style="height: 1px; width: 1px; position: absolute; z-index: 100000; top: 0px; visibility: hidden;"><iframe id="a2a_sm_ifr" title="AddToAny Utility Frame" aria-hidden="true" src="https://static.addtoany.com/menu/sm.25.html#type=core&amp;event=load" style="height: 1px; width: 1px; border: 0px; left: 0px; top: 0px; position: absolute; z-index: 100000; display: none;"></iframe></div></div><div role="status" aria-live="assertive" aria-relevant="additions" class="ui-helper-hidden-accessible"></div><div id="crossmark-widget" style="display: none;"><div class="crossmark-reset crossmark-overlay"></div><div class="crossmark-reset crossmark-popup"><div class="crossmark-reset crossmark-popup__offset"><div class="crossmark-reset crossmark-popup__inner"><div class="crossmark-reset crossmark-popup__header"><button class="crossmark-reset crossmark-popup__btn-close"><span class="sr-only">__("articleCrossmark.closePopup")</span></button></div><div class="crossmark-reset crossmark-popup__content-wrapper"><iframe class="crossmark-reset crossmark-popup__content" title="Crossmark service - Intentionally blank" aria-hidden="false" tabindex="0" src="https://crossmark.crossref.org/dialog?doi=10.1016%2Fj.cell.2020.02.015&amp;domain=www.cell.com&amp;uri_scheme=https%3A&amp;cm_version=v2.0"></iframe></div></div></div></div></div><div id="onetrust-consent-sdk" data-nosnippet="true"><div class="onetrust-pc-dark-filter ot-fade-in" style="z-index:2147483645;"></div><div id="onetrust-banner-sdk" class="otFlat bottom ot-wo-title ot-buttons-fw" tabindex="0" role="region" aria-label="Cookie banner"><div role="dialog" aria-modal="true" aria-label="Privacy"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><div id="onetrust-policy-text">We use cookies that are necessary to make our site work. We may also use additional cookies to analyze, improve, and personalize our content and your digital experience. For more information, see our<a class="ot-cookie-policy-link" href="https://www.elsevier.com/legal/cookienotice" target="_blank" aria-label=", opens in a new tab" rel="noopener">Cookie Policy</a></div></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" class="cookie-setting-link">Cookie Settings</button>  <button id="onetrust-accept-btn-handler">Accept all cookies</button></div></div></div></div><!-- Close Button --><div id="onetrust-close-btn-container"></div><!-- Close Button END--></div></div><div id="onetrust-pc-sdk" class="otPcCenter ot-hide ot-fade-in" lang="en" aria-label="Preference center" role="region"><div role="dialog" aria-modal="true" style="height: 100%;" aria-label="Cookie Preference Center"><!-- Close Button --><div class="ot-pc-header"><!-- Logo Tag --><div class="ot-pc-logo" role="img" aria-label="Company Logo"><img alt="Company Logo" src="https://cdn.cookielaw.org/logos/static/ot_company_logo.png"></div></div><!-- Close Button --><div id="ot-pc-content" class="ot-pc-scrollbar"><div class="ot-optout-signal ot-hide"><div class="ot-optout-icon"><svg xmlns="http://www.w3.org/2000/svg"><path class="ot-floating-button__svg-fill" d="M14.588 0l.445.328c1.807 1.303 3.961 2.533 6.461 3.688 2.015.93 4.576 1.746 7.682 2.446 0 14.178-4.73 24.133-14.19 29.864l-.398.236C4.863 30.87 0 20.837 0 6.462c3.107-.7 5.668-1.516 7.682-2.446 2.709-1.251 5.01-2.59 6.906-4.016zm5.87 13.88a.75.75 0 00-.974.159l-5.475 6.625-3.005-2.997-.077-.067a.75.75 0 00-.983 1.13l4.172 4.16 6.525-7.895.06-.083a.75.75 0 00-.16-.973z" fill="#FFF" fill-rule="evenodd"></path></svg></div><span></span></div><h2 id="ot-pc-title">Cookie Preference Center</h2><div id="ot-pc-desc">We use cookies which are necessary to make our site work. We may also use additional cookies to analyse, improve and personalise our content and your digital experience. For more information, see our <a href="https://www.elsevier.com/legal/cookienotice/_nocache" target="_blank">Cookie Policy</a> and the list of <a href="https://support.google.com/admanager/answer/9012903" target="_blank">Google Ad-Tech Vendors</a>.
<br>
<br>
You may choose not to allow some types of cookies. However, blocking some types may impact your experience of our site and the services we are able to offer. See the different category headings below to find out more or change your settings.
<br>
</div><button id="accept-recommended-btn-handler">Allow all</button><section class="ot-sdk-row ot-cat-grp"><h3 id="ot-category-title"> Manage Consent Preferences</h3><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="1"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-1" aria-labelledby="ot-header-id-1 ot-status-id-1"></button><!-- Accordion header --><div class="ot-acc-hdr ot-always-active-group"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-1">Strictly Necessary Cookies</h4><div id="ot-status-id-1" class="ot-always-active">Always active</div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-1">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
<br><br></p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="1">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="3"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-3" aria-labelledby="ot-header-id-3"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-3">Functional Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-3" id="ot-group-id-3" role="switch" class="category-switch-handler" data-optanongroupid="3" aria-labelledby="ot-header-id-3"> <label class="ot-switch" for="ot-group-id-3"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Functional Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-3">These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="3">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="2"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-2" aria-labelledby="ot-header-id-2"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-2">Performance Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-2" id="ot-group-id-2" role="switch" class="category-switch-handler" data-optanongroupid="2" aria-labelledby="ot-header-id-2"> <label class="ot-switch" for="ot-group-id-2"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Performance Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-2">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="2">Cookie Details List‎</button></div></div></div><div class="ot-accordion-layout ot-cat-item ot-vs-config" data-optanongroupid="4"><button aria-expanded="false" ot-accordion="true" aria-controls="ot-desc-id-4" aria-labelledby="ot-header-id-4"></button><!-- Accordion header --><div class="ot-acc-hdr"><div class="ot-plus-minus"><span></span><span></span></div><h4 class="ot-cat-header" id="ot-header-id-4">Targeting Cookies</h4><div class="ot-tgl"><input type="checkbox" name="ot-group-id-4" id="ot-group-id-4" role="switch" class="category-switch-handler" data-optanongroupid="4" aria-labelledby="ot-header-id-4"> <label class="ot-switch" for="ot-group-id-4"><span class="ot-switch-nob"></span> <span class="ot-label-txt">Targeting Cookies</span></label> </div></div><!-- accordion detail --><div class="ot-acc-grpcntr ot-acc-txt"><p class="ot-acc-grpdesc ot-category-desc" id="ot-desc-id-4">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. If you do not allow these cookies, you will experience less targeted advertising.</p><div class="ot-hlst-cntr"><button class="ot-link-btn category-host-list-handler" aria-label="Cookie Details List" data-parent-id="4">Cookie Details List‎</button></div></div></div><!-- Groups sections starts --><!-- Group section ends --><!-- Accordion Group section starts --><!-- Accordion Group section ends --></section></div><section id="ot-pc-lst" class="ot-hide ot-hosts-ui ot-pc-scrollbar"><div id="ot-pc-hdr"><div id="ot-lst-title"><button class="ot-link-btn back-btn-handler" aria-label="Back"><svg id="ot-back-arw" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#656565" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></button><h3>Cookie List</h3></div><div class="ot-lst-subhdr"><div class="ot-search-cntr"><p role="status" class="ot-scrn-rdr"></p><input id="vendor-search-handler" type="text" name="vendor-search-handler" placeholder="Search…" aria-label="Cookie list search"> <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110" aria-hidden="true"><title>Search Icon</title><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
            s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
            c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
            s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div class="ot-fltr-cntr"><button id="filter-btn-handler" aria-label="Filter" aria-haspopup="true"><svg role="presentation" aria-hidden="true" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 402.577 402.577" xml:space="preserve"><title>Filter Icon</title><g><path fill="#fff" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
      c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
      c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
      C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></button></div><div id="ot-anchor"></div><section id="ot-fltr-modal"><div id="ot-fltr-cnt"><button id="clear-filters-handler">Clear</button><div class="ot-fltr-scrlcnt ot-pc-scrollbar"><div class="ot-fltr-opts" role="list"><div class="ot-fltr-opt" role="listitem"><div class="ot-chkbox"><input id="chkbox-id" type="checkbox" class="category-filter-handler"> <label for="chkbox-id"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div><div class="ot-fltr-btns"><button id="filter-apply-handler">Apply</button> <button id="filter-cancel-handler">Cancel</button></div></div></div></section></div></div><section id="ot-lst-cnt" class="ot-host-cnt ot-pc-scrollbar"><div id="ot-sel-blk"><div class="ot-sel-all"><div class="ot-sel-all-hdr"><span class="ot-consent-hdr">Consent</span> <span class="ot-li-hdr">Leg.Interest</span></div><div class="ot-sel-all-chkbox"><div class="ot-chkbox" id="ot-selall-hostcntr"><input id="select-all-hosts-groups-handler" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-vencntr"><input id="select-all-vendor-groups-handler" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div><div class="ot-chkbox" id="ot-selall-licntr"><input id="select-all-vendor-leg-handler" type="checkbox"> <label for="select-all-vendor-leg-handler"><span class="ot-label-txt">checkbox label</span></label> <span class="ot-label-status">label</span></div></div></div></div><div class="ot-sdk-row"><div class="ot-sdk-column"><ul id="ot-host-lst"></ul></div></div></section></section><div class="ot-pc-footer ot-pc-scrollbar"><div class="ot-btn-container"> <button class="save-preference-btn-handler onetrust-close-btn-handler">Confirm my choices</button></div><!-- Footer logo --><div class="ot-pc-footer-logo"><a href="https://www.onetrust.com/products/cookie-consent/" target="_blank" rel="noopener noreferrer" aria-label="Powered by OneTrust Opens in a new Tab"><img alt="Powered by Onetrust" src="https://cdn.cookielaw.org/logos/static/powered_by_logo.svg" title="Powered by OneTrust Opens in a new Tab"></a></div></div><!-- Cookie subgroup container --><!-- Vendor list link --><!-- Cookie lost link --><!-- Toggle HTML element --><!-- Checkbox HTML --><!-- plus minus--><!-- Arrow SVG element --><!-- Accordion basic element --><span class="ot-scrn-rdr" aria-atomic="true" aria-live="polite"></span><!-- Vendor Service container and item template --></div><iframe class="ot-text-resize" sandbox="allow-same-origin" title="onetrust-text-resize" style="position: absolute; top: -50000px; width: 100em;" aria-hidden="true"></iframe></div></div></body></html>